,ticker,content
0,MDT,stock hit record high holiday shorten week black friday kick holiday shopping several retailer report earning include lowe low dollar tree dltr tech giant salesforce com crm hp inc hpq hewlett packard enterprise hpe justice department moved block time warner twx merger fcc signale ll pare back net neutrality rule marvell technology mrvl agree buy cavium cavm nasdaq rise dow climb set time high higher oil price lift energy stock apple aapl have solid gain marvell cavium deal keep chip rally earning be mixed salesforce hp hpe fall result guidance related stock buy watch top ipos big small cap growth stockslooking best stock buy watch start justice department say megamerger harm consumer combine medium telecom giant extract higher price time warner twx content other video distributor try withhold content emerge rival doj have ask sell turner broadcasting directv satellite business gain approval reject doj claim propose condition suggest president trump animus time warner own cnn be key factor doj move other big merger analyst say time warner rise hewlett packard enterprise hpe fall wednesday weak guidance ceo meg whitman decision step feb ongoing restructure antonio neri be name president june replace whitman october quarter earning revenue top lower expectation january quarter hpe forecast adjust ep cent midpoint guidance vs estimate cent hpe have sell software enterprise service business focus server networking datum storage hardware face stiff competition cisco csco dell technology dvmt pc printer maker fiscal revenue rise earning only meet view gain hp inc hpq give line guidance raise concern company growth outlook hp share fall wednesday marvell technology mrvl announce deal buy fellow chipmaker cavium cavm more create infrastructure solution powerhouse communication datum center marvell agree pay marvell common share cavium share friday close stock rise sharply gain earlier month report deal be close salesforce com crm report earning surge cent share revenue rise top january quarter salesforce com forecast adjust earning cent share vs estimate cent share salesforce com name bret taylor former chief technology officer facebook fb president chief product officer salesforce com acquire startup quip taylor be ceo last year salesforce com name alex dayon chief strategy officer salesforce share fall wednesday just edge lower week right record high republican lead federal communication commission moved closer dismantle obama administration net neutrality rule fcc aim increase investment cable tv company other internet service provider fcc vote dec chairman ajit pai proposal scrap public utility type title regulation be foist isps isps be able charge content provider business partner fee prioritize service regulatory authority consumer protection shift federal trade commission pai say new transparency rule protect consumer related fcc net neutrality reversal later be reversed againpalo alto network panw earning rise revenue swell top consensus cybersecurity firm guide december quarter estimate slightly higher share jump palo alto solid quarter follow soft sale disappointing guidance other computer software security provider monday roche rhhby unveil upbeat datum trial immuno oncology hemophilia send share dow stock merck mrk fall month low roche combination tecentriq cancer drug avastin chemotherapy help reduce risk disease worsening death patient advanced lung cancer merck keytruda chemo combo be approve biogen biib spinoff bioverativ bivv lose nearly roche say hemlibra significantly reduce bleed phase study hemophilia mall be crowd traditional holiday kickoff even online mobile shopping continue grow rapidly retailer kind tout deal well black friday amazon amzn wal mart wmt be expect do well be critical holiday season macy other department store dollar tree dltr ep jump sale beating street estimate deep discounter see ep vs consensus view sale vs consensus view share leap hit new high price apparel chain burlington store burl ep soar cent beating view sale only rise just short same store sale climb share fall week hit record high monday urban outfitter urbn earning unexpectedly rise latest quarter young adult clothier report earning cent vs year sale analyst be expect ep slide cent guess ge top earning view revenue fall short dsw dsw report ep drop miss view shoe retailer also give weak guidance urban outfitter hit month high guess dsw tumble recent buy point share recent ipo qudian qd yirendai yrd other china base provider online credit plunge report china authority have order suspension online small loan approval rapid expansion consumer loan especially online microloan platform have raise concern financial regulator home improvement retailer lowe low third quarter earning revenue same store sale beat estimate help higher home repair demand wake summer string hurricane share fall analyst say wall street have want more acceleration follow weak second quarter express concern thinner margin outlook year earlier month larger rival home depot hd beat view raise full year forecast quickbook turbotax maker earning leap revenue grow october fiscal first quarter easily beating view current quarter intuit intu guide adjust earning share cent sale modestly analyst model share fall tuesday follow earning hit record monday intuit lose week durable good order tend be volatile fall october big gain september core capital good order dip business investment proxy jump vs year earlier october exist home sale rise annual rate slightly view hurricane impact fade janet yellen confirm ll step federal reserve board term central bank chief end early next year many fed policymaker favore december rate hike few be opposed accord minute latest meeting signet jeweler sig crash report weaker expect earning sale offer weak guidance alibaba baba pay stake sun art retail group own more hypermarket china commerce giant expand offline presence alibaba share rise record high deere co report fiscal result top estimate wednesday maker construction agricultural equipment forecast double digit sale increase fiscal deere hit record high bitauto bita fall follow weaker expect third quarter earning revenue revenue guidance top share chinese auto information site have plunge so far november analog device adi beat wall street target fiscal fourth quarter guide higher current quarter chipmaker stock fall monday record high likely magnitude beat wasn large prior quarters alphabet googl unit google cut price cloud compute service include use superfast number crunch processor nvidia nvda ahead amazon com amzn annual user conference china commerce service provider baozun bzun beat quarterly earning revenue estimate give line guidance share fall nearly
1,MDT,dow component johnson johnson jnj surpass wall street third quarter expectation early tuesday strength pharmaceutical unit boost guidance prompt share pop premarket trade xby close bell stock market today stock jump finish share break flat base buy point oct third quarter report sale adjust income share respective vs year earlier quarter metric top consensus analyst poll zack investment research sale share earning rbc analyst glenn novarro attribute sale beat upside pharma unit global sale be forecast consensus pharma revenue top novarro estimate medical device sale lag worldwide pharma sale increase year year basis key product include cancer drug darzalex imbruvica zytiga latter beating novarro view sale new actelion brand be novarro model ibd take isn alone report quarterly result week earning season kick earnest keep tab ibd investing action plan deck day medical device sale grow include shortfall be slightly novarro view orthopedic vision care revenue be light respectively write note client consumer unit grow be just ahead rbc estimate operational basis counter beauty sale grow other category fall highlight continue pressure segment firm also raise guidance sale see adjust income share vs earlier expectation novarro write analyst have modeled sale share earning disclose medical device segment sustain negative impact basis point follow hurricane texas florida puerto rico be number firm manufacturing facility puerto rico investor have be wary effect storm negative impact be attribute lose surgery day area affected stormwater write leerink analyst geoffrey porge note client be supply disruption firm site puerto rico be open generator power run different capacity porge note result extend other biotech space give reliance puerto rico pharmaceutical manufacturing lack disclosure regard demand supply impact be increasingly confident company biopharma coverage not experience material storm related headwind say rbc novarro be bit less bullish result point continue soft market trend medical device diagnostic say exclude acquisition divestiture medical device diagnostic unit grow just year year overall hospital admission be basis point surgical procedure basis point year year basis novarro write orthopedic sale be short weak performance knee spine segment weak knee performance be blame negative impact india implant pricing legislation write estimate sale impact quarter worldwide knee revenue decline year year revenue hip product grow pricing decline likely lose share stryker syk knee product unit novarro say global spine product sale decline lose share spine product segment benefit nuvasive nuva group also suggest continue weak growth quarter spine product market separately look lose share trauma product market stryker worldwide sale grow intuitive surgical isrg medtronic mdt be take piece surgery unit novarro say related be time buy dow dividend machine dow flirt buy point bullish pre earning reportthese medtech player be flail hurricane related headwind
2,MDT,here weekly investing action plan need know investor come week holiday shorten week feature earning surprising number highly rate company include salesforce crm analog device adi baozun bzun intuit intu few key economic indicator be also due not mention minute
3,MDT,hurricane harvey irma marium didn just devastate texas florida puerto rico medtech player medtronic mdt group medical group wmgi be flail headwind monday xin afternoon trading stock market today ibd company medical product industry group medtronic lead market cap fall collective medtronic acknowledge impact hurricane have quarterly metric win be alone rbc analyst glenn novarro write note client news report indicate puerto rico hospital be not operational end third quarter be operational not have be run full capacity say assume lose week procedure end third quarter puerto rico device manufacturer say also conservatively estimate elective procedure be perform puerto rico fourth quarter friday medtronic say expect impact revenue earning fiscal second quarter firm say too early determine be impact latter half year least analyst cut price target stock follow medtronic monday pre announce negative result sustain least price target haircut quarter expect report sale vs year earlier period analyst view firm also trim sale outlook grow share be hardest hit medical product group plunge close monday nuvasive nuva globus medical gmed make medical implant dove respective novarro say be opportunity investor nuvasive nuvasive be capable accelerate organic revenue growth fourth quarter have strong product portfolio operate margin expansion opportunity say expect management team cut guidance due hurricane related revenue shortfall sell past several week be already discounting say nuvasive be deal specific short term issue setup look attractive separate report pre announcement novarro note investor sentiment spine stock remain negative cut price target keep outperform rating say be buyer pullback stock worst be already price argue needham analyst mike matson be more bearish still spine player outside hurricane be impact weaker degenerative deformity procedure growth august september matson write note client likely globus nuvasive miss estimate third quarter matson lower view now see earlier expectation also trim price target keep strong buy rating medtronic topple month low monday series price target cut announce hurricane marium damage puerto rico hit earning revenue also last week zimmer biomet zbh say hurricane be headwind third quarter earning novarro expect abbott laboratory boston scientific bsx chip away sale medtronic implantable heart device several newly launch product be back order status have lower inventory level hurricane firm say press release ibd take medtronic have ibd composite rating best possible meaning underperform more half stock term key growth metric head ibd stock checkup look stronger performer competitor be able take advantage such supply shortage be hard quantify stage novarro say therefore see downside risk revenue earning guidance second half second fiscal quarter novarro trim model sale cent earning share novarro also slash view fiscal model sale earning share forecast ep sale fiscal result price target cut novarro keep outperform rating least other analyst cut price target medtronic stock well fargo downgrade medtronic market perform outperform medtronic topple finish dow component johnson johnson jnj appear sustain minimal damage janssen unit gurabo facility make remicade xarelto prezista number other drug accord ub analyst carter view satellite image facility base utilization most lot site appear activity be return facility write note client fellow drugmaker amgen amgn have visible damage roof building flood access road manufacturing site puerto rico oct roof appear have be fix parking lot be capacity say amgen confirm used diesel generator site contract fuel provider have be make shipment meantime first shipment inventory puerto rico have already fly island say unlikely food drug administration require inspection allow amgen restart production ultimately expect accounting charge related be incrementally less concern potential disruption product supply say related medtronic sink sale lag earning beat robotic player near then topple here drug bellwether sale miss actually bode well sector
4,MDT,general electric ge jeffrey immelt cut ty company month ahead schedule retire chairman leave board xjohn flannery take chief executive officer immelt august be elect chairman ge say statement monday immelt left determine ceo transition have proceed smoothly say maker jet engine gas turbine ultrasound machine shift accelerate ge leadership transition flannery pressure activist shareholder trian fund management seek reverse year biggest stock drop dow jone industrial average new boss ge have say sell fleet corporate jet unload industrial product operation abb abb flannery be expect outline plan ge portfolio business next month immelt have be expect step chairman boston base ge end year pull consideration top job uber technology late august knowledge wide variety industrial business country ge do business immelt be potentially attractive candidate work private equity firm say scott simmon manage director crist kolder associate executive search company gray matter valuable say simmon firm have work company such medtronic mdt polaris industry pii make tough decision duress difficult marketplace be do many clamor have team immelt also depart chairman baker hughe ge company bhge provider oilfield equipment service name ceo lorenzo simonelli chairman baker hughe elect geoffrey beattie lead independent director ge have tumble year share climb less close regular trading new york immelt departure chairman be announce
5,MDT,first run food drug administration gene cell therapy be early stage theoretical concept fda commissioner scott gottlieb say tuesday last month fda approve first cellular therapy drug call kymriah novartis nvs treat form acute lymphoblastic leukemia patient age younger kite pharma kite soon be acquire gilead science gild be expect grab similar approval november gene cell therapy drug biologically copy exist product know biosimilar didn exist gottlieb tell medtech conference san jose calif now have product re review approve say gottlieb be nearly month stint fda commissioner be first appointment president donald trump take office first serve fda deputy commissioner gottlieb background have uniquely prepared head be now much bigger fda say scott whitaker chief executive advame world largest medical technology association gottlieb be diagnosed type lymphoma be younger be kind tumor only hypochondriac doctor have find gottlieb tell audience san jose mcenery convention center doctor gottlieb research type treatment want know have very good chance survival ibd take medtech stock have be ride drug pricing fear have hurt pharma biotech sector analyst say head industry snapshot closer look winner loser political discourse acknowledge not patient fit bucket be very different patient patient be tell have chance survival say re look something experimental something not be approve yet lot different cancer patient part challenge gottlieb say be ensure fda have policy help patient difficult simultaneously serve type patient serve patient potentially impact patient say today fda have hand number area gottlieb say most person be surprised find spend most time work tobacco side win surprise public be fda be work closely ameliorate opioid crisis last month trump declare opioid crisis national emergency cope company boston scientific bsx abbott laboratory medtronic mdt be work therapy call neuromodulation use electricity conceal pain brain gottlieb note medical product step alternative addictive opioid medical device deliver localize therapy patch treat localize pain vs drug have systemic approach be very addictive say fda be also work framework quicker review certification software program rather go longer product review software program be review less information apple appl fitbit fit johnson johnson jnj pear therapeutic phosphorus roche rhhby samsung tidepool verily be involved pilot program seek identify information company need provide quicker review process gottlieb say need modernize regulatory framework so match kind innovation re be ask evaluate foster beneficial technology ensure consumer have access high quality safe effective digital health device say related biotech crater late stage alzheimer drug failure
6,MDT,medtronic mdt share sank early tuesday maker medical device report fiscal first quarter sale lag wall street estimate adjust profit beat cent share early trading stock market today medtronic drop close share fall well flat base begin form late june buy point meanwhile ibd ninth rank medical product industry group advanced medtronic report sale fall short consensus analyst poll zack investment research adjust earning share beat view grow medtronic restorative therapy minimally invasive therapy business contribute revenue miss rbc analyst glenn novarro write note client novarro keep outperform rating company restorative therapy include work spine brain well pain management sale unit rise miss view minimally invasive therapy include surgical monitoring recovery business grow miss ibd take medtronic have ibd composite rating best possible meaning outperform third stock term key growth metric still lag top performer abiom abmd align technology algn have crs visit ibd stock checkup closer look strong performer cardiac vascular sale advanced be tad light medtronic note adoption corevalve evolut pro platform help drive high growth exclude foreign exchange rate sale transcatheter heart valve replacement diabetes tech sale fall miss group be temporarily affected limit supply glucose sensor medtronic say news release medtronic reaffirm full year guidance sale growth adjust ep growth exclude foreign exchange rate cut view diabetes sale growth prior outlook cardiac forecast be boost growth related robotic player near then topple here whyrobot surgeon maker best sale profit drug bellwether sale miss actually bode well sector
7,MDT,here investing action plan tuesday need know investor come day xa light day earning news still yield significant stock action momo momo hover buy point salesforce crm hover just meanwhile medtronic mdt toll brother tol be
8,MDT,here weekly investing action plan need know investor come week xwhat see last chance repeal replace obamacare next year midterm election be come odd success just take sharp dive meanwhile handful notable earning due
9,MDT,thank gilead kite merger biotechs have big week ve also rally year longer haul top health sector etfs rank year date return aug be biotech focuse accord morningstar direct top performer spdr biotech xbi post gain well ahead advance etf featured monday etf leader column break past flat base entry thursday remain buy range share run june flat base start just clear pattern fund launch january have asset bear expense ratio come second be first trust nyse arca biotech fbt ytd gain etf be buy zone past flat base entry year old fund track nyse arca biotechnology index have attract asset carry expense ratio count top holding aug kite pharma kite juno therapeutic juno illumina ilmn kite gap soar aug gilead science gild announce buy kite xbi mentioned also get boost kite ishare medical device ihi take third place ytd return etf recently regain day move average line shape flat base potential buy point fund marked anniversary track dow jone select medical equipment index ibd take gilead science have be news lately due kite pharma acquisition do rank biotechs find now ibd stock checkup top holding aug include medtronic mdt abbott laboratory thermo fisher scientific tmo ihi expense ratio be ishare nasdaq biotechnology ibb round top ytd gain price action be similar other biotech etfs buy range follow thursday flat base buy point case be etf sport expense ratio ibb oldest biotechs year have amassed asset top holding aug be gilead biogen biib celgene celg kite account position portfolio fund have beaten past year return vs gain fund have outperformed past year related gilead science buy kite pharma sector boost stock breakout put apple amazon focusretail lead broad stock sell biotechs find support celgene flirt giant soon join
10,MDT,stock future open pressure wednesday strong early economic datum economic impact houston shutdown widen nasdaq composite manage gain narrow early gain dow jone industrial average slip thin decline rain reportedly ease houston wednesday tropical storm harvey shift north texas louisiana much houston fourth largest city be report still flooded quick fix sight platt estimate late tuesday total barrel day refine capacity total production capability remain offline oil price slump gasoline future spiked heating oil future be early wednesday exxon mobil xom kinder morgan kmi be company report damage facility large portion refine complex remain ongoing path storm up up fedex fdx postal service announce late tuesday have cease delivery hundred city zip code texas louisiana amazon com amzn announce have suspend operation houston area facility due flood houston airport remain close further notice george bush airport be second busiest air hub unite continental holding ual william hobby airport be central southwest airline luv operation port houston nation second largest galveston remain close tanker other ship backed gulf pending inspection clear signal coast guard carnival cruise line ccl reroute galveston base ship new orlean busiest port port southern louisiana report normal operate status wednesday morning apple aapl unite technology utx rise lead dow news report say unite be close bil effort takeover rockwell collin col rockwell share rise verizon vz drop dow weakest open move stock be fourth week flat consolidation
11,MDT,fang stock rise premarket trade netflix nflx step early lead netflix share be pull back testing week support sixth week base effort drone maker aerovironment avav buzz report broad fiscal first quarter beat gain left thinly trade stock extend buy point flat base mazor robotic mzor rolled open gain israel base outfit forward strategic partnership medtronic mdt trigger payment medtronic partnership involve mazor system spinal surgery gain retook buy point cup base initial entry fail early august medtronic share slip ibd list universal display oled swung deutsche bank initiate coverage buy rating price target gain lift universal share back week line support stock work month base effort private sector employer add worker august accord adp national employment report significant jump july new higher nearly new job expect economist more new position be create service sector healthcare hospitality trade transportation accounting largest portion growth commerce department revise estimate second quarter gdp growth upward vs initial estimate consensus view revision growth gdp price index hold steady growth line expectation consumer spending be estimate have increase initial estimate well consensus view gain energy information administration report weekly crude inventory datum et asia market hong kong tokyo rebound loss monday china mainland market post narrow loss europe market be rebound monday sharp loss frankfurt dax cac paris ahead ftse london show gain afternoon trade related stock report earning today investing action bond market be go crazystock climb pattern make nasdaq reversal big cap flex relative strength be buy zone harvey hit airline harder katrina didbest buy crush earning ceo put share
12,MDT,index rise modestly breakout remain scarce google googl wal mart wmt team voice base shopping amazon amzn announce whole food wfm price cut other move roil grocery seller salesforce crm apple aapl supplier broadcom avgo veeva system veev deliver strong result stock have mixed reaction several beaten retailer rally earning nasdaq composite index dow jone industrial average rise less strong gain tuesday trigger market direction shift confirm uptrend nasdaq be back day move average end week federal reserve chief janet yellen opposed roll back post financial crisis bank regulation amazon amzn cut whole food market wfm price monday deal close offer special reward amazon prime member time pretty much many analyst expect news still slam food retailer board kroger kr sprout farmer market sfm wal mart wmt costco cost walgreen boot alliance wba more related amazon cut whole food price monday grocery stock slammedwal mart alphabet google team blow amazon offer hundred thousand wal mart item voice activate google home appear be joint counterstrike amazon echo smart speaker user order item voice command research firm emarketer estimate amazon have share smart speaker market vs google related wal mart google be take common internet foeretail commerce stock industry newsall eye be federal reserve annual monetary policy conference big act be anticlimactic fed chief janet yell didn even talk monetary policy instead opt make defense post crisis bank regulation jackson hole wyo speech be likely yellen last fed chair term set expire february reappointment doubtful yellen have choose not offer clarity fed policy go forward outlook be less clear even inflation show sign make comeback fed act related fed chief yellen mum inflation do just lose job salesforce com crm report fiscal second quarter profit revenue top view also raise full year sale guidance share enterprise software company hit buy point just earning keep rise further china social app developer momo momo beat quarterly earning estimate stock plunge due slower expect growth pay user live video platform account company revenue share china tech service firm baozun bzun plummet report revenue outlook fall short estimate veeva system report october quarter guidance be bit soft overshadow second quarter sale adjust profit cent share top consensus expectation revenue subscription grow year year veeva share fall nearly friday tumble just buy point month low veeva topple soft guide beating sale earning datum analytic software firm late thursday report adjust earning share cent revenue quarter end july analyst expect cent current quarter splunk splk expect revenue base midpoint guidance wall street be modele sale splunk share shot friday race right side consolidation toll bro tol ep jump cent crush view cent revenue climb be short estimate average home price edge backlog climb unit luxury homebuilder see full year delivery unit prior guidance translate full year revenue midpoint consensus lowe low ep rise miss view revenue climb short forecast home improvement retailer now see full year ep vs prior view consensus operate margin come pressure store increase hour customer chipmaker broadcom avgo earn share exclude item year year revenue analyst expect current quarter broadcom guide adjust earning share sale wall street have be modele share broadcom share fall friday just move day line related broadcom beat earning match sale third quarterulta beauty ulta top earning sale view raise full year profit guidance share fall friday month low same store sale growth slow miss estimate slightly several retailer rally thursday burlington store burl dollar tree dltr abercrombie fitch anf signet sig other retailer surprised investor better expect result related ulta beauty beat double digit comp not enough pleasehp inc hpq earn cent share exclude item sale fiscal end july thank strong notebook pc sale improve printer supply business analyst expect cent hp guide roughly line earning share fiscal fourth quarter hp share rise thursday top buy point intraday william sonoma wsm ep grow cent beating view cent revenue rise top estimate commerce revenue rise retail revenue rise comparable brand revenue climb houseware retailer ep revenue midpoint guidance top consensus autodesk adsk maker computer aid design software late thursday deliver fiscal second quarter result beat consensus estimate lose cent share vs year earlier profit cent share revenue wall street expect loss cent share sale autodesk be transition cloud compute business model be hurt result term autodesk rise friday hit record high intraday vmware vmw late thursday report adjust income share sale top consensus respectively share already buy range rise friday medtronic mdt report fiscal first quarter sale lag estimate adjust profit beat cent share recliner sectional maker la boy lzb say be talk amazon amazon marketplace indicate furniture company soon start selling ware commerce giant site la boy already sell furniture wayfair
13,MDT,intuitive surgical isrg be hamstrung psychological barrier share analyst argue friday stock topple robot surgeon maker sale earning beat late thursday number simply weren good enough pull stock evercore analyst vijay kumar say stock market today intuitive surgical stock tumble close share have climb half year close mark thursday hit high intuitive surgical inched hour follow second quarter earning report headline revenue procedure overall system beat point life be good intuitive surgical key question investor be number be enough drive stock higher potentially break psychological barrier kumar say ibd take intuitive surgical be fend robotic advance alphabet googl google medtronic mdt fare offering rival come fruition visit ibd datum story procedure proxy overall health company continue be healthy write note client say procedure guidance imply slowdown second half year first half guidance growth high end imply growth second half year vs see first year write rbc analyst brandon henry doesn see same psychological barrier up price target intuitive surgical stock keep sector perform rating stock henry also increase sale view respectively call adjust profit come respective share meanwhile intuitive surgical be work maintain lead robotic be aim have lung biopsy system launch face robotic competition like google parent alphabet medtronic robotic competition be come intuitive surgical be make necessary investment expand total addressable market remain premium player surgical robotic market write note client related robot surgeon maker best sale profit view
14,MDT,intuitive surgical isrg inched late thursday robot surgeon maker top wall street second quarter sale profit view report nearly growth shipment da vinci surgical system year year basis sale advanced adjust profit share grow metric top analyst expectation period intuitive surgical ship da vinci surgical system firm also launch next generation model da vinci lower cost version robotic assist technology worldwide da vinci procedure grow vs year earlier quarter intuitive surgical say news release ibd take google alphabet googl medtronic mdt other be try crack robot assist surgery space intuitive surgical dominate intuitive surgical stock top stock term key growth metric grab more ibd datum story growth procedure be drive primarily growth general surgery procedure worldwide urologic procedure intuitive surgical say hour trading stock market today intuitive surgical stock rise less share close regular trading session related medtronic undercut robot surgeon maker
15,MDT,here weekly investing action plan need know investor come week earning season be largely do congress well many worker be still august holiday mode market be brace hawkish talk top central banker gather annual conference wyoming federal reserve
16,MDT,bellwether johnson johnson jnj second quarter report bode well biotech sector analyst say tuesday dow component top profit expectation narrowly lag sale view stock market today stock climb biotech stock drop nearly group generic drugmaker inched leerink analyst geoffrey porge remain bullish biotech sector needham analyst mike matson say second quarter result point stable period medtech player boston scientific bsx medtronic mdt stryker syk zimmer biomet zbh quarter drug sale grow sequentially fall vs year earlier period porge partially blame time positive rebate adjustment eliminate year year volume price growth second quarter sale remicade decline year year rivalry biosimilar contribute just decline be lower guidance decline porge write note client ibd take cancer rare disease specialist be expect do well second half positive sentiment return biotech space visit ibd industry snapshot look outperform second quarter also expect currency headwind subside second half call acceleration pharmaceutical unit well positive trend sale outside base presume currency impact firm raise outlook adjust profit share outside drug sale grow sequentially second quarter beating view growth porge say support expectation sequential outside revenue growth company due weaken dollar second quarter say porge expect guidance increase biotechs second quarter earlier week call regeneron pharmaceutical regn easily beat june quarter sale view gilead science gild handily top profit expectation cover company not be negatively impact same prior period adjustment current imminent biosimilar competition surprise consensus remicade market dynamic be view proxy say abbvie abbv see pain sale cancer drug imbruvica grow outside say be partner abbvie imbruvica typically book imbruvica sale porge say translate abbvie imbruvica sale be miss vs consensus estimate say abbvie imbruvica be consider largest growth driver humira patent cliff continue miss consensus expectation repeat second quarter be negative stock related star align biotechs crush earning consensusthese drug giant buy range just beat earning novartis fda cancer also be boon rival
17,MDT,number high profile medical technology firm include like boston scientific bsx abbott laboratory medtronic mdt be unlikely stand way dutch firm philips bid heart device maker spectranetic spnc analyst say wednesday xon stock market today spectranetic stock rocket record close high philips announce plan acquire spectranetic cash share deal value spectranetic euro needham analyst mike matson say bidding likely stop boston scientific abbott medtronic aren expect bid company spectranetic make drug coat balloon call stellarex treatment disease artery leg stomach arm head narrow rival bard bcr boston scientific medtronic already make drug coat balloon matson write note client further becton dickinson bdx be acquire bard leave major firm sector lack drug coat balloon abbott cardinal health cah terumo suspect abbott be too preoccupy st jude medical alere alr acquisition pursue large deal say similarly cardinal be process acquire medtronic medical supply business ibd take heart valve sector heated last year boston scientific make acquisition bring closer compete medtronic edward lifescience head sector leader look battle be shape matson be unsure terumo acquisition strategy similarly doesn expect philips acquisition get catch regulatory issue philips spectranetic only overlap atherectomy process harden narrow artery be remove body philips get area earlier acquisition believe market share be very low think regulatory issue be unlikely say philips say wednesday expect deal close third quarter dutch firm expect see revenue growth profit accretion matson keep buy rating spectranetic stock boost price target reflect acquisition cost related medtronic edward rivale unit outgrow broader market boston heart valve win face trial rival medtronicedward rocket month high strong heart valve sale
18,MDT,google parent alphabet googl medtronic mdt other be try challenge dominance intuitive surgical isrg robot assist surgery space so far have fail disrupt market leader maker da vinci surgery system see ibd smartselect composite rating jump tuesday day revise score mean intuitive surgical now top other stock term key performance metric technical strength best stock tend have better grade begin launch significant move intuitive surgical have climb buy point cup handle clear february tuesday moved past follow buy point week tight pattern intuitive pull back session high close positive territory weak spot be company ep rating track quarterly annual earning share growth look improve better show top stock accumulation distribution rating show moderate buy institutional investor last week company report earning share gain prior report revenue growth increase intuitive surgical hold rank peer medical system equipment industry group idexx laboratory idxx be rank stock group related company be now outperform stock
19,MDT,be upside intuitive surgical isrg guidance analyst suggest tuesday investor be already pay downgrade stock likelihood subdue demand asia canaccord analyst jason mill also see medtronic mdt know make heart valve replacement rival edward lifescience ew stout competitor surgery robotic year date intuitive surgical stock be phenomenal year canaccord analyst jason mill write note client intuitive end year sale growth earning growth cash health care sector have be top performer so far intuitive surgical have be lead charge mill say however investor exuberance company strong performance past few year have drive stock unprecedented valuation level mill downgrade intuitive surgical stock hold rating buy year keep price target close stock market today intuitive surgical be expect intuitive surgical deliver solid result believe risk reward setup tilt too much former present say stock hasn trade valuation be now premium own year average ibd take intuitive surgical stock have ibd composite rating best possible rank fourth ibd company medical system equipment industry group idexx laboratory idxx stock lead group cr look group setup head ibd stock checkup guidance have play big role intuitive surgical stock mill say company typically offer conservative guidance easily outperform thus investor expect positive guidance revision balance not be case easter weekend tailwind first quarter become headwind second quarter outside business be slow mill write procedure growth be expect be subdue japan moderate china think be upside current guidance think re already pay write meantime competition be loom say intuitive surgical make robotic assist perform surgery medtronic reiterate earning call last week plan launch surgical robotic outside april fiscal medtronic competitive approach seem be center ability target customer myriad surgical spectrum also deduce conversation management target cost side equation well mill say medtronic not become much competitor late early domestic launch creep closer intuitive surgical investor begin account upcoming competition multiple afford share say related robot surgeon maker launch record high strong
20,MDT,medtech player medtronic mdt tack growth heart valve replacement sale outgrow broader market fiscal fourth quarter revenue earning top wall street expectation medtronic share rise stock market today market open thursday medtronic release fiscal result evercore analyst vijay kumar call well round performance dublin base medical device maker earn share exclude item sale also fiscal fourth quarter end april analyst have modeled respectively fourth quarter result be strong finish fiscal year balanced diversify growth group region medtronic ceo omar ishrak say statement fiscal year be solid year overall medtronic robust sale minimally invasive therapy group include electrosurgical tool advanced vessel sealing device help medtronic total sale beat view globally unit pull rbc analyst glenn novarro call novarro keep outperform rating medtronic stock note restorative therapy group top view strong growth brain specialty therapy respectively spine revenue grow miss novarro forecast meanwhile cardiac vascular group just meet expectation revenue sale pacemaker implantable cardioverter defibrillator decline low single digit range group also see growth sale transcatheter aortic valve replacement tavr top broader market growth tavr be method insert heart valve replacement catheter be less invasive safer open heart surgery sector medtronic corevalve product rival sapien device edward lifescience ew boston scientific bsx also have compete device call lotus isn approve medtronic also guide growth fiscal sale growth earning share certain item be generally line previous communication evercore kumar say note client ibd take medtronic stock hit buy point tuesday else be report thursday take look investing action plan related boston heart valve win face trial rival medtronicedward rocket month high strong heart valve salescardinal health plunge big deal medtronic
21,MDT,here investing action plan thursday need know investor come day opec meeting dominate headline tomorrow send energy stock motion outcome not produce surprise more actionable news come quarterly report best buy bby medtronic mdt
22,MDT,boston scientific bsx lotus heart valve prove superior rival medtronic mdt corevalve yearlong trial boston scientific medtech player say tuesday prompt share jump early lotus corevalve be transcatheter aortic valve replacement tavr patient harden artery be not eligible surgery process be less invasive open heart surgery allow new valve be insert catheter year boston scientific study pair lotus valf show superiority medtronic corevalf primary effectiveness lotus valf be not fda approve also prove inferior safety risk death disable stroke paravalvular leak result insufficient sealing site replace valve be lower boston lotus medtronic corevalve boston say boston lotus also prove safer have lower rate moderate severe paravalvular leak medtronic corevalve most leak follow heart valve replacement be minor large leak have be link heart failure ibd take edward lifescience be leader medtech ibd composite rating landing third spot top company medical product industry group head ibd stock checkup list other leader separately rate disable stroke lotus patient be just compare corevalve patient overall stroke rate be closer lotus patient vs corevalve patient larger percentage corevalve patient die result cardiac death corevalve patient lotus patient evercore analyst vijay kumar say fact lotus achieve overall superiority study be link lower rate paravalvular leak note shouldn be surprise lotus have lower paravalvular leak rate be key distinguish feature valve separate study edward lifescience ew sapien valve have comparably low rate leak close stock market today boston stock be lift much earlier day share top buy point flat base april have linger buy zone medtronic stock be fraction share edward be related edward rocket month high strong heart valve salesdid baxter hoodwink fda inspector be probe just extraordinary medtech stock buy ahead
23,MDT,medical related exchange trade fund have rac healthy gain year ongoing quest longer healthier life outperformer be ishare medical device ihi gain year date well ahead gain period fund boast year average annual return vs benchmark index accord morningstar inc ihi launch track dow jone select medical equipment index top holding etf include medtronic mdt abbott laboratory thermo fisher scientific tmo abbott developer generic drug disease screening system other product be buy range clear flat base entry thursday xihi be etf pick featured ibd last month oscar pursche chief executive bruderman brother bruderman asset management opposed take broad view health care sector do overall see great opportunity medical device space investor get exposure ishare medical device etf say also note fund top holding account nearly portfolio increase risk profile ihi be extend past buy point clear april ibd take find biotechs stand benefit most president trump propose tax reform recent tech column spdr health care equipment xhe return ytd year average year old fund track health care equipment select industry index have gather asset top holding include align technology algn intuitive surgical isrg edward lifescience ew account portfolio xhe be trading record high be extend recent bounce day line spdr biotech xbi year have average annual gain past year fund launch january be form flat base buy point entry still july peak vertex pharmaceutical vrtx regeneron pharmaceutical regn abbvie abbv be top name hold xbi top holding make asset related be best health care etf gop move replace etf ride industry recovery
24,MDT,edward lifescience ew stock rocket month high wednesday medical tech player report particular strength heart valve replacement sale follow several quarters up down stock market today edward soar earlier rise much high last achieve october sale transcatheter aortic heart valf tavr grow edward say tuesday first quarter earning conference call beat consensus rbc analyst glenn novarro say note client unexpectedly strong quarter tavr sale couple upward revision revenue earning guidance send edward share market trading novarro say edward late tuesday report tavr be method replace diseased heart valve catheter process have become more popular recent year less risky require shorter recovery period surgery medtronic mdt boston science bsx be also work realm quarter end march edward report sale grow top consensus canaccord analyst jason mill write research report edward report cent adjust earning share beating cent mill be pound drum again primary reason own edward include total addressable market tavr edward outgrow market quarter increase tavr sale vs other company edward have share tavr market mill estimate ibd take boston scientific make acquisition december rattle edward lifescience medtronic pay head sector leader deep dive first quarter validate bullish view tavr market estimate target population penetration model estimate market edward hold share write also note edward strong earning leverage grow opportunity transcatheter mitral valve repair portfolio positively surprise investor earlier acquisition cardiaq be expect drive material profit loss contribution also tuesday edward boost low end yearly sale guidance now see revenue company also raise adjust ep guidance second quarter edward model sale exclude germany stocking sale adjust earning cent cent share mill keep price target buy rating edward stock novarro boost price target maintain outperform rating edward related medtech stock buy ahead boston scientific make acquisition battle medtronic do heart valve study rival reap benefit
25,MDT,xdrug medical supply distributor cardinal health cah say buy medical supply unit medtronic mdt mostly debt weaker earning guidance cardinal share plunge early tuesday cardinal health be acquire medtronic patient care deep vein thrombosis nutritional insufficiency unit include brand used combine unit generate revenue last report quarters medtronic say include product category multiple market setting include brand such curity kendall argyle kangaroo be used nearly hospital well establish product line be complementary medical consumable business fit naturally customer offer reason product portfolio have be radar many year say cardinal health chairman ceo george barrett ibd take cardinal health share have be rebound presidential election investor believe donald trump be less aggressive drug price hillary clinton statement stock tumble day move average find support cardinal now see fiscal earning share low end earlier guidance expect deal be boost gaap ep continue operation more cent still see ep year be flat mid single digit cardinal health finance acquisition cash new debt standard poor fitch put cardinal credit rating risk downgrade cite increase leverage cardinal health share tumble stock market today gapping day day move average medtronic dip cent cardinal fellow drug distributor mckesson mck sank abc cardinal health paid cordis johnson johnson jnj add portfolio device include catheter filter stent medtronic say transaction reduce ep modestly medtronic spend net proceed deal share buyback rest go cut debt related johnson johnson earning top drug sale be drag
26,MDT,move old wall street adage sell go away come mind reminder stock historically tend underperform october period do mean etf investor liquidate holding take summer few extra month resume buy stock november investment strategy most old saying doesn have be take literally even market return tend be bigger november april period investor sit other month miss intermediate rally power reinvest dividend compound return oliver pursche chief executive bruderman brother bruderman asset management doesn think adage prove advantageous most investor be best unreliable inconsistent amount market timing tell ibd take account possible tax consequence miss dividend trading commission math doesn bear pursche oversee new york base firm investment banking wealth management division think be good time investor reassess portfolio click here see list best perform etfs bruderman asset management be register investment advisor rium more asset management here be pursche best etf investment idea own word sell walk away be not strategy feel be particularly smart beneficial investor however enter summer month second half year be need investor revisit investment thesis potentially reallocate portfolio solid double digit run mr trump be elect president portfolio risk assessment be certainly due investor expect continuation current positive sentiment even trump administration be unlikely pass major legislation particular tax reform nonetheless be several key factor be benefit economy consequently corporate earning unite state economy well world whole be benefit cyclical rebound growth consumer demand be help drive corporate earning higher help boost gdp growth more second quarter phenomenon have be interesting observe current earning cycle be strength earning come outside unite state company have report earning so far company earn more revenue offshore have see ep growth nearly company derive earning domestically be experience low middle single digit ep growth last note expect correction point don let change long term investment strategy etfs name perform well current environment persist end year expect related etf be knock sock tech sector
27,MDT,baxter bax stock fall monday worry related department justice investigation potential price fix intravenous fluid allegation analyst deem extraordinary stock market today baxter stock fall justice department send grand jury subpoena baxter employee subpoena be receive friday relate criminal investigation justice department antitrust arm ask document testimony related manufacturing pricing selling shortage intravenous solution baxter communication rival evercore analyst vijay kumar note price fix allegation isn new stem year old investigation begin new york ongoing class action suit northern district illinois related supply shortage shortage be trigger flu season benefit manufacturer hospira third quarter see growth unit produce intravenous fluid kumar say hospira be acquire pfizer pfe class action lawsuit allege manufacturer intravenous fluid falsely create shortage justify spiking price baxter have file motion dismiss suit call allegation extraordinary idea public company voluntarily create supply shortage hope competitor similarly restrict output order raise price seem stretch kumar tell client note ibd take baxter stock trade ibd company medical product industry group be lead medtronic mdt stryker syk boston scientific bsx term market cap medtronic boston edward lifescience ew compete heart valve replacement market check edition sector leader see stack fda regulator regularly inspect manufacturing facility note class action lawsuit seem imply baxter other intravenous fluid manufacturer be able hoodwink inspector post shortage notice say baxter say incur cost comply increase fda regulatory requirement meet supply constraint meanwhile price increase only contribute growth kumar say intravenous fluid solution contribute third segment growth imply pricing be average kumar say assume bag intravenous fluid cost equate increase cent bag apart price collusion prosecutor have argue baxter earning increase intravenous fluid price be reasonable kumar estimate hike price intravenous fluid baxter have margin earning interest taxe related boston scientific make acquisition battle medtronic edward best stock own analyst
28,MDT,be lot hand wring lately iconic have go more year mark new time high don despair re smart etf investor spot opportunity even other agonize stock be stick rut geniuse indexing shop don just offer product track broad basket asset such large cap russell small cap also slice dice index finer segment aim boost return reduce risk sometimes aim do achieve aim screen stock factor characteristic such low volatility high quality several exchange trade fund tracking index base have score time high recently re not only outperform bellwether spdr spy also attract gob new investor money powershare high dividend low volatility sphd proshare dividend aristocrat nobl powershare quality sphq make time high april powershare low volatility splv do same powershare ex rate sensitive low volatility xrlv follow suit sphd cherry pick market rather deliver whole basket accord industry research firm etf com invest least risky highest yielding stock indexing method skews defensive sector such utility centerpoint energy cnp be top stock hold stock be trading week high investor have favore defensive cast income potential utility sector choppy year etf have outperformed spy year date past year vs gain better know peer sphd also see net inflow first month year comparison spy leak proshare dividend aristocrat hold stock parent index have hike dividend payment least consecutive year then equal weight holding account big midcap stake irish medical device maker medtronic mdt be dividend aristocrat portfolio company make heart valve product just ibd leaderboard aristocrat edward lifescience ew do nobl have advanced year date absorb net january april dividend name nobl yield relatively modest less spy sphd
29,MDT,wedbush initiate coverage fitbit fit top rating citigroup upgrade apple aapl chipmaker qorvo qrvo rbc capital upgrade linkedin lnkd raise price target proofpoint pfpt wedbush start coverage outperform rating pt cite expand install base program corporate wellness initiative share fitbit close have swoon more company have ibd composite rating possible citigroup upgrade apple chip supplier qorvo neutral sell downgrading skywork solution swks sell neutral believe qorvo sustain dollar content gain momentum samsung galaxy iphone gain year say citigroup report qorvo share edge skywork fall rbc capital upgrade business social network outperform neutral pt linkedin stock plunge feb mountain view calif company forecast full year revenue consensus estimate owing advertising slowdown rbc mark mahaney say survey human resource professional show linkedin be reasonably well position very large recruitment advertising tam total addressable market linkedin share climb raise pt proofpoint security software firm host analyst day thursday san francisco introduce financial target include reach revenue proofpoint have ibd composite rating possible fall guggenheim security initiate coverage medical product maker boston scientific bsx stryker syk buy rating boston scientific have ibd composite rating possible climb thursday stryker have cr add guggenheim start coverage spectranetic spnc buy rating edward lifescience ew medtronic mdt have neutral rating raymond james longbow research deutsche bank ub downgrade restoration hardware rh neutral home furnishing retailer late wednesday unexpectedly report fiscal loss slash full year profit outlook share plunge other analyst move brean capital downgrade qualcomm qcom hold rw baird upgrade solarcity scty outperform
30,MDT,investor scoff sell go away adage send stock etfs higher past month sharp oil rally offset dismal employment report more evidence corporate america profit be get crushed spdr spy set string high june stock market build rebound february market bottom still caution be word world largest investment manager click here see list top perform etfs latest job growth figure weakest almost year cast doubt recover economy ability absorb interest rate hike summer key june referendum decide britain stay european union uncertainty add big risk global market accord blackrock believe now be good time dial equity credit risk richard turnill blackrock global chief investment strategist write june research note favor dividend grower unstable environment be find exchange trade fund such proshare dividend aristocrat nobl nobl invest exclusively company longest track record year year dividend growth aristocrat include medical device maker medtronic mdt drugmaker abbvie abbv month end last tuesday unite state oil uso best perform etf add commodity etf invest crude future june surge highest level nearly year equity technology stock emerge recent help lead higher ishare phlx semiconductor soxx jump past month hold broadcom avgo climb week high fiscal report ambarella amba part supplier gopro gpro also soar earning report spy post gain past month market resume uptrend ishare msci eafe efa hold foreign develop market stock rise same time vanguard ftse emerge market vwo tack etf investor key question be hold resistance level second half ask money manager best investing idea so portfolio aren range bound even broad market move sideway kimberly woody senior portfolio manager globalt investment atlanta ga asset advisement roughly remain sandwich multiyear trading range call more nimble tactical trading not large strategic tilt choice american voter be stark ever far reach implication economy well multiple industry believe unlikely market race higher global risk abate more clarity be see political front positive development global economy currency commodity market have lead calmer global equity bond market remain hopeful increase economic momentum more evidence recovery be need justify increase risk portfolio robert davis partner chief investment officer round table wealth management new york city asset management term view be cautious relate stock earning have be significantly reduce start year valuation remain premium certain defensive sector growth be not absent however small cap growth sector be demonstrate increase earning believe be area opportunity meaningful sell first half year also view high yield bond attractive area security be higher capital structure provide meaningful yield get investor be flat market lead presidential election
31,MDT,medical device maker boston scientific bsx pop year high wednesday report strong raise guidance boston scientific adjust earning totale cent quarter year earlier quarter beating analyst consensus cent accord thomson reuter revenue rise beating consensus boston scientific add more full year revenue guidance range now midpoint vs last year also add cent full year ep guidance now cent company say sale current quarter be midpoint year high side consensus earning guidance cent share be line wall street estimate cent last year boston scientific stock be morning trading stock market today hit highest point research note wednesday rbc capital market analyst glenn novarro break result cardiovascular revenue year year constant currency easily top estimate consensus write believe cardiovascular result be lead share gain synergy drug eluting stent robust adoption watchman left atrial appendage closure device strong peripheral sale meanwhile medsurg sale year year constant currency year year organic also top expectation drive strong endoscopy result owing spyglass ds direct visualization system launch axio stent system urology woman health downside novarro say cardiac rhythm management sale be light say be due medtronic mdt take share implantable cardioverter defibrillator market however evercore isi analyst vijay kumar write monday approval new mri safe suite pace product help boost division boston scientific growth have be pick last quarters help drive stock strong ibd composite rating
32,MDT,boston scientific bsx say thursday plan acquire swiss firm symetis deal deepen heart valve rivalry medtronic mdt edward lifescience ew symetis offer several transcatheter aortic valve replacement product europe internationally add boston lotus heart valve device late february be recall due mechanical issue deal be expect close second quarter be earning accretive hit return interest third year boston say presentation boston also reiterate plan launch lotus heart valve device device be expect return european market later year believe be offensive rather defensive move needham analyst mike matson say do not believe be stopgap address lotus recall shortcoming lotus ip intellectual property issue matson keep buy rating price target boston scientific stock boston share finished regular trading stock market today follow announcement boston have be pressure recently patent battle edward share fall feb boston voluntarily recall lotus heart valve device company discover mechanical issue lead premature release pin doctor implant device patient die attempt replace lotus heart valve ibd take not first time boston scientific have make acquisition help battle medtronic edward lifescience already have transcatheter aortic heart valve device head sector leader see rivalry be shape boston see symetis complementary lotus have do deal even lotus be not have be recall evercore analyst vijay kumar write note client investor concern symetis acquisition imply lotus be further delay provide reassurance say symetis be also unlikely trigger more patent issue edward kumar say patent doesn appear symetis work support beam locking mechanism heart valve replacement be be contest edward related medtronic edward best stock own analystboston topple heart valve bug wo boost edward do heart valve study rival reap benefit
33,MDT,medtronic mdt edward lifescience ew stock dip monday series bullish report include call heart valve replacement rival stock own term midday trading share medtronic end virtually flat stock market today edward close rbc analyst glenn novarro expect have strong catalyst term note client sunday novarro say see edward medtronic stryker syk zimmer biomet zbh group stock own term call edward medtronic best idea cardiovascular work heart valve replacement recent study medtronic show new method insert heart valve be superior open heart surgery be encourage novarro say result help stoke growth transcatheter aortic valve replacement market say check ibd best mutual fund awardsfollow novarro report evercore analyst vijay kumar upgrade edward stock buy rating raise price target needham analyst mike matson reiterate buy rating price target medtronic stock matson expect medtronic maintain mid single digit sale growth double digit earning growth overcome temporary product cycle competitive issue fiscal third quarter believe medtronic product cycle remain very strong effectively fend competitive product launch investor concern matson write note client medtronic compete edward lifescience smaller outfit heart valve replacement boston scientific bsx also be look break transcatheter aortic valve replacement market doesn yet have fda approval ibd take boston scientific be work catch medtronic edward lifescience strategic acquisition read sector leader next month medtronic have number launch help boost growth company see strong growth emerge market segment make total sale have see double digit growth recent quarters believe medtronic sustain double digit growth market drive market development channel optimization public private partnership matson say saudi arabia see return growth soon rbc novarro expect medtronic continue gain share implantable cardioverter defibrillator market device be used manage tachycardia expect transcatheter aortic valve replacement drug coat balloon perform well novarro call line slightly better first second quarter metric edward expect medtronic launch corevalve evolut drive growth also edward sapien xt device be transcatheter aortic valve implant patient harden heart valf unable undergo open heart surgery novarro recommend own edward stock go second half expectation market growth evercore kumar note edward stock be growth stock therefore volatile nature lower investor expectation believe edward share be poise catch trade offer asymmetric risk reward current level write research report see upside current stock level kumar be previously sideline edward stock competition boston scientific international market boston pull lotus valve market late february give edward first break month still company be likely patent standoff first half related medtronic do heart valve study rival reap benefitsboston scientific win patent battle vs edward german courtboston topple heart valve bug wo boost edward medtronic
34,MDT,stock be lower tuesday morning earning report kick full swing dow jone industrial average fall most goldman sachs gs johnson johnson jnj weigh dow shed nasdaq composite be small cap russell give volume be higher board vs same time monday medical bank oil issue lead downside today stock market action airline food retail stock be few gainer dow stock be active component report earning ibm ibm be slate report close goldman sachs gap fall heavy volume month low big bank result miss view top bottom line share have be consolidate day move average past few week bank america bac rise nearly fast trade top quarterly view stock have also be consolidate week move average johnson johnson jnj drop gapping day line high turnover back buy point last base dow component drug medical device maker report earning beat revenue miss analyst target cardinal health cah gap plunge breaking day day line massive volume medical product distributor say buy medtronic mdt medical supply unit also guide full year earning estimate lower back dow unitedhealth group advanced healthy trade health insurer deliver result top consensus forecast boost full year outlook share be rebound day line related goldman sachs blame weak trading revenue politic bofa topsjohnson johnson earning top drug sale be drag
35,MDT,dow jone industrial average lead downside afternoon trading tuesday hurt weakness goldman sachs gs johnson johnson jnj dow fall loss nasdaq composite be volume nyse nasdaq be tracking higher monday level stock market hold relatively well sharp loss london paris overnight paris cac swoon uncertainty outcome france presidential election meanwhile london ftse slump prime minister theresa say ll seek early election june strengthen hand head brexit talk year treasury yield continue bleed fall basis point bond market continue seem odd fed fed current economic outlook stock market today earning report financial sector remain focus goldman sachs gs slump be poise test day move average currently bank america bac reversed lower strong start share be rise early charle schwab schw have lot good news earning report include earning sale beat well highest number new quarterly account year headline didn help stock much share fall cardinal health cah crash company announce plan buy medtronic mdt medical supply unit cardinal also lower full year earning outlook ibd telecom infrastructure firm dycom industry dy clear base buy point share be afternoon trading verizon inked fiber optic cable deal corning glw dycom provide engineering construction maintenance installation service telecom provider intuitive surgical isrg give back ahead earning report close growth have slow dramatically medical device maker best know da vinci robotic surgical system minimally invasive procedure stock continue hold high company sell da vinci system fourth quarter year quarter related uk prime minister call snap election european stock fallgoldman sack wall street giant blame politic trading wo dow verizon buy corning fiber cable tv acquisition hold
36,MDT,medtronic mdt stock pop tuesday medical product maker top fiscal expectation board evercore analyst vijay kumar call quickest comeback large cap land fiscal end jan medtronic report earning share ex item sale respectively vs year earlier quarter consensus see kumar write research report beat help medtronic stock lift stock market today touch highest point disappointing sale guidance month send share fall ibd take boston scientific make key acquisition late last year help battle edward lifescience medtronic read sector leader boston chance overtake medtronic edward key market highlight include growth cardiac rhythm heart failure brain therapy unit medtronic diabetes group grow vs year earlier quarter lead growth patient monitoring recovery medtronic reaffirm guidance mid single digit sale growth constant currency basis fiscal company see sale grow lower half mid single digit range constant currency basis medtronic compete closely edward lifescience ew boston scientific bsx heart disease market medtronic lead term market cap nearly compare boston edward related medtronic boost ep potential downgrade increase boston st jude rivalriesedward heart valve guidance lag medtronic boston rivalry
37,MDT,here investing action plan need know investor come week crude price barrel next meeting organization petroleum export country add upward momentum smack market back meanwhile apple aapl supplier broadcom avgo medtronic mdt report earning drugmaker discuss cancer fight
38,MDT,stock rise friday end session high investor shrug disappointing economic datum comment federal reserve chair janet yellen suggest higher interest rate be way nasdaq rise add dow jone industrial average edge volume fall nyse nasdaq compare thursday accord preliminary datum market be close monday memorial day holiday yellen say interest rate hike be possible come month improve economic growth trader put probability rate hike fed june meeting chance increase july meeting accord cme group fedwatch tool also friday gdp be revise upward less expect university michigan consumer sentiment gauge also fall short wall street consensus estimate retail stock once again outperformed stock market today discount retailer big lot big jump new high heavy volume announce profit fiscal first quarter end april jump year earlier cent share well wall street estimate revenue rise also well view stock rocket back buy point massive volume just day trigger sell signal sink entry big lot be latest discount retailer spike new high follow strong earning report dollar general dg dollar tree dltr continue rise friday follow earning inspire breakout thursday fei feic lead jump thermo fisher scientific tmo say buy maker electron microscope zoe kitchen zoe medtronic mdt yy yy workday wday be company due report quarterly earning tuesday
39,MDT,stock medical sector top buy point monday make significant move medtronic mdt rise close just buy point long saucer pattern volume be average sign weakness crucial movement monday suntrust initiate coverage stock buy rating
40,MDT,pocket health care sector be ailing other have perked right ishare medical device ihi bound week high thursday eye fourth straight weekly gain relative strength line gauge performance vs be bolt higher defiance overall stock market mood market uptrend have come pressure week ihi be target bet health care niche invest company manufacture distribute medical device edward lifescience ew be top rate ibd stock industry group base measure technical fundamental health such earning sale growth ihi count edward top holding give portfolio weighting edward stock have jump past month california base company be battle top spot heart valve market sapien receive fda approval treatment high risk patient suffering severe symptomatic aortic stenosis chief rival be medtronic mdt hold ihi portfolio edward report quarterly result april close wall street stock analyst track thomson reuter expect gain earning quarter year
41,MDT,major stock hold ihi report week late tuesday surgical robot maker intuitive surgical isrg beat earning estimate stock hit new high wednesday receive series price target hike wednesday orthopedic giant stryker syk also beat expectation raise guidance stryker intuitive stock have fall then volatile trade ihi also have smaller weighting cantel medical cmn steris ste cynosure cyno device specialist top notch ibd composite rating respectively steris provide product prevent infection control contamination report jump sale latest report quarter help buyout base synergy health small cap cantel medical be also infection control prevention business cynosure develop treatment system hair removal skin rejuvenation ihi have relative strength rating mean outperformed other stock etfs ibd database last month accumulation distribution rating point healthy institutional demand share etf see net inflow first quarter asset have grow year year date april ihi have advanced vs broadly diversify health care select sector spdr xlv xlv largest health care etf have be hurt year hefty combine stake underperform pharmaceutical biotech industry past year xlv produce annual average gain vs ihi
42,MDT,surgical robot maker intuitive surgical isrg receive multiple price target hike wall street stock hit new high wednesday follow earning report late tuesday ibd report intuitive surgical earning beat estimate really interested analyst be quarter procedure growth intuitive surgical normally sell only pricey da vinci robotic system quarter so surgical procedure used company consumable accessory service be key steady revenue management raise procedure growth guidance year previous operate expense increase intuitive surgical management also raise opex guidance year revenue previously however likewise raise gross margin guidance intuitive surgical be ibd big cap else make grade intuitive surgical impressive procedure growth be consistent recent positive general surgeon check write rbc capital market analyst brandon henry raise price target maintain sector perform rating intuitive surgical be accelerate operate expense spend believe investment drive increase future robotic adoption help company maintain superior position robotic market upcoming competition company have competitor present medtronic mdt transenterix trxc johnson johnson jnj partner alphabet googl verily division be develop own robotic surgery system leerink analyst richard newitter lift intuitive surgical price target maintain outperform rating now stronger outlook urology gyn general surgery give management confidence raise procedure guidance newitter write research note also management seem be talk more aggressively da vinci use thoracic procedure area think be corner emerge growth driver piper jaffray analyst matt brien raise price target rate stock neutral intuitive surgical stock hit record high early stock market today push year morning trading share be
43,MDT,johnson johnson jnj zimmer biomet zbh be medtech stock own go earning season several other be put buy list pullback analyst say rbc analyst glenn novarro say wednesday large cap medtech stock johnson zimmer offer best risk reward first quarter earning season zimmer be cheapest arena johnson have lag group investor sentiment have turn more favorable johnson recent week anticipate further multiple expansion back strong first quarter result consensus estimate move higher year write research report consensus analyst poll yahoo yhoo broadly expect johnson report sale year year share adjust earning dip johnson be also cusp close acquisition actelion pharmaceutical second quarter sanofi sny be lock battle late last year take swiss biotech johnson bid win company zimmer company just have hit consensus estimate stock move higher novarro say consensus model year year sale growth adjust earning share novarro however say abbott laboratory boston scientific bsx edward lifescience ew stryker syk be attractive pullback see deliver solid result reaffirm guidance investor likely track ongoing litigation abbott alere alr heart valve replacement sale edward boston likely comment voluntary recall lotus heart valve replacement company recall lotus device discover malfunction result premature release pin implantation medtronic mdt onyx stent launch represent term challenge boston still want own boston novarro say small midsize cap world novarro recommend nuvasive nuva medical group wmgi group potential takeout be likely baked stock price nuvasive say ibd take isn first time edward have be list best stock own head ibd technology page deeper dive edward be hold strong remain top pick small midsize medtech group expect play catch group investor focus shift company impressive new product lineup improve international sale growth company experience distributor issue write novarro needham analyst mike matson also prefer zimmer also have strong buy rating share inogen ingn mimedx mdxg see cardiovascular orthopedic market slow diagnostic market improve quarter matson model cardiovascular market growth decelerate fourth quarter orthopedic market advance vs growth prior quarter diagnostic sale likely grow say be standout matson say model transcatheter aortic valve replacement market boston edward medtronic operate have grow orthopedic matson model growth extremity market related medtronic do heart valve study rival reap benefitsboston scientific make acquisition battle medtronic edward
44,MDT,edward lifescience ew boston scientific bsx stock get boost friday medtronic mdt publish study show new method insert heart valve be better alternative open heart surgery close bell stock market today edward stock pop boston stock follow medtronic conduct study exposure transcatheter aortic valve replacement tavr market be smaller share lift fraction company play market boston be still testing product realm patient harden valf condition call aortic stenosis procedure allow new heart valve be insert catheter new device push diseased aortic valve aside trial monitored patient receive heart valve replacement year year mark patient undergo transcatheter aortic valve replacement have die suffer disable stroke vs patient undergo surgery analyst have generally expect rate death disable stroke patient undergo new method heart valve replacement evercore analyst vijay kumar write research report ibd take boston scientific be look take medtronic edward lifescience acquisition december be successful head sector leader look upcoming battle medical technology surgery be much riskier involve longer recovery period medtronic meet goal prove tavr be not inferior surgical method replace diseased heart valve help push more doctor used newer method rbc analyst glenn novarro say believe positive edward stock reaction be due fact larger body clinical evidence show tavr safe effective convince more surgeon consider tavr viable option aortic stenosis patient lower surgical risk write note novarro forecast tavr market exceed grow compound annual growth rate next year see medtronic get fda approval corevalve tavr platform intermediate risk patient next month related boston scientific win patent battle vs edward german courtboston topple heart valve bug wo boost medtronic edwardsedward restart cardiaq heart valve set europe launch rbc
45,MDT,boston scientific bsx edward lifescience ew reach cross licensing agreement design heart valf evercore analyst vijay kumar suggest thursday boston triumph german court patent issue court rule edward infringe boston patent skirt sac reduce leak transcatheter aortic valve replacement court also rule boston infringe edward patent structure heart valve know support beam tossed second edward patent german decision put boston command position ip litigation edward kumar write research report expect boston file court action prevent edward selling heart valve germany injunction be unlikely edward appeal be ongoing write thursday ruling follow decision last week court rule edward patent sac outside anchor provide seal valid infringe second patent fabric seal sapien valve be rule invalid edward say thursday plan appeal german decision company expect court proceedings continue various location extend period time med tech giant also be battle france canada boston scientific stock close stock market today edward jump ibd take boston scientific edward lifescience medtronic be battle heart valve market lead head sector leader deep dive edward be also appeal portion uk court decision precedence doesn look good company kumar write earlier patent battle medtronic mdt regard heart valve tech higher court upheld decision germany uk medtronic edward ultimately settle medtronic pay edward royalty less annually edward have transcatheter aortic valve replacement type heart valve replacement market kumar write medtronic trail used earlier settlement model edward end pay boston less year say duo agree license tech scenario analysis have note event boston scientific win edward lifescience come poorer hand potentially force player arrive cross licensing agreement write related edward stock dip patent loss lawsuit rival bostonmedtronic downgrade increase boston st jude rivalriesboston topple heart valve bug wo boost medtronic edward
46,MDT,medtronic mdt use potential proceed major divestiture add cent earning needham analyst mike matson suggest monday medtronic stock dip stock market today medtronic stock slip share be trading well day move average be year meanwhile ibd company medical product industry group be only bloomberg first report jan medtronic be consider selling covidien acquire medical supply unit business comprise commoditize product include product used nursing care incontinence medical surgical oem product accord insider cite bloomberg deal fetch unit have ebita earning interest taxe amortization matson estimate operate income sale dilute medtronic earning share cent think dilution sale be mostly offset use proceed share repurchase debt retirement needham matson write research report monday additionally sale improve medtronic revenue growth operate margin ibd take medtronic boston scientific edward lifescience be often see battle market share late last year boston scientific say acquire neovasc tissue business take aim rival get bigger scoop ibd sector leader medtronic add cent earning repurchase stock share medtronic use retire debt interest rate add cent ep matson write medtronic also use cash hard predict impact unknown deal write matson keep buy rating price target medtronic stock medtronic be rank first market cap industry group lead stryker syk boston scientific bsx medtronic decline comment rumor potential divestiture ibd related medtronic downgrade increase boston st jude rivalriesedward heart valve guidance lag medtronic boston
47,MDT,boston scientific bsx stock topple week low thursday medtech maker say delay lotus heart valve mechanical issue give rival medtronic mdt edward lifescience ew boost stock market today boston scientific stock fall plunge much edward lifescience stock jump medtronic climb needham analyst mike matson argue investor overreact accord file boston scientific early thursday removal be voluntary enable company deal premature release pin connect lotus delivery system company note excess tension pin mechanism introduce manufacturing process boston be expect relaunch lotus ibd take boston scientific be take edward lifescience medtronic key acquisition read sector leader detail recent buy new business help boston take rival matson estimate boston be take cent hit earning boston earlier guide structural heart sale matson see risk have modeled structural heart sale lotus watchman still expect lotus be differentiate share taker think today sell reduce boston market cap be overdo write be buyer weakness evercore analyst vijay kumar expect boston scientific wo be unexpected boon medtronic edward lifescience medtronic increase confidence organic top line growth see fiscal be sustainable say edward boost sale percentage point still kumar see boston third player transcatheter aortal valve replacement tavr market have buy rating price target boston stock matson keep buy rating price target share delay lotus be doubt disappointing continue believe lotus be meaningful opportunity boston scientific medium term kumar write report success europe adoption give confidence be room third player fast grow tavr market related edward restart cardiaq heart valve set europe launch rbcmedtronic post quickest comeback heart valve brain boost ep potential divestiture
48,MDT,lead medical device maker edward lifescience ew jump monday day artificial heart valve pass hurdle greatly expand market edward conduct large clinical trial compare transcatheter aortic valve replacement tavr sapien traditional open heart surgical valve replacement patient aortic stenosis shrink aortic valve heart be characterize intermediate risk open heart surgery study follow patient day surgery again year later find death stroke be significantly lower sapien group sapien be deliver catheter small incision patient thigh be approve june patient be high risk have open heart surgery add intermediate risk population patient pool lead several analyst hike sale estimate product estimate patient population increase include intermediate risk patient write canaccord genuity analyst jason mill research note raise price target edward lifescience stock increase edward sale estimate pro ep forecast top line projection increase pro ep edward stock rise stock market today close hit new lifetime high stock be already do well ranking ibd also rating spot ibd leaderboard buy point thus profit take zone news also lead analyst lift estimate entire tavr market be currently split edward sapien medtronic mdt corevalve leerink danielle antalffy raise estimate global market edward sapien likely only valve available intermediate risk patient population least next month assume majority incremental market opportunity benefit fall edward antalffy write research note raise price target stock btig analyst sean lavin upgrade stock buy neutral price target medtronic stock rise monday
49,MDT,biotech unite therapeutic uthr say thursday food drug administration have reject partner medtronic mdt application approval device deliver former lung disease drug remodulin send unite therapeutic stock sharply remodulin treatment pulmonary arterial hypertension become top seller unite therapeutic injectable form company have be develop different delivery method broaden patient base also help extend drug patent life unite therapeutic have hope medtronic implantable device treat patient most severe form disease currently only use intravenous form unite therapeutic brief sec filing didn say fda have reject device medtronic have say nothing fda response letter arrived week earlier filing do say letter have note various measure medtronic take make filing approvable company be currently discuss unite therapeutic also note file label extension remodulin approve use device be due decision october unite therapeutic stock hit month low early trading stock market today mid morning be medtronic stock be more top rate stock year unite therapeutic retain stellar ibd ep rank quarterly result miss analyst estimate increase competition start pressure stock even biotech sell start august make pump financially important accord rbc capital market analyst michael yee investor view implantable pump important term program stop slow erosion remodulin generic settlement novartis nvs unit sandoz set allow version start june yee write research note pump be continuously delay then less time convert patient bring approvability question increase risk generic erosion core franchise
50,MDT,share medical device giant medtronic mdt dip sharply tuesday fiscal sale miss estimate earning guidance be line expectation medtronic earning quarter end jan totale share exclude time item year earlier quarter match consensus number calculate thomson reuter survey analyst sale jump adjust last year buyout covidien well foreign exchange rate sale increase just be consensus medtronic affirm full year guidance ep include cent foreign currency impact do not guide earning say sale grow exclude foreign currency impact see amount leerink analyst danielle antalffy write sale miss be largely due higher expect foreign exchange headwind be few sign trouble sale growth do slow bit come growth vs projection represent deceleration growth see fiscal growth see fiscal antalffy write slow growth be likely large part attributable increasingly difficult comparable doesn yet suggest alarm signal broad base slowdown medtronic do deliver positive operate leverage quarter quarter ebit margin vs last quarter improvement fall guidance estimate now leave increasingly positive operate leverage story very much back end load medtronic have deliver operate margin least hit prior guidance report full year antalffy also note medtronic competitor similarly miss sale estimate most recent quarter st jude medical stj boston scientific bsx johnson johnson jnj make medtronic quarter look good comparison medtronic stock be almost late morning trading stock market today stock have be relatively buoyant market sell close monday just few percentage point week high hit last march
51,MDT,medical device maker ibd stock edward lifescience ew beat analyst estimate raise guidance late tuesday send stock fraction hour trading share touch new high regular session edward make cent share quarter exclude time item year earlier quarter top analyst consensus cent accord thomson reuter sale rise vs consensus edward lift full year earning guidance dime guidance issue report add sale range now company also add guidance specifically transcatheter heart valve therapy thvt sapien line valve replacement have drive much edward recent growth now guide sale represent underlie growth edward say market expansion sapien be main driver guidance increase month company sapien transcatheter aortic valve replacement tavr be show reduce death stroke treat aortic stenosis patient intermediate risk open heart surgery boost stock april sapien be only approve patient high risk so add moderate risk patient significantly broaden market company earning conference call analyst tuesday ceo michael mussallem say edward submit datum fda few week be modele approval new indication early come earlier be enthusiastic continue expansion transcatheter base therapy many structural heart patient still need mussallem say statement be confident outlook strong sale growth remain passionate develop impactful therapy help more patient world edward also guide expectation ep cent sale analyst expect earning cent share sale apart thvt business critical care division grow surgical heart valve therapy group decline edward have be exit strategic product line latter group say number surgical procedure be grow edward stock have be roll year hit record high tuesday close fraction ibd composite rating ibd list top perform stock past month strong recent performance explain small move stock make hour tuesday expectation head be elevated edward do not disappoint investor write evercore isi analyst vijay kumar research note be thing have pick be underlie tavr growth international market underlie tavr sale be total tavr growth imply international growth further deceleration conference call mussallem say international thvt sale have actually grow admit have be lose market share abroad sapien line have face competition europe longer have medtronic mdt corevalve be approve year earlier approval january say market share have increase slightly however overall kumar say quarter be very solid expense be say spending come well expectation gross margin decline be already model
52,MDT,allergan agn stock dive tuesday treasury ir announce plan new rule aim curb tax inversion practice allow company avoid taxe buy foreign company move headquarters overseas impact pending deal pfizer pfe ireland base allergan set close year latter be result several recent inversion company say statement late monday be conduct review department treasury action announce today prior complete review win speculate potential impact allergan fall nearly premarket trading be lowest level october pfizer rise nearly latest treasury action limit ability inverted company lend money american subsidiary create deductible interest reduce taxable income treat certain debt issuance stock serial inverter be also target new rule year limit foreign company bulk asset avoid ownership requirement later inversion deal be third set inversion curb rule issue treasury secretary jacob lew last few year lew say office be continue explore additional way limit inversion america corporate tax system give company strong incentive shift headquarters overseas combine federal state corporate rate be highest industrialize world america most nation taxe overseas earning inverted company still have pay tax rate american profit be get relief earning elsewhere other notable recent inversion involved mylan myl medtronic mdt burger king now call restaurant brand qsr deal have already close
53,MDT,edward lifescience ew cardiaq heart valve resume clinical testing company say late friday putt track european launch launch rbc estimate stock market today edward stock jump earlier rise much nearly week high retake day line edward stock plunge feb valve related issue cause company halt enrollment feasibility study have receive requisite regulatory approval begin key trial europe edward opted delay enrollment work issue edward expect resume clinical activity transcatheter mitral valve ibd take boston scientific be make play beat edward medtronic heart valve market read sector leader restart be occur sooner expect rbc analyst glenn novarro write research report see valve launch next year europe novarro keep outperform rating price target edward stock concern tavr transcatheter aortic valve replacement linger acc american college cardiology annual meeting believe cardiaq overhand have now be remove write edward compete boston scientific bsx medtronic mdt heart valve market competitor be larger market cap novarro see edward best growth story large cap medtech related medtronic post quickest comeback heart valve brain therapiesedward heart valve guidance lag medtronic boston downgrade increase boston st jude rivalry
54,MDT,president trump harp drug price tweet early tuesday prompt generic drugmaker teva pharmaceutical teva mylan myl dip even house proposal replace obamacare doesn touch drug price be work new system be competition drug industry trump write tweet open tuesday pricing american person come way drug biotech stock broadly dip response close stock market today ibd company generic drug industry group be fall much earlier touch week low share biotech specialty drug company fall nearly biggest stock loser be specialty drug firm supernus pharmaceutical supn be supernus however also settle patent dispute zydus pharmaceutical marketing generic version supernus seizure treatment trokendi zydus be only company allow market drug certain circumstance start also fall be share endo international endp valeant pharmaceutical vrx plunge trump specific method target drug price competition wasn immediately clear tuesday house release early version bill replace obama linchpin legislation affordable care act ibd take biotech leader celgene major breakthrough head ibd stock analysis deeper dive dub american healthcare act republican proposal end individual mandate bring penalty not have health insurance proposal also repeal medical device tax evercore analyst vijay kumar note latter point be positive general majority device company have be reinvest benefit current temporary repeal device tax be potential boon med tech maker medtronic mdt boston scientific bsx edward lifescience ew make heart valf bill still have long way go make way trump desk evercore analyst terry haine write research report need unanimous support house senate republican democrat likely be opposition be only begin legislative process part aca reform write continue think end june be realistic target document release late monday be merely tax revenue portion aca repeal congress use budget reconciliation process require only majority house portion haine write broader aca reform probably not be finalize year need bipartisanship succeed write today none be apparent be early day related quickly find top rate stock buy point
55,MDT,here weekly investing action plan need know investor come week tesla tsla quarterly report be most eagerly anticipate week mobileye mbly come ex partner tesla charge ahead autonomy continental resource clr other top shale producer report fiber optic stock acacia communication ticker
56,MDT,want put fidelity investment world class research resource work retirement account taxable portfolio course do know boston base asset management giant have deploy asset shareholder stock mutual fund balanced fund help make decision own buy sell example fourth quarter fidelity trim exposure several big technology bellwether stock not fidelity fund act lockstep overall fund complex lighten net share count facebook fb accord todd rosenbluth director etf mutual fund research cfra independent research firm facebook be rank ibd internet content industry group thank part strong composite rating ibd average earning share growth past quarters be highest possible rating be scale fidelity facebook hold be now lightest quarter end level end rosenbluth say new report marketscope advisor facebook have rally begin year time high subsequent disclosure fidelity reveal be buyer facebook share current period fund complex also trim net share count google owner alphabet class share goog class share googl alphabet have rally so far year fade clear buy point flat base jan retake buy point graphic chipmaker nvidia nvda be third tech big name be trim fidelity fidelity also trim salesforce com crm provider customer relationship management software ibd take nvidia rank ibd electronic semiconductor fabless industry group buoy solid gold comp rating straight quarters ep growth acceleration detail check stock vital sign ibd stock checkup still tech remain fidelity biggest sector accounting fund family shareholder money be increase june weighting many fidelity fund include largest remain owner stock overall complex make net trim instance now fidelity growth company fund fdgrx hold alphabet facebook microsoft nvidia salesforce com top year end be several tech name fidelity make net increase share count fidelity boost share count software giant microsoft msft share be highest share count end rosenbluth write be highest share count end rosenbluth write few other stock have double digit percentage share increase include autodesk adsk rosenbluth tell ibd refer developer computer aid design software application financial be fidelity second largest sector shareholder asset increase take place fidelity increase exposure big bank bank america bac jpmorgan chase jpm well fargo wfc see double digit percentage share count growth rosenbluth write add cfra think investor optimism bank improve expectation higher interest rate regulatory reform president trump congress be widely expect lighten regulatory restriction bank addition fidelity make double digit percentage increase share count capital financial cof fidelity blue chip value fbcvx hold alphabet jpmorgan chase well fargo top year end fidelity have weight industrial end fidelity manager make net addition share count aerospace defense contractor northrop grumman noc quarter add share general electric ge comcast cmcsa verizon vz be stock fidelity manager make double digit share increase tech be not only space fidelity fund make cut fidelity manager make double digit decrease telecom titan energy explorer producer chevron cvx medical product maker medtronic mdt athletic apparel footwear equipment maker nike nke decrease appear vindicate early point follow quarter comp rating stock current range anemic chevron nike rosenbluth datum apply fidelity stock balanced fund mixture stock bond together hold nearly shareholder asset accord morningtstar inc fidelity run additional fund hold bond commodity accounting additional shareholder money related st here fidelity have be buy selling
57,MDT,medtronic mdt prep dredge edward lifescience ew share heart valve replacement market johnson johnson jnj boston scientific bsx st jude medical stj be line gouge various piece medtronic business medtronic edward lifescience stock rift tuesday differ analyst view stock market today medtronic stock fall morgan stanley analyst downgrade stock edward stock rise month high david lewis morgan stanley downgrade medtronic stock equal weight overweight also cut price target share close vastly day move average likely be muted growth perspective year lewis say medtronic complete acquisition covidien irish medical product device maker january margin disappear aftermath acquisition expect organic growth serve nice bridge lewis write research report organic growth have decelerate last quarters write be not convince see path outperformance light topline headwind management demonstrate more durable cost opportunity fiscal ibd take late last year boston scientific acquire neovasc tissue business deal hurt rival medtronic edward lifescience check sector leader be battle medical product field medtronic growth hinge part traction minime hybrid close loop diabetes management system food drug administration approval large valve indication intermediate risk patient expect mid lewis project organic growth medtronic launch gain traction meanwhile medtronic see increase competition mri safe launch boston boston st jude be emerge rival deep brain stimulation parkinson patient spectranetic soon compete drug coat balloon dcb treatment be get minimally invasive procedure arena edward stock other hand pull upgrade tuesday guggenheim analyst chris pasquale upgrade edward stock buy neutral establish price target say transcatheter aortic valve replacement tavr expectation have come back earth lackluster still room growth tavr market pasquale write report estimate global tavr sale come edward bring consensus estimate be lower january note have be hard imagine be consider disappointing outcome year yet investor sentiment edward tavr opportunity have soured somewhat wake result fail show kind positive inflection many street model forecast write analyst be exceptionally bullish edward get intermediate risk indication tavr patient august pasquale note temporary capacity constraint center natural ebb flow market likely lead major disappointment pasquale estimate procedure still grow year year last quarter expect worldwide tavr sale double next year trend edward be primary beneficiary even competition increase say related edward heart valve guidance lag medtronic boston rivalryedward guidance likely hinge rivalry medtronic boston
58,MDT,load player here weekly investing action plan need know investor come week dow jone industrial average still try claw way mark market look earning report dow component general electric ge goldman sachs gs ibm ibm well inauguration day
59,MDT,edward lifescience ew fiscal guidance lag wall street heart valve replacement tech fierce competition medtronic mdt boston scientific bsx sale view be line share near month high thursday stock market today edward lifescience stock lift share be year date remain sharply follow edward earning report oct then share topple sale fall short fiscal edward guide sale earning share ex item sale guidance meet consensus growth ep be line analyst expectation evercore analyst vijay kumar write research report transcatheter aortic valve replacement tavr guidance lag consensus kumar write firm guide sale midpoint edward guidance lag analyst view growth kumar note however edward typically guide conservatively end beating raise tavr guidance miss come mount pressure rival medtronic boston scientific food drug administration look likely approve medtronic large valve indication intermediate risk patient mid boston scientific potentially enter tavr market end kumar write report wednesday ibd take boston scientific acquire neovasc tissue business earlier year asset help take medtronic edward lifescience see sector leader be deal ongoing rivalry meanwhile edward peer be see surgical aortic valve replacement savr sale lag try get handle transcatheter mitral valve replacement repair market edward enter replacement side acquisition cardiac recently acquire valtech cardioband repair follow edward disappointing thursday analyst day be clear event kumar say couple factor investor need consider be assumption tavr growth eu likely impact competition be write be important give market growth be trend boston scientific be unchanged thursday medtronic stock fall related medtronic dife month low sluggish diabetes valve salesedward medtronic rebound negative report medtech spiraling
60,MDT,lot investor end not spectacular return finished often tumultuous year gain dec include dividend beat year average annual gain fall short year average yearly return accord morningstar inc mutual fund industry bigwig generally expect more gain win be easy be caution rich weis senior portfolio manager team oversee american century target date target risk asset allocation fund warn rally early november mid december have left less room market rise december many team fund be take year end profit still federal reserve hike key interest rate upward move oil gold price last week well consumer confidence be harbinger reflation rise inflation nominal growth wage say richard turnill asset management mammoth blackrock blk global chief investment strategist tuesday commentary chief beneficiary reflation be value stock especially regional bank health care stock company able expand dividend turnill write see earning growth further rotation big sector such financial underpinning stock market advance be cautious term large inflow new record high write turnill also like european japanese stock go forward part weak currency be wary political policy trade risk eurozone say addition write favor emerge market equity give structural reform improve profitability low valuation darrell riley vice president rowe price asset allocation group expect stock market gain ground again less advanced last year total return be realistic say percent revenue growth margin expansion buyback more dividend best stock mutual fund riley cite factor fuel continue gain market be embrace relatively positive outlook proposal trump tax cut fiscal stimulus say market be already pricing element view expect higher growth rate stronger dollar click here see top perform stock mutual fund still stronger dollar be likely slow business large cap multinational depend export weis say help small cap stock continue outperform say david wagner lead manager rowe price small cap value fund prsvx small cap value fund be top perform group diversify stock mutual fund return small cap blend portfolio be close average advance click here see top perform bond mutual fund late wagner have shareholder money work community bank be largest industry group allocation bank have go tremendous period result financial crisis say regulatory backlash have also be tremendous headwind trump presidency republican congress be expect be friendlier bank clinton administration have be here wagner be position portfolio several sector ibd take western alliance bancshare be tie stock ibd bank west southwest industry group see company growth measurement highest possible ibd composite rating annual pretax margin compare competition visit ibd stock checkup chip rewey lead manager third avenue value fund tavfx look undervalue stock name like include canadian lumber producer get revenue rise rate slow gain housing rate be still historically low housing continue rebound say oil gas name devon energy dvn stand benefit rise energy price rewey say diversify stock mutual fund averaged gain dec top perform fund least asset be aegis value avalx small cap value portfolio gain volatile year many investor seek hedge stock market precious metal fund lead sector soar energy fund be second best spark ahead health care be only sector lose ground slide fix income high yield bond fund lead way total return emerge market debt fund be next notch return overall year consist phase be tale market pre postelection weis say election market be wind be sluggish market leadership indicated be head economic slowdown defensive sector lead once investor begin expect trump republican victory start shortly election be rebound market renew energy optimism weis say investor begin anticipate benefit tax cut less business regulation repatriation corporate cash hold abroad coincide strengthen oil price weis say buoy opec deal cut production stabilization chinese economic growth don expect economy market trend upward interruption see volatility risk aymeric forest head global income multus asset team global asset manager schroder forest cite geopolitical risk globally new administration new administration make mistake say scott clemon chief investment strategist brown brother harriman eventually maybe early rise interest rate slow economic activity weis say forest add be important investor remain flexible take advantage opportunity take multus asset approach especially search income related personal finance action plan stock market reviewhot stock make craig hodge top fund step take now personal financial action plan
61,MDT,edward lifescience ew guidance slate release analyst day event thursday be somewhat strangle likelihood rival medtronic mdt boston scientific bsx pressure heart valve replacement market evercore analyst vijay kumar say tuesday kumar expect edward issue conservative transcatheter aortic valve replacement tavr view tough comp continue competitive pressure fda be expect grant medtronic large valve indication intermediate risk patient mid boston compete year end follow international pressure begin edward tavr sale begin decelerate follow entry medtronic boston kumar write wall street model growth factset polling growth internationally ibd take boston scientific acquisition neovasc rattle medtronic edward lifescience hit sector leader deep dive edward likely issue tavr guidance growth midpoint just miss broader analyst view kumar write edward have historically issue conservative outlook then raise course year say give move part wouldn be surprised see range widen write research report investor be likely key thursday edward plan deal competitive pressure kumar say still edward have strong track record outlasting rival sale grow half thus far additional pressure meanwhile tavr sale be cannibalize savr surgical aortic valve replacement sale kumar say also identify tmvr transcatheter mitral valve replacement repair single largest pipeline opportunity edward lifescience other cardio player next year tmvr be especially important be method treatment replacement repair edward have traditionally play replacement arena acquisition cardiac acquisition valtech cardioband open repair side kumar say kumar see edward touch tmvr market analyst day commentary thought be complementary acquisition investor have wonder be sign edward lifescience be hedge bet crucial pipeline opportunity write keep hold rating price target edward stock close stock market today edward stock be close tuesday more record high touch late september plunge october weak sale share medtronic lift boston add finshed day related medtronic dife month low sluggish diabetes valve salesedward medtronic rebound negative report medtech spiraling
62,MDT,california base intuitive surgical isrg get boost last week new study show patient undergo procedure da vinci surgical system experience fewer complication subject undergo conventional operation be welcome news leader robotic assist surgery help settle long run debate merit minimally invasive quite expensive da vinci equipment compare
63,MDT,load player result new study announce monday show patient undergo procedure da vinci robotic surgical system intuitive surgical isrg experience fewer complication subject undergo conventional abdominal other operation california base medical device maker note better outcome be observed increase complexity patient robotic assist group welcome
64,MDT,load player stock make sustain climb need large infusion capital mutual fund other institutional investor have be sign recently fund manager continue pump more money edward lifescience ew lead maker heart valf other product treat cardiovascular disorder make ibd most recent list
65,MDT,decade research billion dollar have pour develop artificial intelligence have crossed science fiction novelty cusp widespread business application artificial intelligence be area computer science computer be design think operate much human brain support advanced form compute software only smart amount information fed memory bank more information smarter get greatest advancement have be demonstrated area game play ai be now show mettle business world person be start kick tire look see help business bottom line say david schubmehl follow ai field research firm idc return investment evidence be not yet clear start happen facebook fb alphabet googl ibm ibm nvidia nvda be tech leader big artificial intelligence ambition re start see lot company begin use different type ai tech various used say schubmehl re also see lot venture capital money flow lot acquisition take place ibm have deepest ai investment most far reach ability company have pitch cognitive compute tool business cloud base watson platform facebook be used ai decipher best way bring internet service remote area world make news feed feature more relevant user social network alphabet be used enhance google search ability improve voice recognition derive more datum image video nvidia have develop chip technology ai platform used autonomous drive feature enhance driver car communicate alphabet mobileye mbly other also be tap ai race driverless car not enough have google map load self drive system identify pothole weather condition traffic congestion other driver behavior improvising improve fly artificial intelligence term coin be popularize ibm big blue become first computer beat reign world chess champion gary kasparov ibm win again watson computer jeopardy outsmart game show top player ever last october ai computer beat time european champion ancient asian game go build part alphabet google beat fan hui game first time computer program have ever beaten professional go player feat thought be decade away tuesday win first game vs lee sodol be rank world tuesday match show have make big improvement beating rank fan hui last year google paid acquire rapid advance artificial intelligence be still early stage business deployment lot ai be be used today only scratch surface be do say babak hodjat co founder chief scientist sentient technology become so ubiquitous win even call ai anymore sentient emerge stealth mode late massively distribute ai platform company use boost performance shopper shoeme browse photo shoe click one sentient technology narrow selection so person don get overwhelmed choice need text base search drill navigation say hodjat ai technology decipher shopper be look let quickly dive deeper catalog find perfect item otherwise go undiscovered ve revolutionize user experience commerce say hodjat huge change way user interact product online therefore drife conversion sentient have receive venture capital funding most ai startup accord research firm cb insight ai startup have receive funding intel intc alone have invest ai company include saffron technology saffron say platform mimic fundamental principle human remember learn case study saffron help insurer identify fraudulent auto insurance claim week saffron examine claim year state find potential fraud ring then detected ring be part larger ring involved claim insurance company have paid claim saffron be able collect datum identify relevant unknown relationship include different provider demographic injury description create knowledge store have never be do saffron forecast insurer avoid payout ten million dollar year ai go term such machine learn deep learn ibm call cognitive compute october launch cognitive business solution consultant skilled datum analytic cloud compute other area more company have deal use watson cloud service develop commercial product apps service turner broadcasting feb sign deal use watson ad sale effort time warner twx unit own tbs tnt cnn used ibm watson turner expect parse manner datum help draw more advertiser provide greater impact watson health be platform physician researcher insurer other company focuse health wellness medtronic mdt be collaborate ibm personalize care person diabetes analyze patient info datum medtronic device watson predict low blood sugar program hour advance artificial intelligence be used advanced technology help develop brainy reasoning disorganized information unstructured datum derive accurate decision ve do research be really understand add unstructured datum decision say david kenny general manager ibm watson unstructured datum come multitude source be not organized be datum bit photo medical image video audio transmission be ton datum flow camera sensor building smartphone web traffic tweet email government filing business document more information artificially intelligent computer digest smarter get collect datum massive scale be reason ibm acquire several weather co property include weather com weather underground mobile cloud base asset report october ibm be able analyze datum more weather reference point smartphone airplane flight day let offer broad range datum drive product service more client medium aviation energy insurance government industry ibm say provide predictive weather analytic real time analysis social medium chatter detailed understand transportation flow other datum benefit retailer distributor weather co asset serve foundation new watson unit focuse internet thing iot early year ibm announce invest build iot product service
66,MDT,more do smarter watson get smarter ai get say kenny ai be become more widespread work kenny say user ai be save time money re make faster decision get better outcome analysis facebook alphabet google research firm innography show surge ai patent filing begin alphabet currently have more ai patent be active pending government approval facebook have facebook last june open artificial intelligence lab paris goal improve way user interact world largest social network
67,MDT,hope research ultimately help make service news feed photo search even better enable entirely new set way connect share facebook say time also have ai research team menlo park calif headquarters new york facebook february reveal connectivity lab project used ai analyze square mile land used road school other structure determine many person live give area tell facebook aquila drone go provide internet access less develop area part company internet org initiative datum give greater understand population be disperse so government other prioritize investment infrastructure transportation healthcare education facebook say
68,MDT,stock end lower weak volume monday nasdaq wrapping third straight monthly decline lose nasdaq dow jone industrial average slip monday index be testing resistance decline day move average volume be lower stock market today fall nyse nasdaq compare friday accord preliminary datum drugmaker lead decline valeant pharmaceutical vrx drop cancele earning report withdraw guidance separately bloomberg news report security exchange commission be investigate valeant previously unannounced probe investigation be separate exist investigation company salix pharmaceutical valeant buy last year bloomberg report cite person familiar matter drugmaker endo international endp crash massive volume say close astora woman health division end march reduce potential product liability related future vaginal mesh implant endo have fail find buyer astora announcement overshadowed better expect earning report company report profit jump share sale climb ligand pharmaceutical lgnd lead broad decline ibd sink hit resistance day move average mining stock be day best performer follow gold price higher newmont mining nem rise almost try clear buy point long deep cup handle base month edge nasdaq slip accord preliminary datum dow industrial end month halter month skid company due report quarterly earning tuesday include autozone azo dollartree dltr ross store rost medtronic mdt economic datum schedule tuesday include construction spending january auto sale february institute supply management manufacturing index february
69,MDT,medical device maker edward lifescience ew be rise heavy trading thursday receive upgrade base bullish outlook sapien transcatheter aortic valve replacement tavr suntrust robinson humphrey analyst bruce nudell upgrade edward stock buy neutral raise price target base last friday announcement fda have approve new study sapien elderly patient have severe aortic stenosis have low risk death traditional surgical valve replacement edward launch sapien last year high risk patient study potentially expand market base somewhat more lenient standard expect nudell write follow fda approval initiate sapien low risk ide investigational device exemption study year primary endpoint vs anticipate year follow ve update tavr market model reflect expedite timeline label expansion substantial patient pool nudell write research note estimate tavr market increase line company projection currently tavr market be split edward sapien medtronic mdt corevalve leerink analyst danielle antalffy also raise estimate same reason maintain outperform rating edward stock update model assume conservatively so believe just modest uptake low risk patient reach penetration europe year approval antalffy write research note thursday low risk approval believe global tavr market growth be sustainable foreseeable future ramp volume help offset model be mid single digit annual price decline new competitor enter market predominantly edward be lead stock medical product group strong ibd composite rating early afternoon stock market today edward stock be medtronic stock be nearly follow amy reeve twitter ibd_areeve facebook
70,MDT,new high list expand nicely stock market wednesday help follow big percentage gain higher volume index confirm new stock market uptrend edward lifescience ew rise still buy range buy point reclaim entry tuesday average trade edward compete medtronic mdt
71,MDT,medical giant johnson johnson jnj say tuesday restructure device division bid save annually end didn provide many detail press release say discuss project further report earning jan however do specify
72,MDT,medtronic mdt pop month high thursday smash quarterly expectation resolve linger issue diabetes unit post double digit growth pain therapy stock market today medtronic share jump earlier share lift much touch high last see july broader medical product industry group dip fraction quarter medtronic report adjust profit share sale rise respective organically sale increase adjust income grow medtronic say news release consensus have call adjust profit share sale get newsletter deliver inbox more info product service privacy policy term use relative nervousness investor have come expect medtronic earning release thought fiscal fourth quarter print be solid evercore analyst vijay kumar say note client medtronic post nearly perfect board beat diabetes device generate sale rise constant currency basis growth be medtronic note strong demand new sensor augment insulin pump system result help stem ongoing concern medtronic diabetes device segment edward jone analyst john boylan say report client diabetes look particularly strong view be linger doubt medtronic have solve production issue meet demand be erased result say minimally invasive therapy also top consensus evercore kumar say unit bring sale firm say sale unit fall vs last year constant currency basis grow restorative therapy grow constant currency basis sale rise unit spine device bring pain therapy generate rise report basis constant currency basis even spine have nice quarter ongoing sluggish market feel have gain share edward jone boylan say year medtronic guide organic sale growth adjust profit share consensus have modeled sale adjust income share rbc analyst glenn novarro note be look organic growth current fiscal year overall fourth quarter sale be strong growth cardiac vascular unit be slower medtronic be also several competitive market edward jone boylan maintain buy rating medtronic be reiterate view medtronic be position well growth due new product ongoing cost saving covidien acquisition continue focus emerge market say do not believe positive be reflect share stock related chart read basic buy point mark time real tame volatile swing trade half positionlook best stock buy watch start here
73,MDT,boston scientific bsx land broker list top stock analyst suggest tuesday medtech company hit share earning power rbc capital market analyst glenn novarro be bullish boston revenue prospect boston have number implantable device cardiac condition neurological disorder chronic pain relief also have broad portfolio endoscopy urology pelvic health reach novarro earning projection boston have grow compound annual rate last year gaap earning share also have achieve operate margin expansion basis point furthermore new launch peripheral intervention interventional cardiology medsurg be incremental growth say note client therefore organic revenue growth seem quite feasible get newsletter deliver inbox more info product service privacy policy term useon stock market today boston share advanced close same time ibd company medical product industry group collectively rise group rank second industry group ibd track novarro also see margin earning interest taxe ebit realistic goal boston previous report metric set guidance growth basis point upcoming key event include plan launch drug coat balloon call ranger potentially aortic valve system dub acurate neo well boston also begin study implantable heart device call watchman lead approval medtech company be also likely have datum study slow drug delivery system further separate study acurate neo vs edward lifescience ew device call sapien medtronic mdt corevalve evolut complete enrollment second half study have datum get instant access more trading idea exclusive stock list ibd proprietary rating only related much money do need start investing long term retirement investing strategy etfslook best stock buy watch start here
74,MDT,share boston scientific bsx surge monday report wall street journal have be approach stryker syk deal medical device maker unclear boston scientific be open takeover journal say cite source didn identify boston scientific share soar much end regular trading session stryker share fall close trading stock be halter just monday neither company comment merger rumor deal company be latest series large acquisition industry have be consolidate market share package sale hospital doctor health clinic boston scientific make heart device such pacemaker stent other product be worth estimate market value nearly value stryker make orthopedic product artificial hip knee get newsletter deliver inbox more info product service privacy policy term usecombine company let wring cost effort sell product similar set customer also give combine firm more market power merger large health insurer have increase pressure hospital lower expense movement come ongoing debate cost medical care matter company policy do not comment potential stryker jon zimmer say email representative boston scientific didn immediately respond request comment many largest competitor have already execute large takeover recent year abbott laboratory last year buy st jude medical make heart device then month later complete takeover medical testing diagnostic supplier alere medtronic mdt buy covidien make surgical product
75,MDT,integer holding itgr be ibd stock day share break record high friday week medtech player be set report earning integer stock pop close touch record high stock market today share break buy point flat base come bullish view zack equity research say integer stock be stronger abiom abmd stock zack analyst have buy rating integer abiom stock be base improve revision earning expectation integer be outsource manufacturer medical device abiom make heart device early friday report also look forward price earning ratio integer be lower signal stock be undervalue medtech firm be do exceptionally well relative past trend abiom stock have price earning ratio term earning growth expectation integer also have lower peg price earning growth ratio account expect annual earning growth relative price earning ratio ratio integer appear less expensive abiom have ratio zack also subtract company liability asset effort compare market price book value price book ratio integer again come top ratio abiom integer hold value grade abiom have value grade analyst write integer abiom be impressive stock solid earning outlook base valuation figure feel integer be superior value option right now investor be also likely bullish integer upcoming second quarter earning release set early aug analyst poll zack investment research call adjust profit cent share sale year year basis earning specific item be expect grow nearly sale advance more earning prove catalyst company medical product industry group ibd rank group second group track group have remain top past week week be rank first term market cap medtronic mdt stryker syk boston scientific bsx lead group integer be list stock group have ibd composite rating least integer cr put top stock term fundamental technical stock pick criterium related stock market forecast smaller price gain foreign tiltwant income close end fund offer yield beware risksmeet best broker overall online trading need
76,MDT,artificial intelligence now firmly entrench many hospital operate room field robotic surgery be start get competitive giant company alphabet googl johnson johnson jnj medtronic mdt be training sight intuitive surgical isrg king robotic surgery company analyst say boom medical technology segment have lot room run robotic surgery be area grow billion dollar more machine be used treat patient intuitive command space annual sale signature da vinci robotic surgeon however be limit type procedure handle multus limb da vinci be used variety procedure include cardiac colorectal gynecological head neck thoracic urologic surgery only long re minimally invasive big market be be still unclear yet analyst agree potential have yet be tap so more player be move quickly get newsletter deliver inbox more info product service privacy policy term use think investor need understand robotic ai artificial intelligence revolution be happen touch sector economy say jeremie capron director research manage partner robo global index advisory firm specialize robotic industry investment be technological revolution investor afford miss analyst say march auris health become first company formidable threat intuitive catheter base monarch platform gain approval intuitive counterpunch seek approval flexible catheter similar auris device likely year rbc analyst brandon henry say recent report meanwhile other be work area intuitive surgical doesn have foothold nephew snn have robotic assistant knee replacement stryker syk have robotic joint replacement system mazor robotic mzor zimmer biomet zbh have robotic offering brain spinal surgery mazor alone see sale just system player have long way go take intuitive surgical throne intuitive have market cap today worth nearly capron call intuitive amazing stock think investment community have be scratch head try figure impact new entrant intuitive surgical tell investor business daily feel pretty relax size be big enough small player come share medical tech company have be relatively insulate wo frustrate biotech pharmaceutical stock late stock medical equipment maker such intuitive mazor have collectively spiked year date intuitive blowout quarter april help spur excitement evercore analyst vijay kumar say recent note client recent investor day medtronic be help drive frenzy robotic surgery be topic currently medtech blowout quarter intuitive surgical hint pace manual robotic transition be pick kumar say topic competition elicit various response investor intuitive surgical stock be year climb kumar expect intuitive surgical competition become more apparent next month intuitive da vinci surgical system now boast patient count da vinci system be also move deeper hernias be see early stage adoption bariatric surgery perform induce weight loss myriam curet executive vice president chief medical officer intuitive note email ibd estimate prostatectomy be perform robotic assist surgery same be true malignant hysterectomy general surgery be fastest grow specialty be still early stage adoption procedure such ventral inguinal hernia repair colorectal bariatric surgery say believe be substantial opportunity expand robotic usage category be develop additional tool technology do so year intuitive guide first quarter earning conference call growth number procedure perform system year follow many consider strong fourth quarter recur revenue include instrument accessory da vinci system grow recur revenue represent sale pie still even intuitive surgical see early innings expect robotic surgery present huge total addressable market number da vinci procedure perform year grow nearly other robotic surgery company intuitive closest competitor auris doesn trade publicly recently be stealth mode kumar say medical technology company sign agreement division agreement come month auris monarch system grab approval monarch be flexible catheter surgeon thread patient mouth lung remote control approval investor believe credible competitor intuitive be year away kumar say monarch get approval month ahead view intuitive surgical plan seek approval own flexible catheter later year auris say monarch first target be lung cancer expert estimate half lung biopsy be perform year surgeon also use flexible catheter urinary tract procedure number roughly procedure year intuitive isn sweat competition auris chief executive interestingly be frederic moll founder intuitive surgical intuitive current ceo gary guthart joined medical technology firm take ceo have build technology make decision architecture base first principle not look shoulder other person be do really engage customer deeply understand clinical need guthart say recent earning call rbc henry note auris monarch have larger catheter intuitive allow camera intuitive see benefit smaller catheter move deeper lung henry write recent report allow surgeon potentially use remove diseased tissue meanwhile have team google company call verb surgical analyst be unsure system team be create do expect enter robotic surgery market same time medtronic be partner mazor medtronic also expect own robotic surgery system launch not unreasonable suggest intuitive keep market evercore kumar tell ibd new robotic surgery company have differentiate have straightforward too product say investor have put pretty punchy marketable valuation intuitive surgical re still early stage robotic conversation add market be big enough sustain multiple player company mazor zimmer biomet make system call rosa come have system surgeon use brain spinal procedure other mazor ceo ori hadomi say sizing opportunity robotic surgery company be difficult surgeon use mazor system spinal surgery company renaissance system perform spinal brain surgery cost disposable instrument material comprise mazor revenue hadomi tell ibd surgery perform mazor list price be term disposable item estimate half procedure generate stakeholder expect spine procedure grow rapidly person be be more more active say meaning suffer more injury require surgery more often procedure become less invasive safer procedure become more patient be willing interested be treat be operated benefit robotic surgery be plentiful hadomi say revision surgery surgery correct mistake tweak prior surgery be significantly lower robot assist precision robot help curb potential error say last october mazor unveil result patient study find fivefold reduction complication surgery perform mazor robotic surgery technology notably be also sevenfold reduction revision surgery compare freehand lumbar fusion surgery doubt patient perspective not consider go surgery robot know chance go revision surgery be time higher say revision surgery be also costly hospital face reimbursement hurdle agree robotic surgery win replace human surgeon hadomi liken system other toolbox surgeon be simply medical technology tool make operate easier surgeon safer patient say benefit be also grow investor say robo global capron really exciting be fact be inflection point technology enable robotic surgery price point be attractive say now lot action medtronic see confirmation be substantial addressable market related look best stock buy watch start herecan crispr small biotechs cure disease amazon vs walmart locking horn battle retail futurechart read basic buy point mark time real marijuana industry overtake beer legalization spur innovation
77,MDT,dow jone component johnson johnson jnj engage bidding war sweep boston scientific bsx stryker syk analyst say tuesday follow rumor latter merge report emerge monday stryker approach boston takeover bid boston share spiked rumor stryker topple canaccord analyst say stryker be far only medical device maker interest boston headline be substantiated stryker be fact make bid boston scientific see high likelihood emerge potential bidder say note client have be banter potential boston scientific acquirer year bidding war emerge place high likelihood be involved stock market today boston stock dip close stryker share plunge even stock look somewhat dim ease fraction get newsletter deliver inbox more info product service privacy policy term deal have analyst somewhat split tuesday regard materiality report do not find potential such marriage be shocking canaccord analyst say indeed see merit such combination standpoint product line synergy stryker acquisition help add product sector higher potential growth bigger market also help stryker differentiate portfolio technology compete large company medtronic mdt boston case deal cap year turnaround allow end high note canaccord analyst say sum definitively think boston scientific be game do fair deal here say rbc analyst glenn novarro view deal unfavorably acknowledge strategic rationale make sense also likely boston win deal less share combine premier growth company medical device space be limit product overlap say however bar value creation be set high give potential valuation company combine stryker boston scientific have revenue stand grow sustainable higher compound annual growth rate medium term novarro say have enterprise value canaccord analyst call potential deal merger equal stryker be only third larger boston also lead further med tech consolidation consummate create behemoth medical device stryker boston scientific join abbott medtronic say think edward lifescience ew be next potential major acquisition target also highlight nephew snn be last remain pure play total joint operation market related chart read basic buy point mark time real trade stock most penny stock fail make investor basic analyze stock cup handle
78,MDT,san francisco medical equipment maker intuitive surgical isrg st jude medical stj be move opposite direction stock market wednesday issue preliminary result
79,MDT,intuitive maker da vinci robotic surgery system say revenue be year earlier quarter beating analyst consensus do not provide guidance overall say expect procedure used da vinci system increase company be slate report full result jan
80,MDT,intuitive press release do not provide much color company be plan presentation jp morgan healthcare conference thursday san francisco analyst however be positive news
81,MDT,procedure continue show momentum highlight be magnitude strength system placement write evercore isi analyst vijay kumar research note procedure guidance fy be slightly estimate believe reflect amount conservatism give recent trend procedure come estimate
82,MDT,intuitive stock rise year high early trading stock market today close share be fraction day
83,MDT,st jude meanwhile say sale be fraction year earlier quarter short consensus earning be share line estimate
84,MDT,speaking conference wednesday st jude ceo michael rousseau admit exclude last year acquisition thoratec maker device heart failure therapy business have decline say foreign exchange headwind be particularly bad last year cardiac rhythm management business shrank company be lull product cycle
85,MDT,competitor medtronic mdt last year win approval first implantable cardioverter defibrillator safe mri scan already launch mri safe pacemaker st jude start roll similar product europe japan last year be disadvantage medtronic product be clear rousseau say start first half year
86,MDT,thoratec meanwhile outperformed wall street expectation growth constant currency basis
87,MDT,st jude didn offer guidance be expect earning conference call schedule jan leerink analyst danielle antalffy write guidance likely be conservative possibly leave room estimate raise year
88,MDT,follow amy reeve twitter ibd_areeve facebook san francisco medical equipment maker intuitive surgical isrg st jude medical stj be move opposite direction stock market wednesday issue preliminary result intuitive maker da vinci robotic surgery system say revenue be year earlier quarter beating analyst consensus do not provide guidance overall say expect procedure used da vinci system increase company be slate report full result jan intuitive press release do not provide much color company be plan presentation jp morgan healthcare conference thursday san francisco analyst however be positive news procedure continue show momentum highlight be magnitude strength system placement write evercore isi analyst vijay kumar research note procedure guidance fy be slightly estimate believe reflect amount conservatism give recent trend procedure come estimate intuitive stock rise year high early trading stock market today close share be fraction day st jude meanwhile say sale be fraction year earlier quarter short consensus earning be share line estimate speaking conference wednesday st jude ceo michael rousseau admit exclude last year acquisition thoratec maker device heart failure therapy business have decline say foreign exchange headwind be particularly bad last year cardiac rhythm management business shrank company be lull product cycle competitor medtronic mdt last year win approval first implantable cardioverter defibrillator safe mri scan already launch mri safe pacemaker st jude start roll similar product europe japan last year be disadvantage medtronic product be clear rousseau say start first half year thoratec meanwhile outperformed wall street expectation growth constant currency basis st jude didn offer guidance be expect earning conference call schedule jan leerink analyst danielle antalffy write guidance likely be conservative possibly leave room estimate raise year follow amy reeve twitter ibd_areeve facebook
89,MDT,re dominant player rapidly grow market wall street tend take shine stock case edward lifescience ew maker product treat cardiovascular disorder much company growth come market transcatheter aortic valve replacement product edward chief rival medtronic mdt be
90,MDT,special report ce tech show newslas vegas ibm stock ibm cognitive compute system watson have graduate winning jeopardy predict hypoglycemic event diabetes patient provide brain customer service robot ibm ceo ginni rometty discuss partnership involve ibm watson keynote speech ce wednesday la vegas massive annual consumer electronic show end saturday rometty talk medtronic stock mdt armour stock ua softbank robotic be used watson big datum analytic capability vastly different way medtronic ceo omar ishrak say company be used watson page technology diabetes page management new app roll summer medical technology firm medtronic track diabetes patient blood sugar level predict life threaten hypoglycemic event hour advance symptom armour ceo kevin plank say company hooked ibm watson want customer get more meaningful datum backed health fitness insight company ua record app provide athlete timely evidence base coaching sleep fitness activity nutrition include outcome achieve base other app act personal health consultant fitness trainer assistant say plank say be drive create app be frustrated fact person have more datum health car investment own body watson also be provide artificial intelligence social humanoid robot call pepper softbank robotic pepper currently be be used customer service robot limit number mizuho financial group stock mfg bank branch nestle stock nsrgy coffee shop japan watson cognitive compute capability be ready be put use host industry rometty say also ce ibm announce venture involve watson medical diagnostic firm pathway genomic home appliance maker whirlpool stock whr pathway genomic unveil test version pathway genomic ome app power watson app merge cognitive compute deep learn precision medicine genetic enable pathway genomic provide consumer personalize wellness information meanwhile connect appliance whirlpool such kitchen laundry machine use watson service include cognitive analytic provide more personalize service consumer
91,MDT,come surgery intuitive surgical isrg chief executive gary guthart seek follow old camper motto leave campsite be ever trauma involved open patient end be almost damage difficult recover ailment surgery aim remove thus
92,MDT,boston scientific bsx investor breathe sigh relief wednesday medical technology player top analyst first quarter expectation lift guidance day rival edward lifescience ew come short key segment stock market today boston rise close share be consolidate buy point edward stock other hand sank boston be seemingly buck choppy earning season evercore analyst vijay kumar say note client environment feel most medtech stock be expect trade issue report boston be steady go say investor position possibly contribute move today say step away quarter think share be fairly price give current growth outlook relative similar high growth large cap peer cause remain sideline get free access ibd digital april
93,MDT,get premium stock list pass fail stock rating more start first quarter boston report adjust profit cent share rise nearly top consensus penny total sale grow report basis also beating analyst view boston also raise outlook sale adjust profit share metric top consensus sale adjust earning share boston be ride wave choppy earning season kumar say neuromodulator sale be source upside quarter revenue implantable device treat chronic pain neurological disease grow report basis operationally be help sale spectra wavewriter spinal cord stimulator used treat chronic pain device gain approval january subsequently launch revenue implantable cardioverter defibrillator also help grow double digit kumar say cardiac rhythm management sale be line organically interventional cardiology grow organic basis kumar view growth investor be likely nervous boston hasn yet offer update transcatheter heart valve replacement tavr device call lotus tavr be method replace diseased heart valve used catheter rather resort open heart surgery boston voluntarily recall lotus lotus edge aortic valve system europe last year discover issue system february boston say plan launch lotus edge system europe lotus product compete tavr system edward medtronic mdt have respective mid mid split market analyst say have nitpick possibly lack lotus update better revenue flow high end not translate operate margin expansion come mind kumar say sense be be healthy debate stock lotus related chart read basic buy point mark time real invest stock free new apps aim buy stock ahead earning report
94,MDT,larry wood liken aortic stenosis cancer heart aortic stenosis be most common serious valve disease problem restrict blood flow left ventricle aorta cause fatigue pain occur birth defect elderly patient edward lifescience ew medtronic ticker
95,MDT,intuitive surgical isrg break past buy point heavy volume hit record high wednesday knock park once again first quarter analyst say share intuitive jump close stock market today stock break consolidation begin form late january buy point intuitive also joined investor business daily leaderboard sign point strong canaccord analyst jason mill say note client firm continue produce best class result large cap medtech knock park once again first quarter say lion share first quarter metric handily eclipse expectation get newsletter deliver inbox more info product service privacy policy term analyst be more split procedure growth expectation quarter number procedure used intuitive da vinci surgical system rise intuitive cite grow demand general surgery worldwide urologic procedure number da vinci procedure perform grow growth be rest world intuitive raise bottom line outlook growth procedure placement new da vinci system hospital also be highlight grow year year ultimately procedure growth remain key focus investor procedure volume growth have historically be lead indicator additional system placement mill say intuitive expect still early innings large hernia repair market mill say hernia general surgery be expect be biggest procedure volume bucket mill see intuitive fire cylinder evercore analyst vijay kumar note intuitive didn raise top end outlook procedure volume procedure grow say note client question come valuation intuitive stock kumar say hospital be fact purchasing da vinci system anticipation future procedure demand then lofty price earning ratio be justified however give historical comment procedure be lead indicator system placement procedure come line expectation argue greater time price earning ratio capital expenditure revenue beat say maintain high valuation also depend intuitive maintain standing predominant player market kumar say auris health recently launch monarch platform lung biopsy same time dow jone component johnson johnson jnj medtronic mdt be move robotic surgery market investor be more comfortable pay premium price earning ratio asset perceive have monopoly power say other entrant come make case sustenance monopoly power bull argue intuitive have technological lead rival debate be likely come head next month kumar say meantime kumar say be stay sideline canaccord mill up price target intuitive keep hold rating related much volume look stock look best stock buy watch start basic analyze stock cup handle
96,MDT,edward lifescience ew rocket late thursday beating fourth quarter sale estimate better expect demand transcatheter heart valve replacement hour trading stock market today edward share pop close regular session fourth quarter edward report adjust income cent share beating estimate cent sale grow crushed consensus revenue transcatheter heart valve therapy advanced beating consensus evercore analyst vijay kumar write note growth be drive robust adoption more center edward say press release transcatheter heart valve replacement tavr be method replace diseased heart valve resort open heart surgery arena edward compete closely medtronic mdt do not experience much slowdown typically see last week year chief executive michael mussallem say written statement ibd take edward ibd composite rating rise twice last week be now best possible meaning outpace stock term key growth metric head ibd datum story more go edward rating increase surgical heart valve therapy sale advanced drive strong sale aortic valf region share gain new product edward say critical care sale rise company now see sale line midpoint analyst view revenue adjust profit be expect come share crush consensus model march quarter edward expect report sale current foreign exchange rate adjust earning share consensus have see adjust profit share sale related boston scientific top fourth quarter sale view earning linebiotech roundup pop drug merger earning news crispr small biotech company cure disease
97,MDT,medical supplier stock collectively topple month low intraday tuesday becton dickinson bdx biggest loser report emerge amazon com amzn be plan sell supply hospital analyst largely doubt amazon put pressure manufacturer higher tech product include implantable device insulate company medtronic mdt stryker syk cantel medical cmd conm cnmd teleflex tfx needham analyst mike matson write note client other industry amazon have typically disrupt middleman more manufacturer say view amazon model work lower tech product be unlikely work higher tech product matson say lower tech product list lower price single use item don require service be typically used sale representative present higher tech item be often implantable need service require sale rep present use perhaps not surprisingly lower tech product be already typically sell distributor such owen minor omi higher tech product be typically sell directly manufacturer say view amazon simply represent distribution channel lower tech product ibd take stock market remain high market still thro correction important keep tab key action visit big picture evercore analyst vijay kumar say amazon be formidable player basic medical supply category include plastic glove drape simple catheter company cover group be becton baxter bax becton baxter be likely happy supply amazon well other distributor say report client close bell stock market today becton sank finish earlier fall much collectively medical supplier stock topple much low last see april group end day baxter trade medical product group dip medical product stock broadly fall much be marginally close related payer win balk price tag vertex new drugis teva pharma restructure plan actually more reasonable regeneron benefit lackluster datum present rival
98,MDT,key stock index fund rise thursday fang stock other big cap techs power big gain tech heavy powershare qqq trust powershare qqq trust qqq lead upside gain spdr spy spdr dow jone industrial average dium add respective small cap lag slightly ishare russell iwm ishare core small cap ijr climb respectively fang stock boost techs facebook fb gap soar almost retake day move average first time week close wednesday social network report result top view top bottom line amazon netflix pop stock regain day line alphabet googl advanced reclaim day line intel intc microsoft msft rise more dow stock be time high apple aapl add be tough week so far iphone maker share trade day line analyst expect apple earn share revenue report tuesday chip technology biotechs be biggest sector fund gainer stock market today vaneck vector semiconductor smh gap rise retake day line advanced micro device amd surge regain day line earning sale beat late wednesday well higher revenue outlook real estate homebuilder financial underperform stock fund be ailing volatility market health care play hold medtronic mdt abbott laboratory be find healthy support ishare medical device ihi continue consolidate mark record high late january tumble day move average stock market slump early february etf find support have be trading day line then climb back high market environment improve potential buy point be fund track dow jone select medical equipment index turn year old next month health care equipment represent biggest sector weighting tuesday nearly asset life science tool service make health care service rest top holding include medtronic abbott lab thermo fisher scientific tmo becton dickinson bdx dhr account stock portfolio get free access ibd digital april
99,MDT,get premium stock list pass fail stock rating more start herethermo fisher have produce gain wednesday close becton dickinson abbott be medtronic be medtronic have have rough start year share weaken mid february medical device maker suggest first use human hugo surgical robot be delay previously plan start operate patient end fiscal end month fund return year date tuesday accord morningstar inc far ahead loss average annual return past year have also outperformed broader index gain same period be ihi carry expense ratio wednesday pick spdr bank kbe spdr regional bank kre see mixed finish continue work right side respective shallow basis also be interested stock rise boee soar ge sink bitcoin pare lossesai robotic blockchain hot new etf industry trendshere way invest fang stock etf
100,MDT,stock market index fund extend gain monday key dow jone industrial average etf reclaim couldn hold day move average spdr dow jone industrial average dium rally nearly inch day line then retreat gain spdr spy powershare qqq trust qqq also add stock market today foreign market trail ishare msci eafe efa ishare msci emerge market eem edge higher dow stock advanced top blue chip winner include unh merck mrk apple aapl add mark third straight advance iphone maker be work right side shallow base potential buy point raymond james warn apple get hit sell news reaction report expectation be already baked share price utility consumer staple homebuilder be top sector fund gainer spdr homebuilder xhb advanced continue trade day day line aerospace defense also show strength ishare aerospace ita lift build flat base potential buy point defense contractor include raytheon rtn northrop grumman noc dow component unite technology utx rally heel coordinate strike syrium britain france friday raytheon lift clear flat base entry average volume telecom biotech gold miner underperform most biotech health care fund get hurt past month heighten volatility broader market top performer accompany table see healthy year date gain vs wednesday accord morningstar direct first trust nyse arca biotechnology index fund fbt place first year date return even drop past month fund regain day move average thursday be form double bottom base buy point top holding thursday include avexis avxs intrexon xon nektar therapeutic nktr agio pharmaceutical agio intercept pharmaceutical icpt avexis share soar april news novartis nvs buy biotech get newsletter deliver inbox more info product service privacy policy term useark genomic revolution multus sector arkg come second year date return fund invest company involved genomic related field such gene therapy target therapeutic next generation oncology top holding intellium therapeutic ntla edita medicine edit illumina ilmn invitae nvta bluebird bio blue account third stock portfolio fund lose past month have be trading day line late march share be march intraday high third place go ishare medical device ihi gain wednesday fund track dow jone select medical equipment index sit high top holding make stock portfolio be medtronic mdt abbott laboratory thermo fisher scientific tmo becton dickinson bdx dhr alp medical breakthrough sbio spdr biotech xbi round top etfs respective year date gain also be interested stock lower big bank weigh dow apple buck declinestock market rally intel apple boost dow bitcoin biotechs drugmaker fare senate tax bill
101,MDT,alphabet world internet search leader be prospect core business strike success health care world company glucose monitoring contact lens diabetic be inch closer drugstore shelve sale self stabilize spoon design help person uncontrollable hand tremor eat comfortably top first month google restructure last year become largest operate unit new parent alphabet googl buy biotech company lift lab just few month health focuse startup begin product sale point broaden emphasis other health medical advancement alphabet last month rename google life science division verily life science division bring together clinician scientist be focuse understand improve chronic condition impact massive number person health issue include cardiovascular disease diabetes cancer disease mental health be development health care think be far reach be long last be see period convergence technology company health care company california life science association trade group ceo sara radcliffe tell ibd say change drive health care tech firm partnership include explosion big datum result demand way manage patient information growth access datum internet cloud mobile technology such fitbit fit wearable be shift health care maintain tracking health rather simply treat disease say company team uprecent notable health tech partnership include alphabet verily division team last month johnson johnson jnj develop surgical robot news follow september announcement google life science spinoff calico have enter year collaboration north chicago ill base pharmaceutical firm abbvie abbv research age related disease verily have partner too medical device firm dexcom link verily create new class disposable glucose monitoring system be faster cheaper smaller product be currently available johnson johnson verily announce last year have create verb surgical develop new surgical robotic device smaller less expensive intuitive surgical isrg da vinci system now control minimally invasive surgery segment other look join force health tech divide include medical device maker medtronic mdt be collaborate big datum solution provider ibm ibm watson health analyze wave information glean diabetes insulin pump datum vs be not only tech heavyweight seek blend medical altruism big datum big moneymaking plan apple aapl microsoft msft other be also used deep technology expertise create medical related product service year apple introduce health tracking tool monitor user footstep heart rate sleep activity microsoft samsung already offer number so call wearable device also allow person monitor daily movement advance mobile compute artificial intelligence new analytic software be drive effort recent year have be increase interest health care application company traditionally be see be consumer focuse company say iain simpson drug delivery specialist cambridge consultant company such google apple facebook fb amazon com amzn have build consumer focuse business base creation compelling sustainable user experience now simpson say various tech company be head health drive increase relevance capability market create new high value business opportunity particularly work collaboration establish health care player such pharma medical device company health care spending weigh project reach accord california health care foundation profit potential be obvious incentive other factor be also work part reason alphabet focus move needle parkinson treatment be personal google co founder now alphabet president sergey brin mother eugenia have parkinson brin be diagnosed carry mutation lrrk gene have be associate higher rate degenerative disorder central nervous system generally pace medical research be glacial compare used internet brin tell wire interview google amplify process be look lot place collect lot information see pattern lead somewhere legislative change be factor have help open door tech firm put massive compute muscle health care datum drive medicine be key element affordable care act federal law ushered president barack obama health care reform be major force center boom new health technology law provide major financial incentive doctor hospital prove care be effective value base payment rule be spark demand new software track analyze patient datum say lynne dunbrack research vice president idc health insight patient prescribe example dunbrack say hospital be find cheaper send medicare patient have congestive heart failure home weight scale electronic tablet connect app rather risk too many readmission day discharge result hospital get federal reimbursement rate cut have be real financial incentive health care organization purchase use technology be then help drive demand be company be now see new opportunity dunbrack say shift value base care other top area focus health care industry include sequence human genome digitize health care datum say cowen co analyst john blackledge september report alphabet health care strategy health care trend be not occur vacuum be be accommodate technology advance area such social mobile analytic cloud compute be area google expertise blackledge say swirl change tech advance be also help fuel medical ambition tech heavyweight apple annual worldwide developer conference june apple introduce new healthkit app monitor user heart rate sleep weight blood pressure other health related measurement let home health device such heart monitor fitness monitor exchange datum healthkit allow clinician mayo clinic send health information user app turn transmit datum user physician healthkit be logical extension apple exist product digital ecosystem keep user engage increase apple app store business also keep apple product service relevant grow increasingly competitive consumer health market say simpson cambridge consultant apple tech framework researchkit let person want remotely participate clinical medical trial do so used specially design apps iphone instead have show person march apple display apps say help diagnose range condition diabetes heart disease apple say win see datum transmit person opt sharing researcher want researchkit help address few problem medical research current state such limit patient participation infrequent datum sampling apple jeff william now chief operate officer say time person sign single medical study stanford university first hour release researchkit apple ceo tim cook tell cnbc march put perspective stanford have tell have take normally medical center entire year sign many participant so researchkit be absolute game changer say cook call discover cure disease push life expectancy much longer currently be alphabet google have own initiative call fit include developer tool online platform collect datum connect michele chandler twitter ibd_mchandler facebook
102,MDT,alphabet world internet search leader be prospect core business strike success health care world company glucose monitoring contact lens diabetic be inch closer drugstore shelve sale self stabilize spoon design help person uncontrollable hand tremor eat comfortably top first month google restructure last year become largest operate unit new parent alphabet googl buy biotech company lift lab just few month health focuse startup begin product sale point broaden emphasis other health medical advancement alphabet last month rename google life science division verily life science division bring together clinician scientist be focuse understand improve chronic condition impact massive number person health issue include cardiovascular disease diabetes cancer disease mental health be development health care think be far reach be long last be see period convergence technology company health care company california life science association trade group ceo sara radcliffe tell ibd say change drive health care tech firm partnership include explosion big datum result demand way manage patient information growth access datum internet cloud mobile technology such fitbit fit wearable be shift health care maintain tracking health rather simply treat disease say company team uprecent notable health tech partnership include alphabet verily division team last month johnson johnson jnj develop surgical robot news follow september announcement google life science spinoff calico have enter year collaboration north chicago ill base pharmaceutical firm abbvie abbv research age related disease verily have partner too medical device firm dexcom link verily create new class disposable glucose monitoring system be faster cheaper smaller product be currently available johnson johnson verily announce last year have create verb surgical develop new surgical robotic device smaller less expensive intuitive surgical isrg da vinci system now control minimally invasive surgery segment other look join force health tech divide include medical device maker medtronic mdt be collaborate big datum solution provider ibm ibm watson health analyze wave information glean diabetes insulin pump datum vs be not only tech heavyweight seek blend medical altruism big datum big moneymaking plan apple aapl microsoft msft other be also used deep technology expertise create medical related product service year apple introduce health tracking tool monitor user footstep heart rate sleep activity microsoft samsung already offer number so call wearable device also allow person monitor daily movement advance mobile compute artificial intelligence new analytic software be drive effort recent year have be increase interest health care application company traditionally be see be consumer focuse company say iain simpson drug delivery specialist cambridge consultant company such google apple facebook fb amazon com amzn have build consumer focuse business base creation compelling sustainable user experience now simpson say various tech company be head health drive increase relevance capability market create new high value business opportunity particularly work collaboration establish health care player such pharma medical device company health care spending weigh project reach accord california health care foundation profit potential be obvious incentive other factor be also work part reason alphabet focus move needle parkinson treatment be personal google co founder now alphabet president sergey brin mother eugenia have parkinson brin be diagnosed carry mutation lrrk gene have be associate higher rate degenerative disorder central nervous system generally pace medical research be glacial compare used internet brin tell wire interview google amplify process be look lot place collect lot information see pattern lead somewhere legislative change be factor have help open door tech firm put massive compute muscle health care datum drive medicine be key element affordable care act federal law ushered president barack obama health care reform be major force center boom new health technology law provide major financial incentive doctor hospital prove care be effective value base payment rule be spark demand new software track analyze patient datum say lynne dunbrack research vice president idc health insight patient prescribe example dunbrack say hospital be find cheaper send medicare patient have congestive heart failure home weight scale electronic tablet connect app rather risk too many readmission day discharge result hospital get federal reimbursement rate cut have be real financial incentive health care organization purchase use technology be then help drive demand be company be now see new opportunity dunbrack say shift value base care other top area focus health care industry include sequence human genome digitize health care datum say cowen co analyst john blackledge september report alphabet health care strategy health care trend be not occur vacuum be be accommodate technology advance area such social mobile analytic cloud compute be area google expertise blackledge say swirl change tech advance be also help fuel medical ambition tech heavyweight apple annual worldwide developer conference june apple introduce new healthkit app monitor user heart rate sleep weight blood pressure other health related measurement let home health device such heart monitor fitness monitor exchange datum healthkit allow clinician mayo clinic send health information user app turn transmit datum user physician healthkit be logical extension apple exist product digital ecosystem keep user engage increase apple app store business also keep apple product service relevant grow increasingly competitive consumer health market say simpson cambridge consultant apple tech framework researchkit let person want remotely participate clinical medical trial do so used specially design apps iphone instead have show person march apple display apps say help diagnose range condition diabetes heart disease apple say win see datum transmit person opt sharing researcher want researchkit help address few problem medical research current state such limit patient participation infrequent datum sampling apple jeff william now chief operate officer say time person sign single medical study stanford university first hour release researchkit apple ceo tim cook tell cnbc march put perspective stanford have tell have take normally medical center entire year sign many participant so researchkit be absolute game changer say cook call discover cure disease push life expectancy much longer currently be alphabet google have own initiative call fit include developer tool online platform collect datum connect michele chandler twitter ibd_mchandler facebook
103,MDT,go get tough tough build monitor etf watch list most investor be feel skittish sharp stock market sell wise focus inevitable upside smart investor also consider overall direction market make buy sell decision ibd market direction recently shift correction status again so time active etf investor be cautious even several last year etf winner have sunk day move average key support level cautious doesn mean idle several sector equity etfs track ibd be buy point buy etfs stock break buy point price chart base formation increase chance nail big gain here be etfs worth get know wait stock market trend turn bullish again spdr semiconductor xsd hold equal weight stock behemoth intel intc have roughly same stake portfolio asset smaller top notch player such monolithic power system mpwr etf have average daily trading volume roughly share ibd rs rating mean price performance have surpass most stock ibd database past month xsd be buy point cup handle base consolidated hit week high june have rally significantly interim september low last year xsd peg gain global social medium socl hold stock include linkedin lnkd facebook fb tencent holding tcehy etf have average daily volume share have rs rating socl be buy point cup handle base rally day line first second quarters then fall long consolidation full course socl jump ishare medical device ihi target niche medical device manufacturer distributor hold stock biggest position medtronic mdt abbott laboratory thermo fisher scientific tmo etf trade roughly share day average have rs rating ihi be buy point slice key day day support level broad loss stock market monday ihi bag gain
104,MDT,cardiac device giant edward lifescience ew issue guidance low side estimate wednesday raise long term market estimate key product line kick annual investor day edward affirm previous guidance forecast next year sale represent growth
105,MDT,past few year be big year health care merger controversy pfizer pfe agree buy ireland base allergan agn last month bring new plan treasury department presidential candidate curb tax inversion deal company relocate lower tax country device
106,MDT,exchange trade fund popularity keep grow investor plow money popular low cost vehicle offer access basket stock trend doesn appear be wane combine asset etfs surge january accord investment company institute year total number etfs rise january year launch very first etf spdr spy be now fund available variety category style gain further insight etfs potential benefit growth outlook checked todd rosenbluth senior director etf mutual fund research cfra cfra acquire global rosenbluth be director etf mutual fund research capital iq previous experience include manage editor value line mutual fund survey financial advisor morgan stanley full interview rosenbluth also discuss current trend etf space follow ibd investor own etfs rosenbluth investor want exposure stock bond market look etfs typically provide low cost exposure broad investment category narrower thesis benefit diversification transparency example rather own just merck mrk investor health care select sector spdr xlv fidelity msci health care index etf fhlc hold merck peer include johnson johnson jnj pfizer pfe company other related industry include medtronic mdt unitedhealth group unh actively manage mutual fund investor see daily etf determine think continue fit portfolio ibd be too many etfs rosenbluth approximately third cfra rate etfs come market march so think investing investor determine etf serve legitimate investing purpose so more likely gain sufficient asset be viable keep mind cfra rate far more mutual fund etfs several dozen asset manager offer similar sound product give sentiment shift lower cost etfs away more expensive mutual fund cfra expect more mutual fund be close merged response get ibd market prep tech report newsletter free ibd do think fuel further etf growth hinder growth rosenbluth investor advisor adoption etfs design support asset allocation need be go further drive etf growth vanguard voo ishare core msci eafe iefa be example such well diversify product more investor gain comfort etfs money continue flow establish come product investor always favor mutual fund wrapper want active management address many large asset manager include davis fund legg mason pimco vanguard offer actively manage etfs area potential growth ibd even factor base etfs aren new smart beta continue be buzzword have contribute rise popularity smart beta fund rosenbluth actively manage mutual fund struggle keep return msci eafe index investor be seek alternative smart beta etfs launch last year include popular goldman sachs activebeta large cap equity gslc ishare edge msci multifactor usa etf lrgf combine factor approach offer diversify yet lower cost approach quantitative investing here again many large asset manager have expand etf presence used smart beta product response grow demand last month jpmorgan minimum volatility jmin oppenheimer russell low volatility factor ovol usaa msci usa value momentum blend index etf ulvm have launch be cover cfra research ibd esg environmental social governance fund have be news too do think last trend rosenbluth esg mutual fund asset have be quite sticky even many actively manage mutual fund slowly bleed asset favor index base etfs expect time esg etfs gain traction investor further embrace etfs put money work focuse conviction value ibd new trend re see now rosenbluth re see investor look more closely thematic etfs traditional sector well diversify etfs etfs focus robotic blockchain other potentially long term investment trend more narrowly construct product such global robotic artificial intelligence botz robo global robotic automation index robo reality share nasdaq nexgen economy blcn innovation share nextgen protocol etf koin tend charge premium price relative market cap weight etfs more asset manager compete investor interest fee have continue move lower ibd type etfs do expect outperform interest rate rise rosenbluth equity etfs cfra think more economically sensitive sector include financial industrial benefit rate rise due strong economy vanguard financial index etf vfh ishare transportation average iyt be couple example addition interest rate rise cfra be focuse bond etfs limit interest rate sensitivity low duration product reduce downside impact federal reserve raise rate ishare year investment grade corporate bond shyg spdr bloomberg barclay short term high yield bond etf sjnk be example short term etfs rate favorably cfra ibd give feb market sell early redemption velocityshare daily inverse vix short term etn xiv be thought vix tie volatility etfs be appropriate type investor rosenbluth vix base product be not rate cfra focus etfs directly hold stock bond not derivative however investor need understand inverse leverage etfs aggressively move warning loss pile quickly ibd do xiv early redemption mean harder investor manage risk so do affect market operate rosenbluth xiv be exchange trade note not traditional etf be other product ve talk etns investor need understand be issuer risk consider top usual investment risk etf shut investor get fair warning understand portfolio help track receive hold product close xiv mechanic be much different road closure be much shorter important note however happened xiv be spel prospectus so be less example larger market issue more example investor need know exactly re get involved particularly leverage inverse volatility product ibd be sound strategy long term investor etfs rosenbluth long term investor regularly review etfs re hold understand security fit go forward investor also periodically rebalance asset position do not move tandem not necessarily stand still even passively manage etfs ibd do cfra assess etfs do differ other industry researcher rosenbluth cfra provide forward look rating more etfs combine holding analysis fund attribute include expense ratio technical analysis etf much cost be bigger driver future return year track record well track typically unique index etfs rate favorably cfra do so have confidence valuation risk consideration holding also compare etfs separate mutual fund relevant metric differ other compare active mutual fund try beat etfs such spdr seek replicate index equity etf rating launch nearly year global umbrella top rate etfs have outperformed index bottom rate etfs have underperform equity fund research be acquire independent research provider cfra research late investor learn more https newpublic cfraresearch com email protected rosenbluth be twitter also be interested blockchain expand bitcoin amazon nvidia alibabafirst trust launch new blockchain etf meet demanddow back apple reversal gold shine bitcoin fall
107,MDT,index dow jone industrial average undercut day move average friday index nasdaq composite rally strongly walmart wmt sell earning guidance online sale be weaker expect hot recent ipo roku roku tumble revenue outlook home depot hd beat give bullish guidance fed policymaker seem slightly hawkish rite aid rad agree albertson buyout major average suffer modest loss thursday close session lows several time dow jone index fall back day move average friday index surge more close week higher walmart wmt roku be big weekly loser treasury yield pop fresh year high fed minute backed somewhat world largest retailer report better expect sale same store sale earning miss estimate online sale grow less half annual rise walmart wmt struggle compete amazon com amzn walmart still see commerce growth fiscal year earning guidance be light walmart online chief marc lore deny report leave retailer walmart say roll more upscale home furnishing shopping portal walmart stock crash tuesday amazon part reportedly plan roll more cashierless amazon go convenience store recently open first go store seattle general public federal reserve policymaker still backed gradual interest rate hike jan meeting see stronger growth prospect do december part due trump tax cut fed official see inflation rise time year treasury yield already sharply year rise fresh year high push stock lower wednesday meanwhile exist home sale post biggest annual drop year application loan buy home tumble again stream video platform roku roku earn adjust cent share sale vs expectation loss cent share sale current quarter roku expect revenue base midpoint guidance vs wall street expectation roku say active user base rise year year fourth quarter roku stock plunge weak guidance home depot hd report adjust earning share advanced sale climb home depot expect recent tax cut fuel continue growth housing sector even mortgage rate climb home depot expect ep jump year project buy back share share rise fractionally week chipmaker broadcom avgo cut offer buy qualcomm qcom share cash stock qualcomm raise bid nxp semiconductor nxpi broadcom say qualcomm revise nxp offer amount transfer value nxp shareholder qualcomm purchase nxp doesn go broadcom pay share broadcom have ask qualcomm investor vote slate nominee qualcomm board company march shareholder meeting grocery giant albertson private ownership decade announce merge rite aid rad combine company be public have value include debt deal come walgreen boot alliance wba give effort last year buy rite aid due regulatory objection instead acquire less half smaller rival store merger activity be head sector pharmacy look keep market share face grow competition amazon amzn energy information administration say crude stockpile fall barrel vs week prior vs analyst expectation barrel increase production be steady barrel day shale firm parsley energy pe continental resource clr matador resource mtdr concho resource cxo see higher production year oil price rebound planet fitness plnt see ep climb cent share revenue grow fitness chain operator affordable offering have resonate casual first time gym user expect full year sale increase roughly adjust ep grow planet fitness also add stock buyback program share rally friday half former hewlett packard report better expect fiscal first quarter earning hp enterprise hpe server networking equipment datum center gear maker also give upbeat guidance hike dividend boost stock buyback program printer pc maker hp inc hpq also guide higher full year hpe hp inc share jump friday domino pizza dpz come short sale stock appear be prop report say burger king parent restaurant brand international qsr be think make bid quarterly same store sale wendy wen also miss estimate jack box jack meet expectation company say have declare cash dividend cent share cheesecake factory cake be just shy same store sale wingstop wing share fall friday weak ep outlook mgm resort international mgm miss earning share estimate sale top help casino resort operator open mgm national harbor december same store casino revenue be flat mgm see weaker sale la vegas strip norwegian cruise line nclh report ep beat estimate revenue just miss cruise line operator forecast full year ep view stamp com stmp earn share year revenue share jump medtronic mdt tuesday report adjust income share sale beating expectation share fall medtronic say integration testing surgical robot be take longer expect share ubiquiti network ubnt plunge maker wireless internet equipment disclose ongoing sec probe business accounting practice bhp billiton bhp report profit second half year estimate copper revenue surge higher price output boost bhp iron ore division see growth mining giant push back structural change seek activist hedge fund elliott advisor boost dividend say expedite sale shale asset general mill gis buy natural cat dog food maker blue buffalo pet product blue share intuit intu earn cent share beating view penny turbo tax software maker also narrowly exceed revenue expectation bur share fall friday weak guidance oled technology provider universal display oled post better expect december quarter result share fall disappointing sale guidance universal display expect revenue vs analyst expectation sprout farmer market sfm offer bullish ep guidance vs view share sale growth report profit growth cent sale rise share fall be interested invest stock market start simple routinestock buy zone ahead earning
108,MDT,let say design car live rush world probably want test see handle real life want build test car test car drive ground transmission evaporate maybe ll just keep crash wall ve anticipate possible scenario perhaps destroy budget do ford general motor gm boee ba airbus eadsy thousand business worldwide be do be more prudent time more precise design use software make relatively unknown ipo altair engineering altr simulate predict product perform real world usage altair software seem ever likelier analyst say compute cost fall array product include automaker drive bulk altair sale get smarter say altair sale growth be set outpace rival help company early adoption technology acquisition way selling product play engineer curiosity portfolio product have very well position support automotive market space well supplier universe chief financial officer howard morof tell investor business daily not just specific automotive be sensor almost everywhere nowadays year altair portfolio have help nasa better predict space capsule fare splashdown landing have give medtronic mdt more insight design better stent give unilever ul more clarity design better deodorant lynx better know axe body spray fame altair bombard product design code rather element company product test make better decision way design product save money otherwise spend design actual physical prototype re editor say take chapter move character kind thing canaccord genuity analyst richard davis say altair come public just month pay debt enter stock market company already have global presence founder company time have add customer ten thousand user name office nation time pencil drawing paper computer be once basis product testing have give way simulation technology altair chief executive james scapa conference wednesday say have ability dictate parameter design happened now be physical design be be replace simulation deutsche bank analyst nandan amladi say so essentially design physical object simulate environment do crash testing simulation environment so don actually have build physical prototype much later process altair have acquire company technology cram past year rbc analyst say horof say merger continue be part long term growth strategy analyst say altair be head stretch mid teen annual sale gain roughly simulation analysis software market have only grow high single digit overage industry outpace expansion also be propel company unique way selling product model company call unit base model customer receive company entire product line amount dozen application customer license unit base many person use software historically amladi say software company have sell specific set product altair model encourage broader more active use say rbc note average customer used application offer company re innovative engineer nice sandbox play amladi tell ibd essentially use suitable company get most sale hyperworks flagship simulation platform altair also have product internet thing cloud compute accord rbc altair sale come customer automotive industry way work favor ford gm pump more money self drive car electric vehicle expect heavy user industry auto be cyclical peak continue invest new initiative electric vehicle autonomous drive motivate more simulation regardless economic backdrop current business jpmorgan analyst sterling auty say firm investment thesis company none altair customer account more billing auto industry get sick auto sale slip last year be expect do so year altair catch cold too company build sale force execution become more important jpmorgan analyst say re confident altair technology cite sale execution primary risk financial target company other risk include foreign exchange altair also compete much bigger rival germany siemens siegy france dassault systeme have more cushion discount software altair new business come exist customer accord deutsche bank wall street press company shift ratio snap new business new customer something amladi say remain important issue watch new issue only earning report belt few quarters likely be need share even share jump week debut have get choppier past week run red climb back thursday canaccord davis nov initiation note company say potential stock be just then be still too expensive pullback sign better growth profitability year so make company more attractive say guy explain be public be be nibbled death duck davis tell ibd none individual investor kind irritating share altair jump afternoon trading friday
109,MDT,boston scientific bsx dip wednesday announce delay heart valve replacement product call lotus edge potential competitor product medtronic mdt abbott laboratory close bell stock market today boston fall finish abbott lose close medtronic dip end day earlier year boston voluntarily recall lotus lotus edge aortic valve system cite issue locking mechanism have plan relaunch lotus edge europe first quarter file application food drug administration january late tuesday boston say again delay plan be disappoint delay timeline be work carefully analyze implement necessary modification pass rigorous internal quality standard chief executive mike mahoney say prepared statement didn provide timeline plan relaunch europe file boston say doesn expect delay have material impact fourth quarter guidance provide update fourth quarter earning conference call feb boston lotus edge be system replace diseased heart value used open heart surgery abbott medtronic also make device call transcatheter aortic heart valve replacement tavr ibd take boston have ibd composite rating meaning outperform more stock term key growth metric still lag top leader best possible crs get name leader visit ibd stock checkup canaccord analyst jason mill lower worldwide transcatheter aortic heart valve replacement sale model boston respectively also cut price target keep buy rating needham analyst mike matson estimate transcatheter aortic heart valve replacement market grow third quarter prior quarter expect market have grow worldwide year year next year matson call market grow worldwide boston be expect be third market lotus edge say think be still possible note abbott portico tavr pivotal trial enrollment be complete think be launch late matson keep buy rating price target boston stock related medtronic surge top quarterly earning view rival take chunk medtronic heart unit electricity replace opioid treat chronic pain
110,MDT,stock open higher tuesday dow rebound new high several china base stock post strong early move dow jone industrial average pop open bell johnson johnson jnj traveler trv lead early charge gain nasdaq composite edge less apple aapl facebook fb alphabet googl netflix nflx post early loss big retailer show early strength target tgt climb raise first quarter earning outlook high end target share include benefit much cent newly re-form tax law statement say company expect tax reform legislation create additional cash flow plan use capital investment dividend additional share repurchase target have gain june be climb right side deep month consolidation illumina spiked more announce deal market thermo fisher scientific tmo ampliseq tool exist illumina customer ampliseq work gene sequence analysis tool make illumina other limit analysis target zone genome produce result faster limit amount datum generate search illumina share be extend just buy point first stage flat base intel rival advanced micro device amd drop more early trade tuesday microsoft msft say be halter effort patch security gap amd chip set related spectre lapse operate system update be cause computer freeze amd say product be not risk meltdown vulnerability spectre threat be address operate system update microsoft share rise mazor robotic mzor be ear action maker automate surgical guidance system spiked early trade monday then narrow gain end tight week line company report sell robotic surgical system fourth quarter newly implement agreement medtronic mdt mazor be month saucer base buy point ibd stock daqo new energy dq rebound follow dive monday announce exit chief executive ibd leaderboard stock athm bolt more open trade stock be extend week advance include month base pattern national federation independent business report small business optimism index drop point december remain still record high year old survey labor department job opening labor turnover survey be due et minnesota federal reserve bank president neel kashkari be also schedule speak asia market turn strong session tuesday tokyo nikkei return holiday weekend gain hong kong hang seng index climb straight advance europe market be firmly higher afternoon trade cac paris staking high ground follow london ftse gain advance frankfurt dax related big picture bull be undefeated ready software leader boast accelerate ep estimate nvidia share break autonomous car dealsthese top china stock rocket basis breakout
111,MDT,medtronic mdt surge month high tuesday medical device maker top fiscal second quarter earning view report revenue heart valve replacement grow more third xby close bell stock market today medtronic surge close meanwhile share edward lifescience ew medtronic key rival know transcatheter aortic heart valve replacement lift finish regular trading day fiscal second quarter medtronic report adjust income share sale revenue be line medtronic pre announcement beat view earning crushed consensus cent year year basis metric decline medtronic say release adjust foreign exchange rate divestiture impact hurricane marium revenue earning have climb respectively firm cardiac vascular group post sale be help sale transcatheter aortic heart valf tavr grow high thirty percentage tavr be method repair damage heart valve resort open heart surgery ibd take biotech sector large cap struggle quarter smaller firm lead way outperform expectation head industry snapshot breakdown quarter edward rival medtronic tavr boston scientific bsx doesn have product approve be expect re enter european market early recall product due problem locking mechanism minimally invasive restorative therapy group split impact hurricane marium bash puerto rico quarter comparable basis sale group grow apiece firm reiterate guidance constant currency sale growth fiscal adjust profit share growth related rival take chunk medtronic heart unit electricity replace opioid treat chronic painedward lifescience crash heart valve sale miss lofty view
112,MDT,medtronic mdt overcome hurricane marium impact fiscal maker medical device be expect face grow competition abbott laboratory boston scientific bsx heart implant analyst say thursday xin september abbott catch medtronic boston gain approval implantable cardioverter defibrillator icd allow patient undergo mri scan need device be implanted help control abnormal heart rhythm still rbc analyst glenn novarro say lower end medtronic full year forecast august sale growth constant basis remain realistic increase view fiscal sale adjust income share impact mr compliant icds abbott boston be topic interest relate second half fiscal fiscal say medtronic fiscal novarro forecast firm manage constant currency growth competitive concern also extend heart valve replacement novarro say early see boston re enter european market lotus edge product boston recall device not approve due problem locking mechanism ibd take medtronic have ibd composite rating meaning perform top half stock term key growth metric still fall medical product industry group term ranking head ibd stock checkup look better rate medtech player mount competition cardiac vascular group novarro see medtronic capable pull full year guidance expect management reaffirm guidance constant currency revenue growth refine guidance further fiscal third quarter call say only possible change fiscal earning share guidance be impact hurricane marium tuesday medtronic be slate report fiscal second quarter earning consensus expect medtronic report adjust income cent share sale sale view be medtronic pre announcement nov hurricane marium batter puerto rico september be expect have impact medtronic second quarter sale trim adjust profit cent majority impact be company minimally invasive restorative therapy group reason novarro shift segment view medtronic second quarter see diabetes group diving minimally invasive therapy lose expect flat sale restorative therapy partly offset growth cardiac vascular internationally novarro expect cardiac vascular diabetes group grow apiece see minimally invasive restorative therapy group grow respective only pain therapy group be expect decline medtronic diabetes group have be plague recently shortage glucose sensor growth latter half fiscal come back new product medtronic have say close bell stock market today medtronic gain close related electricity replace opioid treat chronic painedward lifescience crash heart valve sale miss lofty viewsdow component pop top view pharma strength
113,MDT,medical device giant medtronic mdt be early trading thursday beat fiscal earning estimate raise low end full year profit guidance quarter end oct medtronic make share exclude time item year earlier quarter cent analyst consensus accord thomson reuter sale totale line consensus pro basis adjust acquisition covidien last spring foreign currency headwind medtronic guide full year ep raise low end previous range cent affirm previous guidance sale growth come fact medtronic be expect stronger foreign currency headwind do take cent full year ep medtronic stock be nearly morning trading stock market today trading time high hit march ep upside be drive slightly better expect expense control lower tax rate lower net interest expense write rbc capital market analyst glenn novarro research note lower tax rate contribute ep lower net interest expense contribute expect ep growth accelerate fiscal second half cost saving covidien kick forecast operate margin second half vs first half leerink analyst danielle antalffy also see potential upside covidien integration underlie operational sale growth guidance fall basically line believe be growth trajectory cardio more broadly notably medtronic primary competitor boston scientific bsx st jude medical stj do believe guidance prove conservative medtronic continue integrate recently acquire covidien potentially recognize sale synergy be too early potentially more come fiscal antalffy add strong sale medtronic coronary structural heart division indicated market transcatheter aortic valve replacement be grow faster expect bode well edward lifescience ew medtronic lone competitor field edward stock be nearly morning trading thursday follow amy reeve twitter ibd_areeve facebook
114,MDT,pfizer pfe be massive deal buy allergan agn redomicile ireland multiple report say even treasury department plan impose new restriction tax inversion pfizer be discuss deal pay share botox maker allergan bloomberg reuter report late wednesday allergan rise wednesday retreat hour follow news inversion rule allergan trade low oct pfizer allergan deal buzz picked pfizer rise wednesday be little change late wednesday share be takeover largest health care deal ever biggest takeover kind year bloomberg say company want announce deal soon monday reuter say announcement be not necessarily imminent say treasury wednesday announcement issue target tax inversion guidance later week affect timing agreement acquire irish drugmaker pfizer be able limit exposure punitive corporate tax system america corporate rate be highest industrial world country taxe company overseas profit be repatriate treasury issue restriction tax inversion september stop abbvie abbv acquisition deal involve burger king now restaurant brand qsr medtronic mdt mylan myl go ahead unclear new limit treasury impose obama administration ban inversion addition inversion benefit pfizer beef brand name drug boost pipeline treatment mid late stage trial pfizer use allergan deal lead pfizer breakup company follow ed carson twitter ibd_ecarson facebook
115,MDT,treasury department say wednesday announce target guidance intend discourage so call tax inversion deal used business relocate lower tax nation
116,MDT,later week intend issue additional target guidance reduce further economic benefit corporate inversion treasury secretary jack lew say letter senior lawmaker further detail be unavailable
117,MDT,be important emphasize however treasury stop inversion new statutory authority lew say congress act creative accountant lawyer continue find new way company move tax residence overseas avoid pay taxe here home
118,MDT,share allergan agn ireland base drugmaker have be mull inversion deal pfizer pfe pfizer be little change hour allergan fall late trade nearly wipe regular session gain allergan be still sharply late october level pfizer buzz begin
119,MDT,treasury department first begin attempt crack tax inversion september follow series inversion attempt particularly pharmaceutical business rule stop abbvie abbv acquisition deal involve burger king now restaurant brand qsr medtronic mdt mylan myl go ahead
120,MDT,tax inversion company seek move be technically be acquire practice relocate company run combine business
121,MDT,many say deal deplete tax revenue allow company much operation dodge taxe many business community say inversion wouldn be need corporate tax rate be lower have world highest tax rate industrial world taxe overseas profit be repatriate here
122,MDT,follow bill peter twitter ibd_bpeter treasury department say wednesday announce target guidance intend discourage so call tax inversion deal used business relocate lower tax nation later week intend issue additional target guidance reduce further economic benefit corporate inversion treasury secretary jack lew say letter senior lawmaker further detail be unavailable be important emphasize however treasury stop inversion new statutory authority lew say congress act creative accountant lawyer continue find new way company move tax residence overseas avoid pay taxe here home share allergan agn ireland base drugmaker have be mull inversion deal pfizer pfe pfizer be little change hour allergan fall late trade nearly wipe regular session gain allergan be still sharply late october level pfizer buzz begin treasury department first begin attempt crack tax inversion september follow series inversion attempt particularly pharmaceutical business rule stop abbvie abbv acquisition deal involve burger king now restaurant brand qsr medtronic mdt mylan myl go ahead tax inversion company seek move be technically be acquire practice relocate company run combine business many say deal deplete tax revenue allow company much operation dodge taxe many business community say inversion wouldn be need corporate tax rate be lower have world highest tax rate industrial world taxe overseas profit be repatriate here follow bill peter twitter ibd_bpeter
123,MDT,medical device maker boston scientific bsx beat analyst estimate raise guidance wednesday send stock sharply boston scientific make cent share quarter exclude time item year earlier quarter beating analyst consensus penny accord thomson reuter revenue rise wall street estimate exclude foreign exchange impact sale grow boston scientific raise full year sale guidance now vs last year raise low end ep guidance now cent cent last year be line consensus boston scientific guide sale earning cent share street estimate cent analyst focuse organic sale growth come significantly higher be look part boost contribution recently close am acquisition well solid pipeline execution write leerink analyst danielle antalffy research note regardless again represent boston scientific strongest ex fx sale growth quarters recent memory rbc capital market analyst glenn novarro write cardiovascular sale largely drive beat believe cardiovascular result be lead strong stent sale owing continue share gain promus premier strong peripheral sale novarro write boston scientific chief rival stent be abbott laboratory medtronic mdt novarro add sale implantable cardioverter defibrillator icds be tad expectation believe medtronic continue take share tri chamber segment icd market say boston scientific stock be nearly early afternoon trading stock market today just shy year high share touch follow amy reeve twitter ibd_areeve facebook
124,MDT,surgeon predict big increase robot assist surgery next year especially colorectal hernia procedure accord survey rbc capital market surgery today involve use robot figure hit year year survey indicate most surgeon be quite satisfied
125,MDT,stock be quiet ahead long weekend nike nke weigh bitcoin continue volatile week trade apple aapl be flat spdr dow jone industrial average dium powershare qqq trust qqq fall spdr spy give emerge market extend gain third straight session ishare msci emerge market eem rise stock market today nike provide biggest drag dow tumble apple meanwhile be flat enter positive territory less flat base buy point initially crossed monday telecom bank health care lead downside sector fund gold miner energy real estate be biggest gainer gold future leap ounce west texas intermediate crude price be flat barrel bitcoin crash pare loss accord coindesk earlier jump nearly level cryptocurrency have top sunday bitcoin investment trust gbtc have make double digit move past session reversed upward gain track snap session slide pare steep early loss gbtc be now tuesday intraday high look set drop week be tumultuous week cryptocurrency string decline be spark coinbase announce support bitcoin offshoot bitcoin cash subsequent probe possible insider trading grow number global central bank have issue warning potential risk bitcoin other digital currency medical stock be often consider defensive play name such abbott laboratory have also proven growth potential ishare medical device ihi have be testing support day move average month solid advance line mark opportunity buy share rise late september rebound day nov intraday high fund marked anniversary have amassed asset track dow jone select medical equipment index be make maker distributor medical device include magnetic resonance imaging scanner prosthetic pacemaker health care equipment represent lion share asset life science tool service contribute health care supply technology service make rest top holding dec include medtronic mdt abbott lab thermo fisher scientific tmo dhr stryker syk top account asset abbott share have rally year thermo fisher have rise stryker be have advanced ibd take make money catch etf uptrend require knowledge read chart learn ibd university etf ytd gain dec outpace return ihi have deliver healthy performance longer haul average annual return past year respectively have return same period ihi bear expense ratio related apple bank boost dow record bitcoin stop slump apple set sight buy point bitcoin dife nvidia gear here apple be weigh dow techs bitcoin high
126,MDT,edward lifescience ew crash lowest point month lag overly aggressive expectation flagship heart valve replacement business analyst say wednesday xby close bell stock market today edward have plunge finish earlier fall much lowest point april share begin form flat base july buy point quarter edward domestic transcatheter aortic valve replacement also know tavr sale grow line market fall short street lofty expectation canaccord analyst jason mill call otherwise rock star business tavr be method fix narrow harden heart valve resort open heart surgery quarter edward transcatheter heart valve therapy unit bring sale consensus have modeled domestic sale think management commentary insinuate market remain strong market be begin incur inevitability law larger number mill say note client ibd take keep earning season bookmarking weekly review quick rundown company report stock be move attempt rein expectation be prudent move say analyst become overly aggressive tavr prediction boston scientific bsx look enter market soon medtronic mdt be increase access more patient create headwind edward edward retain guidance imply tavr growth fourth quarter mill say expect street recalibrate expectation say remain bullish market potential total addressable market relative potential edward growth reacceleration low risk approval write rbc analyst glenn novarro say conversation investor suggest street have be happier domestic tavr sale growth third quarter slow again first quarter second quarter write note client edward be target opportunity segment novarro expect more clarity guidance be give edward investor day december midteen sale compound annual growth rate be sufficient achieve edward transcatheter heart valve therapy sale forecast more believe higher growth rate be necessary edward share maintain healthy premium large cap medtech peer say related edward topple third quarter miss soft glaxosmithkline scoop pfizer counter unit biogen dife top view lilly novartis beat
127,MDT,be nearly year lori swearingen change life forever fall job take decade be be relatively pain free again reno nev firefighter time swearingen be help guide rig back icy hill new year eve slip land backside be only woman crew get right back shake keep go recall swearingen soon begin experience pelvic pain radiate lower back affected daily decade thought check tailbone turn have be fracture number surgery drug fail relieve mind numbing pain discover answer implantable device call neuromodulator xsuch implant be now part big business well someday do job opioid other medication treat pain tell estimate be total addressable market year needham analyst mike matson write recent note client matson expect neuromodulation market grow upper single digit range next few year leader space be medtronic mdt market abbott laboratory boston scientific bsx be heel matson say competition be mount matson estimate medtronic neuromodulation sale be fiscal first quarter report august short original forecast medtronic doesn break neuromodulation sale meanwhile company nevro nvro livanova livn be swipe share neuromodulation also call have be decade only be recent year technique have become less crude say dr mark malone founder advanced pain care austin texas malone used device patient see neuromodulation become mainstream come year last month so new generation have come include abbott burst dorsal root ganglion malone tell investor business daily technique be far more effective really amazing revolution first time ever ve be able say thing cure chronic pain neuromodulation essentially trick brain think region body be longer pain say dr allen burton abbott medical director neuromodulation movement disorder pain modern iteration be result better understand nervous system be application electrical energy nervous system quiet pain impulse tell ibd more language re speaking nervous system language nervous system tell brain pain be longer important burton explain difference old vs new technology term hammer hammer nail miss hit thumb rub thumb dull pain introduce new sensory signal thereby block pain signal call tonic stimulation new technology neuromodulation have adopt electrical signal nervous system abbott used call burstdr dorsal root ganglion stimulation latter treat mysterious pain condition call complex regional pain syndrome boston precision spectra system precision novi precision montage mri product use software call illumina treat chronic pain include complex regional pain syndrome fail back surgery syndrome patient swearingen not specific device maker matter do lot research settle device boston scientific pain relief swearingen have tailbone remove several year incident appendectomy partial hysterectomy back surgery effort ease pain pelvis none help work few year staving pain cocktail opioid antidepressant epidural radio frequency ablation acupuncture sometimes swearingen work emergency medical other time go back fire line pain permit year swearingen finally take medical retirement ibd take company medical product industry group be now rank group track lead align technology have best possible composite rating meaning perform top stock head ibd stock checkup look other strong medtech player meet psychologist learn cope skill technique family not focus pain tell ibd be pretty depress be gain weight have very physical job very physical lifestyle be kind circle depression drain year later discover neuromodulator retire firefighting swearingen moved seattle begin see pain management doctor doctor office featured poster neuromodulation swearingen say didn know anything device first see poster thought maybe be delivery system drug say then realize be lead go spinal cord thought heck spend year look poster physician be look neuromodulation first step treat form chronic pain often back replace doctor penchant prescribe addictive course opioid opioid be huge drug market project reach alone opioid be also tie major unintended consequence include addiction dependence often lead overdose also major black market opioid have create somewhat stigma patient seek pain treatment malone say doctor question motive say mess top current opioid crisis news day so really amazing gift suddenly have treatment so effective even worst pain patient completely drug free malone have have own neuromodulator more month implant be disability year have work part time several year follow back injury see success own patient have medical practice partner implant abbott device difference be night day malone get choke talk relief be tell patient ve be very real say even own wife be wonder have give doesn want work anymore be just layer bed day day pain be real trial period temporary device be implanted sedation attach external battery tape skin patient use remote control flick different signal setting strength malone say abbott burton estimate opt permanent implant neuromodulator differ opioid be completely drug free reversible be implanted patient learn potential risk benefit patient have unique chance try device go permanent still reversible route burton say big problem opioid be person be often initiate much talk risk benefit say first prescription come pain pill short low dose pain become chronic doesn turn heal suddenly patient become resistant start traumatic injury often lead chronic pain problem need sleeping med antidepressant say now patient never need medication be interact electricity isn addictive burton say euphoric side effect still neuromodulation isn end answer type pain have limitation most notable used be chronic back pain include complex regional pain syndrome fail back surgery syndrome wouldn work widespread pain fibromyalgia lion share malone patient be ve go ahead back surgery attain relief needham matson say also market neuromodulation parkinson disease essential tremor incontinence epilepsy depression migraine obesity still neuromodulation remain best accidental secret pain community interventional pain management be new specialty malone say most neurosurgeon orthopedist aren aware swearingen be finally persuade give neuromodulation shot attend patient seminar do exhaustive research own part recommendation give anyone consider implant indeed day trial implant be ready permanent device today back gym strengthen core have lose weight gain due immobility ride bicycle horse lift hay bale property seattle walking mailbox be longer daunting prospect say last couple year husband say have lor back say be back meanwhile swearingen be left wonder have stay firehouse never know be possibility now retire medical point don care return work say instead focuse positive be life change family everyone say related abbott zero year high top sale drug bellwether sale miss actually bode well sectormedtronic sink sale lag earning beat view
128,MDT,pandora medium hold own likely boost user base too even face competition apple aapl music accord report macquarie capital monday bid confidence send pandora stock rise macquarie analyst amy yong say research note monday impact apple
129,MDT,here quick rundown monday close action
130,MDT,jetblue airway jblu say traffic jump capacity increase load factor rise percentage point share be close bell
131,MDT,amgen amgn issue positive trial datum romosozumab show increase estimate bone strength spine hip postmenopausal woman low bone mass share edge late
132,MDT,silicon graphic sgi issue preliminary figure expect revenue range mil mil higher estimate mil see share loss cent vs view cent loss share rise
133,MDT,medtronic mdt say see positive clinical outcome first real world report heart valve product corevalve share be essentially unchanged hour
134,MDT,follow alissa william twitter ibd_awilliam facebook here quick rundown monday close action jetblue airway jblu say traffic jump capacity increase load factor rise percentage point share be close bell amgen amgn issue positive trial datum romosozumab show increase estimate bone strength spine hip postmenopausal woman low bone mass share edge late silicon graphic sgi issue preliminary figure expect revenue range mil mil higher estimate mil see share loss cent vs view cent loss share rise medtronic mdt say see positive clinical outcome first real world report heart valve product corevalve share be essentially unchanged hour follow alissa william twitter ibd_awilliam facebook
135,MDT,medtronic mdt stock get lift wednesday day ahead schedule fiscal earning report analyst raise price target medical device giant share cowen co analyst joshua jenning write research note wednesday medtronic acquire covidien year generate top tier growth earning
136,MDT,medical giant johnson johnson jnj get earning season shaky start medical stock tuesday miss revenue estimate beating ep view only due lower tax rate
137,MDT,say earning totale share exclude time item year earlier quarter beating analyst consensus cent accord thomson reuter revenue shrank short consensus
138,MDT,company raise low end full year ep guidance nickel now however rbc capital market analyst glenn novarro write quarter earning include tax benefit worth cent share accounting beat
139,MDT,device diagnostic business have be soft number quarters usually pharma business have make didn happen quarter
140,MDT,pharmaceutical revenue year year report constant currency miss consensus estimate owing expect oncology portfolio result write novarro research note
141,MDT,single biggest oncology product be prostate cancer drug zytiga sale shrank miss consensus say novarro sale blood cancer drug imbruvica launch year more triple be roughly line consensus accord evercore isi analyst mark schoenebaum
142,MDT,imply potential net sale abbvie abbv report schoenebaum write email client abbvie inherited profit sharing arrangement acquire imbruvica developer pharmacyclic earlier year
143,MDT,product launch diabetes drug invokana miss consensus grow year year single biggest selling drug remicade miss fellow immunology drug stelara simponi beat consensus
144,MDT,device business miss estimate board face competition surgery medtronic mdt newly enlarged area covidien buyout spinal market various player orthopedic novarro write company be lose share such rival stryker syk zimmer biomet zbh overall market be soft thus negative company
145,MDT,also announce stock buyback plan be finance debt issuance
146,MDT,stock open few point late morning be flat
147,MDT,follow amy reeve twitter ibd_areeve facebook medical giant johnson johnson jnj get earning season shaky start medical stock tuesday miss revenue estimate beating ep view only due lower tax rate say earning totale share exclude time item year earlier quarter beating analyst consensus cent accord thomson reuter revenue shrank short consensus company raise low end full year ep guidance nickel now however rbc capital market analyst glenn novarro write quarter earning include tax benefit worth cent share accounting beat device diagnostic business have be soft number quarters usually pharma business have make didn happen quarter pharmaceutical revenue year year report constant currency miss consensus estimate owing expect oncology portfolio result write novarro research note single biggest oncology product be prostate cancer drug zytiga sale shrank miss consensus say novarro sale blood cancer drug imbruvica launch year more triple be roughly line consensus accord evercore isi analyst mark schoenebaum imply potential net sale abbvie abbv report schoenebaum write email client abbvie inherited profit sharing arrangement acquire imbruvica developer pharmacyclic earlier year product launch diabetes drug invokana miss consensus grow year year single biggest selling drug remicade miss fellow immunology drug stelara simponi beat consensus device business miss estimate board face competition surgery medtronic mdt newly enlarged area covidien buyout spinal market various player orthopedic novarro write company be lose share such rival stryker syk zimmer biomet zbh overall market be soft thus negative company also announce stock buyback plan be finance debt issuance stock open few point late morning be flat follow amy reeve twitter ibd_areeve facebook
148,MDT,average diversify stock fund be average taxable bond fund return fund far exceed average here be list top perform stock fund top perform bond fund asset least related mutual fund bigwig expect see stock gain related best stock often follow industry political trend trend push etfs trip personal finance action plan stock market review
149,MDT,boston scientific bsx be prep take edward lifescience ew medtronic mdt acquisition neovasc nvcn advanced tissue business equity stake smaller firm infusion cash also act lifeline neovasc be order pay edward lifescience subsidiary cardiac valve technology
150,MDT,medtronic mdt stock plunge month low tuesday medical device maker report fiscal sale miss wall street view earning top penny lower guidance medtronic stock close heart valve rival edward lifescience ew see share tumble month low fiscal end oct medtronic report sale miss analyst view vs year earlier quarter medtronic earning share ex item be revenue be disappointing do not meet expectation medtronic ceo omar ishrak say earning release face issue affected growth include slower expect revenue await new product introduction particularly cvg diabetes ibd take medtronic stock have ibd composite rating meaning perform middle stock term key growth metric better bet dig ibd stock checkup more revenue medtronic cardiac vascular group cvg rise mainly growth follow acquisition heartware growth aortic peripheral vascular apv division sale coronary structural heart csh division be flat minimally invasive therapy group mitg grow largely due growth surgical solution growth be partially offset competitive pressure reprocess advanced energy tool timing issue middle east medtronic slash guidance mid single digit revenue growth vs earlier view higher single digit growth company now expect sale hit assume exchange rate remain same evercore analyst vijay kumar note medtronic stock have pull back recently customer await new product large valf have be approve transcatheter aortic valve replacement tavr help second half write research note diabetes sale slow growth customer await minime be set launch early minime be first hybrid close loop system get food drug administration approval automatically adjust delivery basal insulin be disappointing quarter medtronic kumar write say think recent pullback underperform vs bake kumar keep buy rating price target medtronic stock related edward medtronic rebound negative report medtech spiraling
151,MDT,edward lifescience ew medtronic mdt stock rebound tuesday report suggest key heart procedure be deadlier surgery medical tech sector remain poise historically bad quarter say evercore ishare medical device etf be year dip monday german study patient treat aortic stenosis show higher death rate treat transcatheter aortic valve replacement tavr vs surgical aortic valve replacement savr year mortality rate tavr patient be vs savr patient adjust sickness level age patient mortality rate be respectively monday share edward lifescience medtronic topple respectively news be alone tavr market edward lifescience rally tuesday close medtronic rise stock market today ibd company medical product industry group fall monday add tuesday ishare medtech etf climb ibd take etfs be good proxy broader sector make sure keep tab ibd etfs fund page hot cold sector evercore analyst vijay kumar say tavr patient be higher risk doesn put much stock report present american heart association conference tavr be important grow area represent opportunity say expect reach look slide believe tavr patient be high risk pool relative savr comparison be apple orange write research report such do not expect german registry datum have impact tavr adoption say medtech industry be downturn relative basis ishare medical device etf be quarter date vs evercore say be second worst quarter financial crisis share duck worst quarter kumar blame uncertainty surround affordable care act follow election donald trump trump campaign premise repeal obamacare have waffle say like piece law provision deny coverage base pre exist condition prior correction medtech be pre empt period soft volume peak pricing pressure not case time kumar say pricing be currently stable utilization have be strong new product be open number greenfield opportunity rather correction be imply aca go away write believe medtech stock be currently pricing scaling back aca lead volume weakness write long be new incremental negative fundamentally think stock be compelling here relatedzimmer plunge lower full year forecast weak salesedward lifescience revenue miss jolt investor
152,MDT,stock be slightly higher tuesday afternoon major index seek direction reach record high nasdaq dow jone industrial climb hold minimal gain make time high monday small cap perform better tuesday russell add volume be tracking higher compare same time monday advancer beat decliner ratio nyse nasdaq metal lead market tuesday particular steel maker industry group climb stock reach level not touch several year schnitzer steel industry schn hit highest price april steel dynamic stld be highest july other steel stock be now extend breakout occur earlier month retail be strong sector discount apparel home furnishing consumer electronic stock rise online retailer amazon com amzn climb more most active trading today stock be recover post earning sell be shape base potential buy point online retailer be consider add sport programming prime premium service wall street journal report airline rise favorable analyst comment hawaiian holding break flat base analyst be silent parent hawaiian airline share rise past buy point volume be only average usually bad sign however hawaiian have low volume breakout oct feb still produce handsome gain late august low volume quickly flopped airline industry group have be climb rank today trading make breathtaking leap week notable medical stock be sharply higher volume normal medtronic mdt gap lowest level february huge volume medical device manufacturer miss sale expectation october end quarter novartis nvs slide deepen month old downtrend drugmaker announce monday acquire privately hold selexys pharmaceutical related delta american unite price target hike fireeye dife month low sluggish diabetes valve salesnovartis stock dip selexys pharma acquisition
153,MDT,biotech stock have nearly round trip donald trump inspire rally rbc analyst michael yee see upcoming food drug administration appointment datum roche rhhby biogen biib act catalyst ishare nasdaq biotechnology ibb spdr biotech xbi exchange trade fund be follow rally trump election wednesday trump dump water analyst theory be less likely go spiraling drug price go bring drug price tell time magazine don have happened drug price trump commentary send biotech stock tumble wednesday ibd company medical biom biotech industry group close ishare biotech etfs end day respectively sink more thursday biotech stock manage climb hole stock market today ibd company biotech group be fractionally be etfs ibd take biotechs recover trump pledge curb drug price get deep dive ibd industry theme yee note trump effect extend far commentary trump have appoint georgia rep tom price health human service secretary price have say favor major overhaul medicare system have advocate affordable care act next appointment light fire biotech stock yee write deck trump be prep announce next commissioner food drug administration medium report target jim neill scott gottlieb lead candidate neill be former venture capitalist manage director peter theil mithril capital have advocate relax fda regulation drug approval gottlieb be vc partner practice physician have serve fda center medicare medicaid service decision follow congress approval late wednesday bill speed fda process trump commentary drug pricing be far set stone yee write research note note republican congress next year be unlikely break conservative dogma work ease drug price worry trump mention drug pricing remind investor have say lot thing past year seem negotiate public eye hasn necessarily be truly perceive actually want do lot yee write outside trump biotechs have suffer industry specific injury include eli lilly lly miss key alzheimer datum lag metric teva pharmaceutical teva medtronic mdt yee write biogen roche have upcoming datum help industry biogen have phase datum alzheimer drug aducanumab due friday roche phase hemophilia datum be due imminently yee say prescription drug free user pdufa be due dec roche multiple sclerosis drug ocrelizumab regeneron regn rival ophthotech opht have phase datum come soon meanwhile look imminent sector johnson johnson jnj be talk buy european biotech actelion sanofi sny be rumore have informal interest actelion insider say pull generalist investor back space yee write perception major term catalyst biotech other cheap need much more get stock rally again write trump tax cut plan republican congress spur biotech trump make drug development great again
154,MDT,stock continue advance record high territory shopper kick shopping season even black friday fade somewhat importance oil future rise opec optimism output cut talk ahead nov deadline joined other major average record territory dow nasdaq rise more week apple aapl retook buy point fang stock gain ground laggard facebook fb move back day move average retail restaurant earning be generally positive urban outfitter urbn be big exception bad clinical trial news hit drug stock shopper once again rushed store deal day thanksgiving unofficial kickoff holiday shopping season black friday store importance have fade more sale be make online deal be spread november december still online black friday sale be expect top adobe predict wal mart wmt kick cyber monday sale friday amazon amzn predict record black friday not surprise target tgt hailed strong sale discount apple aapl product star war toy hasbro have other well smart speaker alphabet googl unit google amazon amzn likely be popular gift black friday score so far target wal mart macy apple mobileurban outfitter urbn miss earning sale send share tumble wednesday back buy point dollar tree dltr top earning forecast revenue fall short same store sale narrowly top forecast specialty discounter see solid holiday sale price retailer burlington store more double earning crush view sale just edge view signet jeweler sig parent jared zale kay jeweler luxury watchmaker movado mov report lower earning sale top view share company rally related burlington store stock near buy zone earning crush viewsdollar tree see strong holiday quarter sale mixed signet movado share shine earning holidayseli lilly lly say wednesday alzheimer treatment solanezumab fail deliver statistically significant slow cognitive decline stage clinical trial lilly not seek regulatory approval share tumble year low other drugmaker work alzheimer treatment also be hurt include biogen biib merck mrk meanwhile juno therapeutic juno halter trial new patient death latest setback immunotherapy treatment juno share fall sharply immunotherapy peer kite pharma kite initially tumble bounce back related eli lilly alzheimer drug fail key trial lilly biogen divejuno stock plummet patient dieu crude price initially rise oil cartel sound optimistic reach deal curb production nov deadline oil price tumble friday erase nearly week gain plan monday meeting opec member participation be scrap russia have say willing freeze not cut output opec still detailed agreement member tend quota libya nigeria reportedly be exempt iraq say join cut have give mixed signal iran also be question mark meanwhile crude supply fall modestly latest week domestic production rise related oil extend loss doubt grow opec output cut dealjack box jack earning shot cracker barrel cbrl ep rise easily top view restaurant report sale growth be slightly view jack box run jack box burger location qdoba eat also guide low jack share break base new high cracker barrel continue rapid postelection run analyst argue consumer confidence rally area countryside theme chain operate related cracker barrel beat profit raise guidance see trump effect china internet leader see stock jump report better expect earning show trend more chinese consumer go online remain strong weibo wb call twitter twtr china web portal company sina sina own weibo wb beat top bottom line so do social networking firm yy yy palo alto network panw stock tumble cybersecurity firm report fiscal revenue billing miss lower expectation forecast current quarter sale view palo alto network blame miss partly large deal do not close quarter palo alto have forecast pickup security spending latter half ibd company computer software security industry group take hit fall day support line proofpoint other stock fall pc printer firm hp inc hpq earn cent share exclude item year year match view sale rise top analyst estimate current hp see adjust ep cent vs view cent hp share tumble enterprise information technology firm hewlett packard enterprise hpe other half former hewlett packard earn cent share ex item sale analyst project cent current quarter hpe forecast profit cent midpoint vs consensus cent hpe share near buy point related cisco hpe view overseas cash trump cautious outlooksstrong notebook pc sale give hp lift ep guide missesdurable good order jump october best gain year core capital good order business investment proxy rise modestly meanwhile october exist home sale reflect actual closing picked fastest pace february new home sale reflect more recent contract signing fall last month downwardly revise september mortgage rate rise october spiking election borrow cost housing cloud base life science software maker ep rise revenue climb beating view veeva system veev also give bullish guidance veeva share break new high clear buy point meanwhile medtronic mdt fall month low sale guidance lag estimate latest medical device product maker give weak result outlook recent week related veeva system hit buy point outlook beat expand dife month low sluggish diabetes valve farm equipment giant report decline earning sale be better expect ep slide cent analyst have expect just cent deere say equipment sale fall see only drop fiscal share leap record high package food giant hormel hrl be upbeat full year forecast campbell soup cpb beat bottom line tyson food tsn hurt part lower beef price investment business jump feed cost deliver weak result company have face more competition fresher fare have become more popular related hormel upbeat fiscal profit campbell soup beatstyson weak profit outlook sink share other meat producer
155,MDT,company devote repatriate overseas cash stock repurchase next year congress enact president elect donald trump proposal lower taxe such move say goldman sachs top overseas cash holder be apple aapl microsoft msft google parent alphabet googl cisco system csco oracle orcl trump have propose time tax cut repatriation company corporate profit hold overseas tax rate fall plan indeed spur company bring back overseas cash say goldman sachs only second time year stockrepurchase account largest share cash used company forecast goldman sachs share buyback rise say investment bank ibd take apple have be raise dividend aggressively nov iphone macbook giant paid cent share cash shareholder learn more ibd income investor estimate buyback be drive repatriate overseas cash say goldman sachs research report forecast company repatriate close total overseas cash be direct primarily share repurchase moody investor service say apple be track have overseas cash end far most company be microsoft then come cisco oracle alphabet biotech company sizable overseas holding include amgen amgn medtronic mdt gilead science gild say ub research report say other company lot overseas cash include johnson johnson jnj coca cola ko probability significant legislative activity have increase result single party control first time republican single party control say goldman sachs report addition tax reform appear be prominent policy agenda expect see initial tax reform proposal march april possible enactment second half year apple alphabet share rise more stock market today microsoft rise fraction oracle be flat cisco slip fraction related apple microsoft cisco eye trump overseas cash tax planapple microsoft alphabet king cashfacebook buy back share stock slide continue
156,MDT,here weekly investing action plan need know investor come week start holiday shopping season headline shorten trading week few highly rate company palo alto network panw veeva system veev report well chinese internet leader sina sina weibo wb keep
157,MDT,apple aapl microsoft msft cisco system csco other technology company gain president elect donald trump support time repatriation company corporate profit hold overseas idea get enact still republican hold congress trump have propose repatriation tax profit corporate foreign subsidiary statutory top overseas cash holder be apple microsoft google parent alphabet googl cisco oracle orcl trump cash repatriation proposal bring flood money back be available dividend share buyback possibly capital investment say kevin logan hsbc economist research report tax revenue raise be used fund infrastructure spending program something be advocate candidate presidential campaign moody investor service say apple be track have overseas cash end follow microsoft cisco oracle google project top have overseas year end total cash expect most company take advantage hypothetical tax reduction permanently repatriate money maximum extent possible devil be always detail moody analyst richard lane tell ibd email nevertheless hypothetical tax offshore project translate tax revenue be invest efficiency enhance domestic infrastructure investment more important temporary time tax relief however be permanent tax reform provide company clarity make long term capital allocation decision trump have also propose reduce corporate tax rate effort keep company leave country lower rate give republican control be possibility tax relief incent company bring foreign cash back offer opportunity invest buyback stock acquire asset lamba mizuho security analyst say report pritchard citigroup analyst say republican controlled house senate be not likely block cash repatriation proposal republican keep narrow lead senate maintain solid advantage house pritchard say adobe system adbe autodesk adsk citrix system ctxs red hat rht vmware vmw be company bring back cash believe chance increase larger share repurchase lesser chance dividend company pritchard say research report biotechs sizable overseas holding include amgen amgn medtronic mdt gilead science gild say ub research report say other company lot overseas cash include johnson johnson jnj coca cola ko specific depend ultimate legislation expect significant amount overseas cash balance perhaps greater be repatriate used continue repurchase share pay dividend also increase pace growth capex latter have be miss component current cycle ub analyst julian emanuel say report big tech stock oracle be cisco add close stock market today meanwhile apple be fraction alphabet slip microsoft share dip related apple microsoft alphabet king cashdrug stock fly clinton defeat
158,MDT,angiodynamic ango power triple usual trade monday give serious boost stock rebound support day move average latham base small cap provide array catheter base product most be used minimally invasive image guide procedure then throw away product include vacuum suck clot
159,MDT,medical device maker medtronic mdt have win approval first artificial pancreas automatically monitor patient blood sugar supply insulin need be report wednesday food drug administration clear device call minime patient type diabetes be least year old decision come month sooner investor expect advisory panel review precede introduction many innovative product device measure blood sugar glucose level minute withhold supply insulin base result agency say prepared statement news didn seem affect medtronic share much stock tick only cent close share rival dexcom dxcm tumble nearly point stock re-cover loss be close dexcom make continuous glucose monitoring system used diabetic be displace medtronic device artificial pancreas allow diabetic turn part daily routine glucose test insulin injection automatic system operate human input be size smartphone wirelessly connect insulin pump glucose monitor blood sugar level be monitored sensor read just skin fda say computer algorithm then ensure patient have right amount insulin hormone need turn blood sugar energy first kind technology provide person type diabetes greater freedom live life have consistently manually monitor baseline glucose level administer insulin jeffrey shuren director fda center device radiological health say statement medtronic say wouldn be ready introduce minime spring device be know artificial pancreas take responsibility human organ be tasked body produce hormone insulin precise quantity medtronic previously release system shut glucose level fall too low didn automatically deliver hormone blood sugar climb system work human involvement exception mealtime patient need manually set device give dose insulin eating
160,MDT,heart valve maker edward lifescience ew plunge month low early wednesday post revenue miss wall street expectation least investment bank lower price target edward lifescience stock result same outfit rbc capital market also maintain outperform rating stock be buyer weakness write rbc analyst glenn navarro research note company earning release edward ceo michael mussallem say revenue be consistent increase expectation company top product sapien valve platform remain track generate more sale originally expect year sale year earlier quarter miss analyst consensus estimate poll thomson reuter rare miss ep ex item cent be merely line view edward lifescience stock plunge stock market today lowest price june ibd take ibd leaderboard be place find top stock be breakout fall leader leaderboard stock don just disappear longer qualify instead move leaderboard cut list ll find edward lifescience number other company earning season shuffle company last month win european approval expand use sapien heart valve certain intermediate risk patient intermediate risk
161,MDT,opportunity be real navarro write ew miss revenue do not perceive structural change tavr market ew ability capitalize very
162,MDT,large market opportunity estimate tavr stand transcatheter aortic valve replacement minimally invasive alternative open heart surgery only edward medtronic mdt be market boston scientific bsx be work get be related market navarro say tavr sale outside miss estimate cite france weaker market also write be already assume more gradual ramp
163,MDT,ous outside sale next year believe mdt bsx capture share also writing expect ew outperform medtech peer
164,MDT,next several year give superior growth profile medtronic stock fall wednesday do boston scientific post ep ex item meet view sale edge wall street estimate company also hike sale outlook year midpoint guidancerelated edward lifescience get expand use sapien europeedward revenue miss stock late
165,MDT,boston scientific bsx have agree buy endochoice holding gi expand endoscopy business move send endochoice share soar early trade tuesday purchase price share be almost double endochoice close price monday endochoice share finished day gain deal be expect close fourth quarter boston scientific say tuesday prepared statement company be base just outside boston marlborough mass share boston scientific be slightly recent trade endochoice base atlanta suburb alpharetta ga develop product service used treatment condition include resection retrieval device needle grasper infection control kit company have sale month end june accord statement annual sale boston scientific be major medical device maker compete like medtronic mdt st jude medical stj medtronic st jude be trading time high st jude be schedule be purchase abbott laboratory end year ibd take boston scientific have be climb back reach low mid stock have be flat base july now be trading day line still hold composite rating ibd highest possible score
166,MDT,investor toast third quarter strongest year september alone be exciting bottle bubbly go flat third quarter rise lift diversify stock mutual fund average broad market advanced barely breaking even september nose upward modest stock fund edge ahead mere last month raise stock fund gain year date stock market start stop motion third quarter have prompt many fund manager plan ahead sticking name drive strong trend such shift cloud compute company seem capable grind growth matter blah growth be broader economy click here see list ibd mutual fund quarterly leader first half year see more defensive lead rally say lew piantedosi manager eaton vance fund total asset reversed cyclical tech industrial do better click here see list mutual fund month leadersworld equity fund advanced outperform diversify stock fund last month world equity fund rise china regional fund gain lead world equity market september rac return cyclical sector stay hot then stock tie transportation industrial good commodity continue third quarter gain piantedosi hold norfolk southern nsc gain third quarter focuse growth opportunity class eifgx july tax manage growth eitmx hold union pacific unp rolled gain most cyclical lose head steam piantedosi prefer long view focus big picture growth trend be sustainable shift macro noise say facebook fb amazon amzn alphabet googl be sustainable grower benefit great secular tailwind say name have do well especially amazon still runway ibd take ibd brian deagon analyze tailwind drive amazon buy sell column julie mak point lead mutual fund have be selling alphabet amazon tech sector be acquisition seem be pick say click here see list mutual fund category say investor brace volatility election democratic white house senate house republican hand mean continue gridlock say still impression be support tax reform be grow party be huge positive say health care wary many drugmaker due political call price regulation still like celgene celg vertex vrtx biogen biib biotechs feel little safer biotech drugmaker say be do wonderful thing cure big disease combine positive reward risk re beaten trading valuation attractive valuation retail like few name area watch head holiday especially more apparel oriented stock piantedosi say be short term theme macy have go markdown have discount last year overstock say mild winter dampen consumer demand warm clothe competition be stiff amazon company have do great job manage inventory go holiday year piantedosi say expectation be low ve be monetize real estate selling close unneeded location continue home improvement giant lowe low home depot hd housing be still strong say interest rate be still low consumer be stock price have come little fear housing slowdown jeff rottinghaus rowe price manager growth income prgix large cap core trulx say stock price general seem fairly price like name health care price have be push call becton dickinson bdx medtronic mdt unitedhealth group unh quiet none be political pressure drug pricing becton develop medical supply medtronic develop implantable cardiac device other product unitedhealth be industry biggest manage care provider yet rottinghaus be shopping biotechs price be so beaten be underweight tech sector like company benefit secular trend cloud compute growth include alphabet microsoft msft also like sustainable secular growth visa facebook rottinghaus also like nextera energy nee have dividend yield largest renewable energy generator say dividend yield be roughly wouldn own low double digit earning growth expect growth oriented sector lead stock fund third quarter charge science technology fund zoom ahead quarter top september gain health biotechnology fund be also strong manufacturing gain quarter small cap growth fund gain average lead diversify stock fund category left year september gain be related stock fund manager seek scarce profit durable growth stocksmarket tread water august investor shift growth stock
167,MDT,ishare medical device etf ihi find high most holding participate hottest segment medical sector year most stock fund fall ibd industry group medical product medical system equipment have be top ibd group many week have best year date performance group make medical sector medical system equipment be group medical product group have climb market low june however biotechs generic drug stock have make much stronger gain still medical equipment subset be period product group be better nearly other health care group win find pharmaceutical company ishare medical device rather company provide tool develop drug help patient deal medical problem indeed company product offering span syringe heart valf robotic surgical system etf be more be try break past buy point flat base hold day move average better chance rise past entry share have best run february early august etf chart closely resemble largest hold medtronic mdt stock have be form shallow base be new high many product medtronic make insulin pump ear infection treatment coronary stent brain stimulus device treat nervous system disorder thermo fischer scientific tmo fund second largest hold rally most september also be near new high company be research equipment service industry group make medical research instrument complete acquisition fei maker high performance microscope acquisition have be part story medical device industry not always result stock gain dhr have be drag portfolio stock be base nicely high august start tumble announcement be acquire cepheid cphd make system fast genetic testing abbott laboratory nearly weighting etf also hasn be much contributor share remain lock month old consolidation ishare medical device have average annual return year year ibd etf leader index show performance model portfolio exchange trade fund be lead overall market computer algorithm select etfs base relative strength other objective performance rating periodic adjustment market trend condition universe etfs be select include fund list related buy cepheid expand diagnostic business
168,MDT,share medical device maker edward lifescience ew pop thursday afternoon fda grant expand indication lead product boost market agency approve sapien sapien xt transcatheter aortic valve replacement tavr patient intermediate risk death complication open heart surgery valf be implanted catheter small incision patient groin be previously approve only patient high risk approval have be expect early april result large clinical trial intermediate risk population drive stock day result show significantly lower rate death stroke patient receive valve tavr method compare surgical method tavr line already account more half edward revenue have be fuel growth well rise stock market june initiation report edward guggenheim analyst chris pasquale write intermediate risk approval increase addressable market half also give edward edge rival medtronic mdt corevalve tavr intermediate risk datum isn due next year edward stock close higher stock market today record close high edward stock hit record high late last month medtronic stock be fraction ibd take highest possible composite rating edward lifescience be longtime resident ibd list lead growth stock also regular ibd big cap growth stock select add stability
169,MDT,medtronic mdt stock retreat medical device titan early thursday deliver mixed quarter affirm guidance meanwhile st jude medical stj tumble claim product be hack medtronic fiscal profit share beat consensus cent be slightly year earlier quarter revenue be bit expectation prior year leerink analyst danielle antalffy write market open probably wouldn help stock expectation be high go peer boston scientific bsx st jude medical edward lifescience ew report strong quarters operate margin key metric medtronic have underperform past again miss street expectation come basis point consensus basis point antalffy write research note ibd take medtronic be strong group medical product currently industry group rank group medtronic rank just smaller upstart abiom take top spot rbc capital market analyst glenn novarro write cardiac vascular group thought outperform be show sign competitive pressure medtronic cardiac therapy device continue outperform market new entrant implantable cardioverter defibrillator evera mri pacemaker micra tps segment appear share gain be slow give recent launch boston scientific novarro write research note medtronic corevalve evolut be benefit strong procedure growth medtronic performance quarter suggest lose share edward antalffy add however medtronic longer term record be solid now consecutive quarters mid high single digit sale growth constant currency basis medtronic continue build consistent track record market growth write medtronic stock fall close stock market today be head sell zone drop flat base have form hit lifetime high july separately st jude medical fall short seller muddy water say st jude icds crt cardiac therapy device be risk cyberattack st jude share fall low intraday lowest nearly month related edward lifescience be take surgery heart round heart failure offering heartware buy
170,MDT,medical device giant medtronic mdt be due report fiscal earning early thursday report peer indicated solid growth sector analyst expect single digit revenue earning growth constant currency basis foreign exchange headwind have see overall sale decline ep dip penny rbc capital market analyst glenn novarro write monday recent report cardiac device company boston scientific bsx edward lifescience ew st jude medical stj signale strength market drive upside surprise medtronic cardiac vascular group see ibd coverage edward earning boston scientific earning margin concern likely prove overblown novarro add preview note gross margin adjust foreign exchange rate be tracking level sg sale general administrative expense similarly adjust be lower year year fiscal benefit ongoing integration medtronic covidien medtronic acquire surgical product leader covidien last year medtronic close acquisition tuesday pay heartware maker ventricular assist device heart failure patient medtronic stock also get buy rating tuesday citi initiate coverage stock have be form flat base hit lifetime high july medtronic stock rise fraction tuesday look set open trading stock market today time high touch last month buy point flat base medtronic stock be so far ibd take medtronic be biggest player field leaderboard stock edward lifescience have be consistently higher stock rating learn edward be ahead medtronic key technology related drife spinal stock ldr nuvasive globus medicalboston scientific stock year high margin boost plan
171,MDT,athletic footwear apparel maker nike nke discount retailer dollar general dg big datum software firm splunk splk receive downgrade wall street analyst friday other hand apparel retailer burlington store burl medical device firm medtronic mdt earn price target hike investment bank riley co downgrade nike stock neutral buy say recent improvement basketball segment have be more offset weakness run nike share dip stock market today thursday nike stock slip telsey advisory group downgrade dollar general stock market perform outperform goodlettsville tenn base retailer report weaker expect sale second quarter telsey also slash price target dollar general stock dollar general share tank thursday fall nearly stock slip fraction friday related forget amazon effect wal mart effect hit dollar storesstifel nicolaus lower rating splunk hold buy san francisco base tech company report wider net loss fiscal splunk share tumble friday thursday ahead second quarter earning report splunk share rise related splunk hour guidance tepid beatsmkm partner upgrade burlington store buy friday several other firm raise price target stock rbc capital market increase price target telsey advisory group up price target late thursday burlington report better expect second quarter result burlington rise thursday inched friday stock hit time high intraday thursday related burlington store earning double stock hit highneedham reiterate buy rating medtronic friday raise price target stock company report fiscal result thursday medtronic rise friday thursday medtronic share rise related medtronic miss high expectation st jude dife hacking claim
172,MDT,be time life medical device company single food drug administration ruling have pivotal impact future edward lifescience recently get such decision ruling come thursday regard sapien edward ew transcatheter aortic valve replacement tavr artificial valve implanted patient aortic stenosis disease bring real valve start malfunction due calcification fda decision mean instantly increase potential market lead product half make sapien different other valf be transcatheter part traditionally aortic valf have be replace medical vernacular crack chest not surprisingly pretty traumatic patient especially risky re talk elderly population suffering heart disease tavr be deliver catheter small hole groin make much less shock less decade first commercial tavr case be perform europe technology have prove not only be invaluable option patient too sick frail undergo open heart surgery also superior treatment strategy large swath traditional surgical population write guggenheim analyst chris pasquale june initiation report edward however fda heart surgeon be naturally cautious new technology give don mess vital organ lightly so first generation sapien be approve be only patient highest risk death surgery expand other patient edward have have conduct large clinical trial segment population prove sapien benefit outweigh risk april edward demonstrated exactly person study patient intermediate risk complication surgery day procedure patient treat tavr die compare patient receive surgical valve replacement year death rate be tavr group surgery group similar contrast appear prevalence stroke investor know meant edward stock leap almost day news hit clinical datum presentation represent best case scenario sapien broader tavr market write rbc capital market analyst glenn novarro research note time key debate be fda accelerate approval timeline intermediate risk label turn fda approve indication past thursday line management recent guidance come sometime third quarter statement edward call major milestone share rise thursday early friday trading timing be significant not only help edward term financial also competitive position only other tavr player market be medtronic mdt acquisition corevalve corevalve sapien hit european market medtronic have lag bit edward timeline get corevalve approve january be more year sapien medtronic also be conduct trial intermediate risk patient result aren due next year expect label use corevalve intermediate risk patient once sapien label be expand penetration population be likely accrue edward medtronic surtavi trial read analyst pasquale write report stake be big be aortic stenosis sufferer alone sapien corevalve have grow analyst have be see not just displace surgery increase demand aortic replacement general quarterly report estimate overall tavr market size go ibd take edward lifescience be top rate stock ibd leaderboard check here find buy range better expect growth now quarters row ramp competition europe signify tavr market be clearly grow seemingly sustainably faster expect now expect exceed time frame edward sapien be best class particularly now datum demonstrate overwhelming superiority vs surgery intermediate risk patient leerink analyst danielle antalffy write research note edward second quarter report july quarterly report push stock new high revenue earning growth accelerate last quarters earning rise year earlier quarter cent share sale be strong financial stock performance have keep edward constant presence ibd big cap last few month tavr line be growth driver now account more half revenue edward be continue work other heart related device aug rolled new intuity elite valve system number product make traditional surgical valve replacement believe surgery continue have vital role patient even tavr expand edward spokeswoman heather chamber tell investor business daily email be patient include younger patient patient complex need continue be well serve surgery chamber add be lot other structural heart defect surgery be best option other defect be also ripe minimally invasive approach transcatheter mitral valve replacement tmvr have lately become hot area cardiac device field medtronic boston scientific bsx abbott laboratory work device edward have be develop house tmvr call fortis last year add program acquire privately hold cardiaq valve technology tmvr turn be even bigger opportunity tavr give higher prevalence mitral regurgitation population challenge treat many patient surgically pasquale write report add many question remain unanswered however include treatment strategy be optimal repair replacement disease morphology benefit most transcatheter approach degenerative functional prospective clinical study be design evaluate new technology
173,MDT,here investing action plan need know investor come week federal reserve annual symposium feature remark fed chairwoman janet yellen well other central banker ulta beauty ulta medtronic mdt lead group lower profile highly rate company report earning share facebook fb nike nke
174,MDT,dollar tree dltr dollar general dg miss forecast thursday medtronic mdt burlington store burl top earning estimate estimate ep be see nearly triple cent share revenue growth result ep cent revenue comp sale rise constant currency outlook ep cent revenue stock share plunge soon open bell stock market today break support day line wednesday ahead result stock be well extend past buy range clear entry point flat base late estimate profit be expect rise share sale growth result ep revenue stock share crash more soon open bell ibd take retailer stock vipshop ulta beauty report late thursday have be leader here consider selling ulta stock estimate ep be expect fall penny sale be see decline result adjust ep revenue stock share be build flat base entry end wednesday stock dip morning trade estimate ep cent revenue result adjust ep cent revenue outlook ep cent sale growth full year ep sale growth stock share rally open bell stock break buy range june enter profit take sell range last month related signet slash outlook cite energy slump sparkleswhat expect ulta beauty earning thursday
175,MDT,treasury department new rule make harder company carry tax inversion deal push merger price tag push share price amount mere band aid obama administration congressional surgery be require expert say federal state combine corporate tax rate be highest
176,MDT,country worldwide have cut corporate tax rate past decade germany lower top rate canada go ireland average top rate country go
177,MDT,unite state have buck trend stubbornly cling top rate slightly more federal level average state
178,MDT,tax foundation scour country find only top corporate tax burden higher unite arab emirate chad
179,MDT,adopt global norm
180,MDT,lower corporate tax rate global norm further politically feasible doubt benefit company investor move global mainstream corporate taxe even hold carrot political class more corporate tax revenue
181,MDT,high corporate tax rate make sense increasingly global economy high rate don raise revenue once do estimate receipt fiscal year even high rate encourage tax drive tactic strategy economy
182,MDT,ve see company move job operation country lower tax rate ve see american company stash nearly profit overseas avoid tax bite
183,MDT,ve see company such burger king worldwide bkw chiquita brand international cqb medtronic mdt abbvie abbv mylan myl announce corporate inversion merger acquisition transfer headquarters overseas just year first month more be likely follow
184,MDT,political class harrumph howl perfectly legal tax avoidance brand company unpatriotic
185,MDT,catcall divert attention politician already have hand fiscally sound economically sensible way keep company america lower country punish corporate tax rate
186,MDT,other country cut corporate rate weren merely kowtow corporate power politician understood lower taxe help keep company home bolster nation economy pay faster growth higher employment add tax revenue
187,MDT,apply laffer curve
188,MDT,unite state doesn necessarily have choose larger budget deficit fix onerous corporate tax system step rest world
189,MDT,economist arthur laffer famously put forward proposition tax rate be so high choke economic activity actually reduce revenue so lower rate raise tax receipt very well be case corporate taxe
190,MDT,american enterprise institute economist kevin hassett alex brill determine tax revenue maximize top corporate rate go late
191,MDT,reason decline increase international mobility capital other country cut corporate tax rate
192,MDT,other country have keep cut corporate tax rate so revenue maximize rate have probably come few percentage point then ll stick hassett brill see take
193,MDT,go revenue maximize rate add third corporate tax receipt lower taxe reduce incentive move abroad stash profit overseas
194,MDT,more important encourage american foreign company expand invest unite state raise overall economic growth corporate earning tax receipt
195,MDT,sound too good be true tax foundation william mcbride take look canada top rate corporate tax revenue averaged gdp
196,MDT,country reduce rate corporate tax revenue rise gdp comparison high corporate tax rate have yielded average revenue just gdp
197,MDT,cut corporate tax rate raise tax earning good news company shareholder
198,MDT,tax kick come greater incentive do business so see more company stay home more transplant overseas more new business more investment domestic foreign source more economic growth lead higher corporate revenue profit
199,MDT,tax gain be more direct profit firm now keep rather stock price gain depend several factor include much actual tax relief company get other country respond more tax cut back envelope calculation suggest market gain be substantial go today high rate even lower
200,MDT,corporate tax rate closer worldwide norm find easier change flaw corporate tax system be handful country tax worldwide revenue force american company pay high rate overseas earning most other country use territorial approach tax only profit earn country
201,MDT,england switch territorial system so british company make profit ireland pay country multinational pay ireland still owe taxe irish earning difference ireland low rate much higher rate
202,MDT,year now democrat republican have call cut corporate tax rate nothing be do sign paralysis grip nation capital
203,MDT,hubbub burger king propose move canada wasn encourage member congress administration seem more interested chastising corporate escapee lower tax penalty ve impose do business here
204,MDT,cox be director neil center global market freedom smu cox school business former chief economist dalla federal reserve
205,MDT,alm be writer residence center country worldwide have cut corporate tax rate past decade germany lower top rate canada go ireland average top rate country go unite state have buck trend stubbornly cling top rate slightly more federal level average state tax foundation scour country find only top corporate tax burden higher unite arab emirate chad adopt global normslowering corporate tax rate global norm further politically feasible doubt benefit company investor move global mainstream corporate taxe even hold carrot political class more corporate tax revenue high corporate tax rate make sense increasingly global economy high rate don raise revenue once do estimate receipt fiscal year even high rate encourage tax drive tactic strategy economy ve see company move job operation country lower tax rate ve see american company stash nearly profit overseas avoid tax bite ve see company such burger king worldwide bkw chiquita brand international cqb medtronic mdt abbvie abbv mylan myl announce corporate inversion merger acquisition transfer headquarters overseas just year first month more be likely follow political class harrumph howl perfectly legal tax avoidance brand company unpatriotic catcall divert attention politician already have hand fiscally sound economically sensible way keep company america lower country punish corporate tax rate other country cut corporate rate weren merely kowtow corporate power politician understood lower taxe help keep company home bolster nation economy pay faster growth higher employment add tax revenue apply laffer unite state doesn necessarily have choose larger budget deficit fix onerous corporate tax system step rest world economist arthur laffer famously put forward proposition tax rate be so high choke economic activity actually reduce revenue so lower rate raise tax receipt very well be case corporate taxe american enterprise institute economist kevin hassett alex brill determine tax revenue maximize top corporate rate go late reason decline increase international mobility capital other country cut corporate tax rate other country have keep cut corporate tax rate so revenue maximize rate have probably come few percentage point then ll stick hassett brill see take go revenue maximize rate add third corporate tax receipt lower taxe reduce incentive move abroad stash profit overseas more important encourage american foreign company expand invest unite state raise overall economic growth corporate earning tax receipt sound too good be true tax foundation william mcbride take look canada top rate corporate tax revenue averaged gdp country reduce rate corporate tax revenue rise gdp comparison high corporate tax rate have yielded average revenue just gdp cut corporate tax rate raise tax earning good news company shareholder tax kick come greater incentive do business so see more company stay home more transplant overseas more new business more investment domestic foreign source more economic growth lead higher corporate revenue profit tax gain be more direct profit firm now keep rather stock price gain depend several factor include much actual tax relief company get other country respond more tax cut back envelope calculation suggest market gain be substantial go today high rate even lower corporate tax rate closer worldwide norm find easier change flaw corporate tax system be handful country tax worldwide revenue force american company pay high rate overseas earning most other country use territorial approach tax only profit earn country england switch territorial system so british company make profit ireland pay country multinational pay ireland still owe taxe irish earning difference ireland low rate much higher rate year now democrat republican have call cut corporate tax rate nothing be do sign paralysis grip nation capital hubbub burger king propose move canada wasn encourage member congress administration seem more interested chastising corporate escapee lower tax penalty ve impose do business here cox be director neil center global market freedom smu cox school business former chief economist dalla federal reserve alm be writer residence center
206,MDT,treasury department new rule crack tax inversion company move headquarters overseas take advantage lower corporate tax rate have immediate impact investor trade business so engage
207,MDT,medtronic mdt share drop late morning trade stock market today minneapoli base medical device maker currently propose inversion deal irish health care product company covidien cov north chicago ill base abbvie abbv see stock fall propose acquisition ireland base firm shire be catch rule crosshair
208,MDT,late monday treasury secretary jack lew announce rule change effective immediately make more difficult business invert use cash generate overseas treasury make change wave inversion deal threaten reduce tax revenue significantly deal have prompt criticism be legal
209,MDT,critic have argue various tax exemption business use corporate tax rate federal level push average factor state taxe be highest industrialize world motivate company look deal overseas move comprehensive tax reform have stall capitol hill
210,MDT,other propose deal potentially affected treasury department action include burger king worldwide bkw have negotiate inversion deal canadian coffee donut chain tim horton thi company see share fall morning trading burger king tim horton chiquita brand international cqb stock drop morning trading later rise rule change affect chiquita propose merger ireland base fruit firm fyffes
211,MDT,treasury move prompt differ partisan reaction
212,MDT,senate finance committee chairman ron wyden ore say lew move reinforce urgency action grow wave inversion erode nation tax base
213,MDT,house way mean committee chairman dave camp mich say few campaign style speech stopgap measure treasury win do hasn work past even secretary lew admit only real solution be tax reform fear administration be only interested do bare minimum just enough say care
214,MDT,man urge congress take action neither call new rule be abolish treasury department new rule crack tax inversion company move headquarters overseas take advantage lower corporate tax rate have immediate impact investor trade business so engage medtronic mdt share drop late morning trade stock market today minneapoli base medical device maker currently propose inversion deal irish health care product company covidien cov north chicago ill base abbvie abbv see stock fall propose acquisition ireland base firm shire be catch rule crosshair late monday treasury secretary jack lew announce rule change effective immediately make more difficult business invert use cash generate overseas treasury make change wave inversion deal threaten reduce tax revenue significantly deal have prompt criticism be legal critic have argue various tax exemption business use corporate tax rate federal level push average factor state taxe be highest industrialize world motivate company look deal overseas move comprehensive tax reform have stall capitol hill other propose deal potentially affected treasury department action include burger king worldwide bkw have negotiate inversion deal canadian coffee donut chain tim horton thi company see share fall morning trading burger king tim horton chiquita brand international cqb stock drop morning trading later rise rule change affect chiquita propose merger ireland base fruit firm fyffes treasury move prompt differ partisan reaction senate finance committee chairman ron wyden ore say lew move reinforce urgency action grow wave inversion erode nation tax base house way mean committee chairman dave camp mich say few campaign style speech stopgap measure treasury win do hasn work past even secretary lew admit only real solution be tax reform fear administration be only interested do bare minimum just enough say care man urge congress take action neither call new rule be abolish
215,MDT,company always look edge way get create trust team operate integrity big purpose serve other say larry julian author god be ceo approach help motivate person drife succeed here do form bond bring organization together sense purpose say diane swanson kansa state university ethic professor come common mission such serve customer shareholder entire group rally point johnson johnson jnj credo putt health patient client first executive integrity be guide sense purpose swanson tell ibd give incentive publicly reward employee follow firm mission recognize work employee safety outstanding service back action re not hire promote person base integrity then not go work swanson say see big picture succeed long term focuse group mission say julian minneapoli base executive coach know need be make money say also important have purpose transcend bottom line go aspect person show result bill george former ceo medical device maker medtronic mdt christmas bring person life be change firm product show employee big difference effort make julian say such display help turn medtronic unit make drug pump cerebral palsy patient back match action belief doesn do good preach importance safety yet cut cost measure help protect worker watch boss budget hire swanson say employee be watch signal matter take blame buck trend push credit other take responsibility problem many manager do reverse important be able put shoe other employee swanson say make count cheryl bachelder ceo popeye louisiana kitchen plki shift restaurant operator focus serve investor meeting need franchisee be tremendous success story julian say not only do help franchisee make money also increase profit share wealth put power hand person swanson say ll take cue keep culture place ceo be go model integrity purpose have be employee watch learn say build character tony dungy start head coaching career national football league change lose culture take tampa bay buccaneer go team senior leader tell have help young player become best be bring assistant coach share value accountability trust teamwork say want championship have focus first build champion julian say then championship come year later bucs have division title then take indianapoli colt coach super bowl season
216,MDT,specialty drugmaker salix pharmaceutical announce oct be do something unusual back merger close back july salix slxp have agree acquire cosmo technology irish subsidiary italian drugmaker cosmo pharmaceutical stock swap value deal have allow salix so many
217,MDT,soon be acquire medical device giant covidien cov beat analyst fiscal estimate thursday send stock modestly
218,MDT,quarter end dec profit rise year earlier quarter share exclude time item beat analyst consensus cent accord thomson reuter sale rise estimate adjust foreign exchange fx headwind sale rise
219,MDT,be acquire medtronic mdt covidien didn offer guidance
220,MDT,rbc capital market analyst glenn novarro write fx headwind hit top line be expect give johnson johnson jnj stryker syk have already report similar issue covidien turn high quality beat due gross margin gm expansion
221,MDT,adjust gms be well estimate consensus believe be partly due fx hedge benefit recall fx benefit gms be basis point last quarter novarro write research note thursday cov operate expense ratio be essentially line estimate
222,MDT,overall believe cov report solid quarter operational basis
223,MDT,ireland base covidien stock be more morning trading stock market today time high hit jan
224,MDT,stock have be climb november medtronic assured investor acquisition be go ahead potential restriction tax inversion deal novarro write expect buyout close late january early february
225,MDT,follow amy reeve twitter ibd_areeve soon be acquire medical device giant covidien cov beat analyst fiscal estimate thursday send stock modestly quarter end dec profit rise year earlier quarter share exclude time item beat analyst consensus cent accord thomson reuter sale rise estimate adjust foreign exchange fx headwind sale rise be acquire medtronic mdt covidien didn offer guidance rbc capital market analyst glenn novarro write fx headwind hit top line be expect give johnson johnson jnj stryker syk have already report similar issue covidien turn high quality beat due gross margin gm expansion adjust gms be well estimate consensus believe be partly due fx hedge benefit recall fx benefit gms be basis point last quarter novarro write research note thursday cov operate expense ratio be essentially line estimate overall believe cov report solid quarter operational basis ireland base covidien stock be more morning trading stock market today time high hit jan stock have be climb november medtronic assured investor acquisition be go ahead potential restriction tax inversion deal novarro write expect buyout close late january early february follow amy reeve twitter ibd_areeve
226,MDT,business pay follow path least resistance consumer demand product don offer want change strategy be happened durable medical equipment dme company business model usually focus deliver stationary oxygen concentrator cylinder patient arrival inogen ingn portable oxygen concentrator pocs market change not only do california base company create lighter quieter more efficient product also choose distribute directly customer bypass dme firm middleman pocs work real time remove nitrogen air directly provide oxygen patient inhalation be need have carry move heavy oxygen tank only provide finite amount oxygen need recharge inogen strategy prove be great success so much so patient start ask pocs conventional dme company initial resistance dme finally come view offer inogen pocs key address increase demand customer better inogen see sale business business segment jump first month vs year earlier international sale advanced reseller ride growth be mostly drive reseller jump opportunity provide inogen pocs online store other mean directly customer addition several dme partner inogen get product client base significant portion be really drive pull demand consumer say inogen chief financial officer alison bauerlein ramp direct consumer advertising see significant pull business business domestic sale patient have really start see brand name name re request other business area have grow significantly inogen surprise company direct consumer segment be still largest revenue contributor sale first month be first quarters year inogen gross margin have be impressive oxygen machine rental sell unit third quarter be take share home oxygen market say mike matson analyst needham co re offer more attractive solution patient other company be ve go direct patient be marketing tv ad magazine ad internet site try attract patient be medicare have insurance even be willing pay unit own pocket oxygen therapy market opportunity be inogen say note pocs now use represent less new home oxygen machinein october inogen release home oxygen concentrator call inogen home be lightest liter minute continuous flow oxygen concentrator currently available weigh just pound vs typical home oxygen machine weight pound be meant be used mostly night patient do not yet require portable solution patient represent total oxygen patient also used less power provide monthly electricity saving still very early process say bauerlein re really try optimize be right selling price be right selling strategy so still very early be new market really isn retail market stationary oxygen concentrator point say firm need least quarter determine best strategy be inogen home however concentrator be less complex pricing most likely be cheaper inogen other machine company portable concentrator include inogen latter be latest lightest machine pound retail price start company be work even smaller lighter model inogen expect be release first half goal be offer product be less expensive manufacture say bauerlein inogen go public february share stock nearly double ipo price end year market cap approach inogen rank size name ibd medical product industry group be dominate like medtronic mdt covidien cov baxter international bax group rank performance ibd track inogen outsized stock gain second half vs group rise be factor lift medical product group place half year inogen largest competitor be invacare ivc inova lab respironic unit philips phg analyst matson say risk be rival try improve inogen product trajectory market be pretty long inogen hold patent least year remain provide buffer zone company have be generate positive cash flow finishing third quarter cash cash equivalent also secure access credit facility jpmorgan chase jpm bank lead inogen ipo dec analyst day event inogen reaffirm revenue guidance raise november expect growth year consensus opinion analyst poll thomson reuter call earning share gain cent gain year cent
227,MDT,share nuvasive nuva moved higher early trading stock market today maker spinal product receive analyst upgrade cite potential grab more market share particularly internationally
228,MDT,morning research note rbc capital market analyst glenn novarro upgrade nuvasive outperform sector perform also raise price target stock cite san diego base company superior sale outlook improve profitability attractive valuation
229,MDT,nuvasive share rise more year high early thursday
230,MDT,be confident nuva management continue take share worldwide spine market novarro note
231,MDT,not only be nuvasive well position roughly mis minimally invasive spine market say also have plenty runway left expand internationally
232,MDT,particularly true china novarro say nuvasive do not have much infrastructure country currently believe potential chinese announcement occur
233,MDT,meanwhile expect nuvasive continue improve margin so move closer margin rival such globus medical gmed ldr hold ldrh
234,MDT,nuvasive have ibd composite rating belong ibd medical product group rank industry track
235,MDT,top rate stock group be edward lifescience ew composite rating biggest stock market cap be medtronic mdt covidien cov baxter international bax share nuvasive nuva moved higher early trading stock market today maker spinal product receive analyst upgrade cite potential grab more market share particularly internationally morning research note rbc capital market analyst glenn novarro upgrade nuvasive outperform sector perform also raise price target stock cite san diego base company superior sale outlook improve profitability attractive valuation nuvasive share rise more year high early thursday be confident nuva management continue take share worldwide spine market novarro note not only be nuvasive well position roughly mis minimally invasive spine market say also have plenty runway left expand internationally particularly true china novarro say nuvasive do not have much infrastructure country currently believe potential chinese announcement occur meanwhile expect nuvasive continue improve margin so move closer margin rival such globus medical gmed ldr hold ldrh nuvasive have ibd composite rating belong ibd medical product group rank industry track top rate stock group be edward lifescience ew composite rating biggest stock market cap be medtronic mdt covidien cov baxter international bax
236,MDT,diversify dutch giant royal philips phg agree acquire san diego base medical imaging company volcano cash wednesday send latter stock morning trading stock market today
237,MDT,philips say volcano volc catheter base imaging technology used heart surgery add portfolio image guide surgery product be build past few year
238,MDT,volcano impressive unique product portfolio be highly complementary strong offer live image guidance solution create opportunity accelerate revenue growth image guide therapy business high single digit rate philips ceo fran van houten say statement
239,MDT,leerink analyst danielle antalffy write note share valuation premium tuesday close price seem fair wednesday move volcano stock have fall nearly half start year due slow market miss quarterly expectation
240,MDT,be other logical acquirer volc namely abbott laboratory medtronic mdt don expect other bidder enter fray re incline think large cap medtech company be likely remain focuse higher growth market scale antalffy write do however view acquisition beacon thing come medtech
241,MDT,philips stock be nearly morning trading wednesday
242,MDT,follow amy reeve twitter ibd_areeve diversify dutch giant royal philips phg agree acquire san diego base medical imaging company volcano cash wednesday send latter stock morning trading stock market today philips say volcano volc catheter base imaging technology used heart surgery add portfolio image guide surgery product be build past few year volcano impressive unique product portfolio be highly complementary strong offer live image guidance solution create opportunity accelerate revenue growth image guide therapy business high single digit rate philips ceo fran van houten say statement leerink analyst danielle antalffy write note share valuation premium tuesday close price seem fair wednesday move volcano stock have fall nearly half start year due slow market miss quarterly expectation be other logical acquirer volc namely abbott laboratory medtronic mdt don expect other bidder enter fray re incline think large cap medtech company be likely remain focuse higher growth market scale antalffy write do however view acquisition beacon thing come medtech philips stock be nearly morning trading wednesday follow amy reeve twitter ibd_areeve
243,MDT,jpmorgan raise price target nevro nyse nvro stock rise monday close time high nevro develop market implantable spinal cord stimulation system call senza design treat chronic pain back leg company raise nov ipo price estimate range june nevro submit premarket approval application food drug administration senza system company plan launch commercially early approve fda system have be commercially available certain european market november nevro report third quarter earning dec revenue rise increase be attributable primarily continue adoption senza system market be available nevro say report net loss compare net loss same period prior year base menlo park calif nevro name medtronic nyse mdt boston scientific nyse bsx st jude medical nyse stj competitor shareholder include johnson johnson nyse jnj follow brian deagon twitter ibd_bdeagon related juno therapeutic ipo hot cancer curer demand
244,MDT,jpmorgan raise price target nevro nvro stock rise monday close time high nevro develop market implantable spinal cord stimulation system call senza design treat chronic pain back leg company raise nov ipo price estimate range june nevro submit premarket approval application food drug administration senza system company plan launch commercially early approve fda system have be commercially available certain european market november nevro report third quarter earning dec revenue rise increase be attributable primarily continue adoption senza system market be available nevro say report net loss compare net loss same period prior year base menlo park calif nevro name medtronic mdt boston scientific bsx st jude medical stj competitor shareholder include johnson johnson jnj follow brian deagon twitter ibd_bdeagon related juno therapeutic ipo hot cancer curer demand
245,MDT,big cap biotech ibd stock unite therapeutic have history confound expectation good way almost exactly year food drug administration approve orenitram pill treat pulmonary arterial hypertension pah progressive tighten artery supply lung make remarkable be fda have reject unite
246,MDT,medical supply giant becton dickinson bdx lift earning guidance related buyout carefusion cfn tuesday send stock new high stock market today sec filing tuesday bd say determine need incur only debt acquisition previous
247,MDT,medical device giant medtronic mdt early tuesday deliver solid quarter modestly bullish revenue guidance digest several small acquisition prepare huge medtronic be early trading stock market today earlier medtronic stock rise high touch time high fifth time past
248,MDT,stock be morning high still firmly positive head lunch hour tuesday
249,MDT,nasdaq climb add dow jone industrial average be volume stock market today be tracking heavier nyse lighter nasdaq compare monday level
250,MDT,russell climb small cap index try snap session lose streak
251,MDT,action camera maker gopro gpro jump heavy volume stock continue climb find support day move average late monday company reveal increase share offer share include ceo nichola woodman
252,MDT,ambarella amba lead ibd climb new time high company design chip process high definition video gopro action camera
253,MDT,century aluminum cenx add heavy trade stock work cup handle base buy point stock have have huge run earn highest possible relative strength rating
254,MDT,medical device maker medtronic mdt climb new time high report quarterly result early tuesday company meet analyst expectation fiscal second quarter earning sale slightly raise full year sale guidance
255,MDT,solar alternative energy stock be top perform industry group midday tuesday stock be morning high still firmly positive head lunch hour tuesday nasdaq climb add dow jone industrial average be volume stock market today be tracking heavier nyse lighter nasdaq compare monday level russell climb small cap index try snap session lose streak action camera maker gopro gpro jump heavy volume stock continue climb find support day move average late monday company reveal increase share offer share include ceo nichola woodman ambarella amba lead ibd climb new time high company design chip process high definition video gopro action camera century aluminum cenx add heavy trade stock work cup handle base buy point stock have have huge run earn highest possible relative strength rating medical device maker medtronic mdt climb new time high report quarterly result early tuesday company meet analyst expectation fiscal second quarter earning sale slightly raise full year sale guidance solar alternative energy stock be top perform industry group midday tuesday
256,MDT,medical device maker edward lifescience ew jump time high stock market today beat earning estimate late thursday get barrage price target increase analyst
257,MDT,edward earning rise year earlier quarter cent share beating analyst consensus cent sale increase more street average estimate
258,MDT,fourth quarter firm expect sale year set ep range cent be level figure be line consensus
259,MDT,rbc capital market analyst glenn novarro raise price target stock note sale artificial heart valve sapien rise year earlier quarter top estimate even have be face new competition year medtronic mdt corevalve keep sector perform rating edward stock friday trading be already target
260,MDT,leerink analyst danielle antalffy affirm outperform rating price target
261,MDT,quarterly sale beat be affirmation global tavr transcatheter aortic valve replacement market growth continue dramatically exceed expectation write research note friday tavr just cusp penetrating much larger intermediate risk patient population europe still probably month away see sustainably strong double digit market growth ahead
262,MDT,security raise price target maintain outperform rating stifel nicolaus raise maintain buy rating piper jaffray lift target
263,MDT,edward sale profit growth drop single digit last year have be accelerate then stock hold stellar ibd composite rating
264,MDT,follow amy reeve twitter ibd_areeve medical device maker edward lifescience ew jump time high stock market today beat earning estimate late thursday get barrage price target increase analyst edward earning rise year earlier quarter cent share beating analyst consensus cent sale increase more street average estimate fourth quarter firm expect sale year set ep range cent be level figure be line consensus rbc capital market analyst glenn novarro raise price target stock note sale artificial heart valve sapien rise year earlier quarter top estimate even have be face new competition year medtronic mdt corevalve keep sector perform rating edward stock friday trading be already target leerink analyst danielle antalffy affirm outperform rating price target quarterly sale beat be affirmation global tavr transcatheter aortic valve replacement market growth continue dramatically exceed expectation write research note friday tavr just cusp penetrating much larger intermediate risk patient population europe still probably month away see sustainably strong double digit market growth ahead security raise price target maintain outperform rating stifel nicolaus raise maintain buy rating piper jaffray lift target edward sale profit growth drop single digit last year have be accelerate then stock hold stellar ibd composite rating follow amy reeve twitter ibd_areeve
265,MDT,prospect approval keystone xl pipeline calgary base pipeline operator transcanada trp brighten gop gain control senate tuesday power shift washington be also expect benefit medical device maker such boston scientific bsx coal miner republican be likely move quickly roll back excise tax pacemaker
266,MDT,health care sector be hot stock market segment look more adrenaline pump medical device maker
267,MDT,medical system equipment group be rank ibd industry group medical biom biotech medical hospital be rank higher no group have climb fast investor device maker be week
268,MDT,natus medical baby strongest group be own mutual fund etfs be least third quarter row increase sponsorship
269,MDT,natus be year be extend well past flat base buy point exceed consensus expectation revenue earning report last week
270,MDT,natus make treatment ailment newborn warm economy affordable care act have make hospital more willing spend natus product say ken farsala co manager oberweis small cap opportunity fund
271,MDT,stock continue appeal depend success cost cut streamline natus new chief financial officer farsala say
272,MDT,dexcom dxcm be year have carved cup handle base pattern recently fda approve dexcom share provide continuous glucose monitoring datum transmit smartphone
273,MDT,sweet talk
274,MDT,system transmit information patient implantable device make much easier diabetic patient check sugar level respond insulin dexcom transmitter cradle be new system face potential threat competitor medtronic mdt farsala say
275,MDT,samuel isaly lead manager eaton vance worldwide health science fund like several name medical product group rank be week be tornier medical nuvasive nuva
276,MDT,only nuvasive be turn profit islay say still like fundamental prospect recover economy make product more affordable patient obamacare expand coverage procedure used product company
277,MDT,stock be base just breaking trend higher
278,MDT,tornier make shoulder replacement product sale hit tuesday tornier trnx gap retake cup handle buy point news dutch company agree merge week tornier fall buy point trigger sell rule
279,MDT,wmgi make reconstructive part ankle foot sale be previous year stock be wednesday
280,MDT,nuvasive make product treatment spinal disorder analyst see profit year
281,MDT,device maker stand lose attraction year obamacare hit group tax levy begin so comparable result have be easier match beat say capital iq analyst jeffrey loo easier comp generally disappear next year
282,MDT,lawmaker friendly group seek end trim tax isaly say health care sector be hot stock market segment look more adrenaline pump medical device maker medical system equipment group be rank ibd industry group medical biom biotech medical hospital be rank higher no group have climb fast investor device maker be week natus medical baby strongest group be own mutual fund etfs be least third quarter row increase sponsorship natus be year be extend well past flat base buy point exceed consensus expectation revenue earning report last week natus make treatment ailment newborn warm economy affordable care act have make hospital more willing spend natus product say ken farsala co manager oberweis small cap opportunity fund stock continue appeal depend success cost cut streamline natus new chief financial officer farsala say dexcom dxcm be year have carved cup handle base pattern recently fda approve dexcom share provide continuous glucose monitoring datum transmit smartphone sweet system transmit information patient implantable device make much easier diabetic patient check sugar level respond insulin dexcom transmitter cradle be new system face potential threat competitor medtronic mdt farsala say samuel isaly lead manager eaton vance worldwide health science fund like several name medical product group rank be week be tornier medical nuvasive nuva only nuvasive be turn profit islay say still like fundamental prospect recover economy make product more affordable patient obamacare expand coverage procedure used product company stock be base just breaking trend higher tornier make shoulder replacement product sale hit tuesday tornier trnx gap retake cup handle buy point news dutch company agree merge week tornier fall buy point trigger sell rule wmgi make reconstructive part ankle foot sale be previous year stock be wednesday nuvasive make product treatment spinal disorder analyst see profit year device maker stand lose attraction year obamacare hit group tax levy begin so comparable result have be easier match beat say capital iq analyst jeffrey loo easier comp generally disappear next year lawmaker friendly group seek end trim tax isaly say
283,MDT,specialty drugmaker salix pharmaceutical slxp friday cancele buyout cosmo technology become first drugmaker pull plug tax inversion deal salix stock be more early trading stock market today
284,MDT,salix agree buy cosmo tech irish subsidiary italian drugmaker cosmo pharmaceutical july stock swap company plan use deal relocate ireland take advantage lower corporate tax rate breakup announcement friday salix ceo carolyn logan say time have change
285,MDT,announce agreement merge cosmo technology july believe combination generate significant value stockholder addition key product development pipeline more efficient corporate structure enhance profitability logan say then however change political environment have create more uncertainty regard potential benefit expect achieve
286,MDT,logan be doubt refer treasury department rule discourage tax inversion apply such deal hadn close
287,MDT,be unique circumstance particular deal be never popular shareholder salix stock actually fall day be announce leerink analyst jason gerberry say many shareholder thought price be too high
288,MDT,more pressingly actavis act allergan agn be widely report be try acquire salix cosmo
289,MDT,cosmo inversion be see investor potential roadblock sale company write sterne agee analyst shibani malhotra research note friday see today termination cosmo deal signal company be sale especially light last night bloomberg report actavis salix be engage merger talk
290,MDT,medical device giant medtronic mdt meanwhile have stick deal buy irish counterpart covidien cov friday medtronic say be change method financing purchase company use external financing complete deal rather draw cash foreign subsidiary originally plan company say be somewhat more expensive be still worth give strategic financial benefit merger
291,MDT,deal be announce june most analyst believe medtronic claim tax inversion be just side benefit merger medtronic tax rate be already pretty low compare peer however firm do cite access overseas cash perk probably explain change financing
292,MDT,medtronic stock pop morning trading covidien stock be nearly
293,MDT,follow amy reeve twitter ibd_areeve specialty drugmaker salix pharmaceutical slxp friday cancele buyout cosmo technology become first drugmaker pull plug tax inversion deal salix stock be more early trading stock market today salix agree buy cosmo tech irish subsidiary italian drugmaker cosmo pharmaceutical july stock swap company plan use deal relocate ireland take advantage lower corporate tax rate breakup announcement friday salix ceo carolyn logan say time have change announce agreement merge cosmo technology july believe combination generate significant value stockholder addition key product development pipeline more efficient corporate structure enhance profitability logan say then however change political environment have create more uncertainty regard potential benefit expect achieve logan be doubt refer treasury department rule discourage tax inversion apply such deal hadn close be unique circumstance particular deal be never popular shareholder salix stock actually fall day be announce leerink analyst jason gerberry say many shareholder thought price be too high more pressingly actavis act allergan agn be widely report be try acquire salix cosmo cosmo inversion be see investor potential roadblock sale company write sterne agee analyst shibani malhotra research note friday see today termination cosmo deal signal company be sale especially light last night bloomberg report actavis salix be engage merger talk medical device giant medtronic mdt meanwhile have stick deal buy irish counterpart covidien cov friday medtronic say be change method financing purchase company use external financing complete deal rather draw cash foreign subsidiary originally plan company say be somewhat more expensive be still worth give strategic financial benefit merger deal be announce june most analyst believe medtronic claim tax inversion be just side benefit merger medtronic tax rate be already pretty low compare peer however firm do cite access overseas cash perk probably explain change financing medtronic stock pop morning trading covidien stock be nearly follow amy reeve twitter ibd_areeve
294,MDT,treasury fall second day company include amazon amzn american express axp sell record amount bond year end borrow rate not far week lows
295,MDT,benchmark year yield also rise labor department forecast release report day show add more job november consecutive month company sell debt enter so call rate lock agreement bet treasury price fall guard higher yield once debt be sell wager be end bloomberg treasury bond index debt due decade more have return year monday large discount market supply say thomas tucci manage director head treasury trading new york cibc world market corp trader usually go number softer tone case job report be better expect benchmark treasury year note yield rise basis point percentage point new york time accord bloomberg bond trader datum price security mature november fall face amount yield drop monday lowest level oct yield end year tucci say investor have become bullish prospect treasury first time almost month accord jpmorgan chase co survey customer net percentage investor hold treasury note increase percentage point week previous week first advance april corporate bond sale swell annual record late year rush borrower lock low interest rate push offering pass amazon issue note part accord datum compile bloomberg sale be first offer bond november datum show american express sell year note corporate issuance be bolster heart rhythm device maker medtronic mdt bond sale monday largest dollar denominate offer more year accord datum compile bloomberg internet commerce company alibaba group baba sell last month help propel year volume past previous high set last year
296,MDT,medical equipment maker becton dickinson bdx carefusion hit new high stock market today buyout deal be announce sunday evening
297,MDT,conference call analyst monday morning company leader say firm complement other technologically geographically carefusion cfn sell mostly bd sell mostly outside combine portfolio product service offer full suite medication management industry say
298,MDT,also fielded question bd be make such large buyout do not fit recent history tuck deal response cite consolidation customer base need cut cost necessity global presence most growth industry be come emerge market
299,MDT,such factor have be drive consolidation medtech market medtronic mdt buyout covidien cov zimmer zmh acquisition biomet already work
300,MDT,third big medtech deal be announce year transaction likely be view yet indication scale be take increase level importance management team plan future position company write leerink analyst richard newitter research note add pressure company strong balance sheet often talk likely acquirer stryker syk abbott put capital work sooner rather later potentially larger size transaction
301,MDT,rbc capital market analyst glenn novarro echo point note add acquisition smaller cap medtech company continue be push large cap medtech company digest recent sizeable acquisition
302,MDT,becton dickinson stock hit new high monday late morning be just carefusion also hit new high late morning be
303,MDT,follow amy reeve twitter ibd_areeve medical equipment maker becton dickinson bdx carefusion hit new high stock market today buyout deal be announce sunday evening conference call analyst monday morning company leader say firm complement other technologically geographically carefusion cfn sell mostly bd sell mostly outside combine portfolio product service offer full suite medication management industry say also fielded question bd be make such large buyout do not fit recent history tuck deal response cite consolidation customer base need cut cost necessity global presence most growth industry be come emerge market such factor have be drive consolidation medtech market medtronic mdt buyout covidien cov zimmer zmh acquisition biomet already work third big medtech deal be announce year transaction likely be view yet indication scale be take increase level importance management team plan future position company write leerink analyst richard newitter research note add pressure company strong balance sheet often talk likely acquirer stryker syk abbott put capital work sooner rather later potentially larger size transaction rbc capital market analyst glenn novarro echo point note add acquisition smaller cap medtech company continue be push large cap medtech company digest recent sizeable acquisition becton dickinson stock hit new high monday late morning be just carefusion also hit new high late morning be follow amy reeve twitter ibd_areeve
304,MDT,facebook fb share finished higher be initiate buy rating thursday nike be give upgrade chipotle grill cmg be rate buy argus research start facebook buy price target be most price target provide other analyst facebook share close stock market today spending much session negative territory meanwhile thursday news report say facebook be testing emojis place iconic button let user share feeling nike share rise be upgrade buy davidson athletic apparel giant stock price touch new high monday nike have excellent ibd composite rating revenue growth have slow single digit recent quarters burrito chain chipotle be initiate buy rating suntrust robinson humphrey give stock price target chipotle share rise thursday fast food giant mcdonald mcd be initiate buy price suntrust robinson humphrey stock price rise nearly set new time high intraday medical device maker medtronic mdt rise be upgrade buy evercore isi group share satellite tv company dish network dish rise be initiate buy price target deutsche bank verifone system pay gain be upgrade strong buy outperform raymond james follow vance cariaga twitter ibd_vcariaga
305,MDT,cardiac device maker edward lifescience ew beat analyst estimate raise guidance late monday send stock more hour trading edward earning totale share year earlier quarter beating analyst consensus cent accord thomson reuter revenue rise consensus
306,MDT,special report mutual fund strategy volatility stock market send investor scurry cover favor dividend be probably less likely panic select carefully dividend stock offer best world stock price performance steady payout so dividend fund be key component long term mutual fund investing here be
307,MDT,medical device giant medtronic mdt beat analyst quarterly estimate affirm guidance thursday send stock much early trading
308,MDT,medtronic report fiscal earning exclude time item share quarter end july year earlier quarter penny view revenue totale last year include recently acquire covidien year number analyst have expect average
309,MDT,medtronic affirm earlier full year guidance sale growth exclude foreign exchange impact ep
310,MDT,quarter be complicate fact be week long due medtronic peculiar fiscal year alternate week even accounting extra week revenue growth be still impressive write leerink analyst danielle antalffy
311,MDT,medtronic deliver yet strong organic sale growth quarter pro basis now third consecutive quarter mid high single digit sale growth covidien acquisition close antalffy write research note growth do slow modestly fiscal vs prior quarter organic pro sale growth rate re incline chalk seasonally slower summer quarter
312,MDT,medtronic inc earning surprise findthecompany
313,MDT,icds highlight spinal lag
314,MDT,nearly medtronic many segment beat street expectation accord evercore isi analyst vijay kumar
315,MDT,key revenue highlight quarter be strong growth icds implantable cardioverter defibrillator grow high single digit adjust extra week be stark contrast soft result peer support strong share gain double service lead cardiocom key element medtronic strategy kumar write research note
316,MDT,medtronic icd peer include st jude medical stj boston scientific bsx
317,MDT,analyst be also impressed continue growth reveal linq cardiac monitor be face more difficult year year comparison february launch hit anniversary
318,MDT,weak point be spinal product grow only meet street low expectation continue trend previous quarter show medtronic have be lose market share upstart such nuvasive nuva globus medical gmed
319,MDT,company earning conference call analyst early thursday medtronic executive say re make restart spine growth top priority
320,MDT,be share donor be core spine be not acceptable say geoffrey martha head restorative therapy group include spinal product re take aggressive action especially term
321,MDT,action be take advantage medtronic broad product offering bundle spinal product other surgery related offering such navigation imaging martha say play contrast medtronic smaller more specialize player
322,MDT,medtronic stock have be unusually volatile late august selloff hit more month low big aug stock market decline have retain strong ibd composite rating
323,MDT,early trading stock market today medtronic stock be fraction
324,MDT,follow amy reeve twitter ibd_areeve facebook medical device giant medtronic mdt beat analyst quarterly estimate affirm guidance thursday send stock much early trading medtronic report fiscal earning exclude time item share quarter end july year earlier quarter penny view revenue totale last year include recently acquire covidien year number analyst have expect average medtronic affirm earlier full year guidance sale growth exclude foreign exchange impact ep quarter be complicate fact be week long due medtronic peculiar fiscal year alternate week even accounting extra week revenue growth be still impressive write leerink analyst danielle antalffy medtronic deliver yet strong organic sale growth quarter pro basis now third consecutive quarter mid high single digit sale growth covidien acquisition close antalffy write research note growth do slow modestly fiscal vs prior quarter organic pro sale growth rate re incline chalk seasonally slower summer quarter icds highlight spinal lagsnearly medtronic many segment beat street expectation accord evercore isi analyst vijay kumar key revenue highlight quarter be strong growth icds implantable cardioverter defibrillator grow high single digit adjust extra week be stark contrast soft result peer support strong share gain double service lead cardiocom key element medtronic strategy kumar write research note medtronic icd peer include st jude medical stj boston scientific bsx analyst be also impressed continue growth reveal linq cardiac monitor be face more difficult year year comparison february launch hit anniversary weak point be spinal product grow only meet street low expectation continue trend previous quarter show medtronic have be lose market share upstart such nuvasive nuva globus medical gmed company earning conference call analyst early thursday medtronic executive say re make restart spine growth top priority be share donor be core spine be not acceptable say geoffrey martha head restorative therapy group include spinal product re take aggressive action especially term action be take advantage medtronic broad product offering bundle spinal product other surgery related offering such navigation imaging martha say play contrast medtronic smaller more specialize player medtronic stock have be unusually volatile late august selloff hit more month low big aug stock market decline have retain strong ibd composite rating early trading stock market today medtronic stock be fraction follow amy reeve twitter ibd_areeve facebook
325,MDT,top chief lead purpose personality inner trait determine outward direction blaze trail genuine leader develop best self copy someone else create false persona wear mask person quickly see say true north author bill george book follow title true
326,MDT,heart surgery giant edward lifescience ew rise more time high monday morning analyst upgrade wake acquisition rbc capital market glenn novarro raise rating outperform sector perform set price target novarro write edward acquisition cardiaq announce close friday
327,MDT,stock remain lower early afternoon trading tuesday analyst warning new apple iphone hurt share company supplier nasdaq be dow jone industrial average be volume be tracking lower nyse higher nasdaq decline stock have small edge advancer nyse loser lead nasdaq solar energy automaker staffing dairy product company be poorest performer stock market today tesla tsla skid more sink deeper day day move average metal retail utility real estate investment trust industry group be best tuesday supplier apple aapl iphone be lower credit suisse warn company be cut back component order iphone model apple share gap loss average volume cirrus logic crus slide busy trading fall day move average skywork solution swks gap day move average shed heavy trading side ruth hospitality ruth better know ruth chris steak house clear buy point double bottom base active trading company beat earning expectation couple week ep jump restaurant industry group have be trend lower ibd group ranking
328,MDT,hot new technology widespread deadly disease whole lot money change hand be story last wednesday st jude medical stj agree pay cash thoratec thor developer implant call left ventricular assist device lvad help heart failure patient keep blood move lately be
329,MDT,heart pump maker abiom abmd be close buy point get ready report earning aug mission recover heart save life abiom develop impella bill world smallest heart pump june justice department say end investigation company marketing
330,MDT,artificial heart valve pioneer edward lifescience still make valf be implanted traditional way open heart surgery smaller profile transcatheter valf implanted catheter be make edward ew pulse beat faster day fast first month year sale transcatheter heart valf thv jump year earlier
331,MDT,medical giant johnson johnson jnj beat wall street estimate lift guidance tuesday stock be fraction early trading revenue decline
332,MDT,earning exclude special item shrank year earlier quarter share beating analyst consensus cent accord thomson reuter exclude impact foreign exchange rate profit rise
333,MDT,revenue fall line consensus exclude fx impact sale fall
334,MDT,lift full year guidance share previous
335,MDT,sale decline come mixture divestiture hepatitis drug olysio sale have shrink dramatically compete product gilead science gild abbvie abbv come late last year say exclude factor fx sale rise
336,MDT,view bode well ability medium term weather significant headwind olysio represent total sale contribute operate margin net incremental investment base estimate be likely face meaningful sale decline come quarters write leerink analyst danielle antalffy research note still strong performance other key drug notably xarelto imbruvica invokana name few be clearly help offset least part major headwind
337,MDT,imbruvica new blood cancer drug be market profit sharing deal pharmacyclic abbvie acquire evercore isi analyst mark schoenebaum calculate take drug mean total abbvie hasn report yet
338,MDT,number appear roughly line im im prescription appear be tracking well current consensus caveat don have clear consensus due abbvie pharmacyclic transaction schoenebaum write email client
339,MDT,abbvie stock be more early trading stock market today
340,MDT,other hand rbc capital market analyst glenn novarro note device business miss expectation continue trend past several quarters deduce company be lose market share spinal business upstart such globus medical gmed share atrial fibrillation market medtronic mdt st jude medical stj
341,MDT,other hand seem be take share medtronic surgical product
342,MDT,medtronic stock be early trading tuesday st jude stock be fraction
343,MDT,follow amy reeve twitter ibd_areeve medical giant johnson johnson jnj beat wall street estimate lift guidance tuesday stock be fraction early trading revenue decline earning exclude special item shrank year earlier quarter share beating analyst consensus cent accord thomson reuter exclude impact foreign exchange rate profit rise revenue fall line consensus exclude fx impact sale fall lift full year guidance share previous sale decline come mixture divestiture hepatitis drug olysio sale have shrink dramatically compete product gilead science gild abbvie abbv come late last year say exclude factor fx sale rise view bode well ability medium term weather significant headwind olysio represent total sale contribute operate margin net incremental investment base estimate be likely face meaningful sale decline come quarters write leerink analyst danielle antalffy research note still strong performance other key drug notably xarelto imbruvica invokana name few be clearly help offset least part major headwind imbruvica new blood cancer drug be market profit sharing deal pharmacyclic abbvie acquire evercore isi analyst mark schoenebaum calculate take drug mean total abbvie hasn report yet number appear roughly line im im prescription appear be tracking well current consensus caveat don have clear consensus due abbvie pharmacyclic transaction schoenebaum write email client abbvie stock be more early trading stock market today other hand rbc capital market analyst glenn novarro note device business miss expectation continue trend past several quarters deduce company be lose market share spinal business upstart such globus medical gmed share atrial fibrillation market medtronic mdt st jude medical stj other hand seem be take share medtronic surgical product medtronic stock be early trading tuesday st jude stock be fraction follow amy reeve twitter ibd_areeve
344,MDT,dividend leader medical mega cap stand have composite rating higher yield composite rating combine many slim factor rating compare other stock composite grade mean stock be outperform market term earning sale growth stock
345,MDT,medical device maker medtronic mdt tuesday report solid fiscal profit margin face head wind company dealt macroeconomic regulatory challenge share fall fraction quarter end oct medtronic make cent share year earlier quarter penny analyst consensus sale rise
346,MDT,ever acquire minime medtronic know heart product have become big player diabetes roughly global market share insulin pump series announcement early june try become more gadget maker june fda approve minime connect system let pump user track
347,MDT,tech company year be practically middle age revenue expect top fiscal year question much growth be left cloud customer relationship management pioneer salesforce com crm top executive steering san francisco base company know automate manner sale function insist be still plenty ceo marc benioff president block believe salesforce reach revenue mark record time enterprise software company time frame be give also believe go sixth largest software company third largest surpass sap sap block say interview ibd put third microsoft msft oracle orcl not just core business sale force automation customer relationship management say think be most relevant technology company world next few year block say be influence advise company gain trust change business model disrupt market key introduce first customer relationship management crm solution year benioff co founder firm addition sale cloud franchise now sell other core service include recently introduce analytic community marketing cloud salesforce platform provide technology power product let customer partner build own apps crm apps allow sale marketing staff record organize automate strategize customer interaction used datum key tool company marketing cloud be born acquisition exacttarget fastest grow top marketing vendor block say cite research gartner analytic be also take market share other top vendor be lose share say analytic cloud be launch november company annual dreamforce conference draw attendee largest technology conference world block say week analytic cloud launch salesforce be close deal several fortune company say however company have not yet report sale result analytic cloud let customer run analytical report digital platform include mobile phone tablet old world go department run report get information week block say don provide insight our be analysis put hand everybody quickly turn insight action firm cloud service be sell customer size salesforce be transition enterprise class company block say say have close nearly transaction fiscal figure more last year other cloud compute company be close transaction size scale volume say drive ubercar service uber used salesforce integrate platform include analytic service marketing cloud power business block say new expand client win first quarter call benioff conference call include bouygue telecom france tyco international tyc jpmorgan chase jpm bank america bac expedia expe medtronic mdt western union wu many other salesforce sign major new deal transportation company world greatest brand category block say call unnamed company be used premise legacy technology oracle say add plan put salesforce mobile device hand more field employee world salesforce chief rival crm be oracle sap microsoft management peg market share crm make player create bow wave movement market other be tie surf wake block say add transition player legacy technology be turn battleship stormy sea salesforce addressable market cloud offering stand expect grow compound annual rate accord rob breza analyst security help fuel growth be new win international market especially europe asia analyst say only salesforce revenue be generate outside lower percentage oracle microsoft largest share be europe revenue grow year earlier constant currency total revenue quarter end april rise put track surpass annual revenue run rate faster other enterprise software company benioff say report operate cash flow jump earning share rise cent base robust result salesforce raise full year revenue forecast high end previous range management also up ep guidance cent cent share year year gain recently initiate coverage salesforce buy rating analyst breza security note billed unbilled backlog reassure investor company sustain long term growth investor drive salesforce stock april bloomberg report be field buyout offer executive company have decline comment market rumor speculation government business ahead analyst expect new win government contract provide solid growth opportunity future jpmorgan analyst mark murphy note general service administration be early stage assemble sizable purchase agreement salesforce crm product salesforce dream achieve revenue be tangible target murphy write research note june customer company say have blossom true multus product success story now ride multiple product pillar substantial scale trajectory
348,MDT,edward lifescience ew be early tuesday jpmorgan upgrade stock overweight neutral say fundamental be strong recent market slowdown increase competition medtronic mdt
349,MDT,analyst michael weinstein write research note edward stock have fall back march high concern slowdown transcatheter aortic valve replacement tavr market
350,MDT,last year market grow robustly due launch edward sapien xt valve entry medtronic corevalve market so year year comparison be tough weinstein admit however say field research suggest market have picked american college cardiology acc meeting mid march
351,MDT,field check suggest tavr market have accelerate post acc meaning edward market be likely surprise upside balance weinstein write reinforce view be survey conduct last week tavr implanter point volume sequentially vs current consensus expectation
352,MDT,weinstein theorize datum support survival benefit tavr acc meeting drive increase
353,MDT,recent pullback edward be lead stock ibd medical product industry group composite rating morning trading stock market today stock be edward stock touch month low
354,MDT,follow amy reeve twitter ibd_areeve edward lifescience ew be early tuesday jpmorgan upgrade stock overweight neutral say fundamental be strong recent market slowdown increase competition medtronic mdt analyst michael weinstein write research note edward stock have fall back march high concern slowdown transcatheter aortic valve replacement tavr market last year market grow robustly due launch edward sapien xt valve entry medtronic corevalve market so year year comparison be tough weinstein admit however say field research suggest market have picked american college cardiology acc meeting mid march field check suggest tavr market have accelerate post acc meaning edward market be likely surprise upside balance weinstein write reinforce view be survey conduct last week tavr implanter point volume sequentially vs current consensus expectation weinstein theorize datum support survival benefit tavr acc meeting drive increase recent pullback edward be lead stock ibd medical product industry group composite rating morning trading stock market today stock be edward stock touch month low follow amy reeve twitter ibd_areeve
355,MDT,triumph jeopardy make stride health care industry ibm ibm watson artificial intelligence supercomputer help disrupt oil gas industry wednesday ibm say be team woodside australia largest independent oil gas company use watson give employee access unstructured historical datum contain project
356,MDT,medical device maker medtronic mdt report solid quarter tuesday morning stock be fraction stock market today profit margin show sign weakness
357,MDT,fiscal end oct medtronic make cent share year earlier quarter penny analyst consensus sale rise line consensus company reiterate guidance full fiscal year call sale growth adjust foreign exchange rate ep growth
358,MDT,analyst danielle antalffy leerink swann note cost control lower share count drive ep beat gross margin be estimate conference call analyst medtronic management guide fiscal gross margin range analyst have mostly be expect bit
359,MDT,positive side revenue implantable cardioverter defibrillator icds rise constant currency basis beating expectation antalffy note recent quarterly report st jude medical stj boston scientific bsx have indicated icd market grow first time early medtronic report confirm trend
360,MDT,downside sale spinal product drop undercut wall street hope rbc capital market analyst glenn novarro write research note tuesday annual meeting north american spine society last month conventional wisdom have long trouble spine market be stable improve
361,MDT,however do not see evidence uptick spinal fusion market write post mdt result continue see evidence point stable spine market medical device maker medtronic mdt report solid quarter tuesday morning stock be fraction stock market today profit margin show sign weakness fiscal end oct medtronic make cent share year earlier quarter penny analyst consensus sale rise line consensus company reiterate guidance full fiscal year call sale growth adjust foreign exchange rate ep growth analyst danielle antalffy leerink swann note cost control lower share count drive ep beat gross margin be estimate conference call analyst medtronic management guide fiscal gross margin range analyst have mostly be expect bit positive side revenue implantable cardioverter defibrillator icds rise constant currency basis beating expectation antalffy note recent quarterly report st jude medical stj boston scientific bsx have indicated icd market grow first time early medtronic report confirm trend downside sale spinal product drop undercut wall street hope rbc capital market analyst glenn novarro write research note tuesday annual meeting north american spine society last month conventional wisdom have long trouble spine market be stable improve however do not see evidence uptick spinal fusion market write post mdt result continue see evidence point stable spine market
362,MDT,ibd drugmaker jazz pharmaceutical jazz miss analyst second quarter earning estimate report line sale late tuesday offer bullish full year guidance share drop nearly hour trading jazz say adjust net income be share year earlier quarter cent short analyst consensus accord thomson reuter sale rise
363,MDT,share device giant st jude medical stj seesaw wednesday investor sort company third quarter result share eventually close st jude post sale year earlier quarter edge wall street consensus adjust foreign exchange rate revenue rise earning share rise
364,MDT,device giant st jude medical stj announce acquisition get upgrade cowen monday morning lift share stock market st jude buy privately own partner nanostim leadless pacemaker have develop st jude support be approve europe conventional pacemaker require more
365,MDT,medical device giant medtronic mdt release preliminary fiscal earning tuesday be expectation warn outlook be batter foreign exchange headwind medtronic be more early trading stock market today medtronic stock touch time high march medtronic say sale quarter end
366,MDT,add internet thing obamacare get big change health care industry so say goldman sachs report call digital revolution come healthcare iot refer wireless technology connect industrial medical automotive consumer device web apple aapl recently introduce monitoring feature healthkit app apple
367,MDT,add internet thing obamacare get big change health care industry so say goldman sachs report call digital revolution come healthcare iot refer wireless technology connect industrial medical automotive consumer device web apple aapl recently introduce monitoring feature healthkit app apple watch
368,MDT,ibm ibm announce investment company advance online travel shopping apps work powerful watson computer ibm be part funding round wayblazer travel search discovery company goal redefine consumer plan personalize purchase travel accord ibm press release say wayblazer used
369,MDT,leadership be broad ibd medical product group tuesday close stock have composite rating higher much leadership have come small cap name such cambrex cbm vascular solution vasc inogen ingn several large cap name cardiovascular focus be act well trading high
370,MDT,edward lifescience ew composite rating be set cup shape base show buy point now try add handle area yield earlier entry
371,MDT,technical health improve quite bit share surge heavy volume week end june move come fda approve thinner version company artificial heart valve dub sapien valve approve europe last year be insert open heart surgery
372,MDT,st jude medical stj large cap name be hold week move work flat base buy point
373,MDT,big player cardiovascular medical device market earlier month company get go ahead fda resume evaluation portico transcatheter aortic valve implantation system
374,MDT,firm well medtronic mdt boston scientfic bsx be expect benefit bright growth prospect asia pacific region come year
375,MDT,meanwhile small cap merit medical system mmsi be trading close point company make disposable device used primarily cardiology radiology endoscopy share surge april firm smash earning estimate rise quarterly profit leadership be broad ibd medical product group tuesday close stock have composite rating higher much leadership have come small cap name such cambrex cbm vascular solution vasc inogen ingn several large cap name cardiovascular focus be act well trading high edward lifescience ew composite rating be set cup shape base show buy point now try add handle area yield earlier entry technical health improve quite bit share surge heavy volume week end june move come fda approve thinner version company artificial heart valve dub sapien valve approve europe last year be insert open heart surgery st jude medical stj large cap name be hold week move work flat base buy point big player cardiovascular medical device market earlier month company get go ahead fda resume evaluation portico transcatheter aortic valve implantation system firm well medtronic mdt boston scientfic bsx be expect benefit bright growth prospect asia pacific region come year meanwhile small cap merit medical system mmsi be trading close point company make disposable device used primarily cardiology radiology endoscopy share surge april firm smash earning estimate rise quarterly profit
376,MDT,stock future hold steady healthy gain ahead monday open market look short week preholiday trade dow future be level trading point fair market value
377,MDT,nasdaq future future be also steady point respectively
378,MDT,stock market today have work cut christmas week trade generally tend be light young uptrend run heavy distribution friday raise question long last
379,MDT,economic news isn likely have much impact chicago federal reserve national activity index most prominent piece economic news prior open show slip november accelerate october contraction be not economist consensus have expect increase
380,MDT,international market also appear have negligible effect stock europe trade modestly higher midday china market rise include jump shanghai composite tokyo nikkei japan slip
381,MDT,dollar rise bond edge oil price slip west texas intermediate bob barrel brent crude just most metal trade higher big gain
382,MDT,be star war effect early trade walt disney be stock lead dow better gain premarket trade goldman sachs gs apple aapl also gain more
383,MDT,disney star war force awaken gross estimate canada weekend be expectation beating prior record holder jurassic world gross premier june avenger pull premier
384,MDT,disney share briefly clear buy point cup handle base november then drop undercut buy point more trigger sell rule
385,MDT,huge screen savvy imax imax jump new star war film reportedly premier imax screen weekend pull set imax record top open weekend take jurassic world accord box office figure deadline hollywood imax ibd stock end friday buy point cup handle base
386,MDT,also ibd list arm armh perked ahead open share cambridge england base chip designer tumble last week end stock converge week line support stock future hold steady healthy gain ahead monday open market look short week preholiday trade dow future be level trading point fair market value nasdaq future future be also steady point respectively stock market today have work cut christmas week trade generally tend be light young uptrend run heavy distribution friday raise question long last economic news isn likely have much impact chicago federal reserve national activity index most prominent piece economic news prior open show slip november accelerate october contraction be not economist consensus have expect increase international market also appear have negligible effect stock europe trade modestly higher midday china market rise include jump shanghai composite tokyo nikkei japan slip dollar rise bond edge oil price slip west texas intermediate bob barrel brent crude just most metal trade higher big gain be star war effect early trade walt disney be stock lead dow better gain premarket trade goldman sachs gs apple aapl also gain more disney star war force awaken gross estimate canada weekend be expectation beating prior record holder jurassic world gross premier june avenger pull premier disney share briefly clear buy point cup handle base november then drop undercut buy point more trigger sell rule huge screen savvy imax imax jump new star war film reportedly premier imax screen weekend pull set imax record top open weekend take jurassic world accord box office figure deadline hollywood imax ibd stock end friday buy point cup handle base also ibd list arm armh perked ahead open share cambridge england base chip designer tumble last week end stock converge week line support
387,MDT,tuesday bring bonanza mostly bullish third quarter earning report high rate drug stock more legal worry questcor pharmaceutical qcor stomp analyst estimate report close sale totale year earlier quarter past consensus compile thomson reuter profit time item jump
388,MDT,medical device giant medtronic mdt meet analyst quarterly profit estimate issue line guidance tuesday sale come short send share close
389,MDT,medtronic mdt earning fiscal first quarter end july rise year earlier quarter cent share match analyst consensus revenue rise vs consensus
390,MDT,maker pacemaker more guide ep fiscal range share previous year line street view
391,MDT,sale implantable cardioverter defibrillator icds treat heart arrhythmia fall worldwide come short consensus
392,MDT,analyst glenn novarro rbc capital market write client note medtronic appear be lose share stiffly competitive market compare rival have report recent result
393,MDT,main beneficiary be st jude medical stj stock jump more bullish report last month icd sale be flat constant currency basis overall shrinkage market meant gain percentage point market share exact same amount medtronic lose accord novarro estimate third major player boston scientific bsx hold steady
394,MDT,conference call analyst however medtronic cfo gary ellis imply icd problem be temporary
395,MDT,due phase timing new product be many instance be not able get new product associate pricing premium new hospital contract end quarter say same time icd implant dynamic change markedly quarter follow midquarter release evera daily implant growth rate shift negative positive back half quarter
396,MDT,evera be launch early be next generation defibrillator company say be more comfortable patient reduce hospitalization heart failure
397,MDT,spinal product sale fall beat
398,MDT,sale spinal product decline quarter be better wall street have fear area medicine have be struggle time
399,MDT,ellis say market appear be stabilize medtronic be gain share new technology improve spinal surgery
400,MDT,also benefit last year buyout china kanghui holding deliver revenue growth excess ellis say
401,MDT,also upside sale structural heart product rise beating consensus much come corevalve transcatheter aortic heart valve implanted patient natural heart valf have degenerate
402,MDT,corevalve have yet be approve rival edward lifescience ew currently own niche be sell europe continue gain new approval edward however have sue medtronic patent infringement european court july german court order medtronic recall corevalve country
403,MDT,tuesday call ellis reiterate medtronic determination fight ruling admit have bump corevalve sale first quarter advance purchase picked apparent fear court rule do
404,MDT,disappointment quarter morningstar analyst debbie wang retain financial forecast company point new product launch say help make shrink market area corevalve be widely expect finally approval second half next year
405,MDT,symplicity renal denervation system novel therapy treatment resistant hypertension be also expect roll time wang write research note be multibillion dollar product
406,MDT,thank medtronic wide range product portfolio pricing discipline firm profitability remain remarkably steady wang write think firm be good shape meet projection fiscal medical device giant medtronic mdt meet analyst quarterly profit estimate issue line guidance tuesday sale come short send share close medtronic mdt earning fiscal first quarter end july rise year earlier quarter cent share match analyst consensus revenue rise vs consensus maker pacemaker more guide ep fiscal range share previous year line street view sale implantable cardioverter defibrillator icds treat heart arrhythmia fall worldwide come short consensus analyst glenn novarro rbc capital market write client note medtronic appear be lose share stiffly competitive market compare rival have report recent result main beneficiary be st jude medical stj stock jump more bullish report last month icd sale be flat constant currency basis overall shrinkage market meant gain percentage point market share exact same amount medtronic lose accord novarro estimate third major player boston scientific bsx hold steady conference call analyst however medtronic cfo gary ellis imply icd problem be temporary due phase timing new product be many instance be not able get new product associate pricing premium new hospital contract end quarter say same time icd implant dynamic change markedly quarter follow midquarter release evera daily implant growth rate shift negative positive back half quarter evera be launch early be next generation defibrillator company say be more comfortable patient reduce hospitalization heart failure spinal product sale fall beatsale spinal product decline quarter be better wall street have fear area medicine have be struggle time ellis say market appear be stabilize medtronic be gain share new technology improve spinal surgery also benefit last year buyout china kanghui holding deliver revenue growth excess ellis say also upside sale structural heart product rise beating consensus much come corevalve transcatheter aortic heart valve implanted patient natural heart valf have degenerate corevalve have yet be approve rival edward lifescience ew currently own niche be sell europe continue gain new approval edward however have sue medtronic patent infringement european court july german court order medtronic recall corevalve country tuesday call ellis reiterate medtronic determination fight ruling admit have bump corevalve sale first quarter advance purchase picked apparent fear court rule do disappointment quarter morningstar analyst debbie wang retain financial forecast company point new product launch say help make shrink market area corevalve be widely expect finally approval second half next year symplicity renal denervation system novel therapy treatment resistant hypertension be also expect roll time wang write research note be multibillion dollar product thank medtronic wide range product portfolio pricing discipline firm profitability remain remarkably steady wang write think firm be good shape meet projection fiscal
407,MDT,share marketo mkto soar wednesday recent ipo post result late tuesday blow past analyst expectation
408,MDT,company provide cloud base software platform design help company execute manage analyze marketing activity
409,MDT,company say revenue rise year earlier quarter well consensus estimate marketo report share loss cent item far ahead cent loss consensus estimate analyst poll thomson reuter also raise guidance year
410,MDT,share marketo be afternoon trading stock market wednesday new high
411,MDT,be marketo first earning report publicly trade company go share
412,MDT,richard davis analyst canaccord genuity research report wednesday say result be major surprise reversal much negative sentiment analyst have see recent ipo least decade
413,MDT,marketo share have jump stock market debut
414,MDT,davis say doubt marketo compete salesforce com crm
415,MDT,marketo add new customer quarter include largest customer date didn identify describe large technical institute now have customer
416,MDT,addition new customer acquisition success also see significant expansion exist customer accenture acn medtronic mdt panasonic samsung just name few marketo ceo phillip fernandez say conference call tuesday
417,MDT,marketo expect revenue analyst consensus estimate be marketo expect full year ep loss year vs consensus estimate loss see revenue increase year quarter
418,MDT,experience healthy new customer growth entire business particularly strong growth enterprise segment company cfo frederick ball say call share marketo mkto soar wednesday recent ipo post result late tuesday blow past analyst expectation company provide cloud base software platform design help company execute manage analyze marketing activity company say revenue rise year earlier quarter well consensus estimate marketo report share loss cent item far ahead cent loss consensus estimate analyst poll thomson reuter also raise guidance year share marketo be afternoon trading stock market wednesday new high be marketo first earning report publicly trade company go share richard davis analyst canaccord genuity research report wednesday say result be major surprise reversal much negative sentiment analyst have see recent ipo least decade marketo share have jump stock market debut davis say doubt marketo compete salesforce com crm marketo add new customer quarter include largest customer date didn identify describe large technical institute now have customer addition new customer acquisition success also see significant expansion exist customer accenture acn medtronic mdt panasonic samsung just name few marketo ceo phillip fernandez say conference call tuesday marketo expect revenue analyst consensus estimate be marketo expect full year ep loss year vs consensus estimate loss see revenue increase year quarter experience healthy new customer growth entire business particularly strong growth enterprise segment company cfo frederick ball say call
419,MDT,unite therapeutic biotech cardiovascular medicine be stack arsenal pulmonary arterial hypertension hope new drug formulation approval build interest investor company be consider leader commercialize therapy pah rare life threaten disease characterize abnormally high blood pressure artery heart lung
420,MDT,big cap biotech ibd stock unite therapeutic uthr miss analyst estimate tuesday drug sale come short send stock tumble early trading unite report revenue year earlier quarter short consensus gaap earning share rise analyst consensus
421,MDT,small medical device firm nevro nvro soar new high monday eventually close more time average volume market seem be respond earning beat monday well late friday fda approval senza spinal cord stimulator treat chronic pain nevro report revenue
422,MDT,stock pare early loss early afternoon trading tuesday bond yield ease follow initial move higher nasdaq dow jone industrial average lose volume nyse nasdaq be run higher compare same time monday
423,MDT,major average be much early session yield year european bond rise highest level month higher bond yield suggest higher borrow cost individual corporation year treasury yield be recently trading basis point
424,MDT,hospital stock be biggest decliner stock market today universal health service uhs operate acute care hospital behavioral health center slide nearly past cup buy point high end buy range
425,MDT,oil gas stock be best performer oil climb barrel weaker dollar expectation datum due wednesday show decline crude stockpile chesapeake energy chk transocean rig rise
426,MDT,edward lifescience ew be nearly heavy volume jpmorgan upgrade stock overweight neutral say fundamental be strong recent market slowdown increase competition medtronic mdt edward be still day move average recently trigger sell signal fall more flat base buy point stock pare early loss early afternoon trading tuesday bond yield ease follow initial move higher nasdaq dow jone industrial average lose volume nyse nasdaq be run higher compare same time monday major average be much early session yield year european bond rise highest level month higher bond yield suggest higher borrow cost individual corporation year treasury yield be recently trading basis point hospital stock be biggest decliner stock market today universal health service uhs operate acute care hospital behavioral health center slide nearly past cup buy point high end buy range oil gas stock be best performer oil climb barrel weaker dollar expectation datum due wednesday show decline crude stockpile chesapeake energy chk transocean rig rise edward lifescience ew be nearly heavy volume jpmorgan upgrade stock overweight neutral say fundamental be strong recent market slowdown increase competition medtronic mdt edward be still day move average recently trigger sell signal fall more flat base buy point
427,MDT,earlier month obama administration reversed course spending cut popular medicare advantage program instead nearly cut payment private health insurer offer advantage plan senior get boost
428,MDT,turnabout hardly make news isn surprising be third year row administration say be plan cut payment only reverse course
429,MDT,be however emblematic fiscal trouble obamacare have plant federal budget
430,MDT,obamacare be be debate opponent say rely unsustainable spending cut medicare tax hike wouldn work expect other political land mine design only so president obama claim sign law be paid be fiscally responsible
431,MDT,recent event be prove opponent right
432,MDT,nearly half obamacare cost example be suppose be paid spending cut medicare include medicare advantage first year
433,MDT,law take effect administration have try minimize cut increasingly popular advantage program let senior choose wide range subsidize private plan now account third medicare enrollee
434,MDT,medicare third rail
435,MDT,administration effectively cancele first year medicare advantage cut bonuse paid part demonstration project widely deride phony also delay rule change have lead further cut
436,MDT,think cms really rac brain see rate relief be implement know senior love program enrollment have be robust ipsita smolinski founder consultancy capitol street tell morning consult
437,MDT,other big chunk medicare saving nearly be suppose come payment cut doctor hospital center medicare medicaid service chief actuarylook provision say such cut be unsustainable medicare part provider operate red
438,MDT,half hospital third skilled nursing facility home health agency be lose money congress just permanently repeal payment cut plan medicare doctor congress have repeatedly delay be enact
439,MDT,even little know medicare improvement fund have prove troublesome obamacare eliminate fund time saving obama sign law re-create fund put more back
440,MDT,tax side obamacare fiscal equation be just shaky spending cut side
441,MDT,rather rely transparent easily measure source revenue pay massive subsidy social security medicare do payroll tax obamacare raise separate taxe most hide taxpayer view
442,MDT,excise tax medical device be suppose raise be hugely unpopular even far left liberal sen elizabeth warren al franken represent state several big device maker medtronic mdt boston scientific bsx oppose tax say kill job thwart innovation house bill repeal have co sponsor include democrat senator vote ditch tax symbolic vote back
443,MDT,so call cadillac tax be set take effect raise first year also face stiff bipartisan opposition mainly union fiercely oppose
444,MDT,tax be suppose discourage gold plait health plan impose huge excise tax premium set limit design tax eventually reach chevy type health plan way premium limit be adjust year
445,MDT,believe be bipartisan support repeal cadillac tax rep rosa delauro conn say recently
446,MDT,revenue pale
447,MDT,several obamacare taxe meanwhile be raise far less money expect medical device tax example take less project first year accord treasury department tax tanning salon be suppose bring decade be raise half
448,MDT,delay expand exemption congressional budget office say employer individual mandate penalty raise less have first expect
449,MDT,cbo also have sharply cut year forecast cadillac tax revenue third
450,MDT,obamacare backer point spending cut tax revenue be less expect obamacare subsidy cost be lower too congressional budget office recently cut year forecast
451,MDT,quickly change however medical spending inflation pick last year example drug spending unexpectedly leap several breakthrough treatment hit market
452,MDT,key feature hold project subsidy cost be little know controversial provision cap insurance subsidy payment cbo say be difficult sustain lead widening gap subsidy premium obamacare plan
453,MDT,government accountability office take more realistic view obamacare eliminate cost cut feel be unlikely happen conclude law increase deficit almost gdp next year
454,MDT,obamacare financing be so complicate know sure even cbo have give make forecast law impact deficit
455,MDT,be clear be budget picture grow even more ominous democrat keep chip away obamacare unpopular financing scheme insist rest law remain intact earlier month obama administration reversed course spending cut popular medicare advantage program instead nearly cut payment private health insurer offer advantage plan senior get boost turnabout hardly make news isn surprising be third year row administration say be plan cut payment only reverse course be however emblematic fiscal trouble obamacare have plant federal budget obamacare be be debate opponent say rely unsustainable spending cut medicare tax hike wouldn work expect other political land mine design only so president obama claim sign law be paid be fiscally responsible recent event be prove opponent right nearly half obamacare cost example be suppose be paid spending cut medicare include medicare advantage first year law take effect administration have try minimize cut increasingly popular advantage program let senior choose wide range subsidize private plan now account third medicare enrollee medicare third administration effectively cancele first year medicare advantage cut bonuse paid part demonstration project widely deride phony also delay rule change have lead further cut think cms really rac brain see rate relief be implement know senior love program enrollment have be robust ipsita smolinski founder consultancy capitol street tell morning consult other big chunk medicare saving nearly be suppose come payment cut doctor hospital center medicare medicaid service chief actuarylook provision say such cut be unsustainable medicare part provider operate red half hospital third skilled nursing facility home health agency be lose money congress just permanently repeal payment cut plan medicare doctor congress have repeatedly delay be enact even little know medicare improvement fund have prove troublesome obamacare eliminate fund time saving obama sign law re-create fund put more back tax side obamacare fiscal equation be just shaky spending cut side rather rely transparent easily measure source revenue pay massive subsidy social security medicare do payroll tax obamacare raise separate taxe most hide taxpayer view excise tax medical device be suppose raise be hugely unpopular even far left liberal sen elizabeth warren al franken represent state several big device maker medtronic mdt boston scientific bsx oppose tax say kill job thwart innovation house bill repeal have co sponsor include democrat senator vote ditch tax symbolic vote back so call cadillac tax be set take effect raise first year also face stiff bipartisan opposition mainly union fiercely oppose tax be suppose discourage gold plait health plan impose huge excise tax premium set limit design tax eventually reach chevy type health plan way premium limit be adjust year believe be bipartisan support repeal cadillac tax rep rosa delauro conn say recently revenue paleseveral obamacare taxe meanwhile be raise far less money expect medical device tax example take less project first year accord treasury department tax tanning salon be suppose bring decade be raise half delay expand exemption congressional budget office say employer individual mandate penalty raise less have first expect cbo also have sharply cut year forecast cadillac tax revenue third obamacare backer point spending cut tax revenue be less expect obamacare subsidy cost be lower too congressional budget office recently cut year forecast quickly change however medical spending inflation pick last year example drug spending unexpectedly leap several breakthrough treatment hit market key feature hold project subsidy cost be little know controversial provision cap insurance subsidy payment cbo say be difficult sustain lead widening gap subsidy premium obamacare plan government accountability office take more realistic view obamacare eliminate cost cut feel be unlikely happen conclude law increase deficit almost gdp next year obamacare financing be so complicate know sure even cbo have give make forecast law impact deficit be clear be budget picture grow even more ominous democrat keep chip away obamacare unpopular financing scheme insist rest law remain intact
456,MDT,st jude medical stj share surge stock market today medical device maker post better expect second quarter earning important cardiac rhythm management crm business show sign improvement st jude adjust earning exclude time charge rise cent share cent higher consensus projection analyst poll thomson reuter
457,MDT,market close lower monday lead new issue plunge close follow earning report
458,MDT,fall dow jone industrial average nasdaq close session lows nasdaq give gain volume fall board accord preliminary figure
459,MDT,close stock market today share light box litb tumble more close price
460,MDT,china base online retailer report adjust net income cent trade share consensus view cent share revenue rise be view
461,MDT,extend hour light box be trading share close price put stock buy point cup handle base trigger sell rule stock
462,MDT,also close urban outfitter urbn share rally apparel retailer result stock be trading vs close price
463,MDT,urban outfitter beat expectation increase earning april end quarter rise revenue
464,MDT,tuesday earning report be expect home depot hd dick sporting good dks medtronic mdt new reading retail sector be due redbook report icsc goldman store sale datum open market close lower monday lead new issue plunge close follow earning report fall dow jone industrial average nasdaq close session lows nasdaq give gain volume fall board accord preliminary figure close stock market today share light box litb tumble more close price china base online retailer report adjust net income cent trade share consensus view cent share revenue rise be view extend hour light box be trading share close price put stock buy point cup handle base trigger sell rule stock also close urban outfitter urbn share rally apparel retailer result stock be trading vs close price urban outfitter beat expectation increase earning april end quarter rise revenue tuesday earning report be expect home depot hd dick sporting good dks medtronic mdt new reading retail sector be due redbook report icsc goldman store sale datum open
465,MDT,medical device giant medtronic early tuesday report quarterly sale beat wall street expectation profit meet estimate guide rest year line consensus view share rise close revenue fiscal second quarter end oct rise sale be constant currency basis
466,MDT,future look tightly mixed start tuesday season straggle earning report most significant premarket action dow future be point well early lows future have pare early loss fraction trade fair market value nasdaq future have turn early loss point gain
467,MDT,ibm introduce watson world game show jeopardy highly intelligent computer outsmart best contestant game show have ever see
468,MDT,watson be just toddler then grow
469,MDT,rather compete trivium game ibm ibm watson be help solve complex issue field health care sifting complex datum help doctor institution find answer tough question
470,MDT,just start
471,MDT,watson be engage more university industry advance develop humanlike capability
472,MDT,watson be help oil gas industry boost production help create better build material help chef create new recipe health coach consumer travel agent
473,MDT,have question watson have answer not always be best answer surely step right direction thing sure say ibm watson represent new era compute
474,MDT,be just initial cusp new era say john gordon vice president ibm watson group say cognitive compute watson represent be bigger internet term communicate process datum
475,MDT,fundamentally internet connect information faster ever open new opportunity gordon say watson be take new challenge not connect process information new way allow new era human innovation
476,MDT,cognitive compute also go name such artificial intelligence augment intelligence machine learn decade research development have go technology draw interest tech elite
477,MDT,company be field include google googl last year paid acquire specialize machine learn advanced algorithms google have used deep learn enhance search result improve android voice recognition derive more datum image video
478,MDT,microsoft msft have also invest heavily field have facebook fb microsoft be used machine learn technology enhance feature performance office software facebook be used artificial intelligence make news feed feature more relevant user social network
479,MDT,diving deeper immense power new compute technology used parallel process neural network explosion big datum analytic advancement computer software
480,MDT,watson process information more human computer do work require thousand computer decade
481,MDT,rather be programme anticipate answer action need perform task cognitive compute system be trained used artificial intelligence machine learn algorithms sense predict infer
482,MDT,system get more intelligent time more information be fed memory bank have more interaction user aids imaging speech recognition
483,MDT,ibm be leader field field allow computer learn have be programme say david schubmehl research director market research firm idc ll see computer system learn time way human do
484,MDT,watson computer be different depend work kind information feed memory bank
485,MDT,watson be also available cloud company essentially rent own personal portion watson platform
486,MDT,ibm doesn sell watson base company line power system computer do provide computer business partner
487,MDT,ibm derive revenue sale watson service also take share revenue partner successfully introduce market watson base apps ibm say have hundred commercial partner support thousand developer entrepreneur be develop thousand apps
488,MDT,re bet share success gordon say expect lot be successful
489,MDT,ibm establish ibm watson group january ibm be investing group research development collaboration research institution business help commercialize watson ibm also have fund invest startup other want build business top watson
490,MDT,ibm investment include san diego base pathway genomic past year have receive financing variety investor pathway founder provide genetic testing service used large hospital physician
491,MDT,year michael nova pathway chief innovation officer call ibm watson group idea want know ibm watson help pathway develop fitness diet tracking app
492,MDT,fee pathway enormous collection health medical datum watson help user answer health related question pathway app be also expect connect wearable health tracking device such fitbit pull person vital such blood pressure weight pulse user log smartphone ask health question such much exercise do today food stop eating nova expect app be available fourth quarter
493,MDT,health care be hardest datum problem be nova say need watson board huge advantage be link
494,MDT,other investment ibm be part funding round wayblazer travel search discovery company goal redefine consumer plan personalize purchase travel
495,MDT,health care be first market watson ibm have spend most time money
496,MDT,start health intentionally figure be go be problem solve be meaningful be right place start gordon say amount information produce field be explode
497,MDT,april ibm unveil watson health cloud unit say provide secure open platform physician researcher insurer other company focuse health wellness
498,MDT,partner include johnson johnson jnj work ibm develop intelligent virtual coaching solution help prepare patient surgery then deal effect
499,MDT,johnson johnson also leverage ibm relationship apple aapl deliver new iphone ipad application apple be work ibm integrate watson base apps healthkit researchkit tool system developer
500,MDT,partner be medical device giant medtronic mdt be collaborate ibm delivery personalize care person diabetes analyze patient info datum medtronic device
501,MDT,ibm also have watson partnership memorial sloan ketter cancer center md anderson cancer center university texas mayo clinic new york genome center
502,MDT,re bullish ve see say gordon innovator be build new company watson new era compute ibm introduce watson world game show jeopardy highly intelligent computer outsmart best contestant game show have ever see watson be just toddler then grow rather compete trivium game ibm ibm watson be help solve complex issue field health care sifting complex datum help doctor institution find answer tough question just start watson be engage more university industry advance develop humanlike capability watson be help oil gas industry boost production help create better build material help chef create new recipe health coach consumer travel agent have question watson have answer not always be best answer surely step right direction thing sure say ibm watson represent new era compute be just initial cusp new era say john gordon vice president ibm watson group say cognitive compute watson represent be bigger internet term communicate process datum fundamentally internet connect information faster ever open new opportunity gordon say watson be take new challenge not connect process information new way allow new era human innovation cognitive compute also go name such artificial intelligence augment intelligence machine learn decade research development have go technology draw interest tech elite company be field include google googl last year paid acquire specialize machine learn advanced algorithms google have used deep learn enhance search result improve android voice recognition derive more datum image video microsoft msft have also invest heavily field have facebook fb microsoft be used machine learn technology enhance feature performance office software facebook be used artificial intelligence make news feed feature more relevant user social network diving deeper immense power new compute technology used parallel process neural network explosion big datum analytic advancement computer software watson process information more human computer do work require thousand computer decade rather be programme anticipate answer action need perform task cognitive compute system be trained used artificial intelligence machine learn algorithms sense predict infer system get more intelligent time more information be fed memory bank have more interaction user aids imaging speech recognition ibm be leader field field allow computer learn have be programme say david schubmehl research director market research firm idc ll see computer system learn time way human do watson computer be different depend work kind information feed memory bank watson be also available cloud company essentially rent own personal portion watson platform ibm doesn sell watson base company line power system computer do provide computer business partner ibm derive revenue sale watson service also take share revenue partner successfully introduce market watson base apps ibm say have hundred commercial partner support thousand developer entrepreneur be develop thousand apps re bet share success gordon say expect lot be successful ibm establish ibm watson group january ibm be investing group research development collaboration research institution business help commercialize watson ibm also have fund invest startup other want build business top watson ibm investment include san diego base pathway genomic past year have receive financing variety investor pathway founder provide genetic testing service used large hospital physician year michael nova pathway chief innovation officer call ibm watson group idea want know ibm watson help pathway develop fitness diet tracking app fee pathway enormous collection health medical datum watson help user answer health related question pathway app be also expect connect wearable health tracking device such fitbit pull person vital such blood pressure weight pulse user log smartphone ask health question such much exercise do today food stop eating nova expect app be available fourth quarter health care be hardest datum problem be nova say need watson board huge advantage be link other investment ibm be part funding round wayblazer travel search discovery company goal redefine consumer plan personalize purchase travel health care be first market watson ibm have spend most time money start health intentionally figure be go be problem solve be meaningful be right place start gordon say amount information produce field be explode april ibm unveil watson health cloud unit say provide secure open platform physician researcher insurer other company focuse health wellness partner include johnson johnson jnj work ibm develop intelligent virtual coaching solution help prepare patient surgery then deal effect johnson johnson also leverage ibm relationship apple aapl deliver new iphone ipad application apple be work ibm integrate watson base apps healthkit researchkit tool system developer partner be medical device giant medtronic mdt be collaborate ibm delivery personalize care person diabetes analyze patient info datum medtronic device ibm also have watson partnership memorial sloan ketter cancer center md anderson cancer center university texas mayo clinic new york genome center re bullish ve see say gordon innovator be build new company watson new era compute
503,MDT,tap vast field datum facebook fb ibm ibm partner help retailer achieve more personalize target ad ibm combine cloud base marketing datum analytic service facebook ad technology have personalize datum more user social network goal be give brand advertiser clearer
504,MDT,big pharma merck stock jump tuesday company first quarter earning beat estimate bolster good news diabetes franchise same time big biotech ibd stock unite therapeutic fall quarter miss view merck mrk report earning cent share year earlier quarter cent better
505,MDT,huntington beach calif new watson health business unit ibm ibm be look leverage wearable mobile app health datum purpose say company be help optimize consumer medical device datum collection analysis feedback look big blue monday say new watson unit
506,MDT,ibm ibm unveil new watson health business unit several big name partner small acquisition expand health care used artificial intelligence computer giant say monday work apple aapl johnson johnson jnj medtronic mdt help optimize consumer medical device datum collection analysis feedback
507,MDT,cardiac implant maker edward lifescience ew beat analyst profit estimate meet revenue view result release late friday also announce key approval sapien heart valve company say earning rise almost year quarter cent share beating analyst consensus cent sale rise
508,MDT,several medical technology stock be move stock market friday good news bad crossed investor screen share medical software company athenahealth athn gap time high firm inked new contract analyst call major deal be new physician service arm
509,MDT,medtronic mdt say late thursday pay acquire china kanghui holding kh maker orthopedic implant medtronic be world largest maker medical device specialize pacemaker spinal implant price come share kanghui holding stock thursday close price share kanghui be
510,MDT,medical stock be generally see defensive medical device offer opportunity risk bet next innovation lately investor have bet edward lifescience new heart valve hit big edward ew product sapien transcatheter heart valve be implant replace aortic valve patient
511,MDT,medical product maker abbott laboratory wednesday meet expectation first quarterly report proprietary drug business sharply differ result emerge develop market share rise
512,MDT,abbott report earning cent share penny analyst consensus cent year quarter exclude pharma business spun abbvie abbv start year sale rise bit shy analyst sale figure include negative impact foreign exchange rate company say
513,MDT,abbott also affirm previous ep guidance full year last year offer guidance cent vs cent year line analyst estimate also guide mid single digit revenue growth quarter year
514,MDT,conference call discuss result abbott ceo mile white emphasize gap develop emerge market overall slow sale growth revenue emerge country rise double digit most product category white echo johnson johnson jnj executive comment tuesday continue sluggish demand medical product north america europe japan
515,MDT,be underlie economic malaise weakness pretty consistent develop market say not unique not unique europe conversely emerge market just opposite re pretty robust
516,MDT,be differ growth rate abbott major business unit however analyst expect nutritional business be key driver increase operate revenue be largest segment total sale business benefit launch new product include new version similac formula most growth be formula infant toddler have see explode demand china other emerge market
517,MDT,call white say company hope persuade chinese adult need nutritional formula also introduce ensure product line company plan boost capacity asian plant
518,MDT,market demographically culture use standpoint be perfect ensure white say
519,MDT,diagnostic rise again lopsided growth certain market core lab sale make majority revenue jump china russia company have also be add product portfolio particularly architect family immunoassay chemistry instrument detect disease
520,MDT,patent pharmaceutical abbott sell only overseas rise just new product launch have fight pricing pressure europe japan medical device come worst sale shrink year abbott stent business have be especially weak lose royalty promus stent japan face new competition medtronic mdt resolute integrity white note however latest addition xience line new absorb stent only just launch so business see improve sale medical product maker abbott laboratory wednesday meet expectation first quarterly report proprietary drug business sharply differ result emerge develop market share rise abbott report earning cent share penny analyst consensus cent year quarter exclude pharma business spun abbvie abbv start year sale rise bit shy analyst sale figure include negative impact foreign exchange rate company say abbott also affirm previous ep guidance full year last year offer guidance cent vs cent year line analyst estimate also guide mid single digit revenue growth quarter year conference call discuss result abbott ceo mile white emphasize gap develop emerge market overall slow sale growth revenue emerge country rise double digit most product category white echo johnson johnson jnj executive comment tuesday continue sluggish demand medical product north america europe japan be underlie economic malaise weakness pretty consistent develop market say not unique not unique europe conversely emerge market just opposite re pretty robust be differ growth rate abbott major business unit however analyst expect nutritional business be key driver increase operate revenue be largest segment total sale business benefit launch new product include new version similac formula most growth be formula infant toddler have see explode demand china other emerge market call white say company hope persuade chinese adult need nutritional formula also introduce ensure product line company plan boost capacity asian plant market demographically culture use standpoint be perfect ensure white say diagnostic rise again lopsided growth certain market core lab sale make majority revenue jump china russia company have also be add product portfolio particularly architect family immunoassay chemistry instrument detect disease patent pharmaceutical abbott sell only overseas rise just new product launch have fight pricing pressure europe japan medical device come worst sale shrink year abbott stent business have be especially weak lose royalty promus stent japan face new competition medtronic mdt resolute integrity white note however latest addition xience line new absorb stent only just launch so business see improve sale
521,MDT,abbvie abbv late wednesday say board director recommendation shareholder reject plan buy shire pharmaceutical board cite new treasury rule issue make tax inversion deal less attractive abbvie say statement breadth scope change include unexpected nature exercise administrative authority
522,MDT,wag mull use loophole tax law save million dollar move headquarters europe former treasury official argue white house close loophole congressional approval article publish monday tax note journal accountant tax lawyer stephen shay former treasury
523,MDT,more leader advanced time high friday market rally palo alto network panw gap rise clear week tight buy point heavy trade stock be now entry piper jaffray reiterate overweight rating raise price target computer security provider
524,MDT,medical product giant st jude medical abbott laboratory beat analyst expectation raise guidance wednesday share have bumpy ride market fresh attack drug industry merger abbott report first sale beat quarters revenue rise consensus earning climb cent share beating estimate cent company add few penny full year ep guidance now analyst average be conference call analyst discuss result abbott cfo thomas freyman say revenue rise low mid single digit be high side analyst expectation growth freyman also guide sale growth similar range say earning be cent cent year be line street estimate have be bit show story last few quarters company work headwind establish product generic drug nutritional business leerink analyst danielle antalffy write research note wednesday now sale ep beat hand prompt ep guidance raise recent transaction execute optimize portfolio include acquisition cfr pharmaceutical chilean base brand generic company divestiture develop market establish product business be near potential sale growth inflection point monday abbott announce be selling develop market establish product business mylan myl plan take opportunity re incorporate netherlands follow virtual stampede drugmaker lower tax country wednesday however treasury secretary jack lew issue letter congress urge moratorium such arrangement comprehensive tax reform be enact lew want ban be retroactive view be caution be certainly warrant concern pending recently announce deal such mylan announce acquisition abbott establish product business bmo capital market analyst david maris write research note wednesday perhaps abbott stock seesaw trading wednesday open then drop midday eventually close fraction analyst be impressed abbott cost control result improvement gross profit margin rbc capital market analyst glenn novarro say make quality beat morgan stanley analyst david lewis project basis point improvement operate margin second half year st jude stj have plan tax inversion say earning rise year earlier quarter share beating analyst consensus cent sale climb vs street company guide ep cent cent bracketing consensus sale guidance miss analyst year st jude guide ep sale slightly higher previous guidance line expectation st jude see share gainson conference call discuss result st jude ceo daniel stark say growth start accelerate second half year due mainly new product launch say ramp continue next year revenue growth mid high single digit vs year expect range stark also say st jude be still gain share implantable cardioverter defibrillator icd market sale division rise st jude say overall market continue shrink stark admit however first quarter firm didn know exactly icd market be do rival boston scientific bsx medtronic mdt have report quarters later earning medtronic boston scientific be still road result however have indicated st jude gain basis point market share still analyst antalffy write st jude guidance be disappointing give beat also point stock be richly value hit time high july trading wednesday do almost reverse abbott drop nearly early recover somewhat close nearly
525,MDT,update downward revision third quarter gdp still sluggish consumer confidence head holiday shopping season left major index mired modest loss tuesday
526,MDT,dow nyse composite give slip less nasdaq surrender close well session lows
527,MDT,datum show late surge trading volume nasdaq handed tech heavy index fourth distribution day recent week
528,MDT,small cap once again fall faster send decline
529,MDT,clothing retailer crew jcg rip gain hour news ep be cent analyst consensus revenue also top expectation company provide guidance line view
530,MDT,blue coat system bcsi add earning revenue just clear forecast maker network security management appliance provide guidance line expectation
531,MDT,wednesday sport busy economic calendar personal spending initial jobless claim durable good order tap early new home sale datum be release soon open
532,MDT,index take moderate loss mixed trade
533,MDT,update downward revision third quarter gdp still sluggish consumer confidence head holiday shopping season left major index mired modest loss tuesday dow nyse composite give slip less nasdaq surrender close well session lows datum show late surge trading volume nasdaq handed tech heavy index fourth distribution day recent week small cap once again fall faster send decline clothing retailer crew jcg rip gain hour news ep be cent analyst consensus revenue also top expectation company provide guidance line view blue coat system bcsi add earning revenue just clear forecast maker network security management appliance provide guidance line expectation wednesday sport busy economic calendar personal spending initial jobless claim durable good order tap early new home sale datum be release soon open index take moderate loss mixed trade
534,MDT,stock future trend higher tuesday market eye rebound monday brisk sell dow future add early gain go point ahead bell nasdaq future rise point future climb point autozone azo gain pre market trade easily top fiscal third quarter analyst view earning
535,MDT,stock future signale lower open wednesday follow prior session rebound
536,MDT,dow nasdaq future be ahead bell
537,MDT,tuesday wall street record biggest day gain volatile day trading ongoing fear economy
538,MDT,reuter poll say economist figure chance have recession mean fed launch round monetary ease
539,MDT,elsewhere gold price remain record high ounce
540,MDT,corporate front macy logged second quarter earning cent share cent prior year nickel view
541,MDT,disney also beat earning sale estimate thank part strong result espn theme park division
542,MDT,overseas tokyo nikkei index rise hong kong hang seng climb europe major index be afternoon trading stock future signale lower open wednesday follow prior session rebound dow nasdaq future be ahead bell tuesday wall street record biggest day gain volatile day trading ongoing fear economy reuter poll say economist figure chance have recession mean fed launch round monetary ease elsewhere gold price remain record high ounce corporate front macy logged second quarter earning cent share cent prior year nickel view disney also beat earning sale estimate thank part strong result espn theme park division overseas tokyo nikkei index rise hong kong hang seng climb europe major index be afternoon trading
543,MDT,just few year drug generate small slice revenue jazz pharmaceutical drug xyrem target small patient population narcolepsy sufferer person prone fall suddenly asleep middle day high price make sale effort worthwhile jazz pharmaceutical jazz keep raise price
544,MDT,stock market fall again tuesday leave outlook less murky have be other day lately nasdaq slip selling picked final minute index close session lows ibd fall only be third straight drop lead stock have
545,MDT,re stay current pursue unique job path seek real person be not person think be key brilliant career say robert kaplan management professor harvard author re really meant do help level worker put oomph back professional adventure young person aren only one try figure meet potential person look have arrived be come see too kaplan tell ibd ceo company surely have arrived right assure have not arrived contend ll be more successful humble profession love flashy dread job fit be not be great middle age retirement kaplan compare smart career steering weight loss say ve lose pound now eat anything want have work rest life stay career sharp keep ask do love most potent source career viability passion say kaplan want make money be fine realize money almost single career think be back end load come result perform high level many year know think time life excel be do best kaplan say be do be task be environment other exercise pretend re wealthy have just year live now do be good high percentage person speak don have clear sense core strength kaplan say same time most person talk accurately describe weakness be writer speaker negotiator coach math whiz mentor help pin then ll grasp dream job be really dream job do want person often have fantasy mean work particular industry example be popular now kaplan say not easy anyone matter person say cocktail party push past romance call so ll know re get talk person ask be thing need be great do job kaplan say lack skill never too late return classroom take work professional lunch ask advice kaplan remind seasoned worker ready grow don let grudge emotional block keep forge new direction life bill george former medtronic mdt ceo kaplan colleague harvard co author true north study top leader figure form powerful authentic chief have problem just everyone else difference use stumble previous month year believe leadership emerge life story george say constantly testing real world experience reframe life story understand be unleashed passion discover purpose leadership
546,MDT,edward lifescience stock jump midday trading stock market today follow fda approval late monday latest artificial heart valve sapien xt edward ew sapien xt be transcatheter aortic valve update version original sapien launch fda approve patient be inoperable high risk death
547,MDT,biotech unite therapeutic uthr be expect report solid growth quarter open tuesday investor await key fda decision drug
548,MDT,analyst poll thomson reuter estimate profit rise year quarter share sale most revenue come trepostinil treatment pulmonary arterial hypertension sell injectable form remodulin inhalable form tyvaso earlier month unite shock wall street refile fda approval oral trepostinil earlier rejection agency be expect make decision march
549,MDT,preview note analyst mark schoenebaum isi group say unite top executive talk analyst ll be listen update trial implantable remodulin pump unite be develop medtronic mdt expect be complete later year say ll also be listen possible change revenue guidance currently news unite patent infringement suit novartis nvs unit sandoz possible generic remodulin
550,MDT,unite therapeutic ibd composite rating be stellar share sharply fda refile valentine day stock be fraction afternoon trading monday day stock market reversed negative territory biotech unite therapeutic uthr be expect report solid growth quarter open tuesday investor await key fda decision drug analyst poll thomson reuter estimate profit rise year quarter share sale most revenue come trepostinil treatment pulmonary arterial hypertension sell injectable form remodulin inhalable form tyvaso earlier month unite shock wall street refile fda approval oral trepostinil earlier rejection agency be expect make decision march preview note analyst mark schoenebaum isi group say unite top executive talk analyst ll be listen update trial implantable remodulin pump unite be develop medtronic mdt expect be complete later year say ll also be listen possible change revenue guidance currently news unite patent infringement suit novartis nvs unit sandoz possible generic remodulin unite therapeutic ibd composite rating be stellar share sharply fda refile valentine day stock be fraction afternoon trading monday day stock market reversed negative territory
551,MDT,re plan go back school fall simply want broaden business skill summer be great time catch read meanwhile crucial deepen knowledge field expand horizon expert say here be country top business professor recommend pick
552,MDT,early wednesday abbott laboratory be set report first quarter half company used be spin proprietary drug business new year day
553,MDT,result year year comparison be bit deceptive current consensus accord thomson reuter call drop sale last year earning fall cent share year number however include company now know abbvie abbv own blockbuster arthritis drug humira other popular drug accord analyst remain division see mixed result
554,MDT,nutritional now make largest division abbott revenue earlier month william blair morgan stanley offer bullish outlook business especially mead johnson mjn ceo peter jakobsen say march crucial chinese market be improve gain further support tuesday french competitor danone danoy report record growth asian sale especially infant formula danone mead johnson share rise more
555,MDT,william blair analyst ben andrew be modele growth abbott nutrition business also modele similar growth diagnostic division again due growth emerge market well new product however expect sale patent drug shrink due austerity measure europe reimbursement cut japan sale stent business be also expect shrink company face rollout medtronic mdt resolute integrity stent
556,MDT,related johnson johnson earning beat expectation early wednesday abbott laboratory be set report first quarter half company used be spin proprietary drug business new year day result year year comparison be bit deceptive current consensus accord thomson reuter call drop sale last year earning fall cent share year number however include company now know abbvie abbv own blockbuster arthritis drug humira other popular drug accord analyst remain division see mixed result nutritional now make largest division abbott revenue earlier month william blair morgan stanley offer bullish outlook business especially mead johnson mjn ceo peter jakobsen say march crucial chinese market be improve gain further support tuesday french competitor danone danoy report record growth asian sale especially infant formula danone mead johnson share rise more william blair analyst ben andrew be modele growth abbott nutrition business also modele similar growth diagnostic division again due growth emerge market well new product however expect sale patent drug shrink due austerity measure europe reimbursement cut japan sale stent business be also expect shrink company face rollout medtronic mdt resolute integrity stent related johnson johnson earning beat expectation
557,MDT,stock future sag ahead monday open currency action company news be most apparent influence
558,MDT,dow future hung point fair market value nasdaq future be point future be point small cap be more re-serve russell future mild point
559,MDT,ahead open stock market today work reconcile raft mixed global economic news european union amp sanction russia oil producer germany july export surge china august export come forecast slowdown import miss projection
560,MDT,currency market be buzz britain pound dive weekend poll show scotland favore independence yen tumble datum show japan economy contract second quarter much broader initially estimate gold drop crude oil benchmark europe backed other commodity be generally stable
561,MDT,stock news china alibaba report offer share price security exchange commission filing friday news report friday say online conglomerate plan begin trading share renaissance capital estimate ipo raise top visa initial offer share yahoo yhoo own stake alibaba be monday open
562,MDT,general electric ge say sell home appliance division swedish brand name electrolux eluxy combination give electrolux estimate share appliance market just ahead whirlpool whr share general electric share rise fraction
563,MDT,glaxosmithkline gsk drop premarket action credit suisse reportedly lower stock price target drugmaker slip sharp correction july
564,MDT,lead stock trade generally narrow mixed range open bell ambarella amba be standout ibd list jump almost imperial capital keep outperform rating stock raise price target
565,MDT,overseas market asia book mixed finish monday european market be trading pressure midday economic calendar federal reserve be slate release july consumer credit datum et stock future sag ahead monday open currency action company news be most apparent influence dow future hung point fair market value nasdaq future be point future be point small cap be more re-serve russell future mild point ahead open stock market today work reconcile raft mixed global economic news european union amp sanction russia oil producer germany july export surge china august export come forecast slowdown import miss projection currency market be buzz britain pound dive weekend poll show scotland favore independence yen tumble datum show japan economy contract second quarter much broader initially estimate gold drop crude oil benchmark europe backed other commodity be generally stable stock news china alibaba report offer share price security exchange commission filing friday news report friday say online conglomerate plan begin trading share renaissance capital estimate ipo raise top visa initial offer share yahoo yhoo own stake alibaba be monday open general electric ge say sell home appliance division swedish brand name electrolux eluxy combination give electrolux estimate share appliance market just ahead whirlpool whr share general electric share rise fraction glaxosmithkline gsk drop premarket action credit suisse reportedly lower stock price target drugmaker slip sharp correction july lead stock trade generally narrow mixed range open bell ambarella amba be standout ibd list jump almost imperial capital keep outperform rating stock raise price target overseas market asia book mixed finish monday european market be trading pressure midday economic calendar federal reserve be slate release july consumer credit datum et
566,MDT,share medical device giant medtronic mdt british orthopedic firm nephew snn pull back stock market today new high wednesday analyst debate buyout rumor bloomberg first publish anonymously source report wednesday open drive stock medtronic new high follow similar rumor last week
567,MDT,medical device maker medtronic mdt be set report fiscal result early tuesday wall street expect modest ep growth company retrench analyst poll thomson reuter estimate profit quarter end oct rise year quarter cent share estimate sale fall medtronic have
568,MDT,share medical equipment maker cyberonic cybx fall sharply report mixed fourth quarter estimate earning estimate full year be lighter expect rolled variety new device maker implantable device treat epilepsy depression other neurological disease say earning share rise vs year cent penny more estimate revenue grow wall street expect full year cyberonic see ep consensus analyst poll thomson reuter be share company light earning projection come shift management higher spending launch several new product april medical device maker name hoare newly create position chief operate officer neill cruz chief medical officer other medical gear maker include highly rate invisalign clear brace maker align technology algn stock be ibd list top rate stock spine disorder treatment gear maker globus medical gmed cyberonic make highly specialize equipment cyberonic make monitoring device system deliver mild electrical pulse vagus nerve patient neck send signal brain cyberonic new aspiresr brand pulse generator treatment epilepsy depression be approve europe february communication food drug administration determine next step approval aspiresr generator be underway cyberonic ceo dan moore say wednesday earning announcement moore have say earlier company be make significant multiyear investment sale force technology pipeline support rollout cyberonic new centro proguardian system be also near submission regulatory agency approval plunge much time usual trading volume cyberonic share be late morning trading stock market today wednesday small company have be steady eddie grow consistent pace last year annual revenue have grow stock price rise early june high feb year begin retreat sync market correction other company company medical product group medical equipment giant medtronic mdt largest group market cap be fractionally baxter international bax fall align technology globus medical be follow james detar twitter ibd_jdetar
569,MDT,medical device giant medtronic mdt early tuesday report soft quarter announce settlement long run patent dispute send share morning trading stock market today medtronic sale fiscal fourth quarter end april rise year earlier quarter miss analyst consensus share profit
570,MDT,stock climb mixed early trade tuesday aid datum show unexpected jump october consumer confidence
571,MDT,nasdaq lead gain volume vs level early monday tack gain dow jone industrial nose trade
572,MDT,stock market today open shadowing positive action overseas market september durable good datum commerce department be mixed case shiller city home price index slump august be home price index second straight slowdown show home price still rise slow rate homebuilder stock be unfazed most show modest gain early trade
573,MDT,consumer outlook improve october send conference board consumer confidence index be well september upwardly revise read confound analyst expectation slight increase original estimate
574,MDT,stock amgen amgn scramble higher report better expect third quarter result monday close management ratchete earning revenue guidance launch share buyback program say increase dividend begin first quarter
575,MDT,amgen uptrend august end monday new high
576,MDT,motion control system provider parker hannifin ph pop cleveland base operation fiscal first quarter earning soar past consensus expectation revenue growth stop fraction short forecast management offer line earning guidance raise quarterly dividend announce share buyback effort
577,MDT,parker hannifin share have post steep gain past week rise october low stock be june high climb right side month consolidation
578,MDT,lead stock notch positive open more stock ibd list advanced start gate
579,MDT,spirit airline save jump front list gain florida base airline report third quarter earning narrowly analyst expectation revenue stop just short forecast stock be october low tuesday gain lift share just day line support
580,MDT,half dozen stock list add more lannett lci climb new high generic drug maker be now cup handle buy point stock climb mixed early trade tuesday aid datum show unexpected jump october consumer confidence nasdaq lead gain volume vs level early monday tack gain dow jone industrial nose trade stock market today open shadowing positive action overseas market september durable good datum commerce department be mixed case shiller city home price index slump august be home price index second straight slowdown show home price still rise slow rate homebuilder stock be unfazed most show modest gain early trade consumer outlook improve october send conference board consumer confidence index be well september upwardly revise read confound analyst expectation slight increase original estimate stock amgen amgn scramble higher report better expect third quarter result monday close management ratchete earning revenue guidance launch share buyback program say increase dividend begin first quarter amgen uptrend august end monday new high motion control system provider parker hannifin ph pop cleveland base operation fiscal first quarter earning soar past consensus expectation revenue growth stop fraction short forecast management offer line earning guidance raise quarterly dividend announce share buyback effort parker hannifin share have post steep gain past week rise october low stock be june high climb right side month consolidation lead stock notch positive open more stock ibd list advanced start gate spirit airline save jump front list gain florida base airline report third quarter earning narrowly analyst expectation revenue stop just short forecast stock be october low tuesday gain lift share just day line support half dozen stock list add more lannett lci climb new high generic drug maker be now cup handle buy point
581,MDT,share biotech unite therapeutic uthr pop heavy trading thursday company startle wall street revive drug have left dead unite therapeutic say food drug administration have accept resubmission approval oral treprostinil infusion form be company best seller remodulin remodulin treat pulmonary arterial hypertension pah
582,MDT,medical device giant medtronic mdt early tuesday report fiscal first quarter result give forecast line wall street expectation keep share month high touch monday company say revenue quarter end july totale year earlier quarter constant currency basis profit rise
583,MDT,share medical device firm covidien cov gap heavy trading early wednesday company say product recall dampen fourth quarter earning
584,MDT,irish firm say stop make surgical tissue reinforcement product call duet trs universal straight articulating single use load unit be voluntarily recall already market product be link abdominal injury covidien already have partially recall product january be link injury death used thoracic surgery
585,MDT,covidien have other product recall time company say loss revenue related cost knock several cent ep fiscal fourth quarter end cent cent ep fiscal current analyst consensus already call earning drop more year quarter share profit be expect rise
586,MDT,covidien stock hit week high aug aid report late july beat view third biggest company medtronic mdt baxter bax ibd medical product group have slide industry group ranking edge top couple month
587,MDT,related medtronic meet expectation share medical device firm covidien cov gap heavy trading early wednesday company say product recall dampen fourth quarter earning irish firm say stop make surgical tissue reinforcement product call duet trs universal straight articulating single use load unit be voluntarily recall already market product be link abdominal injury covidien already have partially recall product january be link injury death used thoracic surgery covidien have other product recall time company say loss revenue related cost knock several cent ep fiscal fourth quarter end cent cent ep fiscal current analyst consensus already call earning drop more year quarter share profit be expect rise covidien stock hit week high aug aid report late july beat view third biggest company medtronic mdt baxter bax ibd medical product group have slide industry group ranking edge top couple month related medtronic meet expectation
588,MDT,here investing action plan thursday need know investor come day ulta beauty ulta medtronic mdt dollar general dg dollar tree dltr be slate report quarterly earning apple aapl be stock watch dip day line apple share have rally mid lows retake
589,MDT,medical stock particularly drugmaker play key role buoy challenged market first half year year date tuesday ibd medical sector industry group show average loss biotechs ethical drugmaker be hardest respectively have left medical group rank
590,MDT,drug industry merger acquisition continue wednesday pharma company sell core asset british giant astrazeneca azn agree sell small molecule biotech antibiotic pfizer pfe upfront payment january milestone payment depend drug still pipeline make market portfolio include already commercialize drug merrem zinforo zavicefta treat range serious infection well late stage pipeline candidate drug resistant infection allergan agn hold north american right zavicefta zinforo continue do so pfizer acquire international right ibd take pfizer size patent loss have keep be big growth stock lately lead dividend stock outlined recently ibd column income investor move fit astrazeneca strategy focuse choose area oncology respiratory autoimmunity cardiovascular metabolic disease pfizer add exist portfolio more infective continue reshape essential health portfolio be focuse area further address global public health need complement core capability experience therapeutic area john young head pfizer essential health say statement deal be expect close pfizer stock close lower stock market today astrazeneca stock fall meanwhile specialty drugmaker mallinckrodt mnk say selling diagnostic nuclear imaging business belgium base iba molecular fact mallinckrodt have not especially related business specialty drug imaging come peculiar history be more diversify company tyco international tyc buy tyco spun medical business covidien now part medtronic mdt then covidien spun mallinckrodt other division be strip spinoff drug business have be grow much faster imaging business so sale have be widely expect deal have clear unusual regulatory hurdle include approval nuclear regulatory commission committee foreign investment unite state so company say close first half mallinckrodt stock drop set month high intraday related pfizer medivation deal reignite biotech buyout speculation more drugmaker beat estimate guidance mixed
591,MDT,intuitive surgical isrg maker robotic surgery system late tuesday post earning revenue handily beat wall street expectation send share rise hour earning share item rise year earlier quarter sale rise analyst poll thomson reuter have expect maker da vinci surgical system minimally invasive surgery didn provide guidance earning release analyst expect ep ex item quarter sale intuitive surgical stock be nearly hour trading company release result share rise fraction tuesday regular session intuitive stock hit time high july move flat base buy point june so share remain buy range da vinci success have spawn more competition alphabet googl verily unit formerly google life science have team johnson johnson jnj advanced surgical robot early tuesday post earning beat johnson johnson stock hit record high tuesday close medtronic mdt make big move field acquisition last year covidien company say number da vinci procedure rise nearly vs ship da vinci system vs pre earning research note leerink analyst richard newitter say intuitive be increasingly benefit next leg growth da vinci xi system launch
592,MDT,ishare medical device etf ihi be year top etf leader ride best part mixed health care sector year medical sector have diverged industry fare much better other biotechs other drugmaker be roughly ibd medical product equipment industry group be only diversify medical company be do quite well health care much outperformance medical device owe superior result top manufacturer innovation have play key role ignite industry leader stock etf medtronic mdt be largest hold more portfolio share have climb much buy point april stock have perform decently fact earning have be basically flat quarters outlook be improve analyst expect profit rise fiscal year end april next year investor day june medtronic forecast mid single digit revenue growth develop product pipeline draw diversify market edward lifescience ew be stock have shoulder etf advance share be time high main move year be april company announce sapien transcatheter aortic valve replacement be show reduce death heart attack patient moderate risk open heart surgery share soar news medtronic corevalve compete edward heart valve replacement patient not able have open heart surgery analyst canaccord genuity remain bullish stock follow earning report say dominate market transcatheter aortic valve replacement show potential market expansion share stryker syk have broadest range orthopedic product peer have climb much year fall sharply july earning report be clear explanation slide other softness emerge market other key contributor ishare medical device be thermo fisher scientific tmo make equipment medical research zimmer biomet zbh just post strongest quarter sale growth nearly decade becton dickinson bdx have be trend higher fall sharply thursday cut full year sale forecast cite currency headwind etf be extend april pullback day move average june remain buy point week tight pattern form july ibd etf leader index show performance model portfolio exchange trade fund be lead overall market computer algorithm select etfs base relative strength other objective performance rating periodic adjustment market trend condition universe etfs be select include fund list
593,MDT,share device maker edward lifescience ew jump early trading stock market today word get late friday company have win court injunction limit sale medtronic mdt corevalve artificial heart valve
594,MDT,medtronic stock be
595,MDT,corevalve have be sell europe several year be approve fda january edward rival sapien product have be sell america have long fought corevalve entry patent litigation jury trial find medtronic have infringe edward patent friday federal judge grant injunction limit corevalve sale patient extreme risk start april medtronic say appeal
596,MDT,judge do say corevalve seem be safer product better outcome order company agree way allow physician trained corevalve implantation currently hospital continue use product accord own clinical judgment
597,MDT,give rare injunction be be surprised court decision write rbc capital market analyst glenn novarro research note monday
598,MDT,novarro see possible outcome point scenario mdt gain stay april be change estimate mdt then move forward appeal injunction play court year
599,MDT,scenario mdt do not stay ew enforce injunction note ew have petition patent trademark office extend anderson patent early thus worst case scenario mdt likely be market early
600,MDT,scenario mdt do not gain stay ew allow mdt sell hospital be currently trained corevalve
601,MDT,novarro maintain sector perform rating stock crt capital upgrade edward buy fairly value jpmorgan upgrade neutral underweight deutsche bank maintain hold rating edward lift price target edward stock be trading monday morning
602,MDT,follow amy reeve twitter ibd_areeve
603,MDT,related medtronic price target raise already beat share device maker edward lifescience ew jump early trading stock market today word get late friday company have win court injunction limit sale medtronic mdt corevalve artificial heart valve medtronic stock be corevalve have be sell europe several year be approve fda january edward rival sapien product have be sell america have long fought corevalve entry patent litigation jury trial find medtronic have infringe edward patent friday federal judge grant injunction limit corevalve sale patient extreme risk start april medtronic say appeal judge do say corevalve seem be safer product better outcome order company agree way allow physician trained corevalve implantation currently hospital continue use product accord own clinical judgment give rare injunction be be surprised court decision write rbc capital market analyst glenn novarro research note monday novarro see possible outcome point scenario mdt gain stay april be change estimate mdt then move forward appeal injunction play court year scenario mdt do not stay ew enforce injunction note ew have petition patent trademark office extend anderson patent early thus worst case scenario mdt likely be market early scenario mdt do not gain stay ew allow mdt sell hospital be currently trained corevalve novarro maintain sector perform rating stock crt capital upgrade edward buy fairly value jpmorgan upgrade neutral underweight deutsche bank maintain hold rating edward lift price target edward stock be trading monday morning follow amy reeve twitter ibd_areeve related medtronic price target raise already beat
604,MDT,stock chopped end mildly higher second straight session monday be leader give strong show nasdaq rise edge be much much session small cap outperformed russell climb
605,MDT,modest gain fade early monday busy day deal make
606,MDT,hour session nasdaq dow jone industrial average lose ease volume new york stock exchange rise friday level nasdaq volume fall
607,MDT,stock market today lithia motor lad be far best percentage gainer ibd share gap rise news acquire dch auto group cash stock dch operate store southern california store new jersey new york
608,MDT,other deal make headline medical device maker medtronic mdt agree buy ireland base competitor covidien cov nearly cash stock share covidien soar news medtronic ease meanwhile chipmaker sandisk sndk agree buy fusion io fio maker storage memory platform head monday fusion io be just june ipo price fusion io soar sandisk gain
609,MDT,other gainer include armour ua share rise rw baird up price target cite momentum apparel growth more complete footwear offer armour continue work right side cup shape base
610,MDT,elsewhere gaslog glog reclaim day move average work right side potential base share jump growth prospect be still bright company gaslog operate fleet liquefy natural gas carrier
611,MDT,day fed meeting start tuesday decision interest rate policy statement be release wednesday et modest gain fade early monday busy day deal make hour session nasdaq dow jone industrial average lose ease volume new york stock exchange rise friday level nasdaq volume fall stock market today lithia motor lad be far best percentage gainer ibd share gap rise news acquire dch auto group cash stock dch operate store southern california store new jersey new york other deal make headline medical device maker medtronic mdt agree buy ireland base competitor covidien cov nearly cash stock share covidien soar news medtronic ease meanwhile chipmaker sandisk sndk agree buy fusion io fio maker storage memory platform head monday fusion io be just june ipo price fusion io soar sandisk gain other gainer include armour ua share rise rw baird up price target cite momentum apparel growth more complete footwear offer armour continue work right side cup shape base elsewhere gaslog glog reclaim day move average work right side potential base share jump growth prospect be still bright company gaslog operate fleet liquefy natural gas carrier day fed meeting start tuesday decision interest rate policy statement be release wednesday et
612,MDT,medtronic buyout fellow medical device giant covidien get mostly friendly reception wall street monday analyst foresee further round mega merger change industry landscape late sunday medtronic mdt announce have agree buy covidien cov cash stock deal give covidien shareholder ownership new company
613,MDT,share medical device maker covidien cov jump stock market today medtronic mdt announce late sunday be buy company medtronic cash stock payment amount share base medtronic close price friday create industry heavyweight annual revenue covidien
614,MDT,concern medicare not cover new heart valve edward lifescience ew sank stock overshadow valve expect fda approval threaten company be spending prepare launch company sapien transcatheter heart valve be design be insert heart catheter rather open heart surgery
615,MDT,stock start friday session upside gain vanished close tune make money stock ibd saturday pm pm pst see listen nasdaq rise fractionally dow jone industrial average fall fractionally index have be much
616,MDT,stock continue slip late trading tuesday most index be pace fourth straight loss nasdaq be nyse composite dow volume continue track higher exchange signale additional distribution day major index china automotive system caas gap shed month low put stock january peak stock action have be wide loose year netflix nflx drop fast trade stock fall buy point double bottom base have be much aug medtronic mdt gap lose heavy trading cite weak sale defibrillator spinal product medtronic lower full year fiscal earning outlook range share prior outlook verifone system pay fall ahead fiscal earning close analyst see provider electronic payment service earn cent share year verifone clear buy point cup handle base july stock be now testing week move average
617,MDT,stock continue pare earlier loss midday tuesday rebound cautious remark chicago federal reserve bank president charle evan ugly exist home sale report nyse composite skid nasdaq dow volume swell nyse nasdaq compare same period monday higher trade indicated institutional investor be selling share add market gloom medtronic mdt plunge heavy volume maker cardiac rhythm device spinal implant other medical equipment gap slash full year fiscal earning guidance borgwarner bwa slump nearly twice usual volume auto part maker stock find support day move average priceline com pcln dip brisk turnover deep discount travel service provider remain strong uptrend earning share rating relative price strength rating
618,MDT,artificial heart valve battle remain bit draw
619,MDT,medtronic mdt edward lifescience ew offer compete set datum artificial heart valf american college cardiology meeting washington last weekend
620,MDT,wednesday rbc capital market analyst glenn novarro hike price target medtronic stock share already trade new price
621,MDT,medtronic be nearly midday trading stock market today edward stock be fraction
622,MDT,company present datum heart valf meeting sunday analyst leane medtronic provide better number edward also be upbeat stock rise ibd report
623,MDT,edward stock climb monday fraction tuesday be midday wednesday medtronic stock rise monday fraction tuesday
624,MDT,novarro have favorite
625,MDT,mdt emerge clear winner clinician enthusiasm company high risk datum set excitement future tavr market overall write research note tavr stand transcatheter aortic valve replacement target high risk patient not candidate traditional open chest surgery
626,MDT,additionally management disclose expand label not have face panel push approval few month say
627,MDT,also say expect company release positive trial result medical conference saturday london pact drug eluting balloon product heart patient result say support fda approval artificial heart valve battle remain bit draw medtronic mdt edward lifescience ew offer compete set datum artificial heart valf american college cardiology meeting washington last weekend wednesday rbc capital market analyst glenn novarro hike price target medtronic stock share already trade new price medtronic be nearly midday trading stock market today edward stock be fraction company present datum heart valf meeting sunday analyst leane medtronic provide better number edward also be upbeat stock rise ibd report edward stock climb monday fraction tuesday be midday wednesday medtronic stock rise monday fraction tuesday novarro have favorite mdt emerge clear winner clinician enthusiasm company high risk datum set excitement future tavr market overall write research note tavr stand transcatheter aortic valve replacement target high risk patient not candidate traditional open chest surgery additionally management disclose expand label not have face panel push approval few month say also say expect company release positive trial result medical conference saturday london pact drug eluting balloon product heart patient result say support fda approval
628,MDT,drive health care medium industry have so far be strongest year merger acquisition dawn financial crisis big deal globally totale june last year past few day have be microcosm rise level communication lvlt
629,MDT,medtronic mdt world biggest maker heart rhythm device say first quarter profit rise increase demand company stent pacemaker other product used surgery net income month end july increase cent share cent year earlier minneapoli base company say today
630,MDT,medical device giant medtronic mdt edward lifescience ew offer compete set datum artificial heart valf weekend stock be morning trading stock market today american college cardiology meeting washington medtronic report patient high risk death open heart surgery have significantly higher survival
631,MDT,medical device giant medtronic early tuesday report quarterly sale beat wall street expectation profit meet estimate guide rest year line consensus view share rise close revenue fiscal second quarter end oct rise sale be constant currency basis
632,MDT,struggle stock cardiac device maker heartware international htwr nearly double monday medtronic mdt say buy company medtronic agree pay share cash heartware close friday soar monday heartware make world smallest ventricular assist device heart failure hvad stock have take beating last year due fail attempt acquire company last year well trial problem next generation mvad device give issue heartware be currently lose market share say evercore isi analyst vijay kumar email client be say believe acquisition make sense medtronic medium term add growth driver round company cardiovascular offer broadest industry heartware ceo doug godshall say statement believe have medtronic infrastructure help accelerate development introduction innovative pipeline product expand access therapy offering sizable heart failure population medtronic expect deal have significant impact term financial heartware month sale be just compare medtronic deal continue trend consolidation cardiac device industry last year st jude medical stj acquire thoratec heartware competitor now st jude be be acquire abbott laboratory medtronic close stock market today share have be trading new high lately sell rest market friday medtronic boast strong overall composite rating
633,MDT,stock market open more loss monday heel last week brexit news raise market uncertainty needle even higher ahead open stock market today dow component intel intintc open financial time report chipmaker be consider selling intel security unit include mcafee buy nearly dow jone industrial average fall shortly market open nasdaq lose european market be likewise soft paris cac german dax london ftse show loss apiece afternoon trading plunge friday royal bank scotland rb lose monday open minute trading barclay bcs slump bring barclay day decline home front spdr bank etf kbe lose merger front medtronic mdt fall nearly news acquire heartware international htwr share heartware soar early trading couple smaller deal make headline dentsply sirona xray agree buy privately hold dental implant system manufacturer mis implant technology meanwhile person unite pbct scoop suffolk bancorp scnb year treasury yield slump basis point west texas intermediate crude oil august delivery fall just barrel
634,MDT,surgical product company endologix elgx hit month high monday raise hope new cardiovascular surgery system follow presentation weekend saturday annual society vascular surgery conference endologix report success multus center study nellix endovascular aneurysm sealing evas system repair abdominal aortic aneurysm aaa death rate cause be rate endoleak blood aneurysm sac be require secondary intervention number be significantly better compete product medtronic mdt cook medical gore medical accord rbc capital market analyst glenn novarro surgeon feedback be very bullish regard datum support prior survey work view nellix be game changer aaa novarro write note raise price target furthermore sense nellix become go graft vascular community anticipate strong demand device once be launch launch be expect late year early next year novarro write canaccord genuity analyst jason mill upgrade rating endologix buy hold set price target anticipate nellix ramp be much faster europe mill write many investor be critical endologix more conservative outside nellix rollout believe company controlled ramp be design drive positive initial result endologix stock rise stock market today reach intraday company have yet turn profit analyst believe happen accord thomson reuter
635,MDT,democratic presidential candidate hillary clinton health care plan release weekend have positive impact company medical hardware development market say evercore isi analyst ross muken write research report clinton plan encourage research development spending give boost provider life science tool service used pharmaceutical development add focus generic biosimilar add additional leg growth pharma end market largely continue benefit chromatography agilent thermo fisher scientific tmo water separation player pall dhr muken write potential offset be increase scrutiny drug pricing lead fewer total dollar spend view unlikely stock be currently highly rate ibd metric especially hold highest possible composite rating be trading time high stock close stock market today touch record high friday agilent share fall thermo fisher also lose water ease clinton also want clear backlog generic drug application fda shorten year exclusivity period grant biosimilar drug muken say accelerate production company make drug drive business contract research organization cro additionally plan intention hold drug company accountable require value base study justify high drug price accelerate pharma adoption real world datum service say adoption provide cro avenue growth outside traditional clinical trial outsource be reason highlighted quintile management quintile im health im merger parexel prxl have also name real world datum service growth driver muken note quintile stock middling cr fall monday parexel hold excellent ibd ep rank dip less outlook be more mixed clinical device system hand plan succeed expand number cover life help boost demand thing orthopedic cardiovascular implant focus woman health be positive hologic holx muken write other hand increase pricing pressure already be dog industry player medtronic mdt be already shift value base business model be best position next leg evolution health care space muken write medtronic stock strong cr hit new intraday high monday close hologic stock have be consolidate company go financial turnaround fall
636,MDT,most lead international stock hail heavyweight economy europe britain china india instance number smaller economy have serve more share leader trading market ireland have be standout be true least part wave drug company inversion merger allow base
637,MDT,share cyberonic cybx gap record high thursday company report better expect earning growth say be merge italy sorin move headquarters europe new treasury rule intend curb tax inversion deal stock transaction create global contender start annual revenue
638,MDT,medical device maker edward lifescience ew be more wednesday morning analyst raise estimate wake strong earning report late tuesday edward profit rise year earlier quarter share beating analyst consensus cent accord thomson reuter sale increase more
639,MDT,stock be still higher tuesday midday gain have fade
640,MDT,trim gain nasdaq pare advance just dow jone industrial average stay session high gain caterpillar cat chevron cvx exxon mobil xom be biggest winner blue chip index volume be run higher board stock market today
641,MDT,lead stock linkedin lnkd rise goldman sachs put share conviction buy list raise price target professional networking operator report earning thursday analyst poll thomson reuter see profit rise cent share linkedin be base buy point
642,MDT,lithia motor lad tack fast trade stock stage upside reversal find support day line monday car dealer report earning feb lithia be expect earn share year
643,MDT,rival asbury automotive group abg be also flat base entry
644,MDT,downside stratasys ssys be still whopping reaction late monday disappointing preliminary fiscal result outlook piper jaffray brean capital downgrade share tuesday stock be still higher tuesday midday gain have fade trim gain nasdaq pare advance just dow jone industrial average stay session high gain caterpillar cat chevron cvx exxon mobil xom be biggest winner blue chip index volume be run higher board stock market today lead stock linkedin lnkd rise goldman sachs put share conviction buy list raise price target professional networking operator report earning thursday analyst poll thomson reuter see profit rise cent share linkedin be base buy point lithia motor lad tack fast trade stock stage upside reversal find support day line monday car dealer report earning feb lithia be expect earn share year rival asbury automotive group abg be also flat base entry downside stratasys ssys be still whopping reaction late monday disappointing preliminary fiscal result outlook piper jaffray brean capital downgrade share tuesday
645,MDT,hard beat medtronic mdt steady share price action earning dividend growth lately share world biggest maker medical device have rise year easily beating re year bottom august stock be past buy point flat base putt well buy range test week line provide follow buy opportunity minneapoli base company announce june be increase quarterly dividend cent share shareholder record july bring annual dividend share good annual yield just average company be commit return free cash flow shareholder year dividend share repurchase still give ample flexibility make necessary investment sustainable growth ceo omar ishrak say time medtronic have boost payout year row make member dividend aristocrat index nearly quadruple past decade stock jump company post better expect increase profit fiscal fourth quarter increase sale also top view medtronic boast year earning stability factor scale be most stable annual profit grow recession medtronic earn revenue outside make vulnerable currency swing recently buy kanghui chinese maker orthopedic implant expand china fast grow medical device market
646,MDT,fda approve medtronic mdt corevalve artificial heart valve friday well ahead april deadline send share competitor edward lifescience ew tumble stock market today
647,MDT,corevalve be transcatheter aortic valve approve treat aortic stenosis patient too frail open heart surgery similar edward sapien have market be approve share market europe edward have sue medtronic patent infringement result jury award earlier week win stop launch compete product edward win permanent injunction
648,MDT,approval earlier expect share loss ew likely occur sooner expect write analyst glenn novarro rbc capital market research note also write corevalve be smaller current sapien model give competitive advantage edward own smaller model sapien xt be approve say be few month
649,MDT,late morning announcement medtronic stock be fraction be trading hit year high jan edward stock be recover year low hit dec be afternoon trading friday
650,MDT,follow amy reeve twitter ibd_areeve fda approve medtronic mdt corevalve artificial heart valve friday well ahead april deadline send share competitor edward lifescience ew tumble stock market today corevalve be transcatheter aortic valve approve treat aortic stenosis patient too frail open heart surgery similar edward sapien have market be approve share market europe edward have sue medtronic patent infringement result jury award earlier week win stop launch compete product edward win permanent injunction approval earlier expect share loss ew likely occur sooner expect write analyst glenn novarro rbc capital market research note also write corevalve be smaller current sapien model give competitive advantage edward own smaller model sapien xt be approve say be few month late morning announcement medtronic stock be fraction be trading hit year high jan edward stock be recover year low hit dec be afternoon trading friday follow amy reeve twitter ibd_areeve
651,MDT,share medical device giant medtronic mdt pop year high tuesday morning company beat analyst expectation
652,MDT,maker pacemaker more early tuesday say sale quarter end april rise year earlier quarter top analyst consensus accord thomson reuter profit exclude special charge climb share beating estimate cent
653,MDT,company guide current year ep growth analyst average
654,MDT,employee be adapt embrace change occur global health care be make significant stride reframe company compete change environment medtronic ceo omar ishrak say company earning press release
655,MDT,firm biggest product line show recovery year decline implantable cardioverter defibrillator sale rise constant currency basis spinal revenue be flat represent improvement ishrak say demand type product increase first time year
656,MDT,stock be more morning trading tuesday earlier stock market share rise much stock hasn trade high september
657,MDT,medtronic carry solid ibd composite rating share medical device giant medtronic mdt pop year high tuesday morning company beat analyst expectation maker pacemaker more early tuesday say sale quarter end april rise year earlier quarter top analyst consensus accord thomson reuter profit exclude special charge climb share beating estimate cent company guide current year ep growth analyst average employee be adapt embrace change occur global health care be make significant stride reframe company compete change environment medtronic ceo omar ishrak say company earning press release firm biggest product line show recovery year decline implantable cardioverter defibrillator sale rise constant currency basis spinal revenue be flat represent improvement ishrak say demand type product increase first time year stock be more morning trading tuesday earlier stock market share rise much stock hasn trade high september medtronic carry solid ibd composite rating
658,MDT,spinal product company nuvasive nuva beat wall street expectation release preliminary result guidance wednesday morning send nuvasive stock year high stock market today company say revenue be year earlier quarter analyst consensus didn give bottom line number
659,MDT,spinal product stock be move tuesday ldr hold ldrh agree be acquire device giant zimmer biomet zbh come nuvasive nuva make smaller buyout late monday ldr stock soar stock market today roughly price zimmer agree pay deal amount total zimmer say buy ldr technology cervical disc replacement call fastest grow segment spine industry ldr technology be design make spinal surgery simpler less invasive ldr founder be still lose money zimmer say have impact ep year next rbc capital market analyst glenn novarro say buyout boost zimmer profile fragmented spine industry combine portfolio raise zimmer spine market share putt company striking distance strkyer syk nuvasive hold market respectively novarro write research note currently ldr rep cover approximately spine surgeon utilize combine sale force zimmer be able quickly expand coverage footprint mobi mivo suite product locally abroad zimmer stock touch record high close stock rank ibd list top perform stock zimmer stock have highest possible composite rating learn more ibd stock checkup nuvasive stock jump briefly time high early trading tuesday finished close late monday company say agree pay cash biotronic neuronetwork make system monitor patient nervous system surgery nuvasive say buyout expand clinical service arm double footprint supplement surgical product offer spine solution surgeon spine startup globus medical gmed rise unusually high volume tuesday perhaps buoy further buyout possibility space leerink analyst richard newitter also note industry giant medtronic mdt say analyst day monday expect growth pick spine business few year lag see positive smaller player still believe medtronic recent spine growth improvement stem more underlie market stabilization improvement less bad infuse erosion vs enhance competitive position vs smaller player thus have doubt company become sustainably more effective fend market share loss player such nuvasive globus medical newitter write research note newitter write prefer nuvasive globus stock ibd rating system agree nuvasive have composite rating globus have cr
660,MDT,stock be set open slightly higher tuesday market return day weekend couple positive economic report future nasdaq dow jone industrial average be consumer spending grow april better increase economist expect accord econoday personal income rise line forecast case shiller city home price index climb march february year earlier figure top econoday estimate apple aapl be most active stock extend trading share be stock have be rebound week lowest level medtronic mdt report operate earning share just estimate april end quarter sale rise medical device maker be unchanged premarket trading share have be time high european trading german dax french cac be ftse be trading flat asia shanghai composite surge shenzhen composite close higher hang seng climb nikkei add
661,MDT,medical device giant medtronic mdt narrowly beat wall street expectation tuesday stock slip margin continue expectation be fairly high go quarter medtronic stock trading time high competitor report indicate market share gain read through boston scientific bsx st jude medical stj indicate medtronic continue gain icd implantable cardioverter defibrillator market share mri safe labele pace share reveal linq advisa mri safe pacer rbc capital market analyst glenn novarro write research note appear be bear report quarter fiscal year end april release early tuesday medtronic sale rise year earlier quarter adjust last year covidien acquisition ahead analyst consensus accord thomson reuter earning exclude time item climb share penny wall street average estimate medtronic guide fiscal ep low side consensus say revenue constant currency basis grow be high side gross operate margin again fall not only consensus also management guidance quarter reinforce believe be ongoing investor concern company ability deliver positive operate leverage target post covidien write leerink analyst danielle antalffy research note add second half current fiscal year medtronic be face ramp top line headwind key business not least include competitive launch new crm cardiac rhythm management de drug eluting stent product well continue pressure spine neuromodulation medtronic stock close stock market today stock hit time high have trade range have strong ibd composite rating putt top stock such key metric sale earning growth
662,MDT,nike nke medtronic mdt sap sap receive downgrade wednesday whole food market wfm get upgrade meanwhile armour ua be handed several price target cut wake tuesday guidance revision athletic apparel giant receive downgrade bank america neutral morgan stanley equal weight morgan stanley jay sole cite weaken athletic apparel category rise competition reason believe sale slowdown be nike future current valuation not accounting risk addition armour sole other analyst have refocuse adida source pressure nike nike share close heel tuesday slightly lower guidance result sport authority bankruptcy liquidation proceedings analyst be quick hand series price target cut armour telsey advisory group lower target susquehanna financial cut target jeffery take price target cowen reduce target armour drop credit suisse upgrade natural organic grocer outperform price target whole food recently open new location whole food market store los angele neighborhood silver lake sub chain grocery store be design attract millennial shopper share climb btig downgrade medical equipment maker medtronic neutral evercore isi downgrade software specialist sap hold share medtronic rise less sap add
663,MDT,medical device giant medtronic mdt issue fiscal result full year guidance line wall street expectation tuesday still face significant head wind business medtronic share be early trading stock market today medtronic stock touch year high jan month end
664,MDT,share medtronic mdt be early trading tuesday company mixed result guidance apparently underwhelm investor medical device giant say revenue rise year earlier quarter bit short analyst consensus earning time item rise cent share beating estimate
665,MDT,medical device giant medtronic mdt be expect report solid growth quarter open tuesday stock trade year high
666,MDT,analyst poll thomson reuter estimate fiscal profit rise year quarter cent share sale rise many peer medtronic raise fiscal guidance early january tax credit be renew now expect ep growth year
667,MDT,show single digit growth pattern most large mature company medtronic stock have be roll year tuesday hit intraday high highest point october next day win fda approval second mri compatible pacemaker advisa dr add revo be approve
668,MDT,estimate third half pacemaker patient eventually need mri medtronic technology address key limitation early generation pacemaker write morningstar analyst debbie wang research note
669,MDT,thursday lazard capital market downgrade stock neutral buy midday trading friday share be more medical device giant medtronic mdt be expect report solid growth quarter open tuesday stock trade year high analyst poll thomson reuter estimate fiscal profit rise year quarter cent share sale rise many peer medtronic raise fiscal guidance early january tax credit be renew now expect ep growth year show single digit growth pattern most large mature company medtronic stock have be roll year tuesday hit intraday high highest point october next day win fda approval second mri compatible pacemaker advisa dr add revo be approve estimate third half pacemaker patient eventually need mri medtronic technology address key limitation early generation pacemaker write morningstar analyst debbie wang research note thursday lazard capital market downgrade stock neutral buy midday trading friday share be more
670,MDT,medical device giant boston scientific bsx beat analyst profit estimate tuesday share fall stock market today analyst spot weakness other aspect report company say profit rise year earlier quarter cent share beating analyst consensus cent accord thomson reuter sale rise
671,MDT,medical device giant medtronic mdt be trading year high monday company prepared report fiscal result open tuesday analyst poll thomson reuter estimate medtronic make cent share quarter end oct year earlier quarter sale be also estimate have rise
672,MDT,medical device maker boston scientific bsx get upgrade morgan stanley oppenheimer monday send stock nearly year high afternoon trading stock market today
673,MDT,morgan stanley david lewis rate stock overweight cite strength company pipeline opportunity margin expansion
674,MDT,past several year company have target investment several market accelerate growth drive leverage write research note believe better recognition strategy drive future outperformance even robust accelerate sale earning growth drive improve financial performance next several year
675,MDT,lewis also see term growth boston new subcutaneous implantable cardioverter defibrillator icd line see differentiate other icd product boston main competitor area be st jude medical stj medtronic mdt also get upgrade jpmorgan monday
676,MDT,st jude stock be afternoon trading monday time high medtronic stock be year high
677,MDT,oppenheimer promote boston scientific overweight equal weight similar reason analyst set price target boston scientific be afternoon trading monday
678,MDT,follow amy reeve twitter ibd_areeve medical device maker boston scientific bsx get upgrade morgan stanley oppenheimer monday send stock nearly year high afternoon trading stock market today morgan stanley david lewis rate stock overweight cite strength company pipeline opportunity margin expansion past several year company have target investment several market accelerate growth drive leverage write research note believe better recognition strategy drive future outperformance even robust accelerate sale earning growth drive improve financial performance next several year lewis also see term growth boston new subcutaneous implantable cardioverter defibrillator icd line see differentiate other icd product boston main competitor area be st jude medical stj medtronic mdt also get upgrade jpmorgan monday st jude stock be afternoon trading monday time high medtronic stock be year high oppenheimer promote boston scientific overweight equal weight similar reason analyst set price target boston scientific be afternoon trading monday follow amy reeve twitter ibd_areeve
679,MDT,biotech unite therapeutic uthr beat sale estimate tuesday send stock new high expense be also higher expect company report revenue year earlier quarter more street consensus earning share be well estimate include stock option
680,MDT,medtronic mdt early tuesday report return double digit profit growth fiscal result narrowly beat estimate guide revenue current year expectation medical device giant say sale rise year quarter compare analyst consensus accord thomson reuter profit rise cent
681,MDT,half year financial meltdown business type be adapt more regulation bill george former biz whiz turn scholar leadership crisis bring new audience be say obsessing short term shareholder value lead only disaster think more ever need have leader
682,MDT,chicago medtronic mdt tuesday report fiscal earning analyst view give disappointing outlook fiscal hurt slowdown demand implantable heart defibrillator spinal treatment biggest product line
683,MDT,medtronic say sale device treat cardiac rhythm disease fall sale spinal device fall hurt weak economy
684,MDT,clearly have see slow implant rate marketplace medtronic chief financial officer gary ellis say conference call analyst
685,MDT,medtronic blame drop demand icds justice department probe announce january physician be follow proper guideline implant device chicago medtronic mdt tuesday report fiscal earning analyst view give disappointing outlook fiscal hurt slowdown demand implantable heart defibrillator spinal treatment biggest product line medtronic say sale device treat cardiac rhythm disease fall sale spinal device fall hurt weak economy clearly have see slow implant rate marketplace medtronic chief financial officer gary ellis say conference call analyst medtronic blame drop demand icds justice department probe announce january physician be follow proper guideline implant device
686,MDT,stock hold solid gain stand session high late afternoon action tuesday nasdaq composite be dow jone industrial average volume be slightly same time monday nasdaq slightly nyse medtronic mdt jump fast trade early tuesday medical device giant post first quarter earning match forecast backed earning revenue target new ceo omar ishrak also strike right note conference call analyst tell reuter highly rate stock fossil fosl surge big turnover watchmaker be try recover tumble week week move average month still recent high key average fossil sport ibd composite rating best possible bloomberg report note cfo mike kovar purchase fossil share recently green mountain coffee roaster gmcr climb strong turnover stock have regain week move average be trading high green mountain have highest possible composite rating
687,MDT,stock hold solid gain stand session high late afternoon action tuesday nasdaq composite be dow jone industrial average volume be slightly same time monday nasdaq slightly nyse medtronic mdt jump fast trade early tuesday medical device giant post first quarter earning match forecast backed earning revenue target new ceo omar ishrak also strike right note conference call analyst tell reuter highly rate stock fossil fosl surge big turnover watchmaker be try recover tumble week week move average month still recent high key average fossil sport ibd composite rating best possible bloomberg report note cfo mike kovar purchase fossil share recently green mountain coffee roaster gmcr climb strong turnover stock have regain week move average be trading high green mountain have highest possible composite rating
688,MDT,stock trade break even early afternoon action tuesday lift session lows news new imf credit line help trouble euro zone nation dow jone industrial average be less trading nearly lower earlier today nasdaq be gain less
689,MDT,smartphone mobile application be start become medical tool create new opportunity device maker company such st jude medical stj medtronic mdt be develop apps complement product more doctor baby boomer adopt smartphone really do open huge market say darren selsky director connectivity st jude apps
690,MDT,plenty leader come phony deal person show re authentic leader truly care staffer company ll get employee best effort stick principle way lead say bill george former ceo medical device maker medtronic mdt now harvard professor money fame
691,MDT,medical product company post small second quarter profit revenue gain top street projection
692,MDT,baxter international bax second largest company ibd medical product group revenue say market open thursday revenue rise vs same quarter last year
693,MDT,earning climb share quarter beating analyst view penny ep rise prior quarters
694,MDT,current quarter baxter expect ep item analyst consensus
695,MDT,medical sector continue grow medical product group also include thoratec thor cyberonic cybx vascular solution vasc medtronic mdt be rank lofty industry group ibd track
696,MDT,baxter share rise early retreat be trading midday
697,MDT,thoratec upgrade outperform zack equity research last week slide midday cyberonic edge cent vascular advanced
698,MDT,medtronic wednesday begin clinical trial evaluate new minimally invasive corevalve system implantation device patient be typically treat open heart surgery be
699,MDT,baxter ceo robert parkinson say company expect grow rapid rate develop new product target acquisition
700,MDT,continue invest new product pipeline seek complementary business development opportunity enhance global presence expand access care create long term value shareholder parkinson say written statement earning be announce
701,MDT,baxter say revenue bioscience unit make product treat hemophilia other bleed disorder immune deficiency vaccine other product rise
702,MDT,exclude impact currency exchange rate sale have be demand rise particularly advate treatment hemophilia
703,MDT,medical product sale also increase solid gain company dialysis product well certain injectable nutrition therapy medical product company post small second quarter profit revenue gain top street projection baxter international bax second largest company ibd medical product group revenue say market open thursday revenue rise vs same quarter last year earning climb share quarter beating analyst view penny ep rise prior quarters current quarter baxter expect ep item analyst consensus medical sector continue grow medical product group also include thoratec thor cyberonic cybx vascular solution vasc medtronic mdt be rank lofty industry group ibd track baxter share rise early retreat be trading midday thoratec upgrade outperform zack equity research last week slide midday cyberonic edge cent vascular advanced medtronic wednesday begin clinical trial evaluate new minimally invasive corevalve system implantation device patient be typically treat open heart surgery be baxter ceo robert parkinson say company expect grow rapid rate develop new product target acquisition continue invest new product pipeline seek complementary business development opportunity enhance global presence expand access care create long term value shareholder parkinson say written statement earning be announce baxter say revenue bioscience unit make product treat hemophilia other bleed disorder immune deficiency vaccine other product rise exclude impact currency exchange rate sale have be demand rise particularly advate treatment hemophilia medical product sale also increase solid gain company dialysis product well certain injectable nutrition therapy
704,MDT,medical device maker boston scientific bsx baxter international bax beat profit expectation predict weak future revenue boston scientific see fourth quarter sale analyst view baxter expect fourth quarter sale growth short estimate share boston scientific drop baxter fall plunge
705,MDT,stock sank deeper red afternoon trade monday nasdaq carved nyse composite fall volume be nyse nasdaq ibd industry group gold miner oil stock advanced medical stock slide trade be heavy top rate stock
706,MDT,stock sank deeper red afternoon trade monday nasdaq carved nyse composite fall volume be nyse nasdaq ibd industry group gold miner oil stock advanced medical stock slide trade be heavy top rate stock
707,MDT,didn take long globus medical gmed make noise wall street less month designer marketer spinal device have initial public offer stock price spiked thank good news regulatory front good news come food drug administration grant globus premarket approval
708,MDT,didn take long globus medical gmed make noise wall street less month designer marketer spinal device have initial public offer stock price spiked thank good news regulatory front good news come food drug administration grant globus premarket approval
709,MDT,obama administration health legislation have less impact health care sector headline suggest observer say many sector health industry device implant diagnostic react force event have little do political war washington yes biggest health story be health care reform say
710,MDT,ipos come week meet mixed reception fact come first place make busiest week new issue march
711,MDT,next week slate be smaller be type emerge innovative tech company market seem
712,MDT,globus medical
713,MDT,ticker gmed
714,MDT,expect deal size
715,MDT,lead underwriter bofa lynch goldman sachs piper jaffray leerink swann
716,MDT,ibd industry group medical product
717,MDT,good rare new issue day emerge medical tech firm globus medical sell large portfolio product used spinal surgery founder firm have be profitable sale have double time last year
718,MDT,bad growth top bottom line have slow teen last couple year company have mature globus face heavy duty competition include medtronic mdt johnson johnson jnj stryker syk industry go face new regulatory burden next year
719,MDT,legalzoom com
720,MDT,ticker lgz
721,MDT,expect deal size
722,MDT,lead underwriter bofa lynch morgan stanley
723,MDT,ibd industry group internet content
724,MDT,good many thing now do internet used have hire person include make legal document legalzoom offer interactive way customize basic document will incorporation also sell subscription longer term legal advice revenue grow more
725,MDT,bad profit have be spotty firm record loss first quarter year company be banking subscription service keep growth steady only be offer
726,MDT,eloqua
727,MDT,ticker eloq
728,MDT,expect deal size
729,MDT,lead underwriter jpmorgan deutsche bank
730,MDT,ibd industry group computer software specialty enterprise
731,MDT,good regularly schedule cloud ipo week come eloqua demand software aids marketing strategy tracking analyze user interaction vendor web page social medium pull together impressive customer list include comcast cmcsa solarwind swi linkedin lnkd drive revenue growth
732,MDT,bad eloqua have yet turn profit sale growth isn explosive other tech ipos have overcome problem most recent ipos field exacttarget et responsys mktg have be mediocre initial pop ipos come week meet mixed reception fact come first place make busiest week new issue march next week slate be smaller be type emerge innovative tech company market seem globus medicalticker gmed expect deal size millionlead underwriter bofa lynch goldman sachs piper jaffray leerink swannibd industry group medical product good rare new issue day emerge medical tech firm globus medical sell large portfolio product used spinal surgery founder firm have be profitable sale have double time last year bad growth top bottom line have slow teen last couple year company have mature globus face heavy duty competition include medtronic mdt johnson johnson jnj stryker syk industry go face new regulatory burden next year legalzoom comticker lgz expect deal size millionlead underwriter bofa lynch morgan stanleyibd industry group internet content good many thing now do internet used have hire person include make legal document legalzoom offer interactive way customize basic document will incorporation also sell subscription longer term legal advice revenue grow more bad profit have be spotty firm record loss first quarter year company be banking subscription service keep growth steady only be offer eloquaticker eloq expect deal size millionlead underwriter jpmorgan deutsche bankibd industry group computer software specialty enterprise good regularly schedule cloud ipo week come eloqua demand software aids marketing strategy tracking analyze user interaction vendor web page social medium pull together impressive customer list include comcast cmcsa solarwind swi linkedin lnkd drive revenue growth bad eloqua have yet turn profit sale growth isn explosive other tech ipos have overcome problem most recent ipos field exacttarget et responsys mktg have be mediocre initial pop
733,MDT,stock rise sharply monday close session high increase exist home sale optimism lawmaker reach deal avert fiscal cliff nasdaq gain charge putt back day line dow jone industrial average rise preliminary figure show volume be
734,MDT,medtronic mdt be target higher revenue emerge market first quarter revenue rise strength international business
735,MDT,world biggest medical device company say revenue grow analyst estimate earning edge cent share meeting wall street view
736,MDT,still expect full year earning midpoint just view
737,MDT,share rise et rival device maker baxter international bax covidien cov stryker syk st jude medical stj be well
738,MDT,medtronic ceo omar ishrak take june also say seek boost efficiency improve return research development effort gross margin fall
739,MDT,sale implantable cardioverter defibrillator fall due part recent medical journal article suggest be overused spinal product sale dip too medtronic mdt be target higher revenue emerge market first quarter revenue rise strength international business world biggest medical device company say revenue grow analyst estimate earning edge cent share meeting wall street view still expect full year earning midpoint just view share rise et rival device maker baxter international bax covidien cov stryker syk st jude medical stj be well medtronic ceo omar ishrak take june also say seek boost efficiency improve return research development effort gross margin fall sale implantable cardioverter defibrillator fall due part recent medical journal article suggest be overused spinal product sale dip too
740,MDT,medtronic mdt be target higher revenue emerge market first quarter revenue rise strength international business
741,MDT,world biggest medical device company say revenue grow analyst estimate earning edge cent share meeting wall street view
742,MDT,still expect full year earning midpoint just view
743,MDT,share rise et rival device maker baxter international bax covidien cov stryker syk st jude medical stj be well
744,MDT,medtronic ceo omar ishrak take june also say seek boost efficiency improve return research development effort gross margin fall
745,MDT,sale implantable cardioverter defibrillator fall due part recent medical journal article suggest be overused spinal product sale dip too medtronic mdt be target higher revenue emerge market first quarter revenue rise strength international business world biggest medical device company say revenue grow analyst estimate earning edge cent share meeting wall street view still expect full year earning midpoint just view share rise et rival device maker baxter international bax covidien cov stryker syk st jude medical stj be well medtronic ceo omar ishrak take june also say seek boost efficiency improve return research development effort gross margin fall sale implantable cardioverter defibrillator fall due part recent medical journal article suggest be overused spinal product sale dip too
746,MDT,nasdaq suffer distribution day tuesday rather peculiar session surface everything appear normal volume sank nyse rise slightly nasdaq major index chalk loss day lower volume allow nyse tie index escape day distribution nasdaq shave nyse composite
747,MDT,find research tool work match way think help reason way challenge be big part develop investing skill
748,MDT,aspect skill include way gauge liquidity stock research
749,MDT,give sense stock resilience buy selling pressure also give way read volatility
750,MDT,be least couple way figure liquidity
751,MDT,most basic be track number share trade do read vertical volume line bottom many daily weekly chart
752,MDT,more share trade mean stock be less likely surge dive big investor grab sell large block share rule thumb minimum share trade day signal decent level institutional support good cushion volatility reduce risk
753,MDT,less common way gauge liquidity be used dollar volume level play field degree thinner higher price stock more heavily trade cheaper stock give time high dollar volume tend produce biggest winner
754,MDT,get daily dollar volume multiply number share trade day share price average daily dollar volume multiply day average trading volume show ibd research table online quote investor com current share price
755,MDT,extreme example berkshire hathaway brka trade average share day nearly put daily dollar volume
756,MDT,apple aapl other hand trade share day be just share give dollar volume slightly north
757,MDT,stock also have similar price yet generate different dollar volume athenahealth athn carry dollar volume peer quality system qsii clock same level dollar volume cerner cern be more medtronic mdt see action day stock currently trade range attract vary level dollar commitment shareholder
758,MDT,doesn necessarily mean cerner better stock be prone less volatility
759,MDT,scanning nyse nasdaq stock carry ibd composite rating higher google goog research motion rimm carry highest daily average dollar volume
760,MDT,brink home security hold ings cfl go public november show lowest dollar volume action
761,MDT,stock today carry top flight composite rating top dollar volume be gilead science gild apollo group apol genentech dna
762,MDT,dollar volume gauge put hmo healthspr hs bottom list leader just daily dollar action
763,MDT,total mutual fund hold share gilead science end fourth quarter be prior year healthspr be own fund hold share increase same period find research tool work match way think help reason way challenge be big part develop investing skill aspect skill include way gauge liquidity stock research give sense stock resilience buy selling pressure also give way read volatility be least couple way figure liquidity most basic be track number share trade do read vertical volume line bottom many daily weekly chart more share trade mean stock be less likely surge dive big investor grab sell large block share rule thumb minimum share trade day signal decent level institutional support good cushion volatility reduce risk less common way gauge liquidity be used dollar volume level play field degree thinner higher price stock more heavily trade cheaper stock give time high dollar volume tend produce biggest winner get daily dollar volume multiply number share trade day share price average daily dollar volume multiply day average trading volume show ibd research table online quote investor com current share price extreme example berkshire hathaway brka trade average share day nearly put daily dollar volume apple aapl other hand trade share day be just share give dollar volume slightly north stock also have similar price yet generate different dollar volume athenahealth athn carry dollar volume peer quality system qsii clock same level dollar volume cerner cern be more medtronic mdt see action day stock currently trade range attract vary level dollar commitment shareholder doesn necessarily mean cerner better stock be prone less volatility scanning nyse nasdaq stock carry ibd composite rating higher google goog research motion rimm carry highest daily average dollar volume brink home security hold ings cfl go public november show lowest dollar volume action stock today carry top flight composite rating top dollar volume be gilead science gild apollo group apol genentech dna dollar volume gauge put hmo healthspr hs bottom list leader just daily dollar action total mutual fund hold share gilead science end fourth quarter be prior year healthspr be own fund hold share increase same period
764,MDT,stock stage late rally wednesday climb higher volume spending session swing gain loss back nyse composite rise dow industrial rise nasdaq add small cap volume picked board swell nyse
765,MDT,update index turn dime late trade rushed solid finish energy issue telecom computer maker lead charge
766,MDT,dow snap back hardest end higher dive afternoon trading
767,MDT,clock gain nyse composite close higher nasdaq composite manage finish
768,MDT,volume surge close positive sign preliminary datum show trading nyse higher nasdaq
769,MDT,oil end flat natural gas future slip lower energy issue run higher exxon mobil xom chevron cvx post solid late day gain pull nyse energy index afternoon loss gain more double advance other sector financial index close nyse only sector finish red
770,MDT,hewlett packard hpq yahoo yhoo home depot hd remain strong day
771,MDT,tap wednesday new housing start new build permit consumer price datum be due market open housing start be likely receive particular attention today weak read builder sentiment national association home builder consensus view call decline new housing start lowest level january
772,MDT,minute federal open market committee meeting hope shed light aggressively fed cut rate dec meeting be due
773,MDT,update stock rise lows still close lower
774,MDT,juan carlos arancibia
775,MDT,major index close higher late rebound
776,MDT,dow lead gain strength hewlett packard hpq oil component exxon mobil xom chevron cvx
777,MDT,rise nyse composite accord preliminary figure
778,MDT,nasdaq rise erase loss surge yahoo yhoo share fade midday
779,MDT,volume rise market third straight session change course final hour trading
780,MDT,more market detail be provide market update
781,MDT,update stock give downside volume steady financial dive hard afternoon trading drag index deep negative territory
782,MDT,nasdaq composite fall nyse composite sunk respectively dow buoy hewlett packard hpq home depot hd hold loss
783,MDT,nyse energy index exchange last holdout upside turn negative just nyse financial index show decline
784,MDT,trading volume track steady nyse nasdaq
785,MDT,mantech international mant trade spiking nearly early trade defense contractor be build low handle month old base
786,MDT,downside footwear maker decker outdoor deck stumble share be third week steep soft volume decline month low
787,MDT,update stock worsen housing datum
788,MDT,vincent mao
789,MDT,stock worsen major index turn negative follow negative housing datum national association home builder
790,MDT,nasdaq be putt closer thursday low fall nyse composite dow hewlett packard hpq hold gain session peak
791,MDT,turnover be tracking vastly higher nasdaq slightly heavier nyse
792,MDT,cite grow problem financial market soft job market economic uncertainty nahb well fargo housing market sentiment gauge tumble record low november october be crisis say sandy dunn chairman nahb hope turn economy congress administration need focus stabilize housing
793,MDT,datum october housing start be wednesday
794,MDT,boee ba fall lowest level march be biggest percentage loser dow production delay stem strike supply chain problem have plague aerospace giant recent month
795,MDT,corning glw tumble year low warning earning sale maker glass substrate also withdraw previous earning forecast
796,MDT,update stock turn mixed midday trade
797,MDT,vincent mao
798,MDT,stock pull back sharply push new session high be mixed midday trading
799,MDT,positive news tech sector nasdaq slip negative territory hit resistance level be
800,MDT,dow earlier gain dwindle nyse composite turn flat
801,MDT,volume be tracking sharply higher nasdaq flat nyse
802,MDT,diamond food dmnd gap gain news be add small cap snack food maker be sixth week new base
803,MDT,emergency medical service em climb new week high ambulance provider quarterly earning sale growth improve recent quarters
804,MDT,downside baidu com bidu fall lowest level drop extend monday decline
805,MDT,update index move higher ground yahoo hewlett packardstock pressed higher midday financial sector loss ease energy stock stage solid gain
806,MDT,dow bob gain nyse composite add nasdaq composite drag heel
807,MDT,yahoo yhoo lead nasdaq hewlett packard hpq continue top dow gainer
808,MDT,volume be tracking firmly monday soft level advance decline issue run almost neck neck
809,MDT,computer maker accident health insurer integrate oil company be make best gain so far
810,MDT,flower food flo rise continue struggle resistance week move average downside ctrip com ctrp gap loss powerful trading china base consolidator hotel airfare arrangement report monday earning growth slow well prior quarters more consensus expectation
811,MDT,digital river driv also gap lose downgrade stanford research be commerce developer fourth downgrade september
812,MDT,update index show upside resolve firm volume
813,MDT,index pull higher morning broadly mixed news
814,MDT,sak sk medtronic mdt deliver downside earning news hewlett packard hpq deliver upside result energy firm cancele merger ford say plan divest most stake mazda
815,MDT,meanwhile producer price datum slump more forecast show unexpected strength core price increase
816,MDT,background lawmaker washington debate wisdom pour additional fund detroit fail auto industry
817,MDT,dow lead advance hewlett packard home depot hd exxon mobil xom do heavy lift nyse composite nasdaq composite post gain energy issue have nyse strongest gain financial pull lower
818,MDT,volume track monday low level nyse nasdaq
819,MDT,oil future hover little change just barrel copper hog silver rise most other metal continue lower aluminum deepen year low peg monday dollar gain euro yen
820,MDT,stock stericycle srcl gap huge volume standard poor announce late monday medical waste collection firm replace anheuser busch index anheuser busch be be acquire belgian brewer inbev stericycle move break past resistance just stock build right side week cup
821,MDT,component brand prescription drug maker cephalon ceph rise move put share buy point week cup handle base
822,MDT,downside new oriental education technology group edu erased heavy trading robert baird initiate coverage neutral rating share be struggle month lows lose bid break resistance week move average
823,MDT,overseas asian market have tough day china shanghai composite dump biggest drop june slide oil commodity price trigger fear deepen global recession exchange halter trading more issue strike loss limit hang seng index hong kong slice lower
824,MDT,japan tokyo nikkei index dip analyst say loss be ease institutional buy bargain hunting public pension fund
825,MDT,index europe reversed early loss pull positive territory late trading cac paris add frankfurt dax edge london ftse remain water commodity bank see heavy selling
826,MDT,update stock vacillate paulson bernanke testify
827,MDT,vincent mao
828,MDT,stock be little change follow rocky open tuesday wall street attention turn federal reserve chairman ben bernanke treasury secretary henry paulson be testify house financial service committee management bailout program
829,MDT,dow be nyse composite fall nasdaq be mostly unchanged
830,MDT,volume be tracking higher exchange
831,MDT,tech issue be mostly higher follow hewlett packard hpq outlook apple aapl oracle orcl research motion rimm gain
832,MDT,meanwhile aerovironment avav rise try rebound dip day move average
833,MDT,downside sak sk fall more report wider forecast loss open operator sak fifth avenue store report third quarter shortfall cent share profit cent prior year much cent loss expect thomson reuter sale decline analyst have expect loss cent share revenue
834,MDT,cite uncertainty economy other factor cliff natural resource clf alpha natural resource anr cancel merger alpha natural share fall former suitor cliff gain
835,MDT,update hewlett packard inspire stock future
836,MDT,vincent mao
837,MDT,stock future point mixed tuesday bright result hewlett packard offset uncertainty automaker
838,MDT,nasdaq future climb point vs fair value future slip point dow future be mostly unchanged
839,MDT,executive ford general motor gm chrysler testify capitol hill press case bailout money democratic lawmaker propose let big tap fund trouble asset relief program automaker already receive loan september
840,MDT,separately ford be reportedly slash stake mazda motor strive raise cash
841,MDT,economic news producer price tumble october vs expectation decline exclude food energy price rise
842,MDT,hewlett packard hpq surge pre market report preliminary result give upbeat guidance maker computer printer announce earning share vs view guide full year profit range share vs view hp release additional detail nov
843,MDT,statement hp chief executive mark hurd say company deliver solid quarter continue benefit global reach diverse customer base broad portfolio numerous cost initiative
844,MDT,group mate apple aapl international business machine ibm rise
845,MDT,home depot hd gain report smaller expect earning decline home improvement giant deliver profit cent share prior year cent view revenue fall also view home depot see drop full year profit continue operation same prior guidance
846,MDT,yahoo yhoo climb jerry yang step chief executive officer late monday share web search firm have fall yang co founder company take ceo june
847,MDT,downside medtronic mdt fall hefty legal charge drag latest quarterly profit hurt charge stem patent dispute johnson johnson jnj medtronic earning fall cent share cent year period exclude item medtronic earn cent share still view cent update index turn dime late trade rushed solid finish energy issue telecom computer maker lead charge dow snap back hardest end higher dive afternoon trading clock gain nyse composite close higher nasdaq composite manage finish volume surge close positive sign preliminary datum show trading nyse higher nasdaq oil end flat natural gas future slip lower energy issue run higher exxon mobil xom chevron cvx post solid late day gain pull nyse energy index afternoon loss gain more double advance other sector financial index close nyse only sector finish red hewlett packard hpq yahoo yhoo home depot hd remain strong day tap wednesday new housing start new build permit consumer price datum be due market open housing start be likely receive particular attention today weak read builder sentiment national association home builder consensus view call decline new housing start lowest level january minute federal open market committee meeting hope shed light aggressively fed cut rate dec meeting be due update stock rise lows still close lower juan carlos major index close higher late rebound dow lead gain strength hewlett packard hpq oil component exxon mobil xom chevron cvx rise nyse composite accord preliminary figure nasdaq rise erase loss surge yahoo yhoo share fade midday volume rise market third straight session change course final hour trading more market detail be provide market update update stock give downside volume steady nasdaq composite fall nyse composite sunk respectively dow buoy hewlett packard hpq home depot hd hold loss nyse energy index exchange last holdout upside turn negative just nyse financial index show decline trading volume track steady nyse nasdaq mantech international mant trade spiking nearly early trade defense contractor be build low handle month old base downside footwear maker decker outdoor deck stumble share be third week steep soft volume decline month low update stock worsen housing databy vincent maostock worsen major index turn negative follow negative housing datum national association home builder nasdaq be putt closer thursday low fall nyse composite dow hewlett packard hpq hold gain session peak turnover be tracking vastly higher nasdaq slightly heavier nyse cite grow problem financial market soft job market economic uncertainty nahb well fargo housing market sentiment gauge tumble record low november october be crisis say sandy dunn chairman nahb hope turn economy congress administration need focus stabilize housing datum october housing start be wednesday boee ba fall lowest level march be biggest percentage loser dow production delay stem strike supply chain problem have plague aerospace giant recent month corning glw tumble year low warning earning sale maker glass substrate also withdraw previous earning forecast update stock turn mixed midday tradeby vincent maostock pull back sharply push new session high be mixed midday trading positive news tech sector nasdaq slip negative territory hit resistance level be dow earlier gain dwindle nyse composite turn flat volume be tracking sharply higher nasdaq flat nyse diamond food dmnd gap gain news be add small cap snack food maker be sixth week new base emergency medical service em climb new week high ambulance provider quarterly earning sale growth improve recent quarters downside baidu com bidu fall lowest level drop extend monday decline update index move higher ground yahoo hewlett dow bob gain nyse composite add nasdaq composite drag heel yahoo yhoo lead nasdaq hewlett packard hpq continue top dow gainer volume be tracking firmly monday soft level advance decline issue run almost neck neck computer maker accident health insurer integrate oil company be make best gain so far flower food flo rise continue struggle resistance week move average downside ctrip com ctrp gap loss powerful trading china base consolidator hotel airfare arrangement report monday earning growth slow well prior quarters more consensus expectation digital river driv also gap lose downgrade stanford research be commerce developer fourth downgrade september update index show upside resolve firm volumeindex pull higher morning broadly mixed news sak sk medtronic mdt deliver downside earning news hewlett packard hpq deliver upside result energy firm cancele merger ford say plan divest most stake mazda meanwhile producer price datum slump more forecast show unexpected strength core price increase background lawmaker washington debate wisdom pour additional fund detroit fail auto industry dow lead advance hewlett packard home depot hd exxon mobil xom do heavy lift nyse composite nasdaq composite post gain energy issue have nyse strongest gain financial pull lower volume track monday low level nyse nasdaq oil future hover little change just barrel copper hog silver rise most other metal continue lower aluminum deepen year low peg monday dollar gain euro yen stock stericycle srcl gap huge volume standard poor announce late monday medical waste collection firm replace anheuser busch index anheuser busch be be acquire belgian brewer inbev stericycle move break past resistance just stock build right side week cup component brand prescription drug maker cephalon ceph rise move put share buy point week cup handle base downside new oriental education technology group edu erased heavy trading robert baird initiate coverage neutral rating share be struggle month lows lose bid break resistance week move average overseas asian market have tough day china shanghai composite dump biggest drop june slide oil commodity price trigger fear deepen global recession exchange halter trading more issue strike loss limit hang seng index hong kong slice lower japan tokyo nikkei index dip analyst say loss be ease institutional buy bargain hunting public pension fund index europe reversed early loss pull positive territory late trading cac paris add frankfurt dax edge london ftse remain water commodity bank see heavy selling update stock vacillate paulson bernanke testifyby vincent maostock be little change follow rocky open tuesday wall street attention turn federal reserve chairman ben bernanke treasury secretary henry paulson be testify house financial service committee management bailout program dow be nyse composite fall nasdaq be mostly unchanged volume be tracking higher exchange tech issue be mostly higher follow hewlett packard hpq outlook apple aapl oracle orcl research motion rimm gain meanwhile aerovironment avav rise try rebound dip day move average downside sak sk fall more report wider forecast loss open operator sak fifth avenue store report third quarter shortfall cent share profit cent prior year much cent loss expect thomson reuter sale decline analyst have expect loss cent share revenue cite uncertainty economy other factor cliff natural resource clf alpha natural resource anr cancel merger alpha natural share fall former suitor cliff gain update hewlett packard inspire stock futuresby vincent maostock future point mixed tuesday bright result hewlett packard offset uncertainty automaker nasdaq future climb point vs fair value future slip point dow future be mostly unchanged executive ford general motor gm chrysler testify capitol hill press case bailout money democratic lawmaker propose let big tap fund trouble asset relief program automaker already receive loan september separately ford be reportedly slash stake mazda motor strive raise cash economic news producer price tumble october vs expectation decline exclude food energy price rise hewlett packard hpq surge pre market report preliminary result give upbeat guidance maker computer printer announce earning share vs view guide full year profit range share vs view hp release additional detail nov statement hp chief executive mark hurd say company deliver solid quarter continue benefit global reach diverse customer base broad portfolio numerous cost initiative group mate apple aapl international business machine ibm rise home depot hd gain report smaller expect earning decline home improvement giant deliver profit cent share prior year cent view revenue fall also view home depot see drop full year profit continue operation same prior guidance yahoo yhoo climb jerry yang step chief executive officer late monday share web search firm have fall yang co founder company take ceo june downside medtronic mdt fall hefty legal charge drag latest quarterly profit hurt charge stem patent dispute johnson johnson jnj medtronic earning fall cent share cent year period exclude item medtronic earn cent share still view cent
848,MDT,update stock pare bulk gain turn mixed late friday house representative pass revise rescue package aim help not only wall street main street
849,MDT,edt nasdaq nyse rise be more session high dow slip be mostly unchanged
850,MDT,volume turn sharply higher nasdaq nyse trade be even compare same time thursday
851,MDT,gold didn provide safe haven metal settle ounce week gold lose
852,MDT,crude oil end barrel cent
853,MDT,second round voting bailout bill pass vote now go president bush key feature modify plan include give treasury secretary power buy toxic asset financial firm raise cap federal deposit insurance well number tax break business middle class
854,MDT,stock sell immediately news
855,MDT,energy conversion device ener jump fast trade
856,MDT,continue bounce back month low solar product maker have spotty earning record profit be slate surge year
857,MDT,fti consult fcn gain active trade stock slip back day move average briefly climb
858,MDT,downside open text otex reversed early gain fall brisk volume downdraft slice stock day day move average thomas weisel downgrade software maker market weight overweight
859,MDT,aeropostale aro drop put apparel retailer further south day line
860,MDT,update stock pull back ahead house vote
861,MDT,vincent mao
862,MDT,stock remain sharply higher midday friday best level session investor await fate financial rescue bill
863,MDT,nyse composite be nasdaq dow
864,MDT,volume be tracking lower exchange vote bill be imminent
865,MDT,global payment gpn gap day move average share rally busy trade late thursday provider payment process service deliver fiscal result expectation raise full year earning outlook view
866,MDT,medtronic mdt jump regain day move average medical device maker win fda approval market lifepak defibrillator
867,MDT,itt educational service itt rise fast trade thursday stock hit month low find support day move average provider post secondary degree program report earning oct profit be slate climb share
868,MDT,downside gen probe gpro drop heavy trading cowen co cut biotech neutral outperform cite weak sale firm ultrio blood screener
869,MDT,gen probe erased gain past session
870,MDT,urban outfitter urbn lose fast trade pali research cut retailer sell neutral
871,MDT,update index extend mixed volume advance
872,MDT,alan elliottstock continue add gain buoy news federally assist buyout bank well fargo congress debate preparation second vote financial rescue package
873,MDT,nyse composite drift higher edt nasdaq composite gain run gain dow rise
874,MDT,volume be mixed nyse higher nasdaq
875,MDT,industry group moved higher morning trade
876,MDT,november crude oil future hold relatively steady barrel natural gas ease gold fall hard ounce dollar launch fifth straight session gain
877,MDT,handful equipment maker moved higher strong trading volume
878,MDT,wabtec wab pull quick touch day move average railroad component maker have be consolidate late august
879,MDT,oil field power transmission equipment maker lufkin industry lufk jump share price remain day move average slip correction early september
880,MDT,azz azz hop electrical equipment component maker be just week move average week possible base
881,MDT,market asia tumble hong kong hang seng index wipe slumping oil price hammer energy issue financial slip exposure fail bank shanghai exchange remain close national holiday
882,MDT,tokyo nikkei slump year low automaker high tech issue broad palette exporter
883,MDT,stock marched higher europe unite kingdom germany frankfurt dax hammer advance cac paris add london ftse pulse
884,MDT,update stock surge mixed trade
885,MDT,vincent mao
886,MDT,stock open vastly higher ahead house second vote financial bailout plan
887,MDT,edt nasdaq nyse composite be
888,MDT,rally dow
889,MDT,volume be tracking sharply lower nyse much higher nasdaq
890,MDT,number financial shot higher
891,MDT,national city corp ncc vault thursday bank say pay dividend penny share series prefer stock
892,MDT,sovereign bancorp sov jump morgan stanley ms goldman sachs gs climb respectively
893,MDT,downside citigroup gap slump morning well fargo wfc agree buy wb kill citigroup deal buy banking operation
894,MDT,elsewhere costco wholesale cost climb follow upgrade goldman sachs raise warehouse club operator buy hold cite valuation broker also raise price target
895,MDT,ism service index slip september august slightly better estimate
896,MDT,update bad job datum boost stock future
897,MDT,vincent mao
898,MDT,stock be poise sharply higher open friday bad job report
899,MDT,nasdaq future rally point vs fair value future rise point dow future climb point
900,MDT,economic news labor department say nonfarm payroll tumble september vs estimate loss job ninth straight monthly decline biggest loss march manufacturing construction retail see largest decline education health service see gain
901,MDT,payroll july august be upwardly revise
902,MDT,unemployment rate hold steady expect average hourly earning rise slightly forecast
903,MDT,future actually improve bad job report suggest investor confidence house pass financial rescue plan later today interest rate cut also be offing
904,MDT,monday house unexpectedly reject bailout package send stock plunge bill intend prevent economic slide help financial crisis get second chance today
905,MDT,well fargo wfc agree buy struggle wb stock deal trump citigroup offer buy banking operation earlier week come government assistance share surge well rise citigroup share slump
906,MDT,american international group aig gain pre market announce plan sell several business unit help repay huge loan government company focus core property casualty insurance operation last month government bail trouble insurance financial service giant year loan
907,MDT,ub ub say cut investment banking job
908,MDT,swiss bank have record more down past year share be mostly flat pre market
909,MDT,ism service index september be release edt
910,MDT,economist expect read august update stock pare bulk gain turn mixed late friday house representative pass revise rescue package aim help not only wall street main street edt nasdaq nyse rise be more session high dow slip be mostly unchanged volume turn sharply higher nasdaq nyse trade be even compare same time thursday gold didn provide safe haven metal settle ounce week gold lose crude oil end barrel cent second round voting bailout bill pass vote now go president bush key feature modify plan include give treasury secretary power buy toxic asset financial firm raise cap federal deposit insurance well number tax break business middle class stock sell immediately news energy conversion device ener jump fast trade continue bounce back month low solar product maker have spotty earning record profit be slate surge year fti consult fcn gain active trade stock slip back day move average briefly climb downside open text otex reversed early gain fall brisk volume downdraft slice stock day day move average thomas weisel downgrade software maker market weight overweight aeropostale aro drop put apparel retailer further south day line update stock pull back ahead house voteby vincent maostock remain sharply higher midday friday best level session investor await fate financial rescue bill nyse composite be nasdaq dow volume be tracking lower exchange vote bill be imminent global payment gpn gap day move average share rally busy trade late thursday provider payment process service deliver fiscal result expectation raise full year earning outlook view medtronic mdt jump regain day move average medical device maker win fda approval market lifepak defibrillator itt educational service itt rise fast trade thursday stock hit month low find support day move average provider post secondary degree program report earning oct profit be slate climb share downside gen probe gpro drop heavy trading cowen co cut biotech neutral outperform cite weak sale firm ultrio blood screener gen probe erased gain past session urban outfitter urbn lose fast trade pali research cut retailer sell neutral update index extend mixed volume advanceby alan nyse composite drift higher edt nasdaq composite gain run gain dow rise volume be mixed nyse higher nasdaq industry group moved higher morning trade november crude oil future hold relatively steady barrel natural gas ease gold fall hard ounce dollar launch fifth straight session gain handful equipment maker moved higher strong trading volume wabtec wab pull quick touch day move average railroad component maker have be consolidate late august oil field power transmission equipment maker lufkin industry lufk jump share price remain day move average slip correction early september azz azz hop electrical equipment component maker be just week move average week possible base market asia tumble hong kong hang seng index wipe slumping oil price hammer energy issue financial slip exposure fail bank shanghai exchange remain close national holiday tokyo nikkei slump year low automaker high tech issue broad palette exporter stock marched higher europe unite kingdom germany frankfurt dax hammer advance cac paris add london ftse pulse update stock surge mixed tradeby vincent maostock open vastly higher ahead house second vote financial bailout plan edt nasdaq nyse composite be rally dow volume be tracking sharply lower nyse much higher nasdaq number financial shot higher national city corp ncc vault thursday bank say pay dividend penny share series prefer stock sovereign bancorp sov jump morgan stanley ms goldman sachs gs climb respectively downside citigroup gap slump morning well fargo wfc agree buy wb kill citigroup deal buy banking operation elsewhere costco wholesale cost climb follow upgrade goldman sachs raise warehouse club operator buy hold cite valuation broker also raise price target ism service index slip september august slightly better estimate update bad job datum boost stock futuresby vincent maostock be poise sharply higher open friday bad job report nasdaq future rally point vs fair value future rise point dow future climb point economic news labor department say nonfarm payroll tumble september vs estimate loss job ninth straight monthly decline biggest loss march manufacturing construction retail see largest decline education health service see gain payroll july august be upwardly revise unemployment rate hold steady expect average hourly earning rise slightly forecast future actually improve bad job report suggest investor confidence house pass financial rescue plan later today interest rate cut also be offing monday house unexpectedly reject bailout package send stock plunge bill intend prevent economic slide help financial crisis get second chance today well fargo wfc agree buy struggle wb stock deal trump citigroup offer buy banking operation earlier week come government assistance share surge well rise citigroup share slump american international group aig gain pre market announce plan sell several business unit help repay huge loan government company focus core property casualty insurance operation last month government bail trouble insurance financial service giant year loan ub ub say cut investment banking job swiss bank have record more down past year share be mostly flat pre market ism service index september be release edt economist expect read august
911,MDT,update major index close split fashion zigzag session tuesday stock be most day defy expect housing datum seller strike close minute trade
912,MDT,nyse composite nasdaq rise dow lose respectively
913,MDT,volume fall nyse climb nasdaq
914,MDT,mixed result few leader score good gain
915,MDT,asiainfo holding asia rally triple average trade clear buy point week base mutual fund ownership stock have climb straight quarters asiainfo provide telecom security product service
916,MDT,shanda interactive entertainment snda jump new record high twice average trade be much session peak still chinese internet gaming firm be biggest percentage gainer ibd
917,MDT,newmarket neu tack more double average volume specialty chemical maker follow clear handle deep base monday newmarket base correct hefty
918,MDT,synaptic syna jump month high recently find support week move average last year maker touch screen interface grow earning analyst see increase year
919,MDT,come wednesday be minute fed april meeting
920,MDT,advance auto part aap anntaylor store ann bj wholesale club bj deere sina sina target tgt be number company report earning wednesday
921,MDT,update stock end mixed late seller pounce
922,MDT,vincent mao
923,MDT,selling final minute trade give major index mixed finish tuesday
924,MDT,nyse composite rise have be much nasdaq also eke gain chip stock show strength send philadelphia semiconductor index
925,MDT,meanwhile dow fall respectively
926,MDT,accord preliminary datum volume end higher board just slightly nyse
927,MDT,steel medium medical stock be best performer insurance bank stock be weakest
928,MDT,update index hover session high
929,MDT,vincent mao
930,MDT,stock remain higher mostly range bound trading late tuesday
931,MDT,nasdaq climb hold session high chip issue continue strengthen philadelphia semiconductor index
932,MDT,meanwhile nyse composite be also intraday peak dow rise respectively
933,MDT,turnover be again tracking higher board
934,MDT,shanda interactive entertainment snda surge heavy trading new time high chinese internet gaming firm have yet test week move average march be news account move
935,MDT,anaren anen rally month high put thin stock past buy point high handle company make product wireless communication market earning sale growth accelerate recent quarters
936,MDT,hewlett packard hpq rise nearly touch day move average dow component report fiscal result close analyst be expect cent share flat year sale be slate slip
937,MDT,credit card firm be lower really have little reaction senate vote ban charge high fee randomly raise person interest rate american express axp capital financial cof drop financial service dfs fall mastercard visa lose
938,MDT,bank be mostly lower cnbc report many be face restriction pay back government bailout fund northern trust ntrs well fargo wfc shed respectively
939,MDT,update nasdaq hit new intraday high
940,MDT,vincent mao
941,MDT,nasdaq rally new session high other major index be little change
942,MDT,boost chip issue nasdaq rise philadelphia semiconductor index jump
943,MDT,meanwhile nyse composite climb dow
944,MDT,volume be again tracking higher board
945,MDT,anglogold ashanti rise nearly bounce back test day move average tuesday south african gold producer be add handle cup base anglogold lose money past year be slate earn share year
946,MDT,downside regal beloit rbc trim loss earlier tuesday maker electrical mechanical product price offer share discount monday close
947,MDT,update index retreat near morning high
948,MDT,update major index close split fashion zigzag session tuesday stock be most day defy expect housing datum seller strike close minute trade nyse composite nasdaq rise dow lose respectively volume fall nyse climb nasdaq mixed result few leader score good gain asiainfo holding asia rally triple average trade clear buy point week base mutual fund ownership stock have climb straight quarters asiainfo provide telecom security product service shanda interactive entertainment snda jump new record high twice average trade be much session peak still chinese internet gaming firm be biggest percentage gainer ibd newmarket neu tack more double average volume specialty chemical maker follow clear handle deep base monday newmarket base correct hefty synaptic syna jump month high recently find support week move average last year maker touch screen interface grow earning analyst see increase year come wednesday be minute fed april meeting advance auto part aap anntaylor store ann bj wholesale club bj deere sina sina target tgt be number company report earning wednesday update stock end mixed late seller pounceby vincent maosel final minute trade give major index mixed finish tuesday nyse composite rise have be much nasdaq also eke gain chip stock show strength send philadelphia semiconductor index meanwhile dow fall respectively accord preliminary datum volume end higher board just slightly nyse steel medium medical stock be best performer insurance bank stock be weakest update index hover session highsby vincent maostock remain higher mostly range bound trading late tuesday nasdaq climb hold session high chip issue continue strengthen philadelphia semiconductor index meanwhile nyse composite be also intraday peak dow rise respectively turnover be again tracking higher board shanda interactive entertainment snda surge heavy trading new time high chinese internet gaming firm have yet test week move average march be news account move anaren anen rally month high put thin stock past buy point high handle company make product wireless communication market earning sale growth accelerate recent quarters hewlett packard hpq rise nearly touch day move average dow component report fiscal result close analyst be expect cent share flat year sale be slate slip credit card firm be lower really have little reaction senate vote ban charge high fee randomly raise person interest rate american express axp capital financial cof drop financial service dfs fall mastercard visa lose bank be mostly lower cnbc report many be face restriction pay back government bailout fund northern trust ntrs well fargo wfc shed respectively update nasdaq hit new intraday highby vincent maothe nasdaq rally new session high other major index be little change boost chip issue nasdaq rise philadelphia semiconductor index jump meanwhile nyse composite climb dow volume be again tracking higher board anglogold ashanti rise nearly bounce back test day move average tuesday south african gold producer be add handle cup base anglogold lose money past year be slate earn share year downside regal beloit rbc trim loss earlier tuesday maker electrical mechanical product price offer share discount monday close update index retreat near morning high
949,MDT,update stock jump holiday week positive note volume be light
950,MDT,nyse composite nasdaq composite take gain dow rise volume fall board
951,MDT,ibd industry group post advance consumer commercial lender hmo post day biggest gain industry group
952,MDT,hewlett packard hpq slump hour trade report fiscal ep gain be line company nov guidance penny analyst consensus estimate revenue slip also line recent guidance consensus forecast
953,MDT,tomorrow prior market open commerce department plan release revise gdp datum case shiller unveil september home price gauge conference board be set deliver november consumer confidence index federal open market committee be schedule release minute nov meeting
954,MDT,tuesday earning calendar include medtronic mdt market open blue coat system bcsi china finance online jrjc crew jcg hour
955,MDT,index hold soft trade
956,MDT,update stock jump holiday week positive note volume be light nyse composite nasdaq composite take gain dow rise volume fall board ibd industry group post advance consumer commercial lender hmo post day biggest gain industry group hewlett packard hpq slump hour trade report fiscal ep gain be line company nov guidance penny analyst consensus estimate revenue slip also line recent guidance consensus forecast tomorrow prior market open commerce department plan release revise gdp datum case shiller unveil september home price gauge conference board be set deliver november consumer confidence index federal open market committee be schedule release minute nov meeting tuesday earning calendar include medtronic mdt market open blue coat system bcsi china finance online jrjc crew jcg hour index hold soft trade
957,MDT,update major index logged heavy loss tuesday sour global economic news loss left little doubt market be correction once again
958,MDT,ibd industry group lose ground steel producer take hardest hit insurer major bank heavy duty truck part maker be close
959,MDT,chrysler announce cut job aim reduction fix cost company say plan new vehicle launch month include new electric vehicle company press release also say automaker be now seek government loan originally request repayment begin
960,MDT,wednesday economic calendar include housing start build permit export import price commerce department federal reserve plan release industrial production capacity utilization number well minute federal open market committee jan meeting
961,MDT,comcast cmcsa deere be company schedule report earning prior wednesday market open cbs cbs hewlett packard hpq priceline com pcln plan report close
962,MDT,update index close broadly lower volume
963,MDT,juan carlos arancibia
964,MDT,stock close broadly steeply lower tuesday dow challenged november low
965,MDT,industrial plunge essentially match nov close low
966,MDT,nasdaq fall nyse composite
967,MDT,volume rise add day bearish tone
968,MDT,financial lead market spdr financial etf xlf moody warn eastern europe bank face downgrade
969,MDT,industrial energy stock also tumble crude price skid
970,MDT,update index hover deep red
971,MDT,update major index logged heavy loss tuesday sour global economic news loss left little doubt market be correction once again ibd industry group lose ground steel producer take hardest hit insurer major bank heavy duty truck part maker be close chrysler announce cut job aim reduction fix cost company say plan new vehicle launch month include new electric vehicle company press release also say automaker be now seek government loan originally request repayment begin wednesday economic calendar include housing start build permit export import price commerce department federal reserve plan release industrial production capacity utilization number well minute federal open market committee jan meeting comcast cmcsa deere be company schedule report earning prior wednesday market open cbs cbs hewlett packard hpq priceline com pcln plan report close update index close broadly lower volume upby juan carlos arancibiastock close broadly steeply lower tuesday dow challenged november low industrial plunge essentially match nov close low nasdaq fall nyse composite volume rise add day bearish tone financial lead market spdr financial etf xlf moody warn eastern europe bank face downgrade industrial energy stock also tumble crude price skid update index hover deep red
972,MDT,update dow skid week not enough undercut weekly low marked nov lowest weekly close march nyse composite saw drop nasdaq composite end lower lose brief bid retake support day move average
973,MDT,nasdaq dow have slip past week nyse
974,MDT,jpmorgan chase jpm bank america bac citigroup be dow worst price decline friday
975,MDT,sun microsystem java research motion rimm hold lowest mark nasdaq
976,MDT,market be close president day holiday monday tuesday calendar fed plan release empire state manufacturing index open earning docket wal mart wmt transocean rig medtronic mdt amedisys am daimler dai plan report prior open
977,MDT,agilent technology axsys technology axys be slate report close
978,MDT,update index close lower volume decline
979,MDT,juan carlos arancibia
980,MDT,stock end volatile session loss friday selling picked final minute
981,MDT,bell dow nyse composite be nasdaq lose
982,MDT,volume fall ahead holiday weekend
983,MDT,index climb lows white house say plan aid housing market be announce wednesday
984,MDT,financial be laggard persistent worry sector health
985,MDT,update index narrow loss foreclosure news
986,MDT,alan elliott
987,MDT,market edge lows afternoon trade follow news citigroup jpmorgan chase jpm agree freeze foreclosure owner occupied home week meantime treasury fed hash specific shore mortgage finance sector
988,MDT,index cling bottom side break even line dow nyse composite be nasdaq composite essentially flat
989,MDT,volume be exchange decline issue lead advancer nyse narrow margin nasdaq
990,MDT,thoratec thor add heavy trading maker heart implant other medical device say pay australia base heartware international move consolidate thoratec lead share market implantable heart assist device share be rise pattern become double bottom base
991,MDT,corinthian college coco scream higher repair damage do thursday career school rout private college operator be extend buy point pullback stock week move average line
992,MDT,update stock turn mixed nasdaq lead rebound
993,MDT,update dow skid week not enough undercut weekly low marked nov lowest weekly close march nyse composite saw drop nasdaq composite end lower lose brief bid retake support day move average nasdaq dow have slip past week nyse jpmorgan chase jpm bank america bac citigroup be dow worst price decline friday sun microsystem java research motion rimm hold lowest mark nasdaq market be close president day holiday monday tuesday calendar fed plan release empire state manufacturing index open earning docket wal mart wmt transocean rig medtronic mdt amedisys am daimler dai plan report prior open agilent technology axsys technology axys be slate report close update index close lower volume decline juan carlos arancibiastock end volatile session loss friday selling picked final minute bell dow nyse composite be nasdaq lose volume fall ahead holiday weekend index climb lows white house say plan aid housing market be announce wednesday financial be laggard persistent worry sector health update index narrow loss foreclosure news alan elliottmarket edge lows afternoon trade follow news citigroup jpmorgan chase jpm agree freeze foreclosure owner occupied home week meantime treasury fed hash specific shore mortgage finance sector index cling bottom side break even line dow nyse composite be nasdaq composite essentially flat volume be exchange decline issue lead advancer nyse narrow margin nasdaq thoratec thor add heavy trading maker heart implant other medical device say pay australia base heartware international move consolidate thoratec lead share market implantable heart assist device share be rise pattern become double bottom base corinthian college coco scream higher repair damage do thursday career school rout private college operator be extend buy point pullback stock week move average line update stock turn mixed nasdaq lead rebound
994,MDT,update index surge mark shift market tone
995,MDT,major index roar back strong gain late session volume increase
996,MDT,nasdaq lead charge dow jump nyse checked gain respectively
997,MDT,late day advance wal mart wmt exxon mobil xom clock dow biggest price gain nyse heavily weight energy index lead add weaker oil price oil drop barrel month low
998,MDT,government backed education lender sallie mae slm mbia mbi be top draw
999,MDT,preliminary datum show volume firmly higher exchange rise trading combine index large gain make follow market
1000,MDT,technical confirmation rally attempt launch last friday bullish sign little way lead stock form sound basis so far
1001,MDT,dollar be indecisive move higher vs yen lose ground euro natural gas future rise gold copper grain lose ground
1002,MDT,advancer seize control decline issue afternoon trading end ahead better exchange
1003,MDT,google goog reversed jump report strong earning sale result bell share add hour trading
1004,MDT,yahoo yhoo pop heavy trade
1005,MDT,day worst loss badger meter bmi topple miss ep view cent fall short revenue expectation gap put share month low week move average
1006,MDT,update stock strengthen late trade
1007,MDT,vincent mao
1008,MDT,dow nyse composite joined nasdaq positive territory late trade thursday pace regain retribution yesterday huge loss
1009,MDT,edt nasdaq climb dow nyse composite
1010,MDT,turnover be still tracking sharply higher board
1011,MDT,crude oil fall settle barrel lowest last august
1012,MDT,yahoo yhoo reversed loss jump fast trade stock turn lowest level more year microsoft msft ceo steve ballmer say technology conference buyout internet search engine still make sense economically software giant later issue statement say have interest acquire yahoo
1013,MDT,synaptic syna reversed higher gain active trading bounce back briefly breach day move average maker user interface report earning oct analyst see profit rise cent share
1014,MDT,mircosemi mscc also turn higher gain brisk volume chipmaker announce acquisition babcock maker power supply cash also affirm profit outlook cent cent share sale view be earning cent share sale
1015,MDT,downside hartford financial group hig drop heavy trading insurance financial service firm slash quarterly dividend cent share cent
1016,MDT,update stock turn mixed volatile trading
1017,MDT,vincent mao
1018,MDT,stock bounce back heavy loss be mixed midday thursday
1019,MDT,trading have be volatile session follow barrage earning report round mixed economic datum
1020,MDT,edt nasdaq be dow gain fall meanwhile rise nyse composite lose
1021,MDT,volume be still tracking vastly higher board
1022,MDT,retest oct lows be card
1023,MDT,earlier cboe volatility index vix shot mark record high indicator often view gauge investor fear
1024,MDT,crude oil drop barrel follow larger expect buildup inventory
1025,MDT,amedisys am rally ub upgrade home nursing firm buy neutral stock have meet resistance day move average recent session
1026,MDT,spartan store sptn jump regain day line supermarket operator be recover recent fail
1027,MDT,downside itron itri gap slump heavy trading meter maker fall sympathy badger meter bmi report disappointing earning late wednesday
1028,MDT,google goog shed ahead earning close internet firm profit be expect rise share sale be slate fall
1029,MDT,ebay ebay lower full year profit outlook late wednesday drop
1030,MDT,medtronic mdt slide heavy trading session low medical device maker tumble study link company drug coat endeavor stent more heart complication
1031,MDT,update index dive industrial datum
1032,MDT,alan elliot
1033,MDT,financial issue turn sharply follow unexpectedly weak manufacturing datum send index lower busy trading
1034,MDT,fade dow nyse composite edt nasdaq composite hold loss
1035,MDT,citigroup jpmorgan chase jpm american express ax bank america bac be dow heaviest price percent loser cit group cit prudential financial pru be top dog steep loss ebay ebay google goog amazon com amzn weigh heavy nasdaq
1036,MDT,trading volume be sharply higher aisle nyse higher nasdaq
1037,MDT,decliner lead advance issue nyse nasdaq almost industry group manage gain ground super minimarket food group top list gold silver miner group clock heaviest decline
1038,MDT,natural gas moved firmly higher most commodity lose serious ground crude future dive barrel month low gold skid just ounce dollar gain vs euro yen
1039,MDT,mindray medical mr dump huge volume rip drive china base maker diagnostic patient monitoring equipment year low
1040,MDT,badger meter bmi topple miss ep view cent fall short revenue expectation gap put share month low week move average
1041,MDT,overseas stock slump europe capital continue flow energy commodity london ftse sag cac paris give frankfurt dax surrender
1042,MDT,market asia close sharply tokyo nikkei crater worst day market crash reuter report japanese prime minister taro aso say thursday fall show market believe bank bailout plan not be enough fix financial crisis
1043,MDT,shanghai composite drop hong kong hang seng index slip
1044,MDT,update stock retreat philly fed
1045,MDT,vincent mao
1046,MDT,stock open higher thursday gain be quickly fading big drop regional manufacturing activity
1047,MDT,edt nasdaq be nyse composite be mostly unchanged dow fall
1048,MDT,volume be tracking higher board
1049,MDT,economic news philly fed factory index stumble october september be far estimate rise
1050,MDT,industrial production decline september largely due fallout recent hurricane drop be biggest late more triple expectation decline capacity utilization come view
1051,MDT,financial be mostly higher news more down bank new york mellon bk rise lynch mer gain
1052,MDT,meanwhile ub ub gap gain fast trade investment bank reach agreement swiss national bank transfer mortgage related asset separate entity ub also get capital injection form convertible note
1053,MDT,elsewhere reliance steel rs gap rally strong earning profit surge share cent view sale grow also view
1054,MDT,downside amazon com amzn gap lose month low brisk trade come pressure third straight session web retailer report earning oct profit be slate rise cent share
1055,MDT,update economic datum offset mixed financial result
1056,MDT,vincent mao
1057,MDT,economic datum prop stock future thursday signale higher open nasdaq future rise point vs fair value future climb point dow future rally point
1058,MDT,economic news consumer price be unchanged september estimate increase core price strip food energy rise less expect
1059,MDT,initial jobless claim fall forecast
1060,MDT,philly fed factory index october be edt
1061,MDT,lynch mer decline pre market follow disappointing earning investment bank loss widen share vs loss year quarter result be cent view record down collateralize debt obligation real estate related asset last month agree sell bank america bac bofa share fall pre open
1062,MDT,citigroup post fourth straight quarterly loss still manage top view bank lose cent share third quarter vs profit cent year still be dime estimate citi book down security banking business company also cut job share be fractionally lower pre market
1063,MDT,bank new york mellon bny edge higher pre open disappointing result hurt charge related bankruptcy lehman bro company earn cent share third quarter cent year earlier cent view update index surge mark shift market major index roar back strong gain late session volume increase nasdaq lead charge dow jump nyse checked gain respectively late day advance wal mart wmt exxon mobil xom clock dow biggest price gain nyse heavily weight energy index lead add weaker oil price oil drop barrel month low government backed education lender sallie mae slm mbia mbi be top draw preliminary datum show volume firmly higher exchange rise trading combine index large gain make follow market technical confirmation rally attempt launch last friday bullish sign little way lead stock form sound basis so far dollar be indecisive move higher vs yen lose ground euro natural gas future rise gold copper grain lose ground advancer seize control decline issue afternoon trading end ahead better exchange google goog reversed jump report strong earning sale result bell share add hour trading yahoo yhoo pop heavy trade day worst loss badger meter bmi topple miss ep view cent fall short revenue expectation gap put share month low week move average update stock strengthen late tradeby vincent maothe dow nyse composite joined nasdaq positive territory late trade thursday pace regain retribution yesterday huge loss edt nasdaq climb dow nyse composite turnover be still tracking sharply higher board crude oil fall settle barrel lowest last august yahoo yhoo reversed loss jump fast trade stock turn lowest level more year microsoft msft ceo steve ballmer say technology conference buyout internet search engine still make sense economically software giant later issue statement say have interest acquire yahoo synaptic syna reversed higher gain active trading bounce back briefly breach day move average maker user interface report earning oct analyst see profit rise cent share mircosemi mscc also turn higher gain brisk volume chipmaker announce acquisition babcock maker power supply cash also affirm profit outlook cent cent share sale view be earning cent share sale downside hartford financial group hig drop heavy trading insurance financial service firm slash quarterly dividend cent share cent update stock turn mixed volatile tradingby vincent maostock bounce back heavy loss be mixed midday thursday trading have be volatile session follow barrage earning report round mixed economic datum edt nasdaq be dow gain fall meanwhile rise nyse composite lose volume be still tracking vastly higher board retest oct lows be card earlier cboe volatility index vix shot mark record high indicator often view gauge investor fear crude oil drop barrel follow larger expect buildup inventory amedisys am rally ub upgrade home nursing firm buy neutral stock have meet resistance day move average recent session spartan store sptn jump regain day line supermarket operator be recover recent fail downside itron itri gap slump heavy trading meter maker fall sympathy badger meter bmi report disappointing earning late wednesday google goog shed ahead earning close internet firm profit be expect rise share sale be slate fall ebay ebay lower full year profit outlook late wednesday drop medtronic mdt slide heavy trading session low medical device maker tumble study link company drug coat endeavor stent more heart complication update index dive industrial databy alan elliotfinancial issue turn sharply follow unexpectedly weak manufacturing datum send index lower busy trading fade dow nyse composite edt nasdaq composite hold loss citigroup jpmorgan chase jpm american express ax bank america bac be dow heaviest price percent loser cit group cit prudential financial pru be top dog steep loss ebay ebay google goog amazon com amzn weigh heavy nasdaq trading volume be sharply higher aisle nyse higher nasdaq decliner lead advance issue nyse nasdaq almost industry group manage gain ground super minimarket food group top list gold silver miner group clock heaviest decline natural gas moved firmly higher most commodity lose serious ground crude future dive barrel month low gold skid just ounce dollar gain vs euro yen mindray medical mr dump huge volume rip drive china base maker diagnostic patient monitoring equipment year low badger meter bmi topple miss ep view cent fall short revenue expectation gap put share month low week move average overseas stock slump europe capital continue flow energy commodity london ftse sag cac paris give frankfurt dax surrender market asia close sharply tokyo nikkei crater worst day market crash reuter report japanese prime minister taro aso say thursday fall show market believe bank bailout plan not be enough fix financial crisis shanghai composite drop hong kong hang seng index slip update stock retreat philly fedby vincent maostock open higher thursday gain be quickly fading big drop regional manufacturing activity edt nasdaq be nyse composite be mostly unchanged dow fall volume be tracking higher board economic news philly fed factory index stumble october september be far estimate rise industrial production decline september largely due fallout recent hurricane drop be biggest late more triple expectation decline capacity utilization come view financial be mostly higher news more down bank new york mellon bk rise lynch mer gain meanwhile ub ub gap gain fast trade investment bank reach agreement swiss national bank transfer mortgage related asset separate entity ub also get capital injection form convertible note elsewhere reliance steel rs gap rally strong earning profit surge share cent view sale grow also view downside amazon com amzn gap lose month low brisk trade come pressure third straight session web retailer report earning oct profit be slate rise cent share update economic datum offset mixed financial resultsby vincent maoeconomic datum prop stock future thursday signale higher open nasdaq future rise point vs fair value future climb point dow future rally point economic news consumer price be unchanged september estimate increase core price strip food energy rise less expect initial jobless claim fall forecast philly fed factory index october be edt lynch mer decline pre market follow disappointing earning investment bank loss widen share vs loss year quarter result be cent view record down collateralize debt obligation real estate related asset last month agree sell bank america bac bofa share fall pre open citigroup post fourth straight quarterly loss still manage top view bank lose cent share third quarter vs profit cent year still be dime estimate citi book down security banking business company also cut job share be fractionally lower pre market bank new york mellon bny edge higher pre open disappointing result hurt charge related bankruptcy lehman bro company earn cent share third quarter cent year earlier cent view
1064,MDT,medtronic mdt share sank early tuesday firm suggest first used surgical robot hugo human likely be push analyst say share drop come medical device maker top wall street quarterly expectation diabetes business revenue handily beat consensus medtronic put production issue rearview mirror rbc analyst brandon henry write note client stock market today medtronic sank close robotic issue previously medtronic have say competitor intuitive surgical isrg begin operate patient end fiscal full launch fiscal call firm say software hardware integration testing be take longer expect believe commentary suggest first human case medtronic surgical robot slip fiscal henry say believe slippage medtronic surgical robot timeline be slight positive intuitive transenterix trxc ibd take hard identify start uptrend simply rely headline so do savvy trader look uptrend head investor corner key tip operate resurgent market delay medtronic give transenterix longer second mover advantage henry say transenterix gain approval october senhance surgical robotic system sell first system hospital system florida november intuitive surgical gain close transenterix gain cent fiscal third quarter medtronic report adjust income share sale third quarter rise respectively vs year period analyst have call adjust profit share sale rbc analyst glenn novarro note segment contribute upside cardiac vascular sale rise constant currency basis restorative therapy minimally invasive therapy diabetes sale grow respectively get ibd market prep tech report newsletter free edward jone analyst john boylan credit sale beat diabetes group bring worldwide handily beating estimate evercore analyst vijay kumar say consensus have project diabetes sale revenue beat be drive broad strength board standout mind be diabetes drug eluting stent pain therapy kumar say note drug eluting stent grow midteen percentage pain therapy rise medtronic reiterate guidance adjust earning grow year year imply share edward jone boylan write consensus have modeled share sale be expect grow constant currency basis consensus be modele sale fiscal year end april related be explosive year biotech biotech stock need anesthesia collapse nearly abbott laboratory jump boost quarterly dividend
1065,MDT,corporate tax inversion deal size propose consummate have push global merger acquisition level not see worldwide have be report accord thomson reuter datum most year big jump
1066,MDT,stock turn narrowly mixed late trading tuesday moody cut portugal debt rating junk status nyse composite fall slip nasdaq maintain gain volume be again tracking lower exchange moody cut portugal credit rating notch ba notch junk territory say
1067,MDT,follow turbulent management scandal shake hewlett packard hpq say late thursday add new member board effective friday incumbent win stand re election march
1068,MDT,new director include meg whitman former ceo ebay ebay last year lose race california governor other be patricia russo former ceo alcatel lucent alu shumeet banerji ceo booz co gary reiner former cio general electric ge special adviser private equity firm general atlantic dominique senequier ceo axa private equity
1069,MDT,surprise announcement come wake messy ceo transition former hp chief executive mark hurd be force resign august board inquiry charge sexual harassment make former marketing contractor
1070,MDT,board say find evidence harassment hurd be find have file improper expense report conceal personal relationship marketer month later hurd be hire co president rival oracle orcl
1071,MDT,november hp hire former sap sap ceo leo apotheker ceo name ray lane former oracle chairman
1072,MDT,lane apotheker be shore board weakness clear house say brian marshall analyst gleacher co board have make strange decision other say
1073,MDT,decision be old hurd crony new person help power hp not only largest tech company also best say marshall rate stock buy
1074,MDT,history board have be fairly dysfunctional analyst say go forward applaud change re make
1075,MDT,latest twist hp soap opera come week hurd reportedly say win step stop shareholder suit claim hp board waste money severance reportedly
1076,MDT,federal suit san jose calif propose independent probe look board approval hurd departure package accord court filing
1077,MDT,director leave be joel hyatt vice chairman current medium john joyce cfo silver spring network lucille salhany ceo jhmedia robert ryan ex cfo medtronic mdt follow turbulent management scandal shake hewlett packard hpq say late thursday add new member board effective friday incumbent win stand re election march new director include meg whitman former ceo ebay ebay last year lose race california governor other be patricia russo former ceo alcatel lucent alu shumeet banerji ceo booz co gary reiner former cio general electric ge special adviser private equity firm general atlantic dominique senequier ceo axa private equity surprise announcement come wake messy ceo transition former hp chief executive mark hurd be force resign august board inquiry charge sexual harassment make former marketing contractor board say find evidence harassment hurd be find have file improper expense report conceal personal relationship marketer month later hurd be hire co president rival oracle orcl november hp hire former sap sap ceo leo apotheker ceo name ray lane former oracle chairman lane apotheker be shore board weakness clear house say brian marshall analyst gleacher co board have make strange decision other say decision be old hurd crony new person help power hp not only largest tech company also best say marshall rate stock buy history board have be fairly dysfunctional analyst say go forward applaud change re make latest twist hp soap opera come week hurd reportedly say win step stop shareholder suit claim hp board waste money severance reportedly federal suit san jose calif propose independent probe look board approval hurd departure package accord court filing director leave be joel hyatt vice chairman current medium john joyce cfo silver spring network lucille salhany ceo jhmedia robert ryan ex cfo medtronic mdt
1078,MDT,update soft slide financial issue throttle market effort salvage upside day dow dove nyse nasdaq composite shed nyse financial index faltered loss
1079,MDT,volume track lower session preliminary datum show decline nyse drop nasdaq vs average trading level friday
1080,MDT,hunker continue industry sector citigroup layoff target tgt cut capital spending suspend stock buyback program hung day so do potential gridlock washington bailout plan big automaker
1081,MDT,news report close quote treasury secretary henry paulson say remain trouble asset relief program fund be set aside new program initiate clear need paulson federal reserve chairman ben bernanke be schedule give democratic leader update progress program late today
1082,MDT,day notable loss include unite therapeutic uthr baidu com bidu intuitive surgical isrg upside be world fuel service int green mountain coffee roaster gmcr
1083,MDT,slate tuesday core producer price datum be due schedule earning report include home depot hd sak sk medtronic mdt
1084,MDT,update stock try comeback
1085,MDT,vincent maoan earlier rebound attempt fail shift stock back negative territory late trading monday equity be try comeback
1086,MDT,nasdaq be dow nyse composite
1087,MDT,turnover continue track lower exchange
1088,MDT,crude oil settle barrel seesaw session
1089,MDT,baidu com bidu dive year low very heavy trading weekend china central television report web search firm sell link medical company unproven claim accord interfax china news agency baidu com have stop include result unlicensed drug firm
1090,MDT,group mate sohu com sohu sina sina lose respectively
1091,MDT,hartford financial service hig drop active trading fall renew concern large guarantee variable annuity business last week goldman sachs say hartford have liability
1092,MDT,upside world fuel service int erased morning loss ramp fuel provider upside reversal recoup bulk friday loss
1093,MDT,update index battle back midday trading
1094,MDT,vincent mao
1095,MDT,major stock index head midday monday shake weak retailer outlook more job cut mixed economic datum
1096,MDT,nyse composite be boost energy issue dow be nasdaq major index earlier have be
1097,MDT,volume be tracking lower board just slightly nyse breadth turn positive advancer just edge decliner exchange
1098,MDT,oil slip cent barrel seesaw trading
1099,MDT,genoptix gxdx reversed early loss jump stock be try rebound recent fail mutual fund ownership laboratory service provider have more double past quarters company have report triple digit earning growth straight quarters analyst see growth wane quarter
1100,MDT,lowe low also reversed morning gloomy outlook tack trade
1101,MDT,almost family afam rally fast trade bounce back decline last week provider home nursing care nearly have fail
1102,MDT,downside portfolio recovery associate praa drop brisk trade earlier collection service provider test oct low company late october report third straight quarter wane profit growth analyst see streak end period
1103,MDT,update index drift lower soft trading financial issue drag nyse computer market pull nasdaq weak industrial production datum massive layoff announcement citigroup hammer stock
1104,MDT,dow dredge loss nasdaq nyse composite skid lower
1105,MDT,volume trend weak side nyse nasdaq decliner lead advancer side nyse nasdaq
1106,MDT,oil plow higher more barrel natural gas add gold reversed earlier gain edge lower first time session dollar be slightly weaker vs euro yen
1107,MDT,soybean corn price advanced report farmer intend withhold recent harvest price fall more year lows last week forecast call global soy production year begin october be ton earlier forecast nearly last year crop more ton forecast consumption
1108,MDT,stock intuitive surgical isrg gap lose maker robotic surgical instrument end friday session bottom range session slump monday drop drive share month low
1109,MDT,baidu com bidu also gap loss china base internet search engine provider have consistently find ceiling week line drive lower past week share be now month lows
1110,MDT,upside green mountain coffee roaster gmcr jump vermont base coffee vendor last week report jump fiscal earning more better analyst expectation also give line guidance fiscal monday jump hoist share test resistance stock week move average
1111,MDT,medical waste collection operator stericycle srcl add gain follow week share add strong volume stock be ninth week possible cup shape base
1112,MDT,overseas market asia close mixed shanghai composite swell news report say government plan broaden economic aid industry director general government financial service office shanghai also tell conference regulator let brokerage begin trading margin begin early december shanghai hang seng index end volatile session fraction
1113,MDT,japan tokyo nikkei edge strong volume session institutional buyer apparently outweighed friday downside economic datum euro zone
1114,MDT,stock trade generally lower europe london ftse be afternoon trade frankfurt dax shed cac paris surrender bank commodity weigh heavy volkswagen re-trace lower ground report sale drop october
1115,MDT,update index fight back lower open
1116,MDT,vincent mao
1117,MDT,stock open lower monday economic worry continue linger have pare loss
1118,MDT,dow be nasdaq nyse composite fall
1119,MDT,volume be tracking slightly lower board
1120,MDT,unite therapeutic uthr gap plunge huge volume biotech say oral sustain release version hypertension drug remodulin fail late stage study
1121,MDT,alliance datum system ad gap drop heavy trading be news decline stock be close october low
1122,MDT,bank america bac shed news boost stake china construction bank bofa exercise option raise ownership interest
1123,MDT,upside general motor gm rise struggle automaker sell entire stake suzuki motor order raise cash congress discuss potential bailout automaker today
1124,MDT,economic front industrial production grow october beating view decline september drop be revise much biggest decade
1125,MDT,update stock set early tumble
1126,MDT,vincent mao
1127,MDT,economic worry weigh stock future once again point much weaker open
1128,MDT,nasdaq decline point vs fair value future lose point dow future drop point
1129,MDT,economic news leader world vow boost respective economy tighten financial regulation weekend meeting washington also set agenda meeting president elect barrack obama take office next year
1130,MDT,empire state manufacturing index tumble november october fresh record low slightly view
1131,MDT,industrial production october be shortly open
1132,MDT,home improvement retailer lowe low report earning cent share year earlier nickel view sale edge also view many retailer recently lowe offer weak guidance see income cent cent share vs consensus estimate cent share fall pre market lowe also cut full year outlook range share prior forecast
1133,MDT,group mate home depot hd shed pre open report tuesday analyst expect cent share prior year
1134,MDT,target tgt say profit fall cent share penny view sale tick nearly view retailer cut capital spending budget suspend bulk share buyback activity
1135,MDT,accord medium report citigroup plan slash job cut expense last week report suggest layoff drag mortgage related investment bank have lose money straight quarters sale have also drop sharply time citigroup share fall pre market
1136,MDT,jpmorgan chase jpm also lose pre open britain sunday telegraph say bank cut more job
1137,MDT,goldman sachs gs drop pre open citi analyst cut earning estimate analyst prashant bhatia now expect goldman lose share quarter prior view profit
1138,MDT,update soft slide financial issue throttle market effort salvage upside day dow dove nyse nasdaq composite shed nyse financial index faltered loss volume track lower session preliminary datum show decline nyse drop nasdaq vs average trading level friday hunker continue industry sector citigroup layoff target tgt cut capital spending suspend stock buyback program hung day so do potential gridlock washington bailout plan big automaker news report close quote treasury secretary henry paulson say remain trouble asset relief program fund be set aside new program initiate clear need paulson federal reserve chairman ben bernanke be schedule give democratic leader update progress program late today day notable loss include unite therapeutic uthr baidu com bidu intuitive surgical isrg upside be world fuel service int green mountain coffee roaster gmcr slate tuesday core producer price datum be due schedule earning report include home depot hd sak sk medtronic mdt update stock try comebackby vincent maoat nasdaq be dow nyse composite turnover continue track lower exchange crude oil settle barrel seesaw session baidu com bidu dive year low very heavy trading weekend china central television report web search firm sell link medical company unproven claim accord interfax china news agency baidu com have stop include result unlicensed drug firm group mate sohu com sohu sina sina lose respectively hartford financial service hig drop active trading fall renew concern large guarantee variable annuity business last week goldman sachs say hartford have liability upside world fuel service int erased morning loss ramp fuel provider upside reversal recoup bulk friday loss update index battle back midday tradingby vincent maothe major stock index head midday monday shake weak retailer outlook more job cut mixed economic datum nyse composite be boost energy issue dow be nasdaq major index earlier have be volume be tracking lower board just slightly nyse breadth turn positive advancer just edge decliner exchange oil slip cent barrel seesaw trading genoptix gxdx reversed early loss jump stock be try rebound recent fail mutual fund ownership laboratory service provider have more double past quarters company have report triple digit earning growth straight quarters analyst see growth wane quarter lowe low also reversed morning gloomy outlook tack trade almost family afam rally fast trade bounce back decline last week provider home nursing care nearly have fail downside portfolio recovery associate praa drop brisk trade earlier collection service provider test oct low company late october report third straight quarter wane profit growth analyst see streak end period update index drift lower soft trading dow dredge loss nasdaq nyse composite skid lower volume trend weak side nyse nasdaq decliner lead advancer side nyse nasdaq oil plow higher more barrel natural gas add gold reversed earlier gain edge lower first time session dollar be slightly weaker vs euro yen soybean corn price advanced report farmer intend withhold recent harvest price fall more year lows last week forecast call global soy production year begin october be ton earlier forecast nearly last year crop more ton forecast consumption stock intuitive surgical isrg gap lose maker robotic surgical instrument end friday session bottom range session slump monday drop drive share month low baidu com bidu also gap loss china base internet search engine provider have consistently find ceiling week line drive lower past week share be now month lows upside green mountain coffee roaster gmcr jump vermont base coffee vendor last week report jump fiscal earning more better analyst expectation also give line guidance fiscal monday jump hoist share test resistance stock week move average medical waste collection operator stericycle srcl add gain follow week share add strong volume stock be ninth week possible cup shape base overseas market asia close mixed shanghai composite swell news report say government plan broaden economic aid industry director general government financial service office shanghai also tell conference regulator let brokerage begin trading margin begin early december shanghai hang seng index end volatile session fraction japan tokyo nikkei edge strong volume session institutional buyer apparently outweighed friday downside economic datum euro zone stock trade generally lower europe london ftse be afternoon trade frankfurt dax shed cac paris surrender bank commodity weigh heavy volkswagen re-trace lower ground report sale drop october update index fight back lower openby vincent maostock open lower monday economic worry continue linger have pare loss dow be nasdaq nyse composite fall volume be tracking slightly lower board unite therapeutic uthr gap plunge huge volume biotech say oral sustain release version hypertension drug remodulin fail late stage study alliance datum system ad gap drop heavy trading be news decline stock be close october low bank america bac shed news boost stake china construction bank bofa exercise option raise ownership interest upside general motor gm rise struggle automaker sell entire stake suzuki motor order raise cash congress discuss potential bailout automaker today economic front industrial production grow october beating view decline september drop be revise much biggest decade update stock set early tumble
1139,MDT,vincent mao
1140,MDT,economic worry weigh stock future once again point much weaker open
1141,MDT,nasdaq decline point vs fair value future lose point dow future drop point
1142,MDT,economic news leader world vow boost respective economy tighten financial regulation weekend meeting washington also set agenda meeting president elect barrack obama take office next year
1143,MDT,empire state manufacturing index tumble november october fresh record low slightly view
1144,MDT,industrial production october be shortly open
1145,MDT,home improvement retailer lowe low report earning cent share year earlier nickel view sale edge also view many retailer recently lowe offer weak guidance see income cent cent share vs consensus estimate cent share fall pre market lowe also cut full year outlook range share prior forecast
1146,MDT,group mate home depot hd shed pre open report tuesday analyst expect cent share prior year
1147,MDT,target tgt say profit fall cent share penny view sale tick nearly view retailer cut capital spending budget suspend bulk share buyback activity
1148,MDT,accord medium report citigroup plan slash job cut expense last week report suggest layoff drag mortgage related investment bank have lose money straight quarters sale have also drop sharply time citigroup share fall pre market
1149,MDT,jpmorgan chase jpm also lose pre open britain sunday telegraph say bank cut more job
1150,MDT,goldman sachs gs drop pre open citi analyst cut earning estimate analyst prashant bhatia now expect goldman lose share quarter prior view profit vincent maoeconomic worry weigh stock future once again point much weaker open nasdaq decline point vs fair value future lose point dow future drop point economic news leader world vow boost respective economy tighten financial regulation weekend meeting washington also set agenda meeting president elect barrack obama take office next year empire state manufacturing index tumble november october fresh record low slightly view industrial production october be shortly open home improvement retailer lowe low report earning cent share year earlier nickel view sale edge also view many retailer recently lowe offer weak guidance see income cent cent share vs consensus estimate cent share fall pre market lowe also cut full year outlook range share prior forecast group mate home depot hd shed pre open report tuesday analyst expect cent share prior year target tgt say profit fall cent share penny view sale tick nearly view retailer cut capital spending budget suspend bulk share buyback activity accord medium report citigroup plan slash job cut expense last week report suggest layoff drag mortgage related investment bank have lose money straight quarters sale have also drop sharply time citigroup share fall pre market jpmorgan chase jpm also lose pre open britain sunday telegraph say bank cut more job goldman sachs gs drop pre open citi analyst cut earning estimate analyst prashant bhatia now expect goldman lose share quarter prior view profit
1151,MDT,be sign respite ongoing market uncertainty due apprehension trade war hand asian stock have start revive improvement north korea relationship other hand investor be restrain possibility trade loss due propose china trade restriction medical device catch trade war stormgoing datum provide article christian jone mondaq medtech firm unite state currently sell annually china nation import china total billionin medical device export medical device last year totale create worldwide trade surplus needless say medical device lobby be extremely apprehensive propose tariff chinese product significantly affect international trade medtech trade group advame make more specific comment claim chinese tariff account more half medtech import region massdevice article trade group state industry propose additional tariff import nearly bn medical technology product be wrong action wrong time advame counter unite state trade representative ustr claim china unfair trade practice medical device harm export significantly group argue trade china medical device ustr list be fact slight surplus accordingly propose tariff diagnostic product other medical device make unite state china be not drop result trade imbalance rbc capital market estimate propose tariff get implement cost medical device industry year go latest update financial express report bipartisan group lawmaker have urge trade representative robert lighthizer remove worth medical device list chinese product propose trump administration additional tariff investor trouble risk trade war largest economy heighten investment medical device stock be take backseat propose imposition additional tariff chinese product china retaliatory effort have result widespread share loss so far medical device sector bearish emerge market trade outlook have dealt severe blow bigwig note sector have gain significantly profit earn number medical device company bric nation regard note stock medtronic plc mdt free report ge healthcare ge free report other be witness considerable weakness mar talk china trade war start do round note medtronic earlier buy orthopedic device maker china kanghui holding then have be consistently shipping product unite state operation shipment be now subject additional tariff definitely hamper company china business ge healthcare have also urge administration remove certain part list chinese product additional tariff go mass device report china produce part be essential number ge device include ultrasound machine patient monitor mri machine ct machine ray machine be produce ge own facility china other be produce local chinese company medtech stock counter trade restriction hazardconcern implementation trade tariff medtech product have be weigh stock lately even market have not yet show steady plunge such fear be likely dampen investor sentiment go forward have shortlist medtech stock spite tumultuous market condition be well poise strong fundamental timely strategic development selection be also backed good zack growth score zack rank have narrow choice help new style score system research show stock growth score combine zack rank strong buy buy offer best investment opportunity value investing space see complete list today zack rank stock here baxter international inc bax free report company have strong presence overseas market have such business relation china hence spite consider international diversification core component company strategy company very well sidestep volatility china trade war continue enjoy bountiful scope offer emerge market company fact be benefit develop country incremental investment health care system baxter have growth score zack rank company have impressive long term expect growth rate higher industry varian medical system inc var free report second quarter fiscal varian medical global market share growth be drive order base share gain emea fact varian medical be award contract truebeam system stockholm sweden further company sign agreement acquire australia base sirtex focuse interventional oncology therapy apart varian medical have recently announce open new facility jundiaí brazil extend global manufacturing training footprint region varian medical have business greater china company huge global base outside country shield severe damage occur result trade restriction varian medical have growth score zack rank abiom inc abmd free report just baxter have strong international foothold abiom do not have significant presence china fourth quarter fiscal germany japan witness strong adoption exclusive impella product line germany revenue grow fourth quarter fiscal japan abiom exceed expectation expect add revenue fiscal abiom have growth score zack rank more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1152,MDT,hormel food corporation hrl free report share decline report fiscal second quarter adjust earning share miss zack consensus estimate shareshare medtronic plc mdt free report surge report fiscal fourth quarter adjust earning share beating zack consensus estimate sharemckesson corporation mck free report share fall report fourth quarter fiscal earning share miss zack consensus estimate shareshare william sonoma inc wsm free report increase report first quarter fiscal adjust earning share surpass zack consensus estimate share
1153,MDT,medtronic plc mdt free report report fourth quarter fiscal adjust earning share ep beating zack consensus estimate adjust earning rise year year adjustment quarter primarily include impact restructure charge intangible asset amortization debt redemption premium acquisition related item adjust foreign exchange tailwind cent adjust ep be adjustment company report net earning share compare cent previous year full year adjust ep come improvement year number also exceed zack consensus estimate share total revenue report quarter gross organic basis report basis top line surpass zack consensus estimate organic revenue quarter include adjustment divestiture patient care deep vein thrombosis compression nutritional insufficiency business cardinal health positive impact foreign currency fiscal worldwide revenue be organic basis report basis also remain ahead zack consensus estimate quarter review sale total revenue fall year year adjust divestiture develop market revenue totale total revenue reflect increase organically report emerge market revenue total revenue amount organically report segment company currently generate revenue major group viz cardiac vascular group cvg minimally invasive therapy group mitg restorative therapy group rtg diabetes group cvg comprise cardiac rhythm heart failure crhf coronary structural heart csh aortic peripheral vascular division apv mitg now include surgical innovation si respiratory renal rgr division divestiture patient care deep vein thrombosis compression nutritional insufficiency enteral fee business rtg comprise spine brain therapy specialty therapy pain therapy segment diabetes group incorporate intensive insulin management iim intensive diabetes therapy ndt diabetes service solution dss division cvg revenue improve constant exchange rate cer report drive strong low teen growth csh mid single digit growth apv low single digit growth crhf cer crhf sale totale year year cer report come back low single digit growth arrhythmia management apart double digit growth af solution mechanical circulatory support tyrx infection control also contribute growth csh revenue be cer report back low constant currency growth transcatheter aortic valf result strong global uptake corevalve evolut pro platform moreover continue uptake resolute onyx drug eluting stent unite state japan revive coronary business apv revenue register growth cer report drive low single digit growth aortic peripheral mid teen growth endovenous medtronic plc price consensus ep surprise medtronic plc price consensus ep surprise medtronic plc quotein mitg worldwide sale reach mark year year increase cer report basis high single digit growth si low single digit growth rgr comparable cer basis rtg worldwide revenue be year year cer report low double digit growth brain therapy pain therapy mid single digit growth specialty therapy low single digit growth spine business moreover revenue diabetes group increase cer report marginsgross margin report quarter expand basis point bps rise gross profit adjust operate margin contract bps year year owing rise research development expense uptick selling general administrative expense other expense report quarter totale compare year quarter company have provide fiscal earning revenue guidance full year organic revenue growth be expect be range currency fluctuation be expect negatively impact top line current zack consensus estimate revenue be peg fiscal adjust ep be expect range growth year number mid point range assume cent benefit foreign exchange zack consensus estimate share fall upper end guide range takemedtronic exit fiscal solid note better expect fourth quarter performance company demonstrated improve segmental performance cer growth business segment however escalate cost continue be concern moreover major business group contribute solid top line growth cer highlighted sustainability group region addition display successful integration achievement synergy target be also encourage company solid growth trend unite state well healthy global acceptance advanced therapy apart product innovation company be focuse geographical diversification business zack rank peer have zack rank hold few better rank stock report solid result earning season be abiom inc abmd free report baxter international inc bax free report quest diagnostic inc dgx free report abiom sport zack rank strong buy baxter quest diagnostic carry zack rank buy see complete list today zack rank stock here abiom report fourth quarter fiscal earning share cent huge improvement year quarter revenue rise baxter post first quarter adjust earning share cent improvement year quarter figure cent revenue quarter rise year year basis constant exchange rate quest diagnostic report first quarter adjust ep year number revenue moved year year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
1154,MDT,be medical practitioner yes then be aware dublin ireland base world lead medical technology giant medtronic plc mdt free report have global reach extend more country last year more person benefit medtronic medical therapy treat cardiac vascular disease diabetes neurological musculoskeletal condition currently medtronic have zack rank hold change follow positive fourth quarter fiscal earning report have just release see complete list today zack rank strong buy stock here have highlighted key detail just release announcement medtronic plc price ep surprise medtronic plc price ep surprise medtronic plc quoteearning current zack consensus estimate stand share medtronic adjust earning share exceed estimate revenue medtronic post revenue beating zack consensus estimate revenue key stat revenue medtronic cardiac vascular group rise constant exchange rate cer revenue minimally invasive therapy group decline cer revenue restorative therapy group rise cer revenue diabetes group rise cer major factor management fourth quarter performance be encourage moreover company witness growth business segment also buoy optimism stock price follow earning release share price do not show movement pre market trading session check back later full medtronic earning report later wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
1155,MDT,late medtronic plc mdt free report spine business have be register soft performance due challenge market scenario let see be possibility rebound time company be schedule report fourth quarter fiscal result open bell click here know company overall performance be likely be spine glancein last report quarter medtronic spine division be flat year year mid single digit growth bmp bone morphogenetic protein cer low single digit decline core spine hampered overall sale however company note growth be sluggish be line global spine market management combination advanced technology imaging navigation power instrument nerve monitoring have spur growth division company have also start demonstrate positive outcome related distribution relationship mazor robotic medtronic plc price ep surprise medtronic plc price ep surprise medtronic plc begin fiscal medtronic be suffering significant pricing pressure business offset strong procedural growth company believe price reduction basically stem consolidation hospital company state hospital be get more sophisticated buy pattern be consolidate vendor base result price decline medtronic expect competitive pricing pressure reduce next couple quarters lead net procedural growth company however look company outlook be uncertain term recovery company earlier note spine broader restorative therapy group rtg segment growth be mar impact slower spine market soon be report quarter zack rank stock currently carry zack rank hold few better rank stock broader medical sector be intuitive surgical isrg free report illumina inc ilmn free report amedisys inc am free report intuitive surgical illumina sport zack rank strong buy amedisys carry zack rank buy see complete list today zack rank stock here intuitive surgical have long term expect earning growth rate illumina have long term expect earning growth rate amedisys have long term expect earning growth rate hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
1156,MDT,medtronic plc mdt free report diabetes group have be solid growth trajectory late encourage contribution majority sub segment expect strength reflect fourth quarter fiscal result be schedule release open bell click here know company overall performance be likely be diabetes focusmedtronic diabetes group presently comprise intensive insulin management iim intensive diabetes therapy ndt diabetes service solution dss division diabetes segment develop manufacture market advanced integrate diabetes management solution include insulin pump therapy continuous glucose monitoring cgm system therapy management software note management expect double digit revenue growth diabetes group fourth quarter fiscal management consistently strong adoption minime system unite state enhance sensor supply capacity drive upside consequently zack consensus estimate diabetes group revenue indicate rise year quarter also estimate diabetes group revenue unite state reflect rise year medtronic plc price ep surprise medtronic plc price ep surprise medtronic plc quote last report quarter segment record improvement sale benefit increase uptake new sensor augment insulin pump system unite state well international market enhance production capacity same notably minime system have serve patient unite state apart management be optimistic uptick consumable revenue corporation johnson johnson diabetes care company user third quarter fiscal moreover have state company be progress well transition user expect trend continue yet be report quarter well fourth quarter fiscal medtronic proceed initiative boost performance minime portfolio february company expand product portfolio addition minime advance infusion set latest offer diabetes business be plan be make commercially available canada hong kong certain country europe fourth quarter fiscal same month company announce fda have approve new arm indication guardian sensor continuous glucose monitor cgm used minime insulin pump notably guardian sensor be company latest most accurate cgm medtronic be only sensor have receive fda nod control automate insulin delivery hybrid close loop system minime new arm indication guardian sensor offer more convenience flexibility patient be available unite state use minime system believe development be beneficial company diabetes group portfolio get reflect yet be report quarter result let see thing be shape sub segment fourth quarter release iim revenue rise high teen cer third quarter fiscal however company witness growth new patient count unite state growth be lead solid uptake minime system unite state guardian sensor cgm addition division deliver low digit constant currency growth international market account continue strength minime system give development regard minime system expect top line contribution continue uptake product rise get reflect soon be report quarter result dss grow mid single digit cer consumable benefit rise install base enhance patient utilization improvement business be expect continue zack rank stock currently carry zack rank hold few better rank stock broader medical sector be intuitive surgical isrg free report illumina inc ilmn free report amedisys inc am free report intuitive surgical illumina sport zack rank strong buy amedisys carry zack rank buy see complete list today zack rank stock here intuitive surgical have long term expect earning growth rate illumina have long term expect earning growth rate amedisys have long term expect earning growth rate hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
1157,MDT,quality system inc qsii free report fourth quarter fiscal earning be schedule release lucrative prospect revenue cycle management rcm service solid recur revenue base high demand nextgen solution be expect drive company top line quarter be report notably quality system pull positive average earning surprise trail quarters last report quarter company deliver adjust earning cent share line zack consensus estimate however adjust earning decline year year basis revenue totale quarter marginally beat zack consensus estimate revenue increase year year quarter be report zack consensus estimate revenue be peg reflect year year decline same earning be peg cent show year year fall quality system inc price ep surprise quality system inc price ep surprise quality system inc quote let delve deeper factor playlucrative prospect rcm spacequality system be major player rcm market company nextgen rcm platform continue contract healthcare provider company be also increase headcount boost rcm adoption nextgen healthcare score highest ambulatory vendor performance follow key rcm area effectiveness claim process patient face support performance efficiency gain customer sustainability pricing trust business partner base popularity rcm solution company plan expand dental hospital market further boost thetopline quarter be report fact base exclusivity quality system solution company announce several platform receive certify status hitrust march hitrust csf certification provide organization certain platform safeguard sensitive datum comprehensive flexible framework security protocol be likely boost company fourth quarter bottom line solid demand nextgen solutionsapart rcm quality system continue benefit strong demand other nextgen solution include hospital ehr practice management fourth quarter nextgen inpatient clinical lab patient portal ehr solution have also be gain considerable traction latest deal platform eagledream entrada look promising fact nextgen healthcare unveil new corporate logo brand identityin march new logo be perfect representation quality system recent acquisition provide company competitive edge medtech space recur revenue recur revenue base have be growth catalyst quality system offset decline perpetual license related service solid expansion recur base be likely boost company upcoming quarterly result meanwhile peek last report quarter reveal subscription base recur revenue account total revenue fact recur revenue grow year year do model predict proven zack model company favorable zack rank strong buy buy hold have good chance beating estimate also have positive earning esp quality system have zack rank earning esp combination suggest company be likely beat earning estimate yet be report quarter uncover best stock buy sell re report earning esp filter conversely caution sell rate stock go earning announcement especially company be see negative estimate revision other stock worth lookhere be few other stock worth consider also have right combination element post earning beat quarter be report brady corporation brc free report have earning esp zack rank see complete list today zack rank stock here medtronic mdt free report have earning esp zack rank dxc technology company dxc free report have earning esp zack rank hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
1158,MDT,medtronic plc mdt free report restorative therapiesgroup rtg have be strong growth trajectory late encourage contribution majority sub segment expect strength reflect fourth quarter fiscal result be schedule release open bell click here know company overall performance be expect be rtg focusmedtronic rtg presently comprise spine brain therapy specialty therapy pain therapy division note management expect revenue growth rtg business fourth quarter fiscal management guidance balance ongoing strength pain brain therapy segment adverse impact weaken spine market consequently rtg zack consensus estimate revenue indicate rise year quarter medtronic plc price ep surprise medtronic plc price ep surprise medtronic plc quotein last report quarter segment record improvement sale drive low double digit growth brain therapy mid single digit growth specialty therapy high single digit growth pain therapy cer however revenue spine business remain flat cer year year basis let see thing be shape sub segment fourth quarter result brain therapy brain therapy now include neurovascular neurosurgery business company have be witness major development neurovascular business receive solid contribution stroke portfolio last report quarter medtronic announce receipt fda approval riptide aspiration system january add valuable tool company acute ischemic stroke ais product portfolio benefit get reflect yet be report quarter further april medtronic announce ce mark receipt launch visualase mri guide laser ablation system europe notably visualase system be used neurosurgery procedure provide advanced mri guide laser ablation technology development help company continue witness strength brain therapy business pain therapy pain therapy division now include pain spinal cord stimulation drug pump interventional spine business contribute encouragingly company top line third quarter fiscal pain therapy witness growth solid uptake intelli platform spinal cord stimulation well strength drug pump january company announce receipt fda approval new clinician programmer use synchrome ii intrathecal drug delivery system again april medtronic announce launch optisphere embolization sphere resorbable embolic platform develop embolization hypervascular tumor view company effort develop pain therapy division believe solid trend continue reflect be report quarter result well spine medtronic spine division include core spine bmp kanghui business last report quarter low single digit decline core spine be more offset mid single digit growth bmp cer management combination enable technology imaging navigation power instrument nerve monitoring mazor robotic spine implant have spur growth division expect encourage top line contribution business be report quarter zack rank stock currently carry zack rank hold few better rank stock broader medical sector be intuitive surgical isrg free report illumina inc ilmn free report amedisys inc am free report intuitive surgical illumina sport zack rank strong buy amedisys carry zack rank buy see complete list today zack rank stock here intuitive surgical have long term expect earning growth rate illumina have long term expect earning growth rate amedisys have long term expect earning growth rate look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
1159,MDT,jul issue update research report medtronic plc mdt free report be encourage company global accept advanced therapy escalate cost expense raise concern stock have zack rank hold past month share medtronic have outperformed industry stock have grow compare industry rise notably medtronic exit fiscal solid note better expect fourth quarter performance major business group contribute solid top line growth cer highlight sustainability group region addition display successful integration achievement synergy target also gradually stabilize cardiac rhythm heart failure crhf market buoy optimism stock receipt fda approval dbs deep brain stimulation therapy adjunctive treatment reduce partial onset seizure raise hope company target medical market medtronic be also focuse geographical diversification business company be highly positive foray standalone cgm continuous glucose monitoring market guardian connect be currently upbeat latest fda nod minime system patient type diabetes year age significantly medtronic new restructure initiative enterprise excellence plan be aim annual growth run rate saving end fiscal company new program have be design increase effectiveness growth related reinvestment ability provide consistent boost margin expansion well drive ep leverage flip side company have be expose steep cost expense weigh heavily margin also guidance remain conservative apprehension lackluster cardiac vascular group cvg minimally invasive therapy group mitg performance turn dampen investor confidence stock key picksa few better rank stock broader medical sector be genomic health ghdx free report align technology inc algn free report stryker corporation syk free report genomic health have expect earning growth rate quarter be report stock sport zack rank strong buy see complete list today zack rank stock here align technology have project long term earning growth rate zack rank buy stryker have estimate long term earning growth rate zack rank look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
1160,MDT,value investing be easily most popular way find great stock market environment wouldn want find stock be fly radar be compelling buy offer tantalize discount compare fair value way find company be look several key metric financial ratio many be crucial value stock selection process let put medtronic plc mdt free report stock equation find be good choice value oriented investor right now investor subscribe methodology look elsewhere top pick pe ratioa key metric value investor always look be price earning ratio pe short show much investor be willing pay dollar earning give stock be easily most popular financial ratio world best use pe ratio be compare stock current pe ratio ratio have be past compare average industry sector compare market whole front medtronic have trail month pe ratio see chart level actually compare pretty favorably market large pe stand focus long term pe trend medtronic current pe level put midpoint past year number have rise rapidly past few month further stock pe also compare favorably industry trail month pe ratio stand very least indicate stock be relatively undervalue right now compare peer also point medtronic have forward pe ratio price relative year earning just so be fair say slightly more value oriented path be ahead medtronic stock term too ratioanother key metric note be price sale ratio approach compare give stock price total sale lower read be generally consider better person metric more other value focuse one look sale something be far harder manipulate accounting trick earning right now medtronic have ratio higher average come right now however see chart be well high stock particular past few year anything mdt be lower end range time period metric suggest level undervalue trading least compare historical norm broad value outlookin aggregate medtronic currently have value score putt top stock cover look make medtronic solid choice value investor stock overall medtronic be good choice value investor be plenty other factor consider investing name particular be worth note company have growth score momentum score give mdt zack vgm score overarch fundamental grade read more zack style score here meanwhile company recent earning estimate have be downbeat current quarter have see estimate go higher past day compare lower full year estimate have see same time period have have just small impact consensus estimate current quarter consensus estimate have decrease past month full year estimate have inched lower see consensus estimate trend recent price action stock chart medtronic plc price consensus medtronic plc price consensus medtronic plc stock have zack rank hold be look line performance company term bottom linemedtronic be inspire choice value investor be hard beat incredible lineup statistic front however sluggish industry rank bottom more industry zack rank be hard get too excited company overall fact past year broader industry have clearly underperform market large see so value investor want estimate analyst sentiment turn name first once happen stock be compelling pick make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
1161,MDT,medtronic plc mdt free report be schedule report fourth quarter fiscal result open bell last report quarter company deliver earning ahead zack consensus estimate fact medtronic bottom line outpaced estimate trail quarters average beat let see thing be shape prior announcement key catalystswe look forward quarter solid growth company successful execution growth strategy such therapy innovation globalization increase medtronic economic value combine demographic age population positive have start open opportunity medtronic further get reflect fiscal fourth quarter well medtronic plc price ep surprise medtronic plc price ep surprise medtronic plc quote space therapy innovation be filled multiple development cardiac vascular group cvg new therapy be help company gain traction rapidly grow medtech market left ventricular assist device lvad transcatheter aortic valve replacement tavr drug coat balloon atrial fibrillation ablation insertable diagnostic be report quarter medtronic be expect have maintain market share core pace icd implantable cardioverter defibrillator crt cardiac therapy product line scope crhf cardiac rhythm heart failure create new meaningful market enhance company weight average market growth tavr space company hope see continue global growth strong adoption evolut pro valve world well expansion traditional tavr center share capture result medtronic new intermediate risk indication several quarters dull drug eluting stent de performance coronary company de product line witness growth unite state japan last few quarters upside be drive recent launch resolute onyx say market further development buoy optimism strengthen belief strong quarterly performance company notably follow fda approval february medtronic announce launch resolute onyx mm de smallest size de market expect contribute company de business yet be report quarter zack consensus estimate cvg revenue fiscal fourth quarter be peg higher year number minimally invasive therapy group mitg surgical innovation register sturdy growth drive new product advanced stapling advanced energy advanced stapling growth come back endo stapling specialty reload tri staple technology well signia advanced energy growth bank consistent rollout company ligasure instrument valleylab ft energy platform medtronic currently remain confident ability grow mitg mid single digit longer term restorative therapy group rtg company witness encourage development regard brain therapy space division experience growth fiscal third quarter drive high teen growth neurovascular strong sale stealthstation navigation well arm imaging technology further lead low double digit growth neurosurgery expect bullish trend continue last complete quarter well pain company await positive customer uptake intelli platform evolved zack consensus estimate rtg revenue soon be report quarter stand year report figure here quantitative model predict proven zack model company favorable zack rank strong buy buy hold have good chance beating estimate also have positive earning esp medtronic have zack rank increase predictive power esp earning esp raise confidence positive surprise together combination suggest company be likely beat earning period be report uncover best stock buy sell re report earning esp filter conversely caution sell rate stock go earning announcement especially company be see negative estimate revision other stock considerhere be other stock worth consider same space proven model show too have right combination element surpass estimate upcoming release best buy co inc bby free report have earning esp zack rank see complete list today zack rank stock here dxc technology company dxc free report have earning esp zack rank brady corporation brc free report have earning esp be zack rank player more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1162,MDT,veeva system inc veev free report first quarter fiscal earning be schedule release grow demand cloud base vault application new product launch industry focuse approach international expansion be expect drive company top line result be likely reflect growth core subscription service segment other initiative also drive earning notably veeva system pull positive average earning surprise trail quarters last report quarter veeva system deliver adjust earning cent share bottom line beat zack consensus estimate couple cent improve year quarter figure total revenue be quarter year year moreover top line beat zack consensus estimate strong growth subscription revenue segment drive metric quarter be report zack consensus estimate revenue be peg reflect year year growth same earning be pin cent show year year growth let delve deeper veeva system inc price ep surprise veeva system inc price ep surprise veeva system inc service drive subscription service segment be significant contributor veeva system revenue accounting net revenue last report quarter recently company strengthen recur part revenue mix significant growth subscription revenue moreover launch veeva vault veeva commercial cloud platform be encourage company thrive considerable strength crm platform zack consensus estimate subscription service revenue be peg reflect sequential growth figure reflect increase year year company subscription revenue growth estimate least fiscal buoy optimism fact flagship vault platform be expect drive subscription revenue last quarter veeva vault content management product add record number new customer fourth quarter subscription service revenue be year year upside be backed stronger expect booking quarter other factor playview quarter be report veeva system expect total revenue adjust operate income be expect range adjust earning be expect range cent veeva system provide fiscal outlook total revenue be estimate band adjust operate income be expect adjust earning share be project meanwhile zack consensus estimate fiscal revenue be peg fall provide range zack consensus estimate fiscal earning be project also fall give range professional service drive service unit be also likely drive quarterly result last report quarter professional service revenue rise almost zack consensus estimate professional service revenue be peg first quarter reflect improvement year year fact professional service have be grow mid high teen last year come quarters management expect mid high single digit growth segment veeva system commercial excellence integrate master datum compliant commercial content multichannel crm collaboration sponsor cro site provide competitive edge medtech space industry specific focusveeva system industry specific focus give significant leverage view company knowledge base different component life science industry be help build target product product veeva opendata provide customer datum healthcare professional hcp healthcare organization hco affiliation life science major market do model predict quantitative model do not show beat veeva system earning season be stock need have positive earning zack rank strong buy buy hold be able beat estimate earning esp earning esp veeva system be uncover best stock buy sell re report earning esp filter zack rank veeva system carry zack rank stock worth lookhere be few stock worth consider have right combination element post earning beat quarter brady corporation brc free report have earning esp zack rank see complete list today zack rank stock here quality system qsii free report have earning esp zack rank medtronic mdt free report have earning esp zack rank more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1163,MDT,unite state have hit rough water late few analyst label trouble self invite other foresee revolution rise trade war tension unite state china be show sign abatement issue have escalate point imposition tariff retaliatory tariff go side moreover president trump mull restriction chinese company come investing tech firm avert technology export be likely worsen scenario wasn enough unite state be urge country stop import oil iran november raise supply related trump decision impose tariff steel aluminum import china european union mexico canada threat higher tariff import car auto part have raise concern medtech stable groundin wake such rocky scenario investor be consistently lookout safer sector tailwind favorable consumer behavior grow demand liquid biopsy test defer implementation industry wide medical device tax back sector medical device space seem be safer territory emergo medical device industry be likely be worth minimally invasive surgical device market hog investor try pick sub industry boom prospect minimally invasive surgical device market be final stop reduce stay hospital lower healthcare cost pain scare tissue damage be certain benefit opt minimally invasive surgery traditional process persistence market research estimate global minimally invasive surgical device market value cagr report mordor intelligence minimally invasive surgery device market be project see cagr factor drive marketthe minimally invasive surgical device market be largely dependent age population census bureau report person age more be likely total almost double estimate population datum also show median age be increase most area country global scenario be pretty similar strengthen emerge market have be contribute largely rise demand minimally invasive surgical device geographically market be divide north america europe latin america asia pacific middle east africa wise guy report demand minimally invasive surgical device be solid asia pacific region expect cagr be grow dominance ai application healthcare technological revolution new avenue opportunity minimally invasive surgical device space robot assist surgery be vogue context first generation surgical robot be be install number operate room globally stock watch forwe have picked company believe help tap boom prospect minimally invasive surgical device market intuitive surgical inc isrg free report zack rank hold company design manufacture market da vinci surgical system advanced robot assist surgical platform mechatronic base platform enable minimally invasive surgery help avoid trauma associate open surgery see complete list today zack rank stock here company plan expand usage da vinci general thoracic surgery colorectal surgery hernia repair day come intuitive surgical have expect earning growth rate current year past month intuitive surgical have outperformed industry stock have gain industry fall medtronic plc mdt free report zack rank company have minimally invasive therapy group formerly refer covidien group follow completion covidien acquisition segment company offer ablation system acute care ventilation system brain capnography monitoring system host other product medtronic have expect earning growth rate current year stock have deliver positive earning surprise trail quarters average beat be past month medtronic have outperformed industry stock have rise compare industry nuvasive inc nuva free report zack rank company lead global medical device spine market focuse develop minimally disruptive surgical product procedurally integrate solution spine company principal product include minimally disruptive surgical platform call maximum access surgery mas recent past company have launch xlif crestline lateral alif lateral mis fixation nuvasive have expect earning growth rate current year past month nuvasive have outperformed industry stock have gain compare industry medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
1164,MDT,medtronic plc mdt free report continue hit headline steady strategic development recently company catch investor attention receipt expand clearance company kyphon hv bone cement fixation pathological fracture sacral vertebral body new breakthrough be expect expand company interventional pain therapy business broader restorative therapy group rtg medtronic fixation be do used sacral vertebroplasty sacroplasty expand indication company be able broaden commitment treatment pathological fracture vertebral body cause osteoporosis cancer benign lesion company claim advancement offer clinician more option cure patient sacral insufficiency fracture sif notably sif be common cause debilitating back pain american journal neuroradiology anjr sif be frequent yet often unsuspected reason low back pain elderly patient very recently sacroplasty emerge alternative therapy treatment sif accord anjr prospective study case report suggest be safe effective remedy medtronic sif show symptom lumbar spine pathology go study more third sif patient fail associate pain traumatic event evidently be often be prescribe conservative treatment option include physical therapy prolong bed rest be highly expensive choice induce loss productivity healthcare system also patient put bed rest be rise risk pulmonary embolism dvt well further muscle atrophy bone loss meanwhile sif patient treat sacroplasty experience immediate pain relief allow resume daily activity physical therapy suffering pain physical limitation more encouragingly procedure sacroplasty hv cement be pretty simple owing minimally invasive procedure therapy be perform outpatient set demographic change sifgoing report publish national center biotechnology information ncbi epidemiologic change first second world country inevitably lead constant increase grey populace also unite nation datum global age population age year come more double figure register strength senior citizen be worldwide number be again expect grow twice dense be project reach nearly therefore detection sif elderly adult be markedly gain prominence huge prospect treatment market hence believe medtronic latest innovation space be well time strategic price performance medtronic have outperformed industry month time stock have gain compare industry rise key picksmedtronic currently carry zack rank hold better rank stock broader medical space be genomic health ghdx free report abiom abmd free report stryker corp syk free report genomic health have expect earning growth rate second quarter stock sport zack rank strong buy see complete list today zack rank stock here abiom have project long term earning growth rate zack rank stryker have project long term earning growth rate stock carry zack rank buy hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
1165,MDT,medtronic plc mdt free report recently announce initiation clinical study bifurcation cohort evaluate efficiency safety standard drug eluting stent de treat bifurcation lesion study bifurcation cohort part resolute onyx post approval study cover patient bifurcation lesion site unite state europe be enrolling patient suffering coronary artery disease cad receive resolute onyx de diameter size vary mm notably resolute onyx de be not approve treat bifurcation lesion unite state further primary endpoint study be target vessel failure month medtronic datum study be submit fda expand indication approval include bifurcation lesion resolute onyx de further company state bifurcation lesion be responsible percutaneous coronary intervention thus believe positive datum provide impetus company effort achieve expand fda approval resolute onyx de accelerate business growth csh be consistently try enhance coronary structural heart csh segment be part cardiac vascular group cvg segment csh revenue third quarter fiscal be cer report low constant currency growth transcatheter aortic valf result strong customer uptake corevalve evolut pro platform expand fda approval include patient intermediate risk moreover continue uptake resolute onyx drug eluting stent unite state japan revive business encouragingly note medtronic recently receive fda nod launch resolute onyx mm drug eluting stent stent be smallest size market presently resolute onyx de be available use size unite state europe country recognize ce mark market strategy gain traction csh segment seem be align datum provide transparency market research report global coronary stent market be expect see cagr more specifically de market coronary stent market be expand fast be estimate witness cagr period market be likely expand unite state asia pacific europe well rest world stock performance past month medtronic have outperformed industry gain compare industry zack rank key picksmedtronic currently carry zack rank hold few better rank stock broader medical sector be intuitive surgical isrg free report illumina inc ilmn free report cooper company inc coo free report intuitive surgical illumina sport zack rank strong buy cooper company carry zack rank buy see complete list today zack rank stock here intuitive surgical have long term expect earning growth rate illumina have long term expect earning growth rate cooper company have long term expect earning growth rate make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
1166,MDT,medtronic plc mdt free report recently announce fda approval minime system patient type diabetes year age notably approval be base positive datum home pediatric study study multus center study have enrolled participant year age group trial have week run phase study period month notably participant choose continue used system continue access program study result also demonstrated datum pivotal trial minime system patient age year minime glancepost receipt fda approval medtronic have commercially launch minime june be hybrid close loop hcl insulin delivery system type diabetic patient minime system feature medtronic latest guardian sensor glucose sensor increase accuracy enhance performance be only fda approve sensor control hybrid close loop system include diagnostic technology continuously check sensor health system also have medtronic most advanced algorithm smartguard hcl technology diabetes business focusmedtronic be consistently try enhance diabetes business company see rise constant exchange rate diabetes business revenue fourth quarter fiscal company benefit solid uptake new sensor augment insulin pump system unite state international market increase production capacity same recently company announce receipt fda approval guardian connect continuous glucose monitoring cgm system diabetes patient age year notably system be schedule be make available first quarter fiscal july company also announce fda have approve new arm indication guardian sensor continuous glucose monitor cgm be used minime insulin pump notably medtronic expect double digit growth segment fourth quarter fiscal courtesy consistent performance minime system unite state enhance sensor supply capacity additionally medtronic have be gear international introduction minime launch new professional cgm ipro market potentialan agee population unhealthy lifestyle rise awareness higher expenditure healthcare be likely drive highly competitive diabetes market report mordor intelligence global market diabetes care device be project reach value cagr consider bullish market sentiment believe latest development have be strategic share price have be gain investor confidence consistently positive result past month company share price have outperformed industry stock have gain comparison industry increase zack rank key picksmedtronic carry zack rank hold better rank stock broader medical space be genomic health ghdx free report abiom abmd free report stryker corp syk free report genomic health have expect earning growth rate current quarter stock sport zack rank strong buy see complete list today zack rank stock here abiom have project long term earning growth rate zack rank stryker have project long term earning growth rate stock carry zack rank buy hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
1167,MDT,several tailwind gradually flow opportunity be grow enormously medical device space sector be currently enjoy investment world attention investor be putt effort pick subindustry be beam prospect name pop first be cardiovascular device market world health organization cardiovascular disease be disorder heart blood vessel include coronary heart disease cerebrovascular disease rheumatic heart disease other condition go latest heart disease stroke statistic report american heart association adult be live form cardiovascular disease effect stroke further cardiovascular disease have be deem be major cause death person unite state notably be gradually take shape deadly epidemic globally scenario be quite intriguing report cardiovascular disease be major cause global death take life person notably projection related disease hint continuation present trend regard number death globally due cardiovascular disease be expect increase more moreover total direct expenditure related cardiovascular disease be expect rise go say rise incidence cardiovascular disease globally have open opportunity cardiovascular device maker market be expect witness cagr reach report visiongain accordingly investor be keen effectively put money longer term gain cardiovascular device market undoubtedly hold immense potential factor drive cardiovascular device marketrising healthcare expenditure unhealthy lifestyle practice expand treatment option have be drive demand center medicare medicaid service report publish advisory board healthcare spending be project rise represent gdp base assumption affordable care act continue cardiovascular device market be largely dependent age population census bureau report person age more be likely total almost double estimate population datum also show median age be increase most area country global scenario be pretty similar strengthen emerge market have be contribute largely rise demand cardiovascular device article lead market intelligence firm life science intelligence demand cardiovascular device have be grow solid double digit rate many emerge country include bric nation brazil russia india china turkey late ai bring new eraaccord research firm techemergence ai be be broadly used follow category better management cardiovascular disease artificial intelligence be be apply automate atrial fibrillation process fall ecg monitoring category be also be used company accurately predict risk cardiovascular disease related impact finally company be also involved actively used ai platform improve accuracy patient scan detect cardiovascular disease be certain development deserve mention here lead digital health company analytic life be actively involved design machine learn algorithm detect coronary artery disease invasively radiation accelerate heart cardiotrack india base start recently introduce technology platform used hand hold device cloud storage artificial intelligence capture analyze signal specific heart condition stock watch forwe have select company believe tap promising prospect cardiovascular device market boston scientific corporation bsx free report zack rank buy company have cardiovascular cardiac rhythm management crm reportable segment cardiovascular include interventional cardiology peripheral intervention business company be lead player interventional cardiology market coronary stent product offering see complete list today zack rank strong buy stock here company also market balloon catheter rotational atherectomy system guide wire guide catheter embolic protection device diagnostic catheter well intravascular ultrasound imaging system crm segment company deal implantable device monitor heart deliver electricity treat cardiac abnormality boston scientific project earning growth rate current year be stock deliver positive earning surprise trail quarters average beat past month boston scientific outperformed industry stock have improve compare industry gain period medtronic plc mdt free report zack rank hold company have cardiac vascular group cvg reportable segment cvg comprise cardiac rhythm heart failure crhf coronary structural heart csh aortic peripheral vascular division apv crhf division develop manufacture commercialize product diagnosis treatment management heart rhythm disorder heart failure apv division offer comprehensive portfolio product therapy treat aortic disease such aneurysm dissection transection well peripheral vascular disease critical limb ischemia further csh division offer therapy treat coronary artery disease heart valve disorder medtronic have expect earning growth rate current year stock have deliver positive earning surprise trail quarters average beat past month medtronic outperformed industry stock have improve compare industry gain period abbott laboratory free report zack rank company have cardiovascular neuromodulation business broader medical device segment company offer wide range rhythm management heart failure vascular structural heart device treatment cardiovascular disease well neuromodulation device management chronic pain movement disorder product be manufacture market distribute globally heart failure related product include heartmate left ventricular device family vascular product include xience family drug eluting coronary stent system develop multus link vision platform rhythm management product include assurity mri endurity mri pacemaker system be prominent product offer company abbott have expect earning growth rate current year stock have deliver positive earning surprise trail quarters average beat past month abbott outperformed industry stock have improve compare industry gain period conclusiona say strike iron be hot be opportune time cash bountiful opportunity rapidly grow cardiovascular device market make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
1168,MDT,mckesson corporation mck free report fourth quarter fiscal earning be schedule release market open result be likely show growth core distribution solution segment other initiative also drive earning mckesson fiscal third quarter performance be promising adjust earning share beating zack consensus estimate earning also rise year quarter revenue last report quarter come surpass zack consensus estimate increase year year basis zack consensus estimate fourth quarter revenue be peg reflect year year growth same earning be pin show year year growth notably mckesson have positive average earning surprise trail quarters let delve deeper distribution solution drive revenuesthis segment be mckesson key segment engage distribution brand generic pharmaceutical drug other healthcare related product last report quarter segment be sole contributor company worldwide revenue overall sale segment improve constant currency cc basis mckesson corporation price ep surprise mckesson corporation price ep surprise mckesson corporation quarter be report zack consensus estimate segment revenue be peg reflect rise prior year quarter fiscal third quarter revenue north america pharmaceutical distribution service totale cc zack consensus estimate sub segment be peg year quarter zack consensus estimate international pharmaceutical distribution service be pin year year last report quarter sub segment post revenue cc management upside be drive acquisition market growth other factor considerview solidmckesson strong earning guidance fiscal instill investor confidence stock management adjust earning share be expect indicate year year growth outlook be expect primarily benefit lower adjust tax rate improve operational performance furthermore company provide fiscal outlook have set preliminary target adjust earning share range zack consensus estimate fiscal earning be pin be give range new growth company recently prioritize investment expand supply chain service pharmaceutical medical supply manufacturer other area focus include enhance solution rapidly grow specialty pharmaceutical market new offering strengthen expand role retail pharmacy patient care delivery strategic recently acquire kentucky base rxcrossroad be likely expand improve company service reimbursement access health pharmacy solution further compliment company offering include plasma logistic specialize field support company also aim strengthen commerce capability retail pharmacy customer recent acquisition canada base well do model predict quantitative model show beat mckesson earning season be stock need have positive earning esp zack rank strong buy buy hold be able beat estimate zack esp earning esp mckesson be uncover best stock buy sell re report earning esp filter zack rank mckesson carry zack rank stock worth lookhere be few stock worth consider have right combination element post earning beat quarter brady corporation brc free report have earning esp zack rank see complete list today zack rank stock here quality system qsii free report have earning esp zack rank medtronic mdt free report have earning esp zack rank today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
1169,MDT,medtronic plc mdt free report have make encourage move respect aortic peripheral vascular apv business company recently announce receipt fda approval mm mm length pact admiral drug coat balloon dcb treat long superficial femoral artery sfa lesion patient peripheral artery disease pad company april medtronic receive approval treat sfa lesion mm length back support clinical datum complex lesion imaging cohort pact global study also cover long lesion stent restenosis chronic total occlusion group lesion length mm note pact admiral dcb receive fda approval december treat superficial femoral popliteal artery moreover be commercially available europe receipt ce mark approval so far more pad patient europe have be treat device glimpse apv medtronic revenue apv division improve year year constant exchange rate fourth quarter fiscal moreover peripheral vascular business grow low single digit latest development boost company performance segment market strategy gain traction peripheral vascular sub segment seem be align datum provide report interventional cardiology peripheral vascular device market be expect see cagr reach value believe high incidence peripheral artery disease due unhealthy lifestyle age population penetration company untapped market rise need minimally invasive angioplasty procedure technological advancement increase awareness person continue drive global acceptance technology view encourage factor believe company development regard pact admiral dcb be strategic be expect broaden customer base share price past month medtronic have be underperform broader industry stock have gain comparison industry increase nevertheless believe latest fda approval boost investor confidence stock zack rank key picksmedtronic currently carry zack rank hold few better rank stock broader medical sector be intuitive surgical isrg free report illumina inc ilmn free report amedisys inc am free report sporting zack rank strong buy see complete list today zack rank stock here intuitive surgical have expect long term earning growth rate illumina expect long term earning growth amedisys have expect long term earning growth rate today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
1170,MDT,suspension controversial medical device tax year medical device industry be currently ride high optimism advame medical device industry lobbying group strongly advocate relief note tax repeal provide huge impetus company channelize turnover strategic consolidation research development also help create new job opportunity accord article publish daily news tax go effect january save device company much year suspension medical device market be undergo substantial transformation age population longer expectancy life grow healthcare awareness emerge economy combine powerful long term tailwind include merger acquisition product innovation have be contribute growth sector boom continue be yet be see far benefit tax repeal have be redirect now meanwhile accord mark bonifacio president bonifacio consult service private equity strategic oem original equipment manufacturer buyer be compete asset sector medical contract manufacturing broaden portfolio investing new technology strongly state start be sluggish respect be due uncertainty change global healthcare market fate obamacare medical device tax now doubt be gradually get clear industry be once again head year significant activity year biggest deal seem be card wall street journal latest rumore news related mammoth medtech space boston scientific bsx stryker corporation syk free report report say rival consider bid consolidation analyst seem be optimistic rumore deal believe colossal merger medtronic mdt free report covidien abbott st jude medical last couple year boston scientific also need make mammoth move maintain foothold highly competitive medical technology space follow company consolidation st jude medical january abbott recently close acquisition alere successful wrap transaction combine company be anticipate emerge lead player point care diagnostic space mega consolidation recent time be medical device major becton dickinson co medical surgical diagnostic patient care device provider bard completion deal january becton dickinson be way expand new area vascular access segment piccs peripherally insert central catheter midline drug delivery port baxter international bax purchase thrombin topical preveleak surgical sealant specialty pharmaceutical company mallinckrodt plc mnk free report varian medical var free report also inked major deal company recently sign agreement acquire australia base global life science company sirtex medical limit total deal value investment strengthen company position interventional oncology therapy apart effort gain foothold emerge economy company recently acquire cooperative cl enterprise lead distributor radiotherapy equipment taiwan johnson johnson jnj free report subsidiary depuy synthe inked deal acquire medical enterprise distribution apart boston scientific announce several strategic acquisition include nxthera nvision urology pelvic health emcision endoscopy securus ep millipede structural heart inorganic expansion plan bode well stock operational growth divestment medical device major continue offload core business line asset be similar one acquire merger focus main segment divesture have be mandate federal trade commission ftc other international trust regulator restrict chance monopoly market earlier month johnson johnson get offer fortive corporation sell subsidiary ethicon inc advanced sterilization product business unit fortive jnj accept proposal be step streamline business strategic roadmap better resource utilization higher shareholder return apart accord massdevice report medtronic recently divest stake lifetech scientific china everbright ltd unnamed investor bd also divest soft tissue core needle biopsy line aspira product line merit medical divestment be related acquisition bard april henry schein hsic announce decision spin company major segment global animal health business believe initiative remain part henry schein strategic plan focus more dental medical business accord company transaction enable make most opportunity dental space order deliver quality clinical care advanced wellness prevention apprehend china drug distribution reform slow company growth region accord reuter report cardinal health sell china business shanghai pharmaceutical hold follow announcement major buyout abbott divest eye care business abbott medical optic amo johnson johnson streamline newly add business line marketer aesthetic treatment system cynosure sell hologic notably hologic acquire outstanding cynosure share approximately emerge market healthcare scenario bright survey report gallup analytic last july reveal adult cite healthcare second major problem face country new presidential administration follow new healthcare reform announcement december gallup poll reveal past decade marked biggest increase uninsured rate meanwhile explode population rise middle class increase governmental awareness health issue emerge geography be face huge demand modern cheaper healthcare option go report guardian international finance corp ifj datum show develop country account global death chronic disease indicate enormous market opportunity recent bcg report share emerge market be currently less quarter global medtech revenue be likely increase nearly third revenue medtech market china currently second largest world be project grow annually india fifth largest medtech market world currently record annual growth pace india emerge strong competitor japan germany give huge potential region long back johnson johnson have set manufacturing center brazil china india company emerge market medical device segment continue grow time faster develop market abbott continue lead emerge market investment trend sale region recent quarters sale key emerge market be double digit drive strength bric well strong growth several country latin america include colombia mexico peru argentina medtronic mdt free report fourth quarter fiscal business latin america middle east africa eastern europe china show sustain strength grow double digit overall medtronic long term outlook emerge market be encourage boston scientific emerge market business register growth first quarter reflect significant increase growth business china be once again remarkable year year key pick spacein medical instrument space be positive abiom inc abmd intuitive surgical inc isrg free report carry zack rank strong buy see complete list today zack rank stock here medical product stock baxter international surmodic inc srdx free report boston scientific orasure technology inc osur free report be also well poise zack rank buy weak linkswe advise investor stay away company offer little growth opportunity term include company estimate revision trend reflect bearish sentiment stock do not look inspiring moment be nephew plc snn tg therapeutic inc tgtx free report nxstage medical inc nxtm free report insys therapeutic inc insy free report carry zack rank sell orthofix international ofix free report eagle pharmaceutical inc egrx hold zack rank strong sell zack ipo watch listbefore look stock mentioned want get head start potential tech ipos be pop zack radar imagine be first wave investor jump company almost unlimited growth potential special report give current scoop go public time have drive valuation year other be little less obvious already show jaw drop growth download ipo watch list today free
1171,MDT,medtronic plc mdt free report brain therapy business get boost recent fda approval company latest deep brain stimulation dbs clinician programmer application approval have come close heel european ce mark approval same march notably dbs therapy be surgical procedure place medical device deliver electrical stimulation accurate lead location brain order reduce most disable motor symptom medtronic application design use samsung galaxy tab tablet incorporate input clinician globally therefore treatment be helpful streamline workflow enhance clinical programming experience company also claim program be useful provide support neurologist neurosurgeon treat parkinson dystonia patient used company dbs system therapy apart neurological disease medtronic dbs clinician programmer be also approve use medtronic dbs system treat medically refractory epilepsy therapy be launch later year unite state approximately medtronic device have be globally implanted so far needless say latest fda ce mark approval application immediately improve programming interaction be critical post implant care thousand patient programmer also enable upgrade rechargeable implantable neurostimulator service life year provide patient additional year next device replacement medtronic brain therapyin brain therapy medtronic be lead development endovascular therapy market treatment ischemic stroke result high teen growth neurovascular last report fourth quarter fiscal company also have great quarter neurosurgery low double digit growth highlight strong demand stealthstation navigation system mazor robotic guidance system visualase mri guide laser ablation system worldwide medtronic dbs therapy have already gain much popularity have win approval several place internationally include unite state europe cure disable symptom essential tremor parkinson disease company announce receipt health canada license suretune software dbs europe canada australia dbs therapy already own license treat refractory epilepsy transparency market research report global deep brain stimulation device market be estimate reach value worth cagr company clearly boast huge growth potential market share price performanceover past month share medtronic have outperformed industry belong stock have grow compare industry increase zack rank key picksmedtronic currently carry zack rank strong sell few better rank stock broader medical space be abiom inc abmd free report genomic health inc ghdx free report stryker corporation syk free report abiom have long term growth rate stock sport zack rank strong buy see complete list today zack rank stock here genomic health have expect growth rate zack rank stryker have project long term earning growth rate stock carry zack rank buy medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
1172,MDT,patterson company inc pdco free report fourth quarter fiscal result be expect release market open result be likely show decline core dental segment growth other segment be likely make extent third quarter fiscal be dismal adjust earning cent share decline year year moreover figure lag zack consensus estimate cent patterson record revenue also fall shy zack consensus estimate also revenue drop year quarter fourth quarter fiscal zack consensus estimate revenue be peg reflect year year decline same earning share be pin cent show year year decline notably patterson have negative average earning surprise trail quarters let delve deeper patterson company inc price ep surprise patterson company inc price ep surprise patterson company inc quotedental segment focusin last report quarter segment account total sale revenue segment come quarter constant currency cc revenue be mar change sale force disruption enterprise resource plan implementation expansion company digital equipment portfolio moreover quarter be report zack consensus estimate segment revenue be peg show decline year year basis dental consumable account total revenue last report quarter segment post revenue year year quarter be report zack consensus estimate sub segment revenue be pin prior year quarter meanwhile equipment software sub segment account total sale fiscal third quarter segment post revenue worth year furthermore quarter be report zack consensus estimate segment revenue be fix year year other factor playguidance downbeatfollow unsatisfactory fiscal third quarter patterson lower guidance fiscal company now expect adjust earning share range much lower previously issue band deal amortization expense cent share be expect fiscal moreover company estimate integration business restructure expense cent share erp loss exclusive distribution right dentsply sirona have force company shift new enterprise resource plan erp system efficiently manage inventory ongoing erp transition have proven be disruptive performance be likely challenge day ahead last report quarter erp issue have dent margin lead gross margin contraction basis point bps moreover dental segment sale be affected company expand digital equipment portfolio management company work capital continue be impact negatively implementation erp system company be also grapple certain legislative issue believe headwind mar patterson result quarter be report animal health segmentper management patterson core animal health segment face product mix related challenge last report quarter represent total sale furthermore sale rise cc year year basis zack consensus estimate segment fourth quarter revenue be peg sequentially management expect sequential upside sale animal health consumable be also expect see strong fourth quarter zack consensus estimate sub segment sale be pin sequentially do model predict quantitative model do not show beat patterson earning season be stock need have positive earning esp zack rank strong buy buy hold be able beat estimate zack esp earning esp patterson be uncover best stock buy sell re report earning esp filter zack rank patterson carry zack rank sell stock worth lookhere be few medical stock worth consider have right combination element post beat earning season quality system qsii free report have earning esp zack rank see complete list today zack rank stock here mckesson corporation mck free report have earning esp zack rank medtronic mdt free report have earning esp zack rank medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
1173,MDT,major setback company investor medtronic mdt free report recently foresee significant impact hurricane marium second quarter fiscal sale have acquire category status hurricane marium have be place top most intense atlantic hurricane record thus hit company business puerto rico quite hard add wo company have level manufacturing setup business group viz cardiac vascular group cvg minimally invasive therapy group mitg restorative therapy group rtg diabetes group puerto rico facility be gradually get operative oct site be only partially active present power supply back generator considerable repair do company expect normal manufacturing process get fully restore come week financial have provide statement company financial health badly hurt marium further affect overall business notably line business continuity protocol company be utilize exist inventory level increase manufacturing process location outside puerto rico multiple product medtronic project fiscal second quarter revenue adjust net earning show impact extent more specifically mitg rtg group be expect be worst hit notably quarter close oct significantly company forecast recur expense directly related recovery effort puerto rico be exclude adjust earning however expense related effect outside puerto rico be consider operate expense incidentally medtronic be lack enough visibility impact marium post second quarter however forecasting strong new product demand particularly cvg diabetes group company continue expect mid single digit revenue growth comparable constant currency basis second half fiscal marium related impact company reaffirm fiscal second quarter full year fiscal guidance company many support disaster management medtronic foundation have direct disaster relief date be match employee contribution authorize agency price performance last month medtronic have be observed underperform broader industry stock have decline versus broader industry gain period sad true gloomy scenario be likely continue company latest financial prediction due marium zack rank key picksmedtronic currently carry zack rank sell few better rank stock medical sector be orthofix international ofix free report thermo fisher scientific inc tmo free report idexx laboratory inc idxx free report orthofix international sport zack rank strong buy idexx laboratory thermo fisher carry zack rank buy see complete list today zack rank stock here orthofix international have long term expect earning growth rate stock have rally roughly last month thermo fisher have long term expect earning growth rate stock have gain last year idexx laboratory have long term expect earning growth rate stock have surge last year look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
1174,MDT,share mazor robotic mzor free report surge wednesday touch new time high now question investor be consider buy surgical robotic maker stock mazor robotic medical device focus robotic guidance technology help assist surgeon company have see stock price skyrocket share start year new time intraday trading high share alone scare away investor be worry be hard mazor robotic break new threshold soon let take look company do current fundamental see be stock investor consider company mazor robotic be young surgical robotic company market cap operate office orlando florida caesarea israel company currently make different piece robotic surgery equipment mazor renaissance product be design help innovate surgical technique spine surgery surgical assurance platform help surgeon maximize procedural predictability patient benefit larger trademark mazor feature workstation large touchscreen monitor serve guidance screen surgeon control panel robotic guidance system have surgical arm camera special tracking surgical control system company core focus be pre op analytic intra op guidance intra op verification allow surgeon review surgical plan brace surgical arm provide more control precision human concept be relatively simple surgeon operate workstation patient robotic component essentially perform physical act surgery patient mazor robotic product have catch investor eye already include medical device giant medtronic plc mdt free report medtronic purchase stake mazor robotic last year part deal allow medtronic distribute mazor system mazor robotic announce recently company further partnership medtronic total investment company climb current fundamental mazor robotic be currently zack rank buy grade growth momentum style score system many young experimental medical biotech company mazor robotic do not currently represent great value investor be still unprofitable company currently have price earning ratio have ratio ratio mazor robotic sale asset ratio fall just short industry average yet company look be solid growth trajectory current cash flow growth beating medical instrument industry average last week company stock price have climb top industry loss mazor robotic year date price change crush industry average well last day surgical robotic company have receive full year upward earning estimate revision well follow year mazor robotic earning be project pop current quarter base consensus estimate firm full year ep be expect fall post share loss yet company revenue be project skyrocket quarter year indicate early stage medical device company be clearly expand rapidly expansion have be costly bottom lineinvestor handle ebb flow often come young firm biotech medical device industry consider mazor robotic especially medtronic decide buy firm road hacker put money portfolio earlier month credit bureau equifax announce massive datum breach affect american cybersecurity industry be expand quickly response similar event stock be better investment other zack have just release cybersecurity investor guide help zack com reader make most year investment opportunity create hacker other threat reveal stock worth look right away download new report now
1175,MDT,be medical practitioner yes then be aware minnesota base world lead medical technology giant medtronic plc mdt free report have global reach extend roughly country last year more person benefit medtronic medical therapy treat cardiac vascular disease diabetes neurological musculoskeletal condition currently medtronic have zack rank sell change follow positive first quarter fiscal earning report have just release see complete list today zack rank strong buy stock here have highlighted key detail just release announcement earning current zack consensus estimate stand cent share medtronic adjust earning share exceed estimate medtronic plc price ep surprise medtronic plc price ep surprise medtronic plc quoterevenue medtronic post revenue miss zack consensus estimate revenue key stat revenue medtronic cardiac vascular group rise constant exchange rate cer revenue minimally invasive therapy group increase cer also revenue restorative therapy group rise cer revenue diabetes group decrease cer major factor management second quarter performance be encourage spite company face hurricane california wildfire manufacturing operation puerto rico be affected hurricane marium company deliver sequential acceleration organic revenue growth moreover company have reiterate full year revenue ep guidance stock price follow earning release share price do not show movement pre market trading session zack hide tradeswhile share many recommendation idea public certain move be hide everyone select member portfolio service peek curtain today view start now next month invite follow zack private buy sell real time value momentum stock etf option mover insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack secret trade
1176,MDT,nov issue update research report medical device major medtronic plc mdt free report stock carry zack rank sell company release second quarter fiscal earning result nov market depict bearish picture latest preliminary sale update medtronic past month share company have significantly underperform broader industry stock have decline versus broader industry gain preliminary result worldwide revenue quarter be expect dip year year dull revenue estimate quarter be report be mainly due company divestiture patient care deep vein thrombosis compression nutritional insufficiency business cardinal health begin quarter also preliminary report impact hurricane marium be approximately company second quarter top line hurricane left adverse impact roughly cent second quarter gaap earning share ep however year year drag preliminary sale be encourage note latest projection be actually improvement company earlier anticipation marium impact financial standing provide month back time medtronic have project fiscal second quarter revenue adjust net earning extent also believe aforementioned divestiture align company discipline portfolio management strategy company business do not fall medtronic core product line hence remain deprive require investment focus present divestment core profitable business help medtronic focus more core product turn also enable company invest long term high return internal external opportunity be more directly align company growth strategy therapy innovation globalization economic value stabilize trend global cardiac rhythm heart failure crhf market be upside be optimistic solid growth trend continue unite state well healthy global acceptance advanced therapy key picksa few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have surge roughly year align technology have long term expect earning growth rate stock have sky-rocket last year myriad genetic have long term expect earning growth rate stock have soar last year look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
1177,MDT,be medical practitioner yes then be aware minnesota base world lead medical technology giant medtronic plc mdt free report have global reach extend roughly country last year more person benefit medtronic medical therapy treat cardiac vascular disease diabetes neurological musculoskeletal condition currently medtronic have zack rank hold change follow positive first quarter fiscal earning report have just release see complete list today zack rank strong buy stock here have highlighted key detail just release announcement earning current zack consensus estimate stand share medtronic adjust earning share exceed estimate medtronic plc price ep surprise medtronic plc price ep surprise medtronic plc quoterevenue medtronic post revenue miss zack consensus estimate revenue key stat revenue medtronic cardiac vascular group rise constant exchange rate cer revenue minimally invasive therapy group increase cer other hand revenue restorative therapy group rise cer revenue diabetes group decrease cer major factor medtronic exit first quarter fiscal mixed note bottom line exceed zack consensus estimate top line miss same company year year top line performance be also impressive business group diabetes group witness decrease cer company reiterate fiscal year revenue earning share growth guidance stock price follow earning release share price decrease pre market trading session zack minute stock pick secretsince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar here something even more remarkable master proven system go single class seminar then apply portfolio little minute month learn secret
1178,MDT,share dynavax technology corp dvax free report jump food drug administration advisory committee announce safety datum hepatitis vaccine aid approvalshare scripps network interactive inc rise enter agreement discovery communication inc disca free report be buy cash stock amount sharemedtronic mdt free report complete sale part patient monitoring recovery division cardinal health cah free report cash deallabcorp lh free report enter agreement buy chiltren international limit whopping cash
1179,MDT,unite therapeutic corporation uthr free report report adjust earning share include stock base compensation benefit exclude charge second quarter be better share year quarter unite therapeutic say have set aside potential settlement department justice doj resolve investigation related contribution profit organization provide financial assistance patient thereby violate federal security law quarter company record charge estimate loss contingency relation matter also record impairment charge related cost method investment privately hold company experience event trigger impairment analysis include charge stock base compensation benefit company incur loss share miss zack consensus estimate revenue report quarter rise year year beat zack consensus estimate stronger sale pulmonary arterial hypertension pah franchise pull top line quarter better expect sale performance share decline almost thursday response potential settlement expense look unite therapeutic share price movement show stock have underperform industry year so far unite therapeutic stock have decline period industry rise quarter detailunite therapeutic market product treatment pah remodulin tyvaso adcirca orenitram orenitram report sale quarter year year adcirca sale be year year tyvaso sale totale year year remodulin sale be year year however sale tyvaso remodulin improve sequentially quarter unituxin treatment pediatric patient high risk neuroblastoma sale be year year lately growth unite therapeutic pah drug orenitram tyvaso remodulin have slow due competition last quarter company have say patient be stay longer front line oral ambition therapy adcirca gilead science inc gild free report letairis delay transition inhaled injectable therapy tyvaso remodulin thereby hurt demand meanwhile drug be also face strong competition actelion now part johnson johnson jnj free report new drug uptravi selexipag initial treatment pah be typically orally deliver drug follow prostacyclin therapy first quarter earning call management have say longer use oral therapy result large backlog patient eligible prostacyclin therapy pah medicine suggest sale trend improve sale tyvaso remodulin orenitram improve second quarter first quarter level management believe be see early sign transition ambition regimen back pah drug research development expense include stock base compensation benefit increase due higher cost support pipeline cardiopulmonary cancer drug develop organ manufacturing project selling general administrative sg expense include stock base compensation benefit decline lower consult marketing cost offset higher legal cost pipeline updateunited therapeutic be work medical device maker medtronic inc mdt free report get implantable pump deliver remodulin remosynch approve fda order launch remosynch unite therapeutic medtronic be pursue parallel regulatory filing related device drugwe remind investor april unite therapeutic announce regulatory issue delay plan launch remosynch company now expect launch remosynch sometime first half year expect previously unite therapeutic be also work deka development pre filled semi disposable pump system subcutaneous delivery remodulin remunity launch expect clinical study remopro pain free new chemical entity version treprostinil be expect begin year other phase iii pipeline program include oral combination therapy orenitram oreniplus freedom ev study tysuberprost esuberaprost combination tyvaso tyvaso ild tyvaso be evaluate patient pah associate idiopathic pulmonary fibrosis orenileft pah left ventricular diastolic dysfunction unite therapeutic be also develop dinutuximab active ingredient unituxin small cell lung cancer phase iii other high risk form cancer gd express cell tumor such ovarian cancer several sarcomas unite therapeutic carry zack rank hold see complete list today zack rank strong buy stock here hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
1180,MDT,world largest medical technology service solution company medtronic plc mdt free report be make effort expand pelvic health gastric therapy business part company core restorative therapy group company have announce interstim system provide sustain long term efficacy improve quality life overactive bladder oab patient end year be interstim system notably interstim system deliver sacral neuromodulation therapy bladder control issue interstim therapy used neuromodulation gentle nerve stimulation normalize brain bladder communication pathway other hand oab hamper quality life disturbing routine activity individual urinary incontinence excessive urination interstim system be thought restore bladder function target sacral nerve help alleviate symptom take rapidly grow market oab consideration expect development be perfectly strategic medtronic go datum provide medtronic number oab patient america be imply individual face problem america accord market research report technavio analyst oab therapeutic market see cagr almost period insite study result reveal oab patient have therapeutic success greater improvement symptom end year sustain safe better quality life notably thestudy assessed efficiency safety system year patient have bothersome oab symptom not tolerate more traditional treatment include urinary urge incontinence ui urgency frequency uf however implant interstim system be risky surgical procedure device related unfavorable event be undesirable change stimulation implant site pain ineffectiveness last month medtronic have outperformed index latest share price movement company have gain compare gain zack rank key picksmedtronic currently carry zack rank hold few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably mesa laboratory insys therapeutic sport zack rank strong buy align technology carry zack rank buy see complete list today zack rank stock here mesa laboratory have positive earning surprise last quarters stock have add roughly last month insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month trade profit big league trump policiesif stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
1181,MDT,johnson johnson jnj free report have accept offer private equity firm platinum equity sale lifescan diabetes device unit company have announce receipt bound offer platinum equity march lifescan unit make blood glucose monitoring product generate revenue last year stock have decline year so far compare unfavorably decrease record industry move be line strategic plan diabetes business company have be plan streamline core asset last year part streamline effort have announce close operation corporation diabetes care unit october last year company have arrange deal medical device maker medtronic inc mdt free report transition patient insulin pump medtronic pump meanwhile also receive offer fortive corporation ftv free report earlier month advanced sterilization product business moreover sale diabetes care franchise decline due price decline competitive pressure thus streamline asset be likely boost margin well cash position company johnson johnson price johnson johnson price johnson johnson quotezack rankj currently carry zack rank hold eli lilly company lly free report be better rank large cap pharma stock carry zack rank buy see complete list today zack rank strong buy stock here lilly earning share estimate moved last day share company be year so far hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
1182,MDT,share boston scientific corporation bsx free report gain close jun follow speculation company rival stryker corporation syk free report consider bid acquire former news be wall street journal report trading stock be temporarily pause monday session nyse yesterday close boston scientific market cap be compare stryker follow reuter report state be still unclear boston scientific be open potential buyout proposal stryker prospective acquirer too decline comment report meanwhile benzinga report write bid have surpass share accord stifel nicolaus well fargo predict share be value base becton dickinson cr bard deal accord bloomberg previous bsx stryker be not first time stryker boston scientific have come strategic collaboration back orthopaedic device giant buy boston scientific neurovascular unit time rationale divestment decision boston scientific come part company aggressive restructure initiative more specifically neurovascular division company core business be struggle depress sale rationale latest rumore boston scientific position prospect possible sell rumor be still unknown analyst believe reason company contemplation probable sell lie interest gain further competitive edge medical device space be important note post colossal merger medtronic mdt free report covidien abbott free report st jude medical last couple year boston scientific also need make mammoth move maintain foothold highly competitive medical technology space merger get materialize finally consider boston scientific stryker present market cap then consolidated entity have combine market cap more accord well fargo security be position only medtronic johnson johnson term total device revenue react widely speculate buyout bid retire twin city med tech stock analyst thom gunderson say make perfect sense go big go home be rule day analyst seem optimistic allege deal believe finally work boston scientific score vantage point fast grow competitive heart valve replacement market be currently trail edward lifescience ew free report medtronic also merger be expect reduce cost combine company time healthcare industry be already battle severe pricing pressure share price comparisonover past year share boston scientific have rally ahead stryker increase broader sector remain much rise boston scientific stryker currently carry zack rank buy see complete list today zack rank stock here more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1183,MDT,medical device tax suspension jan be very few amendment have garner maximum number bipartisan vote house enactment tax have be quite menace medical device industry statement advanced medical technology association lobbying group tax have significant negative impact medical innovation employment consider house place suspension tax january december only bring back jan recently house come bill tax cut include abatement infamous medical device tax medtech fraternity have be cheer latest repeal share price net margin performance medical device manufacturer be show different story let delve deeper glitzy be repeal medtech innumerable report claim repeal ramp domestic production increase hire skilled professional lower nation overdependence offshore production further medtech bigwig be expect enhance improve margin launch product reduce capital depreciation invest early stage medtech company execute clinical trial turn fuel next generation medical device industry reinvest profit tax saving notably johnson johnson jnj free report shell lump sum medical device sale tax meanwhile medical device giant stryker corporation syk free report report net earning paid approximately medical device excise tax nearly earning datum med device online report tax didn exist analyst believe company have used cash expand improve pipeline draw heavy criticism compelling democrat republican lift tax history say different storysince tax be abolish end company be expect rake profit also put impressive show bourse start however price performance margin trend contradict expectation fact tax repeal news create quite stir analyst back deal blow share medical device manufacturer datum show broader medical product industry have underperform market last year industry cut sorry figure comparison here take sneak peek net margin trend company last tax repeal single metric determine profitability business accurately investor count net margin get fair idea amount profit company be make decline net margin post tax repeal amendment throw light enormous risk cost associate compliance requirement medtech manufacturer also raise question tax repeal provide impetus medtech space do nothing significant year back stock grapple decline price net marginhere have medtech stock have witness significant margin contraction tax repeal draw attention share price net margin performance company follow tax abolition past year medtronic plc mdt free report have be observed underperform broader market latest share price movement stock lose compare unfavorably gain company have be face escalate cost expense be weigh margin also company reiteration guidance projection favorable foreign currency translation fail lift investor spirit past year henry schein inc hsic free report have underperform index stock have lose be disappoint continue deterioration company gross operate net margin thank higher cost sale expense also tough competitive landscape pricing pressure weigh stock healthcare product service distribution industry be highly competitive consist principally national regional local distributor north american dental product market company face stiff competition patterson dental business patterson company inc benco dental supply dentsply sirona inc xray free report share price movement have be disheartening past year company have lose period lackluster margin trend same time frame indicate company failure garner profit post tax repeal day comedentsply expect gross operate margin remain flat decline slightly level underlie margin rate improvement be expect be offset adverse foreign exchange target inventory equipment reduction allscript healthcare solution inc mdrx free report have underperform broader market term price past month notably stock have return compare rally further company margin have contract significantly past year allscript also expect modest increase operate expense company face sluggishness international market competition larger player bruker corporation brkr free report have underperform broader market term price past year stock have return just much lower market further company margin have decline steeply past year bruker conduct business international market result currency fluctuation continue result foreign currency transaction loss latest medtech tax overhaul paint different picture stock history repeat analysis clearly show broader industry hasn react positively tax repeal amendment be legislate consider repeal effect medtech space trend be expect continue time well however medtech industry have be favore massive change consumer behavior lately couple change market dynamic lead dramatic transformation healthcare system last couple year be evident rise minimally invasive surgery higher demand liquid biopsy test use quick improve patient care shift payment system value base model further strategic application artificial intelligence sphere healthcare provide boost productivity medtech space company have adopt ai technology witness reduction healthcare cost be expect record strong margin expansion well never know current favorable trend turn table medtech industry more stock news company verge apple rundid miss apple stock explosion launch iphone now look be pivotal year get emerge technology expect rock market demand soar almost nothing report suggest save life decade turn save healthcare cost bonus zack special report name breakthrough best stock exploit apple company be already strong coil potential mega gain click see right now
1184,MDT,go latest center disease control prevention report more adult be live diabetes prediabetic condition notably be gradually take shape deadly epidemic diabetes rate unite state have moved furthermore diabetes be seventh lead cause death unite state result approximately medical cost reduce productivity year article state obesity globally scenario be quite intriguing global report diabetes world health organization prevalence diabetes adult rise moreover worldwide expense related diabetes be international diabetes foundation notably projection related disease hint continuation present trend regard number patient age year diagnosed diabetes be expect rise international diabetes foundation go say rise incidence diabetes have open opportunity diabetes device maker market be expect see cagr reach worth report mordor intelligence globally market be expect value cagr transparency market research report thus investor be keen place bet healthcare space long term gain diabetes device market undoubtedly hold immense potential factor drive diabetes device marketrising healthcare expenditure unhealthy lifestyle practice expand treatment option have be drive demand center medicare medicaid service report publish advisory board healthcare spending be project rise represent gdp base assumption affordable care act continue diabetes device market be largely dependent age population census bureau report person age more be likely total almost double estimate population datum also show median age be increase most area country global scenario be pretty similar strengthen emerge market have be contribute largely rise demand diabetes care device report cision put more light report demand insulin delivery blood glucose monitoring device have be rise highly populate country china india accord international diabetes federation china record highest number diabetic patient follow india ai shape diabetes device artificial intelligence ai have be transform way diabetes be manage world tech medical device analytical predictive diagnostic tool be help create customize program support blood glucose management improve medication adherence go report statista worldwide revenue ehealth solution diabetes be expect furthermore market be expect see cagr accord report grow demand increase availability connect medical device home usage apps smartphone aid self management telemedical service service oriented apps have be stimulating growth niche market view mentioned factor number bigwig have be expending lump sum amount continuously innovate develop device improve efficacy side effect instance back medtronic plc mdt free report partner ibm watson utilize latter machine learn algorithms incorporate ai diabetes app minime company jointly launch first artificial pancreas system medtronic have utilize sugar iq cognitive compute capability ibm watson detect important pattern trend diabetes line development diabetes business february abbott laboratory free report announce availability freestyle librelink app europe use smartphone iphone android encouragingly note abbott be plan mobile app solution freestyle libre user outside europe base country regulatory approval moreover boston taipei hong kong bangalore base company have develop diabetes ai provide personalize metric analysis decision make tool physician patient improvise pre diabetes diabetes management stock bet onwe have select company believe tap promising prospect diabetes device market nordisk nvo free report company have strong presence diabetes care market global market share company boast most extensive diabetes portfolio industry encompass new generation insulin full portfolio modern insulin well once daily glp analog once weekly glp analog also company have strong presence total insulin modern new generation insulin market company have be ride high continue uptake long act insulin tresiba nordisk price nordisk price nordisk zack rank buy company have earning growth rate current year estimate revision trend stock have be encourage estimate move upward compare downward movement past month resultantly earning estimate increase share sanofi sny free report company have be commit develop strengthen insulin franchise lantus toujeo soliqua suliqua insulin company have launch soliqua suliqua unite state europe receipt approval insulin lispro biosimilar same region also note company have be gain substantially availability lantus country courtesy solid sale unite state china france germany sanofi price sanofi price sanofi zack rank hold company have earning growth rate current year estimate revision trend stock have be solid estimate move upward compare downward movement past month resultantly earning estimate increase share see complete list today zack rank strong buy stock here becton dickinson company bdx free report company commonly know bd offer portfolio syringe pen needle other product related injection infusion insulin other drug diabetes care business notably company have be consistently try improve performance diabetes care unit bd medical segment bd see diabetes care revenue growth constant exchange rate first quarter fiscal becton dickinson company price becton dickinson company price becton dickinson company quote regard company recently launch bd ultra fine micro pen needle mm use pen injection device needle offer comfortable injection experience enhance customer satisfaction bd have widen needle length option diabetic patient interestingly most insurance plan include medicare part cover bd ultra fine micro mm pen needle zack rank company have earning growth rate current fiscal estimate revision trend stock have be solid estimate move upward compare movement opposite direction past month resultantly earning estimate increase share conclusiona say strike iron be hot be opportune time cash bountiful opportunity rapidly grow diabetes device market hacker put money portfolio earlier month credit bureau equifax announce massive datum breach affect american cybersecurity industry be expand quickly response similar event stock be better investment other zack have just release cybersecurity investor guide help zack com reader make most year investment opportunity create hacker other threat reveal stock worth look right away download new report now
1185,MDT,recent report reuter stryker corporation syk free report be likely take boston scientific corporation bsx free report create market value more deal materialize combine entity have medtech broadest spectrum product offering include cardiology orthopaedic surgical supply neuroscience yesterday share stryker have drop close boston scientific share have increase close likely be deal materialize chance deal be uncertain be confirmatory statement press release company representative fact investor never forget stryker highly rumore acquisition plan nephew never materialize brighter side be not first time stryker have be tie boston scientific stryker acquire boston scientific neurovascular unit indicate probability second collaboration now however reach particular conclusion moment be bit too early analyst wall street journal claim agreement be largest year be shape be busiest ever merger acquisition deal mature well fargo security analyst lawrence expect outpace medtronic mdt free report johnson johnson jnj free report total device revenue morningstar analyst debbie wang focuse need increase consolidation healthcare provide comprehensive product portfolio customer stryker suppose deal boston scientific seem prudent regard stryker benefit deal happen stryker gain control boston scientific line heart device such stent defibrillator watchman device prevent blood clot boston scientific achieve clinical milestone ranger drug coat balloon watchman left atrial appendage closure device further company also leverage boston scientific solid foothold underpenetrated emerge economy company also register double digit growth year year basis emerge market last report quarter deal materialize stryker profit boston scientific strength especially bric nation stryker have zack rank buy share company have outperformed industry year time stock have return almost better industry rise stryker acquisition profile shine brightstryker have be follow acquisition drive strategy boost growth recently company acquire entellus medical inc cash transaction share equity value approximately stryker also acquire vexim vexim specialize development sale vertebral compression fracture solution stryker complete acquisition novadaq net purchase price novadaq be lead developer spy fluorescence imaging technology provide surgeon visualization blood flow perfusion more clinical study array specialty company product portfolio be highly complementary stryker visualization platform let watch stryker manage acquire boston scientific medical world achieve solid benchmark term provide comprehensive suite medtech solution reduce pricing pressure competition further company strong acquisition policy gain rapidly expand large customer base moderate leverage enhance cash flow meanwhile medtech fraternity have be ride ongoing merger acquisition trend make most profitable investment arena glance major acquisition recent past becton dickinson company takeover bard johnson johnson buyout covidien deserve mention datum provide biospectrum asia activity medtech space surge increase value aggregate more more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1186,MDT,jun issue update research report medtronic plc mdt free report be encourage global acceptance company advanced therapy escalate cost expense raise concern stock have zack rank hold past month share medtronic have outperformed industry stock have grow industry decline notably medtronic exit fiscal solid note better expect fourth quarter performance major business group contribute solid top line growth cer highlight sustainability group region addition display successful integration achievement synergy target also gradually stabilize cardiac rhythm heart failure crhf market buoy optimism medtronic plc price medtronic plc price medtronic plc quote receipt fda approval dbs deep brain stimulation therapy adjunctive treatment reduce partial onset seizure raise hope company target medical market medtronic be also focuse geographical diversification business company be highly positive foray standalone cgm continuous glucose monitoring market guardian connect be currently upbeat medtronic recently launch restructure initiative call enterprise excellence plan aim annual growth run rate saving end fiscal company new program have be design increase effectiveness growth related reinvestment ability provide consistent boost margin expansion drive ep leverage flip side company have be expose steep cost expense weigh heavily margin also guidance remain conservative apprehension lackluster cardiac vascular group cvg minimally invasive therapy group mitg performance turn dampen investor confidence stock key picksa few better rank stock broader medical sector be intuitive surgical isrg free report illumina inc ilmn free report amedisys inc am free report intuitive surgical illumina sport zack rank strong buy amedisys carry zack rank buy see complete list today zack rank stock here intuitive surgical have expect long term earning growth rate illumina expect long term earning growth amedisys have expect long term earning growth rate hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
1187,MDT,abbott free report ellipse implantable cardioverter defibrillator icd recently gain fda approval magnetic resonance mr conditional labele solidify company footprint rhythm management space post approval patient implanted ellipse device durata optisure lead be able undergo mri scan moreover ellipse now be available patient suffering severely high heart rhythm need icd mri scan thus believe latest regulatory approval expand company customer base drive top line moreover ellipse be embed feature know abbott tailoredtherapy be capable directly securely wirelessly forwarding therapy related datum patient physician merlin net patient care network continue effort expand mr conditional labele enabled device company receive fda approval mr conditional labele assurity mri pacemaker tendril mri pace lead also company have receive certain prior mr conditional labele approval europe meanwhile abbott have apply fda approval mri conditional labele quadra assura cardiac therapy defibrillator crt product quartet family left ventricular lead interestingly company witness softness rhythm management segment majorly due tough competition mri conditional category product market be dominate well establish player medtronic plc mdt free report boston scientific corporation bsx free report edward lifescience corporation ew free report other abbott strategy gain traction rhythm management sub segment seem be align datum provide ally market research report global cardiac monitoring cardiac rhythm management market be expect see cagr reach value believe unhealthy lifestyle rise agee population continue result high incidence cardiovascular disease be further support datum provide gbi research report global cardiovascular disease market see cagr space market be expect witness highest momentum cagr make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
1188,MDT,boston scientific bsx free report recently launch advanced resonate family implantable cardioverter defibrillator icd cardiac therapy defibrillator crt system feature heartlogic heart failure diagnostic notably device be fda approve conditional use magnetic resonance imaging mri environment help physician improve heart failure hf management personalize care device combine company smartcrt technology enduralife battery technology allow physician customize device setting accord individual patient need drain battery have go unnecessary replacement procedure heartlogic diagnostic alarm doctor worsening hf condition combine datum sensor assess heart sound respiration rate volume thoracic impedance heart rate activity crt ds resonate family device be enabled smartcrt technology help physician modify pace lower chamber heart used multisite pace capability multus electrode pace company recently initiate enrolment patient manage hf study further assess heartlogic diagnostic boston scientific recently announce positive clinical trial datum multisensor chronic evaluation ambulatory heart failure patient multisense study study base patient be conduct examine performance heartlogic diagnostic prediction possibility study demonstrated heartlogic diagnostic increase ability classify patient high low risk experience hf event last report second quarter boston scientific cardiac rhythm management crm segment reflect year year increase sale meanwhile company have be consistently focuse product development strengthen position niche accord report globaldata heart failure market be estimate reach value cagr consider huge potential market believe latest development be strategically place however company be face tough competition global cardiac monitoring device market establish player abbott free report medtronic plc mdt free report edward lifescience corporation ew free report make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
1189,MDT,medtronic plc mdt free report recently initiate post market forward pro clinical study measure performance corevalve evolut pro transcatheter aortic valve implantation tavi system regular clinical treatment study evaluate long term performance next generation self expand tavi system patient severe symptomatic aortic stenosis be intermediate high extreme risk open heart surgery notably system have recently be approve commercial use europe unite state management multus center study enroll patient site europe moreover study involve measure safety standard corevalve evolut pro valf analyze cause mortality stroke rate day clinical performance cover valve hemodynamic paravalvular regurgitation moreover company patient be continue be follow evaluate year encouragingly note march corevalve evolut pro system have receive fda approval use symptomatic patient be high extreme risk open heart surgery moreover self expand tavi system have be grant regulatory approval europe well thus believe clinical study datum display efficiency product help company gain traction coronary structural heart csh space interestingly medtronic csh revenue be constant exchange rate back high constant currency growth transcatheter aortic valf result strong customer uptake corevalve evolut pro platform unite state continue demand corevalve evolut mm valve unite state well europe notably report medgadget global heart valve repair replacement market be expect grow cagr believe unhealthy lifestyle rise agee population continue result high incidence cardiovascular disease be further support datum provide gbi research report global cardiovascular disease market see cagr space market be expect witness highest momentum cagr medtronic be base highly fragmented heart valve repair replacement market however market be dominate well establish player abbott free report boston scientific corporation bsx free report edward lifescience corporation ew free report other boston scientific lotus valve platform edward lifescience sapien xt sapien offering be worth mention here more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1190,MDT,mazor robotic mzor free report recently announce receipt ce mark mazor surgical assurance platform allow company market mazor european union commercial partner medtronic mdt free report management medtronic be responsible marketing system europe platform be display eurospine conference dublin ireland launch mazor have receive encourage demand fact mazor robotic broad product spectrum have be key growth driver mazor last report quarter company receive purchase order surgical guidance system include mazor system renaissance system be mazor primarily major hospital corporation renaissance system order be distribution partner australia thailand mazor robotic system backlog end second quarter totale global basis company end second quarter system worldwide unite state mazor align software earlier year company have announce receipt fda clearance mazor align software software be design assist surgeon plan spinal deformity correction spinal alignment procedure perform mazor surgical assurance platform market prospectswe be encourage opportunity global spine surgery market research report market market suggest niche market reach worth cagr meanwhile company face stiff competition like zimmer biomet holding zbh free report intuitive surgical isrg free report more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1191,MDT,medtronic plc mdt free report announce receipt fda approval guardian connect continuous glucose monitoring cgm system diabetes patient age year notably system be available first quarter medtronic fiscal year july guardian connect cgm guardian connect be first only standalone cgm system help diabetes patient be aware potential high low glucose event minute advance notably guardian connect enable patient use multiple daily injection mdi manage disease proactively patient relative stay inform track glucose real time even receive text alert system system user have exclusive access sugar iq smart diabetes assistant help deal regular complication related diabetes sugar iq assistant consistently study response individual glucose level food intake insulin dosage daily routine other factor sugar iq assistant combine guardian connect transform difficult determine pattern personalize well actionable insight enable patient keep glucose level target range press release latest sensor withintelligent algorithms allow user predict understand glucose excursion particularly hypoglycemia be likely make diabetes more comprehensible person inject insulin used cgm help diabetes patient achieve more glycemic time range reduce risk hypoglycemia diabetes business consistently try enhance diabetes business medtronic witness rise constant exchange rate diabetes business revenue third quarter fiscal company benefit positive uptake new sensor augment insulin pump system unite state international market enhance production capacity same recently company announce fda have approve new arm indication guardian sensor continuous glucose monitor cgm be used minime insulin pump notably medtronic expect double digit growth segment fourth quarter fiscal courtesy consistent performance minime system unite state enhance sensor supply capacity additionally medtronic have be gear international introduction minime launch new professional cgm ipro market potentialan agee population unhealthy lifestyle rise awareness higher expenditure healthcare be likely drive growth highly competitive diabetes market report mordor intelligence global market diabetes care device be project reach value cagr consider bullish market sentiment believe latest development have arrived opportune moment stock performance estimate revisionover past month share medtronic have underperform industry stock have return compare industry rally index gain also estimate revision trend current year be unfavorable estimate move south last month compare opposite direction earning estimate fall share zack rank key picksmedtronic carry zack rank hold better rank stock broader medical sector be bio rad laboratory bio free report athenahealth inc athn free report perkinelmer pki free report bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here company have long term expect earning growth rate athenahealth be zack rank player company have long term expect earning growth rate perkinelmer have long term expect earning growth rate stock carry zack rank breaking news cryptocurrency now bigger total market cap cryptos recently surpass more increase previous month re now bigger morgan stanley goldman sachs even visa new asset class expand even more rapidly new investor continue pour wall street become increasingly involved zack have just name company enable investor take advantage explosive growth cryptocurrency stock market click here access stock
1192,MDT,medtronic plc mdt free report recently present encourage outcome pivotal extreme risk study real world notion trial nordic aortic valve intervention trial corevalve tavr system datum be present american college cardiology acc annual scientific session development remain part company consistent effort strengthen position high potential transcatheter aortic valve replacement tavr market be project reach datum cision study result notion trial enrolled patient age least year be subject surgical aortic valve replacement savr tavr corevalve system notably study evaluate patient year post implant corevalve tavr system result demonstrated patient experience enhance quality lifealong strong hemodynamic performance year believe result boost uptake corevalve tavr system development corevalve tavr corevalve evolut platform comprise corevalve corevalve evolut corevalve evolut pro system notably july medtronic receive fda approval extend use self expand corevalve evolut tavr system approval patient symptomatic severe aortic stenosis intermediate risk open heart surgery become eligible treatment used technology again march corevalve evolut pro system receive fda approval be used symptomatic patient be high extreme risk open heart surgery continue slew development last september medtronic announce initiate post market forward pro clinical study measure performance corevalve evolut pro transcatheter aortic valve implantation tavi system regular clinical treatment thus believe clinical study datum display efficiency product help company gain traction coronary structural heart csh space interestingly medtronic csh third quarter fiscal revenue be constant exchange rate back low constant currency growth transcatheter aortic valf result strong customer uptake corevalve evolut pro platform expand fda approval include patient intermediate risk market prospectsper report medgadget global heart valve repair replacement market be expect grow cagr believe unhealthy lifestyle rise agee population continue result high incidence cardiovascular disease be further support datum provide gbi research report global cardiovascular disease market see cagr space market be expect witness highest momentum cagr thus release positive study datum help medtronic cash abundant opportunity pancreatic cancer therapeutic market share price movementover past month company share price have underperform broader industry stock have gain comparison broader industry gain believe latest development help stock rebound zack rank key picksmedtronic carry zack rank hold better rank stock broader medical sector be bio rad laboratory bio free report athenahealth inc athn free report perkinelmer pki free report bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here company have long term expect earning growth rate athenahealth be zack rank player company have long term expect earning growth rate perkinelmer have long term expect earning growth rate stock carry zack rank buy breaking news cryptocurrency now bigger total market cap cryptos recently surpass more increase previous month re now bigger morgan stanley goldman sachs even visa new asset class expand even more rapidly new investor continue pour wall street become increasingly involved zack have just name company enable investor take advantage explosive growth cryptocurrency stock market click here access stock
1193,MDT,cogentix medical inc recently announce have enter definitive merger agreement laborie medical technology deal laborie medical technology buy outstanding share cogentix medical net worth company be lead player urology gynecology colorectal fieldscogentix medical expect transaction close first half second quarter once complete cogentix medical become wholly own subsidiary laborie medical technology price medical share have return past year compare index rally stock have also outperformed industry gain cogentix medical have market cap cogentix medical have zack rank hold agreement detailper term agreement laborie medical technology initiate tender offer outstanding share cogentix medical common stock share cash company execute deal wholly own subsidiary lm parent inc camden merger sub inc follow successful completion tender offer be second step merger outstanding share cogentix medical common stock be not tender be converted right receive share common stock cash transaction be subject other customary close condition notably cogentix medical be lead player global urology market company recent initiative sign licensing agreement allow launch endo urology product line unite state be noteworthy product be focuse minimally invasive treatment kidney stone initial response physician product have be positive management latest transaction be also great financial opportunity deliver strong margin expansion long haul market potentialper market market urology device market be estimate reach worth cagr consider prospect niche space expect cogentix medical gain solid prominence day come however company face stiff competition medtech giant medtronic plc mdt free report key picksa few better rank stock broader medical sector be perkinelmer pki free report bio rad laboratory bio free report perkinelmer have long term expect earning growth rate stock carry zack rank buy bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here company have long term expect earning growth rate breaking news cryptocurrency now bigger total market cap cryptos recently surpass more increase previous month re now bigger morgan stanley goldman sachs even visa new asset class expand even more rapidly new investor continue pour wall street become increasingly involved zack have just name company enable investor take advantage explosive growth cryptocurrency stock market click here access stock
1194,MDT,unite therapeutic corporation uthr free report report adjust earning share first quarter rise year quarter due lower sg cost tax rate zack consensus estimate be peg share adjust earning exclude impact share base compensation gain revenue report quarter be beating zack consensus estimate revenue rise year year sale however decline sequentially due unfavorable timing pricing distributor order unite therapeutic first quarter revenue be usually flat prior year fourth quarter level due unfavorable timing magnitude distributor order be typically place once month base current utilization trend contractual minimum inventory requirement share unite therapeutic be almost wednesday fact stock have underperform industry year so far have decline compare industry decline period quarter detailunite therapeutic market product treatment pah remodulin tyvaso adcirca orenitram please note unite therapeutic buy exclusive right commercialize adcirca tadalafil treatment pah unite state eli lilly lly free report november lilly market tadalafil ciali erectile dysfunction lilly carry zack rank buy see complete list today zack rank strong buy stock here adcirca sale be year year drive price increase orenitram sale amount quarter year year due patient growth time positive impact amendment contractual minimum inventory level distributor remodulin sale be year year due reduction order international distributor tyvaso sale totale year year due price increase however amendment contractual minimum inventory level discuss hurt sale remodulin tyvaso please note remodulin adcirca be expect face generic competition year reduce sale product unituxin treatment pediatric patient high risk neuroblastoma sale be flat year year research development expense escalate due higher cost support company pipeline cardiopulmonary cancer drug develop organ manufacturing project selling general administrative sg expense decline pipeline update unite therapeutic be work expand indication market product orenitram tyvaso company present have phase iii program field cardiopulmonary disease oncology phase iii freedom ev study be evaluate oral combination therapy orenitram oreniplus full datum study be expect year meanwhile phase iii beat study be evaluate tysuberprost esuberaprost combination tyvaso datum study be also expect year unite therapeutic be also work new delivery mechanism remodulin company be work medtronic plc mdt free report get remosynch implantable pump deliver remodulin intravenously approve fda order launch remosynch unite state unite therapeutic medtronic be pursue parallel regulatory filing related device drug medtronic premarket approval application pma catheter remosynch be approve fda december unite therapeutic resubmit new drug application get remosynch approve fda january month review period fda action be expect jul unite therapeutic expect launch remosynch system early unite therapeutic have also develop pre filled semi disposable pump system subcutaneous delivery remodulin remunity partnership deka february deka file remunity fda filing be accept review fda clinical study remopro pain free new chemical entity version treprostinil be expect begin year several datum read out regulatory update be expect acquire week unite therapeutic announce definitive merger agreement steadyme ltd stdy free report unite therapeutic acquire steadyme include contingent payment deal unite therapeutic add steadyme drug device pipeline product trevyent pah patient portfolio have pose competition unite therapeutic remosynch trevyent be single use pre filled pump have be develop steadyme deliver day supply treprostinil subcutaneously used steadyme patchpump technology treat pah steadyme receive refuse file letter fda want further information steadyme intend resubmit nda end unite therapeutic corporation price consensus ep surprise unite therapeutic corporation price consensus ep surprise unite therapeutic corporation quote medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
1195,MDT,apr issue update research report medtronic plc mdt free report be encourage global acceptance company advanced therapy escalate cost expense raise concern company have zack rank hold positive note be upbeat medtronic recently launch restructure initiative call enterprise excellence plan aim annual growth run rate saving end fiscal company new program have be design increase effectiveness growth related reinvestment ability consistent boost margin expansion drive ep leverage also gradually stabilize movement witness global cardiac rhythm heart failure crhf market bode well further improvement come quarters medtronic plc price medtronic plc price medtronic plc quote meanwhile end third quarter fiscal medtronic note have successfully meet covidien synergy commitment time significantly come company priority be optimize commitment medtronic have start deliver cost synergy annual saving end fiscal flip side share medtronic have underperform broader industry past month stock have lose versus broader industry gain company have be expose escalate cost expense weigh heavily margin reiteration guidance favorable foreign currency translation forecast dampen investor confidence stock key picksa few better rank stock broader medical sector be bio rad laboratory bio free report athenahealth inc athn free report edward lifescience corporation ew free report bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here have long term expect earning growth rate athenahealth be zack rank player have long term expect earning growth rate edward lifescience have long term expect earning growth rate zack rank buy today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
1196,MDT,transcatheter aortic valve replacement tavr market be project witness cagr report analytic publish reportsnreport have be constantly radar market expert courtesy stir cause forerunner space boston scientific corporation bsx free report last february company voluntarily recall core lotus valve device include lotus depth guard drag share pre market trading session article medical device diagnostic industry sadly again november boston scientific announce further delay re launch lotus edge aortic valve system fail meet commit timeline hurt shareholder sentiment even more article medical device diagnostic industry company have opted piper jaffray healthcare conference new york same day pull stock be follow decline market cap meanwhile rejoice situation be edward lifescience corporation ew free report lead player tavr market encouragingly company share have soar lotus valve device recall last february let take sneak peek brewing market investor be keen effectively put money healthcare space backdropboston scientific have be consistently dominate headline development lotus valve device unpleasant reason last february company have call back lotus valve device due issue related premature release pin connect lotus valve delivery system however be not first time company have face such situation earlier company have retract lotus edge valve system similar ground even have face brunt fda order withdraw unit lotus valve circulation europe due lotus valve get unlock delivery system release company have also be disappointing investor continuously delay filing premarket approval pma fda lotus edge valve system currently company expect lotus edge be back european market not also intend roll same unite state same year nevertheless major market analyst believe such numerous product misstep have always end tarnishing brand image deviate customer clinician interest edward lifescience seize boston scientific hit rough patch issue surround lotus valve device edward lifescience reap maximum benefit solid transcatheter heart valve therapy thvt platform company annual investor conference chairman ceo michael mussallem note come end performance accomplishment year significantly exceed expectation expect be strong year edward lifescience primary factor drive company global growth be prosper transcatheter aortic valve therapy business further assert regard management currently project sale transcatheter heart valve therapy moreover edward lifescience expect global tavr opportunity be more make most company have be fire cylinder lately line edward lifescience have term product pipeline track expect new sapien ultra system feature balloon delivery system next generation sheath technology be launch unite state europe later year also company anticipate begin pivotal trial ce marked centera valve system furthermore edward lifescience expect result partner trial sapien valve be present acc follow fda approval later year note market speculator believe edward lifescience solid global presence particularly high potential region europe japan delay comeback key competitive product boston scientific lotus valve help company further cement hold highly potential tavr space other major player ride gain medtronic plc mdt free report corevalve evolut tavr platform comprise corevalve corevalve evolut corevalve evolut pro system have well maintain company position formidable player tavr space article reuter share medtronic have inched boston scientific announcement withdrawal lotus valve device last february notably company record tavr growth mid unite state low international market last report quarter furthermore post acquisition st jude medical abbott laboratory free report integrate popular ce marked portico tavr former structural heart portfolio be expect gain momentum space boston scientific rebound card winston have rightly say man make mistake only wise man learn mistake unwilling let go bountiful opportunity tavr market boston scientific acquire symetis sa structural heart company focuse minimally invasive tavr device company have start selling acurate neo aortic valve europe be also work design acurate neo aortic valve system equip enhance outer sealing skirtfeature moreover boston scientific be look forward leverage exist lotus infrastructure enhance acurate neo valve system better field support geographic expansion next generation product company plan invest unite state japan trial well acurate replace lotus however several opinion have be make round tavr space late market expert believe company eventually replace lotus valve device symetis portfolio other speculate deal have be clinch cushion jitter stem lotus valve device withdrawal few analyst be also opinion boston scientific expend huge amount symetis buyout deal use contingency plan case lotus valve device issue remain unresolved nonetheless dismiss such speculation boston scientific have be consistently emphasize symetis acquisition move broaden tavr suite not replacement lotus valve device end speculation let watch find not boston scientific lotus valve find right weather bloom again zack editor chief go stockfull disclosure kevin matra now have more own money particular stock other believe short term profit potential also prospect more double today reveal explain surprising move new special report download free
1197,MDT,era big datum portfolio be tune evolve digital trend make prudent investment choice prove be daunting task millennial have start recognize increase need emerge automation trend subsequently robotic iot printing be become part daily life latest buzzword be artificial intelligence ai siri google have make life easier latest version global position system help track almost anything everything intelligent route map also not be pro social network site facebook twitter snapchat be see primitive accord investment giant jim cramer ai big datum soon let company bat interestingly benefit same not remain restrict particular industry be feel business segment investment arena ai help medtech gain tractionnon healthcare bigwig apple aapl free report google amazon amzn free report ibm microsoft digital affluence be already eyee healthcare device market late courtesy solid prospect thing be note here health treatment cost have sky-rocket past few year surprisingly medical device pharmaceutical account only small portion healthcare expense josh makower md general partner venture capital firm new enterprise associate greater part healthcare cost go pay salary healthcare employee ai help curtail high labor cost go deloitte datum global health care spending be project increase annual rate significant escalation just report rise labor cost be act major spending growth driver also growth age population necessity ai have increase leap bound census bureau report be significant rise age population unite state population age older be project be almost double estimate population datum also show median age be increase most area country be global scenario well notably industry be bearing brunt explode population present world health organization latest available datum show more member state worldwide report have less physician population density physician patient unite state be strategic application ai sphere healthcare provide impetus productivity evidently company adopt ai technology have already witness reduction healthcare cost have also experience improve patient outcome more medtech stock go ai waymedtronic mdt free report be undoubtedly first medtech manufacturer forge ahead initiative bring ai technique manufacturing process back company partner ibm watson utilize latter machine learn algorithms incorporate ai diabetes app minime jointly launch first artificial pancreas system metronic have utilize sugar iq cognitive compute capability ibm watson detect important pattern trend diabetes ehr technology developer cerner cern free report be also adopt ai technique rapidly lately company have be headline courtesy effort digitize electronic health record system regard company recently enter collaboration salesforce renown player field customer relationship management other centrus health clinically integrate physician lead network latest development company be plan advance flagship big datum platform healtheintent intuitive surgical isrg free report design manufacture market da vinci surgical system advanced robot assist surgical platform ai platform enable minimally invasive surgery help negate trauma associate open surgery company plan expand usage da vinci general thoracic surgery colorectal surgery hernia repair late boston scientific bsx free report have also be putt effort incorporate ai technique neuromodulation cardiac rhythm management cardiology peripheral intervention oncology endoscopy urology pelvic health conclusiona long debate be structure intelligent machine intensive technology make human capability outmoded gradually different story several adversity ai undoubtedly have emanate change behavioral pattern consumer medical device space other sector once again go jim cramer say love behavior change investing be incredibly lucrative have behavior change theme use selloff pick stock base change thus go say market hold ample promise proper execution ai definitely prove be trump card space zack top stock addition stock discuss know finest buy hold ticker entirety last year zack top stock portfolio produce double digit winner include fmc corp vmware rac stellar gain now brand new portfolio have be handpick company cover zack rank don miss chance get long term buy access zack top stock today
1198,MDT,medtronic plc mdt free report announce fda have approve new arm indication guardian sensor continuous glucose monitor cgm used minime insulin pump notably guardian sensor be company latest most accurate cgm medtronic be only sensor have receive fda nod control automate insulin delivery hybrid close loop system minime be important note medtronic commercially launch minime system june system be hybrid close loop insulin delivery system type diabetic patient age year older minime system feature medtronic guardian sensor glucose sensor increase accuracy enhance performance new arm indication guardian sensor now offer more convenience flexibility patient be available unite state use minime system progress minime have be forge ahead initiative boost performance minime portfolio recently company expand product portfolio unveil minime advance infusion set recent offer diabetes business be commercially available canada hong kong certain country europe fourth quarter fiscal however company plan extensive launch same also company report positive datum home pediatric study patient age year outcome be base minime system be demonstrated advanced technology treatment diabetes international conference vienna austria development diabetes witness rise constant exchange rate diabetes business revenue third quarter fiscal company benefit positive uptake new sensor augment insulin pump system unite state well international market enhance production capacity same notably medtronic expect double digit growth segment fourth quarter fiscal courtesy consistent performance minime system unite state enhance sensor supply capacity additionally medtronic have be gear international introduction minime launch cgm system guardian connect sugar iq late new professional cgm ipro regard company have earlier announce favorable result support use cgm patient type diabetes october market potentialan agee population unhealthy lifestyle rise awareness well expenditure healthcare be likely drive growth diabetes market report mordor intelligence global market diabetes care device be project reach value cagr consider bullish market sentiment believe latest development have arrived opportune moment stock performance estimate revisionover last month share medtronic have underperform industry stock hasdipped industry growth index gain also estimate revision trend current year remain unfavorable estimate move south last month compare couple opposite direction earning estimate inched share same time frame zack rank key picksmedtronic carry zack rank hold few better rank stock broader medical sector be perkinelmer pki free report bio rad laboratory bio free report becton dickinson company bdx free report perkinelmer have long term expect earning growth rate stock carry zack rank buy bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here company have long term expect earning growth rate becton dickinson company be zack rank player company have long term expect earning growth rate don even think buy bitcoin read most popular cryptocurrency sky-rocket last year give investor chance bank return even more gain however come serious volatility risk bitcoin sank more time zack have just release new special report help reader capitalize explosive profit potential bitcoin other cryptocurrency significantly less volatility buy directly see crypto related stock now
1199,MDT,have be month last earning report medtronic plc mdt free report share have lose time frame recent negative trend continue lead next earning release be mdt due dive investor analyst have react late let take quick look most recent earning report order get better handle important driver recent report third quarter fiscal adjust earning share ep beating zack consensus estimate penny earning rise year year adjustment quarter primarily include impact restructure charge intangible asset amortization divestiture related item acquisition related item adjust unfavorable foreign exchange impact penny adjust ep be adjustment company report net loss share compare cent previous year include net tax expense related tax reform total revenue report quarter gross constant exchange rate cer basis report basis top line surpass zack consensus estimate foreign currency fluctuation favorably impact medtronic third quarter revenue quarter review sale total revenue fall year year cer develop market revenue totale total revenue reflect increase cer report emerge market revenue total revenue amount cer report segment company currently generate revenue major group viz cardiac vascular group cvg minimally invasive therapy group mitg restorative therapy group rtg diabetes group cvg comprise cardiac rhythm heart failure crhf coronary structural heart csh aortic peripheral vascular division apv mitg now include surgical innovation si respiratory renal rgr division divestiture patient care deep vein thrombosis compression nutritional insufficiency enteral fee business rtg comprise spine brain therapy specialty therapy pain therapy segment diabetes group incorporate intensive insulin management iim intensive diabetes therapy ndt diabetes service solution dss division cvg revenue improve cer report drive strong balanced growth division crhf sale totale year year cer report come back growth arrhythmia management lead high teen growth atrial fibrillation solution cer amplify penetration micra transcatheter pace system strong uptake tyrx absorbable antibacterial envelope apart strong demand company suite quadripolar cardiac therapy pacemaker crt growth mechanical circulatory support drive heart failure division revenue csh revenue be cer report back low constant currency growth transcatheter aortic valf result strong customer uptake corevalve evolut pro platform expand fda approval include patient intermediate risk moreover continue uptake resolute onyx drug eluting stent unite state japan revive coronary business apv revenue register growth cer report drive continue adoption valiant stent graft system peripheral be drive double digit growth percutaneous transluminal angioplasty drug coat balloon moreover solid contribution venaseal closure system drive high single digit growth endovenous mitg worldwide sale reach mark year year increase cer report basis high single digit growth si low single digit growth rgr cer rtg worldwide revenue be year year cer report low double digit growth brain therapy mid single digit growth specialty therapy high single digit growth pain therapy cer however revenue spine business remain flat cer year year basis moreover revenue diabetes group increase cer report marginsgross margin report quarter expand basis point bps rise gross profit adjust operate margin expand bps year year owing rise research development expense uptick selling general administrative expense other expense report quarter totale compare year quarter reiterate fiscal constant currency revenue ep guidance company maintain full year revenue growth projection range cer however company revise foreign currency fluctuation estimation be now project have positive impact fiscal result compare estimate earlier zack consensus estimate revenue remain fiscal adjust earning share growth be still expect range cer currency translation be likely have adverse impact cent compare earlier expectation negative effect cent zack consensus estimate fiscal earning be peg fourth quarter fiscal medtronic expect currency translation have favorable impact revenue currency translation be expect affect fourth quarter earning share cent have estimate be move then past month investor have witness downward trend fresh estimate have be revision lower current quarter medtronic plc price consensus medtronic plc price consensus medtronic plc quotevgm scoresat time mdt have subpar growth score be lag bit momentum front however stock be allocate grade value side putt second quintile investment strategy overall stock have aggregate vgm score aren focuse strategy score be be interested company stock be suitable solely value base style score outlookestimate have be broadly trend downward stock magnitude revision indicate downward shift interestingly mdt have zack rank hold expect line return stock next few month
1200,MDT,medtronic plc mdt free report announce dull preliminary sale result second quarter fiscal preliminary worldwide revenue quarter dip year year zack consensus estimate remain tad higher report preliminary revenue figure medtronic year year decline preliminary sale performance be drive company divestiture patient care deep vein thrombosis compression nutritional insufficiency business cardinal health occur begin quarter comparable constant currency basis adjust divestiture positive impact foreign currency company second quarter preliminary revenue increase year year company also note exclude impact hurricane marium second quarter revenue growth have be comparable constant currency basis medtronic plc price medtronic plc price medtronic plc quotealso preliminary report impact marium be approximately company second quarter top line hurricane left adverse impact roughly cent second quarter gaap earning share ep exclude effect marium medtronic reaffirm fiscal second quarter guidance company expect adjust ep be flat slightly comparable constant currency basis year quarter also expect favorable impact penny foreign currency translation quarter adjust ep year year drag preliminary sale be encourage note latest projection be actually improvement company earlier financial impact marium be provide month back time medtronic have project fiscal second quarter revenue adjust net earning extent more specifically minimally invasive therapy group restorative therapy group be expect be worst hit notably medtronic be slate release second quarter fiscal result november market open zack rank key picksmedtronic carry zack rank sell few better rank stock broader medical sector be petm express inc pet free report luminex corp lmnx free report myriad genetic inc mygn free report stock sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have soar roughly year luminexha long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have surge year time make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
1201,MDT,cardinal health inc cah free report report first quarter fiscal adjust earning share beat zack consensus estimate however earning decline year year basis revenue increase year year basis almost miss zack consensus estimate stock have zack rank sell segmental segment pharmaceutical revenue inched year year basis segment witness strong growth specialty business also gain huge number pharmaceutical distribution customer segment witness drop profit thank generic pharmaceutical pricing company recent investment pharmaceutical platform however solid performance red oak sourcing platform have partially offset negative effect medical segment revenue segment increase primarily higher contribution new exist customer medical segment profit increase courtesy higher contribution new exist customer acquisition however lower contribution veteran affair contract partially affected sale segment cardinal health inc price consensus cardinal health inc price consensus cardinal health inc quote major highlightsin report quarter cardinal health close acquisition medtronic mdt free report patient recovery business cash further cardinal health launch connectsource new cloud base patient engagement platform first quarter cardinal health enter agreement first quarter distribute self manufacture surgeon glove directly certain international market company also announce agreement make cordis subsidiary exclusive distributor medinol coronary stent unite state marginsas percentage revenue gross margin expand basis point bps net revenue distribution selling general administrative sg expense increase year year basis report quarter company reaffirm fiscal guidance adjust earning share continue operation takecardinal health end first quarter fiscal solid note courtesy solid performance medical segment encourage fiscal guidance instill confidence stock meanwhile company be banking strategic buyout joint venture supply agreement drive growth deal medtech bigwig medtronic be likely boost company growth trajectory flipside pharmaceutical segment witness strong growth specialty business gain huge number pharmaceutical distribution customer profit segment be hurt generic pharmaceutical pricing increase generic pricing pressure be major headwind intensify competition customer concentration be other bottleneck sluggish macroeconomic scenario tough product pricing environment be likely impede growth peer surgical inc isrg free report post adjust earning share third quarter beating zack consensus estimate stellar revenue growth stock have zack rank buy petm express inc pet free report adjust earning share cent second quarter fiscal be year quarter also earning surpass zack consensus estimate stock sport zack rank strong buy see complete list today zack rank stock here wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
1202,MDT,be thick earning season more index total market capitalization have already release quarterly number meanwhile medtech space uncertainty related trump administration obamacare repeal replacement effort continue make headline latest uproar be related president newly release executive order design provide affordable quality healthcare nation let now have quick look medical device space have fared so far report cycle report suggest hurricane end third quarter be likely mar revenue earning several medtech company primarily florida texas puerto rico medtech major ecolab ecl free report expect impact hurricane full year sale cost be approximately cent share fact medtronic mdt free report acknowledge impact hurricane marium quarterly metric company expect almost impact revenue earning overall lack visibility befuddle favorable trend past few quarters broader medical sector zack sector latest earning preview third quarter expect earning growth rate sector be revenue growth comparison report earning growth rate second quarter be quite impressive revenue growth note be powerful long term tailwind medical space include merger acquisition emerge market expansion positive demographic trend new product innovation have be major drive force sector impressive performance past few quarters even severe socio economic political instability make right pick existence number industry player find right stock have potential beat earning be daunting task proprietary methodology make fairly simple narrow list choice look stock have combination favorable zack rank strong buy buy hold positive earning esp earning esp be proprietary methodology determine stock have best chance surprise next earning announcement show percentage difference most accurate estimate zack consensus estimate research show stock combination have chance positive earning surprise earning beat boost investor confidence stock be reflect rapid price appreciation uncover best stock buy sell report earning esp filter choicesbelow be medical device player have right combination element post earning beat quarter henry schein inc hsic free report headquarter melville ny henry schein be lead distributor health care product service globe company serve office base dental medical animal health practitioner dental laboratory government well institutional health care clinic other alternate care site henry schein be expect report third quarter earning nov have beaten zack consensus estimate trail quarters deliver average positive earning surprise zack rank stock have earning esp see complete list today zack rank stock here biosystem inc ttoo free report be emerge player field diagnostic company be focuse provide better healthcare reduce cost healthcare empower clinician effectively treat patient faster ever company be set report third quarter result nov company have miss zack consensus estimate precede quarters result average earning miss currently company have earning esp carry zack rank opko health inc opk free report be diversify healthcare company diagnostic business include bioreference laboratory lead clinical laboratory unite state core genetic testing business opko be expect report third quarter earning nov have beaten zack consensus estimate trail quarters deliver average positive earning surprise zack rank stock have earning esp icu medical inc icui free report company develop manufacture sell advanced medical device used vascular therapy critical care application product portfolio include iv smart pump set connector close transfer device hazardous drug cardiac monitoring system pain management safety software technology icu medical be set report third quarter result nov company have surpass zack consensus estimate precede quarters average earning beat currently company have earning esp carry zack rank more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1203,MDT,mazor robotic ltd mzor free report recently receive ce mark approval mazor surgical assurance platform approval allow mazor robotic partner medtronic mdt free report commercialize co promote market mazor platform country recognize ce mark mazor robotic medtronic have sign deal distribute mazor mazor robotic spine surgery system medtronic have make third tranche investment mazor robotic recently regard note mazor robotic recently report second quarter revenue approximately compare year quarter revenue upside be drive strong mazor system sale increase procedure volume last report second quarter mazor robotic receive purchase order mazor system unite state expect ce mark drive order system accord report mordor intelligence global market spinal surgery device have be estimate reach worth cagr period consider opportunity niche see company latest development strategic however company be face tough competition industry well establish player likestryker corporation syk free report zimmer biomet holding inc zbh free report estimate revision trend estimate revision trend have be favorable company current year estimate moved north compare movement opposite direction last month result zack consensus estimate full year have narrow loss cent share loss cent stock watch massive equifax stock spiked recent news datum breach affect american stock be best buy candidate right now do future hold cybersecurity industry equifax be just most recent victim computer hacking identity theft be more common ever zack have just release cybersecurity investor guide inform zack com reader year space more importantly highlight cybersecurity pick strong profit potential get new investing guide now
1204,MDT,medtronic plc mdt free report continue broaden portfolio pain therapeutic solution follow fda approval company have recently make significant breakthrough launch intelli platform management certain type chronic intractable pain medtronic intelli platform be able overcome certain limitation related current spinal cord stimulation scs system battery performance platform power evolve standardize guidance balance high dose hd low dose ld therapy setting other advancement platform be worth mention be manage samsung galaxy tab tablet interface provide physician faster delivery evolve workflow software upgrade intelli platform include medtronic proprietary mri technology broadest access available mri diagnostic imaging simple eligibility determination well adaptivestim technology automatic adjustment deliver right therapy dose right location pain target shift accord body position transparency market research report global pain management therapeutic market be expect ascend medtronic back problem be top most expensive medical condition estimate patient annually undergo lumbosacral spine procedure develop chronic intractable pain keep problem mind be look forward solid customer adoption intelli platform consider huge grow market chronic pain management medtronic plc price medtronic plc price medtronic plc quote last month medtronic have underperform broader industry stock have lose versus gain broader industry period zack rank key picksmedtronic carry zack rank sell better rank medical stock be edward lifescience corporation ew free report cheme corporation che free report amedisys inc am free report edward lifescience sport zack rank strong buy cheme amedisys carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have rally roughly last month cheme have long term expect earning growth rate stock have gain last month amedisys have long term expect earning growth rate stock have gain last month trade profit big league trump policiesif stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
1205,MDT,month have go last earning report medtronic plc mdt free report share have lose time frame underperform market recent negative trend continue lead stock next earning release be due dive investor analyst have react late let take quick look most recent earning report order get better handle important catalyst recent report financial result first quarter fiscal adjust earning share ep report quarter come surpass zack consensus estimate year year adjustment quarter primarily include certain impact restructure charge intangible asset amortization acquisition related item adjust unfavorable foreign exchange impact cent adjust ep come year year adjustment company report net income cent share year year total revenue report quarter gross constant exchange rate cer basis report basis top line miss zack consensus estimate foreign currency fluctuation affected medtronic fiscal first quarter revenue quarter review sale total revenue increase year year develop market revenue totale total revenue reflect increase cer report emerge market total revenue amount cer report segment company currently generate revenue major group viz cardiac vascular group cvg minimally invasive therapy group mitg restorative therapy group rtg diabetes group cvg comprise cardiac rhythm heart failure crhf coronary structural heart csh aortic peripheral vascular division apv mitg include surgical solution patient monitoring recovery pmr division rtg include spine brain therapy specialty therapy pain therapy segment diabetes group incorporate intensive insulin management iim intensive diabetes therapy ndt diabetes service solution dss division revenue cvg improve cer report drive strong balanced growth division crhf sale be year year cer report come back growth arrhythmia management lead high teen growth atrial fibrillation solution cer amplify penetration micra transcatheter pace system strong uptake tyrx absorbable antibacterial envelope continue worldwide customer demand reveal linq insertable cardiac monitor apart heartware international acquisition drive growth heart failure division csh revenue be cer report back high constant currency growth transcatheter aortic valf result strong customer uptake corevalve evolut pro platform unite state continue demand corevalve evolut mm valve unite state well europe apv revenue register growth cer report drive continue adoption endurant iis aortic stent graft remarkable strength heli fx endoanchor system peripheral be drive low double digit growth atherectomy drug coat balloon mitg worldwide sale reach mark year year increase cer same report mid single digit growth surgical solution low single digit growth pmr rtg worldwide revenue be year year cer same report high single digit growth brain therapy mid single digit growth specialty therapy low single digit growth spine thus mitigate decline pain therapy however revenue diabetes group decrease cer same report marginsgross margin report quarter contract basis point bps increase gross profit adjust operate margin remain flat year year be owing decline research development expense be offset rise selling general administrative expense other expense report quarter be compare year period reiterate fiscal constant currency revenue ep guidance company still expect full year revenue growth range cer however company revise foreign currency fluctuation estimation be now project have positive impact fiscal year compare expect positive impact state previously zack consensus estimate revenue remain fiscal fiscal adjust earning share growth be still expect range cer currency translation be now expect have adverse impact cent positive impact cent compare earlier expectation negative impact approximately cent zack consensus estimate fiscal earning be peg moreover second quarter fiscal medtronic expect currency translation have favorable impact revenue currency translation be expect have favorable impact cent second quarter earning share have estimate be move then analyst be quiet last month none issue earning estimate revision medtronic plc price consensus medtronic plc price consensus medtronic plc quotevgm scoresat time medtronic stock have nice growth score be lag lot momentum front stock be allocate grade value side putt top investment strategy overall stock have aggregate vgm score aren focuse strategy score be be interested zack style score indicate company stock be suitable value growth investor stock have zack rank sell expect average return stock next few month
1206,MDT,earning season have take center stage member account index total market capitalization have report number latest earning preview total earning company be same period last year higher revenue beating earning surpass revenue estimate member line release quarterly result week be decidedly bullish equity market be gradually demonstrate improvement sequentially needless say ongoing week be crucial season end have result more bigwig medical broader sector zack sector be expect put impressive show quarter third quarter expect earning growth rate sector be revenue growth comparison report earning growth rate second quarter be quite impressive revenue growth let take look major factor be likely influence earning result medtech company broader medical universe factor influence medtech hurricane wreak havoc various report suggest hurricane end third quarter be likely mar revenue earning several medtech company primarily florida texas puerto rico medtech major ecolab ecl free report expect impact hurricane full year sale cost be approximately cent share fact medtronic mdt free report acknowledge impact hurricane marium quarterly metric company expect almost impact revenue earning apart natural factor rise unemployment short live decline consumer income couple increase aggregate spending be likely deal heavy blow medtech number political conundrumwhile overall investment world have be gain prominence investor medtech industry be unfortunately see reverse trend stock tumble thing get riskier graham cassidy bill retract obamacare fail gain support again president trump latest executive order have already become serious threat healthcare community large regard let not forget tax reform pledge trump have take abolish infamous medical device sale tax investor confidence trend upwards hope enactment new tax reform believe market have not get whiff due lack favorable development regulatory front favorable consumer behavior political issue healthcare space change consumer demand market dynamic lead dramatic transformation entire healthcare system last couple year be evident grow prevalence minimally invasive surgery rise demand liquid biopsy test use ensure quick improve patient care shift payment system value base model let take look major medical product stock slate release quarterly report nov becton dickinson company bdx free report becton dickinson be schedule report fourth quarter fiscal result open bell fiscal revenue be anticipate increase look quarterly estimate zack consensus estimate bd medical segment be fourth quarter signify sequential growth meanwhile zack consensus estimate medical surgical system be peg last quarter report number company innovative product pipeline be key catalyst view plethora regulatory approval unite state international market be help company rapidly expand product portfolio read more be becton dickinson poise beat earning buoy solid prospect quantitative model show beat company give combination zack rank buy earning esp becton dickinson company price consensus becton dickinson company price consensus becton dickinson company corporation abc free report be schedule report fourth quarter fiscal result market open quarterly result be expect show steady growth pharmaceutical distribution segment significant contributor company revenue zack consensus estimate segment stand reflect improvement almost year quarter flipside generic inflation have be nominal rate deflation be rise gradually furthermore anticipate shift product mix lower margin higher price specialty brand drug affect company bottom line read more earning disappoint meanwhile zack consensus estimate earning stand share year year consensus estimate net revenue be peg signify growth year year basis proven model do not predict earning beat company season thank earning esp zack rank hold see complete list today zack rank strong buy stock here corporation hold co price consensus corporation hold co price consensus corporation hold co quoteteleflex incorporate tfx free report teleflex be expect announce third quarter result market open believe company medical surgical instrument device segment drive top line season zack consensus estimate segment revenue stand year report number company strong focus high flow nasal cannula therapy hfnct be likely lend competitive edge niche space solid growth preload microbial thrombogenic vps piccs platform be likely strengthen vascular platform surgical segment new product efx ae product fortify company foothold finally company flagship lma unique product strengthen anasthesia product line quantitative model predict earning beat teleflex third quarter stock currently have zack rank earning esp notably zack consensus estimate revenue be third quarter year year basis consensus estimate earning be peg signify growth year year teleflex incorporate price consensus teleflex incorporate price consensus teleflex incorporate quote more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1207,MDT,unite therapeutic corporation uthr free report report earning share third quarter substantially higher share year quarter zack consensus estimate stand share however adjust earning exclude share base compensation expense impairment cost other item come share same period increase compare year quarter revenue report quarter be beating zack consensus estimate revenue also grow year year stronger sale pulmonary arterial hypertension pah franchise improve top line quarter share unite therapeutic have underperform industry so far year have decline industry have decrease period quarter detailunite therapeutic market product treatment pah remodulin tyvaso adcirca orenitram company report orenitram sale quarter year year adcirca sale be year year remodulin sale be year year tyvaso sale totale year year sale tyvaso also decline sequentially quarter unituxin treatment pediatric patient high risk neuroblastoma sale be year year research development expense escalate due higher cost support company pipeline cardiopulmonary cancer drug develop organ manufacturing project selling general administrative sg expense plunge lower consult marketing cost offset higher legal cost pipeline updateunited therapeutic be work medical device maker medtronic inc mdt free report get implantable pump deliver remodulin remosynch approve fda order launch remosynch unite state company be pursue parallel regulatory filing related device drug remind investor april unite therapeutic announce regulatory issue delay plan launch remosynch company now expect launch same sometime instead first half year expect previously unite therapeutic be also work deka technology company develop pre filled semi disposable pump system subcutaneous delivery remodulin remunity clinical study remopro pain free new chemical entity version treprostinil be expect begin year other phase iii pipeline program include oral combination therapy orenitram oreniplus freedom ev study tysuberprost esuberaprost combination tyvaso tyvaso ild tyvaso be evaluate patient pah associate idiopathic pulmonary fibrosis orenileft pah left ventricular diastolic dysfunction company have also begin clinical development dinutuximab active ingredient unituxin small cell lung cancer phase iii distinct study unite therapeutic corporation price consensus ep surprise unite therapeutic corporation price consensus ep surprise unite therapeutic corporation quotezack rank key picksunite therapeutic carry zack rank hold better rank stock healthcare sector include ligand pharmaceutical inc lgnd free report nordisk nvo free report ligand sport zack rank strong buy nordisk carry zack rank buy see complete list today zack rank stock here ligand earning share estimate have moved last day company deliver positive earning surprise trail quarters average beat share price company have surge year date nordisk earning share estimate have inched last day company come positive earning surprise trail quarters average beat share price company have rally year date look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
1208,MDT,medtronic plc mdt free report announce positive result analysis conduct adaptivcrt algorithm european heart rhythm association ehra scientific session barcelona spain study demonstrated adaptivcrt algorithm reduce atrial fibrillation af episode higher patient activity level result be base heart failure patient medtronic cardiac therapy crt device center italy first study show significant reduction occurrence af episode measure duration patient adaptivcrt compare patient traditional crt second study reveal adaptivcrt be link higher daily activity level patient feature compare patient conventional crt company crt be establish treatment patient heart failure use implantable defibrillator crt pacemaker crt enhance heart pump efficiency adaptivcrt platform glancein medicine crt resynchronize contraction heart ventricle send electrical impulse heart muscle thus crt help heart pump blood body more efficiently be very promising technique market cardiac rhythm management heart failure medtronic adaptivcrt platform minutely evaluate cardiac rhythm back pace operation namely adaptive lv adaptive major crt platform medtronic clarium mri crt percepta crt mri deserve mention development cardiac rhythm heart failure company be consistently try improve cardiac rhythm heart failure division part cardiac vascular group cvg line medtronic recently announce receipt fda approval commercial launch portfolio azure pacemaker bluesync technology medtronic receive fda approval quadripolar cardiac therapy pacemaker crt ps improve therapy delivery patient heart failure market potentialper globaldata report global heart failure market be set reach worth cagr consider bullish market sentiment believe latest development be timely stock performance estimate revisionover past month share medtronic have underperform industry stock have dip industry index gain also estimate revision trend current year be unfavorable estimate move south last month compare opposite direction earning estimate fall share zack rank key picksmedtronic carry zack rank hold few better rank stock broader medical sector be bio rad laboratory bio free report athenahealth inc athn free report varian medical system inc var free report bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here company have long term expect earning growth rate athenahealth be zack rank player company have long term expect earning growth rate varian medical have long term expect earning growth rate stock carry zack rank buy make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
1209,MDT,emerge market investment have take backseat late thank nonstop blow economy linger geopolitical tension gulf debt policy related hazard latin america missile test north korea have lead stock investor reconsider outlay market earlier proclaim offer better growth opportunity unite state go msci emerge market index last year annualize growth rate be just other hand gdp capita growth rate last year unite state be international monetary fund world economic outlook database face such adversity goldman sachs statement bloomberg last week address emerge market stock world best bet have create quite stir investment world accord report follow selloff february other market correction investor be keen put money riskier asset emerge economy time msci index have not show significant improvement then comment sheila patel chief executive officer international gsam have force investor think again take asset market go bloomberg report goldman sachs be particularly bet indian healthcare firm consumer stock argentine debt expect india government boost spending public health prime minister narendra modi political risk be ignore investor pessimism mexico argentina be overdo report say emerge market healthcare scenario way better unite patel particularly talk grow prospect indian healthcare market datum show prospect broader emerge market be equally encourage contrary healthcare scenario unite state be muddle survey report gallup analytic last july reveal adult cite healthcare second major problem face country new presidential administration follow new healthcare reform announcement december gallup poll next month state past decade marked biggest increase uninsured rate new healthcare reform bring term scenario remain pretty unclear now meanwhile explode population rise middle class increase governmental awareness health issue emerge geography be face huge demand modern cheaper healthcare option go report guardian international finance corp ifj datum show develop country account global death chronic disease indicate enormous market opportunity emerge market opening medtechper recent bcg report share emerge market be currently less quarter global medtech revenue be likely increase nearly third revenue medtech market china currently second largest world be project grow annually india fifth largest medtech market world currently record annual growth pace india emerge strong competitor japan germany other emerge geographical region latin america even face economic stagnation hold enormous potential january report medtech intelligence central south american nation significantly increase capita spending healthcare give huge potential region long back johnson johnson jnj free report have set manufacturing center india china brazil company emerge market medical device segment continue grow time faster develop market abbott free report continue lead emerge market investment trend sale region recent quarters sale key emerge market be double digit drive strength bric well strong growth several country latin america include colombia mexico peru argentina medtronic mdt free report second quarter fiscal business china latin america southeast asia show sustain strength grow double digit overall medtronic long term outlook emerge market be encourage boston scientific bsx free report emerge market business register organic growth fourth quarter reflect significant increase growth business china be once again remarkable year year growth pace emerge market have decline pre financial crisis year however market have historically play crucial role large corporation hedge international trade risk accord bcg report go forward emerge market gdp be project grow faster develop economy market account total consumer spending more investor point view be imprudent immense growth potential emerge economy due occasional rough spot today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
1210,MDT,johnson johnson jnj free report announce have receive bound offer approximately private equity firm platinum equity lifescan diabetes device unit lifescan unit make blood glucose monitoring product generate revenue last year stock have decline year so far compare unfavorably gain record industry have time jun offer fail expire accept offer transaction be expect close end year sale diabetes care franchise decline due price decline competitive pressure have be evaluate potential strategic option diabetes care unit specifically lifescan corporation calibra medical early last year fact october announce close operation corporation diabetes care unit exit insulin pump business stop manufacturing vibe onetouch ping insulin pump say deal medical device maker medtronic inc mdt free report patient used insulin pump be offer option transfer medtronic pump carry zack rank hold better rank large cap pharma stock include abbvie inc abbv free report pfizer inc pfe free report zack rank buy see complete list today zack rank strong buy stock here abbvie earning share estimate have moved almost last day share company have shot year pfizer earning share estimate have moved last day share price company have increase past year more stock news be bigger iphoneit become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1211,MDT,few month line republican complete full year power unfortunately political power change healthcare community hasn have many opportunity rejoice survey report gallup analytic last month reveal adult cite healthcare second major problem face country new presidential administration fact debate repeal affordable care act aca obamacare have be rage now report peaked reach congress august consider prevailing uncertainty implementation health policy respite term seem unlikely medtech unite state blur pictureneedless say current crisis medtech industry integral part broader healthcare space show sign abate few month back company space be hopeful promise cancellation medtech tax obamacare new government unquestionably latest political development have land medtech space uncertain territory investor be mull retain exist medtech stock forego holding favor company other industry boost financial resource say spite future hold believe investor stick medtech space have show sign prosperity recent time globally yes read right even consider dull performance medical device market still hold lead position almost third world market share rise regulatory legislative uncertainty global growth have be quite encourage industry grow pace last see financial crisis emerge market hold immense uncertainty unite state worsening economic condition europe automatically shift focus emerge geography china india latin america other emerge economy be see rise uptake medical device largely due grow medical awareness economic prosperity age population increase wealth government focus healthcare infrastructure expansion medical insurance coverage make market happy hunting ground global medical device player add rise healthcare spending improve healthcare infrastructure growth continue go recent bcg report share emerge market be currently less quarter global medtech revenue be likely increase nearly third revenue medtech market china currently second largest world be project grow annually india medtech market fifth largest world be currently demonstrate annual growth continue india give good competition japan germany other emerge geography latin america even face general economic stagnation hold enormous potential january report medtech intelligence central south american nation significantly increase capita spending healthcare period accord world bank datum guatemala increase spending brazil chile colombia uruguay paraguay ecuador lower domestic production latin america have make open market exporter investment emerge market player look sensiblein such scenario believe be wise investor be keen medtech stock keep eye company have turn emerge market happy hunting ground expertise network wonder stock cash enormous growth potential emerge geography have perfectly shield political turmoil unite state let look few medtech player significant emerge market presence give huge potential region long back johnson johnson jnj free report have set manufacturing center brazil china india company medical device segment emerge market be grow time faster develop market have be do business china nearly year be expand further here back synthe acquisition johnson johnson price consensus johnson johnson price consensus chart johnson johnson quote abbott free report continue lead emerge market investment trend sale region recent quarters sale key emerge market be double digit drive strength bric well strong growth several country latin america include colombia mexico peru argentina abbott laboratory price consensus abbott laboratory price consensus chart abbott laboratory quote medtronic mdt free report last report first quarter fiscal business china latin america southeast asia show sustain strength grow double digit overall medtronic remain confident long term outlook emerge market company be focuse develop new public private partnership well execute channel optimization strategy medtronic plc price consensus medtronic plc price consensus chart medtronic plc quote boston scientific bsx free report emerge market business register organic growth second quarter significant increase growth business china be once again remarkable year year company be currently look forward much better performance ahead china banking recent approval synergy china boston scientific corporation price consensus boston scientific corporation price consensus chart boston scientific corporation quote thermo fisher tmo free report too be leave stone unturned expand presence emerge market company garner total revenue high growth asia pacific emerge market thermo fisher scientific inc price consensus thermo fisher scientific inc price consensus chart thermo fisher scientific inc quote wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
1212,MDT,wall street be gear third quarter release republican have lose battle pertain repeal affordable care act aca obamacare recent graham cassidy bill defeat sometimes lose battle find new way war president trump however recent development suggest table turn again president latest executive order aim exempt certain association health plan buy health insurance core obamacare schedule take shape serious threat healthcare community large also rep lindsey graham promise revisit graham cassidy legislation deserve mention here issue medtech industry have so far have bullish run notwithstanding third quarter be likely take hit policy debacle fact latest gop defeat dampen probability new republican healthcare reform better tax paradigm time soon here take sneak peek other burn issue be likely impact quarterly number medtech fraternity tax wo present point focus capitol hill seem be tax cut medtech community have be quite hopeful change presidential power trump propose policy have be favor abolition infamous medical device sale tax undoubtedly abolition tax paradigm be far be achieve add stronger dollar pricing shipping related issue well core market challenge be likely affect quarterly number medtech major season hurricane deal blow various report suggest unfortunate occurrence hurricane end third quarter be likely mar revenue earning several medtech company primarily florida texas puerto rico medtech major medtronic mdt free report acknowledge impact hurricane marium quarterly metric company expect almost impact revenue earning apart natural calamity rise unemployment short live decline consumer income couple increase aggregate spending be likely deal heavy blow medtech number stock buy solid return have take help zack stock screener shortlist medtech stock zack rank strong buy buy be expect yield solid result third quarter have zero stock andhave favorable growth style score research show stock style score combine zack rank offer best investment opportunity furthermore estimate revision trend stock have be solid current quarter idexx laboratory inc idxx free report zack rank company have growth score idexx laboratory be developer manufacturer distributer product service primarily companion animal veterinary livestock poultry water testing dairy market company expect livestock poultry dairy revenue witness stellar growth quarter strong growth china last month analyst moved north compare movement opposite direction zack consensus estimate increase current quarter same time frame company be expect see sale growth quarter be report furthermore earning be expect increase year year basis idexx laboratory inc price consensus idexx laboratory inc price consensus idexx laboratory inc quotesteris corp ste free report zack rank company have growth score recent past steris have be strategically pursue expansion adjacent market acquisition dilution earlier year company sell uk linen business have late complete divestment linen business come estimate revision trend current quarter analyst moved north compare movement opposite direction completion synergy health deal steris combine business be expect gain market traction overseas additionally strong cash balance position be encourage steris be expect witness growth earning quarter be report year year basis steris plc price consensus steris plc price consensus steris plc quotek group holding inc free report zack rank company have growth score estimate revision trend stock have be solid upward estimate revision last month zack consensus estimate current quarter increase same time frame solid operational execution group be expect enjoy edge spinal fusion market quarter furthermore significant progress product development print product portfolio be positive company be expect witness growth sale rise earning third quarter group holding inc price consensus group holding inc price consensus group holding inc quotetandem diabetes care inc tndm free report zack rank company have growth score demand tandem next generation slim pump be expect stay high add stellar growth insulin pump sale be expect drive company third quarter number estimate revision trend stock have be solid estimate move upward compare downward last month zack consensus estimate current quarter rise same time frame company be expect witness growth sale rise earning third quarter tandem diabetes care inc price consensus tandem diabetes care inc price consensus tandem diabetes care inc quoteintersect ent inc xent free report zack rank stock have growth score successful launch past propel contour be expect be key driver third quarter sale company initial product propel propel mini be drug eluting implant use patient chronic sinusitis offer product therapy ear nose throat surgeon improve treatment patient chronic disease intersect be expect witness year year growth sale rise earning quarter be report intersect ent inc price consensus intersect ent inc price consensus intersect ent inc quotetoday stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
1213,MDT,benchmark end negative territory monday follow slump healthcare financial sector share general electric decline drag dow lower however share apple gain follow speculation gain new tax code propose trump administration dow jone industrial average djia close decline index inx decrease close meanwhile nasdaq composite index ixic close decrease total share be trade monday lower last session average share decline issue outnumber advancer nyse ratio nasdaq decliner outnumber advancer ratio cboe vix increase close nasdaq post lossesthe lose almost point end negative territory monday trading just point intraday record earlier session major sector end negative territory healthcare financial lead decliner health care select sector spdr etf xlv financial select sector spdr etf xlf be respectively share medtronic mdt free report express script hold esrx free report decline respectively be biggest draghunt healthcare sector moreover financial sector tank share blackrock blk free report citigroup free report bank america bac free report well fargo wfc free report decline respectively see complete list today zack rank strong buy stock here share ge weigh dow shed almost point finish negative territory share general electric ge free report tank almost weigh heavily blue chip index share auto maker plunge follow news ceo jeff bornstein plan step post end year follow be marketing chief ge beth comstock international executive john rice step respective post carmaker also announce have give board position activist investment firm trian fund management trump new tax code keep market boostedin announcement earlier month trump aide unveil new reform tax policy effectively lower taxe business individual proposal seek decrease corporate tax rate moreover pass business taxe currently categorize individual tax code be slash subsequently plan also reveal current personal tax slab be reduce only respectively boost gain broader market investor remain highly hopeful new tax code be sign law stock make lng project come online achieve new milestoneenergy behemoth chevron corporation cvx free report recently commence production wheatstone lng project western australia read more phillip announce share repurchase program worth bmidstream energy player phillip psx free report have receive consent new share repurchase program board director read more today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
1214,MDT,medtronic plc mdt free report have present positive datum home pediatric study patient age year notably datum be base minime system be demonstrated advanced technology treatment diabetes international conference vienna austria study result multus center study have enrolled participant year age group trial consist week run phase study phase month participant choose continue used system part continue access program moreover study result demonstrated datum pivotal trial minime system patient age year used study result company have apply expand fda approval include patient range year eligible used minime system same time company be work expand usage product child age year hope be harbore effectiveness system get greater customer adoptability time minime glancepost receipt fda approval medtronic have commercially launch minime system june be hybrid close loop insulin delivery system type diabetic patient age year older minime system feature medtronic latest guardian sensor glucose sensor increase accuracy enhance performance be only fda approve sensor control hybrid close loop system include diagnostic technology continuously check sensor health system also carry medtronic most advanced algorithm know smartguard hcl technology development diabetes witness sluggish growth diabetes business last quarter however company gain strong uptake new sensor augment insulin pump system unite state well international market growth be temporarily offset limit supply continuous glucose monitor cgm sensor moreover strong customer enrollment priority access program briefly affected revenue management diabetes business witness revenue growth third quarter fiscal company have finished shipping pump priority access program also company be move steadily sensor capacity expansion plan schedule be complete fourth quarter fiscal additionally medtronic gear international launch minime launch cgm system guardian connect sugar iq late new professional cgm ipro regard company also announce favorable result support use cgm person type diabetes october apart be upbeat corporation johnson johnson diabetes care company exit insulin pump business medtronic partner support transition patient caregiver healthcare provider notably patient used insulin pump be offer choice switch medtronic pump market potentialan agee population unhealthy lifestyle rise awareness expenditure healthcare be likely drive growth diabetes market report mordor intelligence global market diabetes care device be project reach value cagr give bullish market sentiment believe latest positive study result have come opportune moment share price have be gain investor confidence consistently positive result past month company share price have outperformed broader industry stock have gain comparison broader industry increase zack rank key picksmedtronic carry zack rank hold better rank stock broader medical sector be perkinelmer pki free report bio rad laboratory bio free report becton dickinson company bdx free report perkinelmer have long term expect earning growth rate stock carry zack rank buy bio rad laboratory have zack rank see complete list today zack rank strong buy stock here company have long term expect earning growth rate becton dickinson company be zack rank player company have long term expect earning growth rate wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
1215,MDT,medtronic plc mdt free report be schedule report third quarter fiscal result open bell feb last quarter company deliver earning ahead zack consensus estimate fact medtronic bottom line outpaced estimate trail quarters average beat let see thing be shape prior announcement key catalystswe look forward quarter solid growth company successful execution growth strategy such therapy innovation globalization increase economic value medtronic combine demographic age population positive have start open opportunity medtronic get reflect third quarter well space therapy innovation be filled multiple development cardiac vascular group cvg new therapy be help company gain traction rapidly grow medtech market left ventricular assist device lvad transcatheter aortic valve replacement tavr drug coat balloon atrial fibrillation ablation insertable diagnostic medtronic plc price ep surprise medtronic plc price ep surprise medtronic plc quote fiscal third quarter medtronic be expect have maintain market share core pace icd implantable cardioverter defibrillator crt cardiac therapy product line scope crhf cardiac rhythm heart failure create new meaningful market enhance company weight average market growth tavr space company expect see continue global growth strong adoption world evolut pro valve well expansion traditional tavr center share capture result medtronic new intermediate risk indication several quarters dull drug eluting stent de performance coronary company de product line witness growth unite state japan last couple quarters upside be drive recent launch resolute onyx say market further development buoy optimism strengthen belief strong quarterly performance company be report quarter fiscal cvg be project rise growth pertain third quarter fiscal more favorable prior year comparison zack consensus estimate cvg revenue fiscal third quarter be peg higher year report number minimally invasive therapy group mitg surgical innovation register sturdy growth drive new product advanced stapling advanced energy advanced stapling growth come back endo stapling specialty reload tri staple technology well signia advanced energy growth bank continue rollout company ligasure instrument valleylab ft energy platform medtronic expect mitg revenue increase range fiscal notably first half fiscal lodge lower mitg rise due adverse impact hurricane marium imply accelerate second half improvement restorative therapy group rtg company witness encourage development regard brain therapy space division experience very strong second quarter drive high growth neurovascular strength entire stroke portfolio mid teen increase neurosurgery expect bullish trend continue third quarter well medtronic estimate rtg growth approximately fiscal balancing impact hurricane marium spine market projection be flat slightly continue strength brain therapy zack consensus estimate mitg revenue soon be report quarter be peg higher year report figure overall medtronic expect full year revenue growth cer currency fluctuation be expect leave positive impact fiscal result zack consensus estimate revenue remain adjust earning share growth fiscal be expect range cer currency translation be expect adversely impact couple cent consensus mark fiscal earning be peg here quantitative model predict medtronic do not have right combination main ingredient positive earning esp favorable zack rank strong buy buy hold increase odd earning beat zack esp medtronic have earning esp uncover best stock buy sell re report earning esp filter zack rank medtronic carry zack rank hold increase predictive power esp however company need positive esp be confident earning surprise hence combination leave surprise prediction inconclusive caution sell rate stock go earning announcement especially company be see negative estimate revision stock considerhere be stock want consider same space proven model show have right combination element beat earning upcoming release universal health service inc uhs free report have earning esp zack rank see complete list today zack rank stock here inogen inc ingn free report have earning esp zack rank exelixis inc exel free report have earning esp be zack rank player don even think buy bitcoin read most popular cryptocurrency sky-rocket last year give investor chance bank return even more gain however come serious volatility risk bitcoin sank more time zack have just release new special report help reader capitalize explosive profit potential bitcoin other cryptocurrency significantly less volatility buy directly see crypto related stock now
1216,MDT,boston scientific corporation bsx free report have recently announce major investment santa rosa base millipede inc augment position field mitral regurgitation mr millipede be developer iris transcatheter annuloplasty ring system treatment severe mr term agreement boston scientific have purchase portion millipede company have also keep option acquire remain share millipede point time prior completion first human clinical study meet certain parameter also millipede have option compel boston scientific purchase remain share closure clinical study full buyout millipede need additional payment boston scientific further be paid achievement commercial milestone regard management note mr occur leak mitral valve cause blood regurgitate left ventricle left atrium heart condition gradually lead heart failure heart rhythm problem patient severe mr often complain compromise heart function tolerate open heart surgery repair replacement leak valve management be optimistic large patient population space be unfortunately underserved moment hence area represent lucrative market be tap patient population benefit fully percutaneous transcatheter procedure fix dilate mitral reduce regurgitation undergo surgery encouragingly millipede iris annuloplasty ring claim be highly customizable specific patient anatomy disease state device be supply transcatheter transseptal delivery system follow standard surgical approach mend decrease size dilate mitral positive note global transcatheter mitral valve replacement market be grow stupendously cagr approximately datum provide technavio apart boston scientific other major player field be edward lifescience corporation ew free report medtronic plc mdt free report abbott free report wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
1217,MDT,masimo corp masi free report report earning cent share fourth quarter outperform zack consensus estimate cent bottom line improve year quarter figure cent revenue improve year quarter beat zack consensus estimate segmental analysisproduct revenue product revenue deliver strong quarter double digit growth fourth quarter masimo acquire significant renewal renown hospital hospital system revenue growth segment be double digit product revenue also witness impressive growth overseas market new product include nomoline capnography sedline brain function monitoring organ oximetry contribute result revenue segment be year year company worldwide direct product revenue increase year year basis direct product revenue be total product revenue oem sale increase year year basis fourth quarter account total product revenue revenue sale masimo rainbow product surge fourth quarter compare year quarter royalty other revenuesrevenue segment be quarter year quarter management royalty revenue medtronic mdt free report decline margin analysistotal gross profit fourth quarter be year year gross margin be net revenue basis point bps year year product gross margin fourth quarter be net revenue compare year quarter balance sheetat end fourth quarter total cash cash equivalent be compare year quarter masimo repurchase approximately share common stock total cost revenue be estimate total product revenue be estimate royalty other revenue be estimate adjust earning share ar expect reflect increase approximately year year other company solid earning resultsother medtech company report impressive result earning season be petm express pet free report perkinelmer pki free report petm report third quarter fiscal result jan adjust earning share be cent prior year quarter revenue rise year year basis perkinelmer report fourth quarter adjust earning share cent jan adjust revenue be approximately year quarter hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
1218,MDT,abbott free report have recently enter agreement diagnostic technology player surmodic inc srdx free report term deal former have exclusive worldwide right surmodic surveil drug coat balloon deal remain align abbott focus expand broad line vascular care product notably surveil drug coat balloon surmodic be used treat superficial femoral artery be evaluation pivotal clinical trial significantly new generation device be likely complement extend company vascular device portfolio include stent vessel closure device address peripheral artery disease pad american heart association pad be narrowing artery cause reduce blood flow leg stomach arm head accord abbott condition be often underdiagnosed lead other serious vascular condition regard drug coat balloon have emerge important treatment option treatment pad globally person be affected pad american alone age year be suffering disease undoubtedly market therapy related indication look lucrative abbott surveil drug coat balloon hold greater promise capture market compare traditional device be include proprietary drug excipient formulation durable balloon coating be manufacture used innovative process improve coating uniformity pre clinical datum surveil have show time higher target tissue drug concentration more evenly distribute durable drug effect lower incidence downstream drug particle comparison control drug coat balloon accordingly surmodic deal seem highly strategic abbott point view monopolize huge grow market pad regulate drug coat balloon apart surveil related pact abbott have choice negotiate agreement surmodic knee arteriovenous fistula drug coat balloon product currently pre clinical development datum reportsnreport global market peripheral vascular intervention include lower extremity stent percutaneous transluminal angioplasty pta balloon pta drug eluting balloon carotid stent renal stent be estimate rise cagr major player drug coat balloon market be medtronic inc mdt free report becton dickinson company bdx free report hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
1219,MDT,share mazor robotic ltd mzor free report rally new week high sep eventually close little lower stock currently carry zack rank buy israel base developer robotic technology product have market cap roughly average volume share trade last month be company have expect long term earning share growth mazor robotic have outperformed industry past year company share have moved period compare industry gain strategic partnership medtroniclast wednesday mazor robotic announce have amend strategic partnership medtronic plc mdt free report amendment duo enter next phase agreement earlier be expect medtronic assume exclusive worldwide distribution mazor system make third tranche investment mazor robotic grow installation mazor systemsin last report quarter company have receive purchase order surgical guidance system include mazor system renaissance system be mazor customer primarily major hospital corporation renaissance system order receive be sell internationally distribution partner australia thailand mazor robotic system backlog end second quarter reach global basis company end second quarter system install worldwide unite state solid revenue growth second quartermazor robotic report total revenue beating zack consensus estimate notably revenue marked increase year year basis solid performance be drive positive factor strong sale order pipeline new mazor system continue utilization renaissance install base favorable regulatory year company announce receipt fda clearance mazor align software software be design assist surgeon plan spinal deformity correction spinal alignment procedure perform mazor surgical assurance platform consider development be encourage opportunity global spine surgery market research report market market suggest niche market reach worth cagr other key pickssome other medical stock worth consider be lantheus holding inc lnth free report idexx laboratory inc idxx free report stock carry zack rank see complete list today zack rank strong buy stock here lantheus holding have long term expect earning growth rate stock have gain last month idexx laboratory have long term expect earning growth rate stock have gain last month zack minute stock pick secretsince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar here something even more remarkable master proven system go single class seminar then apply portfolio little minute month learn secret
1220,MDT,aug issue update research report medtronic plc mdt free report medtronic exit fiscal first quarter mixed note earning exceed zack consensus estimate revenue miss same last month medtronic have underperform broader industry company have witness decline share price release quarterly result last share price movement company have lose broader industry gain last month moreover escalate cost expense be weigh margin also unfavorable foreign exchange continue remain drag positive note apart display successful integration achievement synergy target medtronic major business group continue contribute top line growth highlighted sustainability segment geography recently company announce receipt ce mark attain stability quad mri active fixation heart lead be also encourage solid growth trend continue unite state well healthy global acceptance advanced therapy moreover consistent gradually stabilize movement global cardiac rhythm heart failure crhf market be observed improve further come quarters be also look forward medtronic receive cash patient monitoring recovery pmr division divestment strengthen company position make further developmental investment meanwhile post covidien acquisition consolidated company have so far successfully demonstrated strong segmental performance reflect successful integration achievement synergy target apart note face severe macroeconomic pressure medtronic see growth emerge market last report quarter contribute nearly company overall revenue strong growth figure be line company double digit growth projection long term company be currently resort possible mean boost growth include penetrating emerge market expansion portfolio restructure initiative benefit medtronic long term be also encourage foray rapidly grow transcatheter mitral valve replacement market acquisition california base medical device start inc present medtronic carry zack rank sell key picksa few better rank medical stock be edward lifescience corporation ew free report idexx laboratory inc idxx free report lantheus holding inc lnth free report edward lifescience sport zack rank strong buy lantheus holding idexx laboratory carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have rally roughly last month lantheus holding have long term expect earning growth rate stock have gain last month idexx laboratory have long term expect earning growth rate stock have gain last month zack minute stock pick secretsince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar here something even more remarkable master proven system go single class seminar then apply portfolio little minute month learn secret
1221,MDT,abbott laboratory free report have make encourage move respect medical device business company recently announce fda approval full maglev heartmate left ventricular assist device lvad build sophisticated full maglev fully magnetically levitated flow technology heartmate system provide advanced short term hemodynamic support advanced heart failure patient full maglev technology enable heartmate system lower trauma blood pass pump optimize blood flow interestingly heartmate be upgrade version exist heartmate ii system be used longer duration much await fda approval be award abbott post successful result momentum clinical study also encouragingly note heartmate receive ce mark management person unite state suffer heart failure roughly new patient be diagnosed condition year support datum statista report heart failure market state market be project value witness cagr moreover see encourage growth user penetration rate share ailing person thus consider datum base believe latest fda nod accelerate top line growth report culrav org global lvad market be project value witness cagr moreover transperency market research north american market ventricular assist device be expect see cagr period thus consider market potential abbott latest development help gain traction lvad space interestingly abbott medical device operate segment total revenue stand highest revenue gross business second quarter moreover company cardiovascular neuromodulation sub segment be highest contributor make total medical device revenue sale unite state alone thus company latest development help boost performance segment believe agee population unhealthy lifestyle rise awareness expenditure healthcare continue drive growth heart failure market however market be dominate many well establish player medtronic plc mdt free report boston scientiific corporation bsx free report be most prominent one moreover abbott have be gain investor confidence consistently positive result past month company share price have outperformed industry stock have gain higher broader industry gain company have also outperformed gain market same time frame zack rank key pickabbott carry zack rank hold better rank medical stock be edward lifescience corporation ew free report zack rank strong buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have rally roughly last month zack minute stock pick secretsince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar here something even more remarkable master proven system go single class seminar then apply portfolio little minute month learn secret
1222,MDT,share medtronic plc mdt free report dip post second quarter revenue miss zack consensus estimate coty inc coty free report share fall report fourth quarter adjust earning miss zack consensus estimate share tronc inc trnc free report surge company announce ross levinsohn new chief executive officer dsw inc dsw free report rally report second quarter earning share beating zack consensus estimate
1223,MDT,medtronic plc mdt free report lead global player medical technology service solution have make encourage move respect cardiac rhythm heart failure crhf business companyrecently announce ce mark approval attain stability quad mri active fixation heart lead be line company strategy focus research development high end medical device product core business line notably company be engage clinic trial evaluate attain stability quad mri active fixation heart lead unite state canada other region medtronic latest offer feature active fixation technology assist precise lead placement stability pair company quadripolar cardiac therapy defibrillator crt pacemaker crt company also initiate multicenter clinical study target enroll roughly patient site unite state canada europe hong kong malaysia global study be aim evaluate safety efficacy lead heart failure patient interestingly medtronic cardiac vascular group cvg segment account total revenue first quarter fiscal moreover company crhf sub segment be highest contributor make total cvg revenue be largely backed strong growth arrhythmia management well heartware international acquisition thus company latest development help boost performance segment medtronic strategy gain traction crhfsub segment seem be align datum provide ally market research report global cardiac monitoring cardiac rhythm management market be expect see cagr reach value believe high incidence cardiac disease due unhealthy lifestyle penetration concern company untapped market technological advancement increase awareness person continue drive global acceptance technology view encourage factor believe company european development attain stability quad mri active fixation heart lead be strategic broaden customer base however last month medtronic have be underperform broader industry stock have decline compare industry fall also underperform decline same time frame nevertheless believe latest ce mark approval boost investor confidence stock zack rank key picksmedtronic currently have zack rank hold few better rank medical stock be edward lifescience corporation ew free report lantheus holding inc lnth free report idexx laboratory inc idxx free report edward lifescience sport zack rank strong buy lantheus holding idexx laboratory carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month idexx laboratoriesha long term expect earning growth rate stock have rally roughly last month lantheus holding have long term expect earning growth rate stock have gain last month surprising tech stock keep eye tech stock have be major force market record high pick best one buy be tough simple way invest success entire sector zack have just release special report reveal thing tech company literally function more importantly reveal top stock set skyrocket increase demand device encourage get report now next wave innovation really take see stock now
1224,MDT,medtronic plc mdt free report have make encourage move respect aortic peripheral vascular apv business company recently announce receipt regulatory approval pact admiral drug coat balloon dcb japanese ministry health labour welfare mhlw medtronic pact admiral dcb gain approval treat peripheral artery disease pad upper leg particularly thigh superficial femoral artery knee popliteal artery however commercial launch product medtronic have collaborate japanese mhlw attain reimbursement approval company believe reimbursement approval widen global customer base pact admiral dcb japanese regulatory approval be grant pact admiral dcb ground successful result pact sfa japan trial development be line company strategy focus research development high end medical device product core business line note pact admiral dcb receive fda approval december treat superficial femoral popliteal artery moreover be commercially available europe receipt ce mark approval so far pad patient europe have be treat device interestingly medtronic revenue apv division improve year year constant exchange rate first quarter fiscal moreover peripheral vascular business grow low double digit atherectomy drug coat balloon latest development boost company performance segment medtronic strategy gain traction peripheral vascular sub segment seem be align datum provide report interventional cardiology peripheral vascular device market be expect see cagr reach value believe high incidence peripheral artery disease due unhealthy lifestyle age population penetration company untapped market rise need minimally invasive angioplasty procedure technological advancement increase awareness person continue drive global acceptance technology view encourage factor believe company japanese development pact admiral dcb be strategic broaden customer base however last month medtronic have be underperform broader industry stock have decline contrast industry gain also underperform gain same time frame nevertheless believe latest japanese regulatory approval boost investor confidence stock zack rank stock currently carry zack rank sell few better rank medical stock medical sector be edward lifescience corporation ew free report lantheus holding inc lnth free report amedisys inc am free report edward lifescience sport zack rank strong buy lantheus holding amedisys carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have rally roughly last month lantheus holding have long term expect earning growth rate stock have gain last month amedisys have long term expect earning growth rate stock have gain last month more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1225,MDT,medtronic plc mdt free report report financial result first quarter fiscal adjust earning share ep report quarter come surpass zack consensus estimate year year adjustment quarter primarily include certain impact restructure charge intangible asset amortization acquisition related item adjust unfavorable foreign exchange impact cent adjust ep come year year adjustment company report net income cent share year year total revenue report quarter gross constant exchange rate cer basis report basis top line miss zack consensus estimate foreign currency fluctuation affected medtronic fiscal first quarter revenue quarter review sale total revenue increase year year develop market revenue totale total revenue reflect increase cer report emerge market total revenue amount cer report medtronic plc price consensus ep surprise medtronic plc price consensus ep surprise medtronic plc quotesegment company currently generate revenue major group viz cardiac vascular group cvg minimally invasive therapy group mitg restorative therapy group rtg diabetes group cvg comprise cardiac rhythm heart failure crhf coronary structural heart csh aortic peripheral vascular division apv mitg include surgical solution patient monitoring recovery pmr division rtg include spine brain therapy specialty therapy pain therapy segment diabetes group incorporate intensive insulin management iim intensive diabetes therapy ndt diabetes service solution dss division revenue cvg improve cer report drive strong balanced growth division crhf sale be year year cer report come back growth arrhythmia management lead high teen growth atrial fibrillation solution cer amplify penetration micra transcatheter pace system strong uptake tyrx absorbable antibacterial envelope continue worldwide customer demand reveal linq insertable cardiac monitor apart heartware international acquisition drive growth heart failure division csh revenue be cer report back high constant currency growth transcatheter aortic valf result strong customer uptake corevalve evolut pro platform unite state continue demand corevalve evolut mm valve unite state well europe apv revenue register growth cer report drive continue adoption endurant iis aortic stent graft remarkable strength heli fx endoanchor system peripheral be drive low double digit growth atherectomy drug coat balloon mitg worldwide sale reach mark year year increase cer same report mid single digit growth surgical solution low single digit growth pmr rtg worldwide revenue be year year cer same report high single digit growth brain therapy mid single digit growth specialty therapy low single digit growth spine thus mitigate decline pain therapy however revenue diabetes group decrease cer same report marginsgross margin report quarter contract basis point bps increase gross profit adjust operate margin remain flat year year be owing decline research development expense be offset rise selling general administrative expense other expense report quarter be compare year period reiterate fiscal constant currency revenue ep guidance company still expect full year revenue growth range cer however company revise foreign currency fluctuation estimation be now project have positive impact fiscal year compare expect positive impact state previously zack consensus estimate revenue remain fiscal fiscal adjust earning share growth be still expect range cer currency translation be now expect have adverse impact cent positive impact cent compare earlier expectation negative impact approximately cent zack consensus estimate fiscal earning be peg moreover second quarter fiscal medtronic expect currency translation have favorable impact revenue currency translation be expect have favorable impact cent second quarter earning share takemedtronic exit fiscal fourth quarter mixed note earning ahead zack consensus estimate report revenue fail meet estimate company demonstrated improve segmental performance cer escalate cost expense continue weigh bottom line unfavorable currency translation act dampener company quarterly performance however fiscal guidance represent chance respite positive note major business group contribute solid top line growth cer highlighted sustainability group region addition display successful integration achievement synergy target be also encourage solid growth trend successfully continue well healthy global acceptance advanced therapy apart product innovation company be currently focuse geographical diversification business zack rank peer currently have zack rank hold few better rank medical stock be edward lifescience corp ew free report haemonetic corp hae free report idexx laboratory inc idxx free report edward lifescience sport zack rank strong buy haemonetic idexx carry zack rank buy see complete list today zack rank stock here edward lifescience second quarter adjust earning improve stupendous year year primarily drive strong sale growth company transcatheter heart valf business stock have gain last month idexx laboratory record second quarter ep cent cer year year report basis moreover revenue rise year year organic basis haemonetic report adjust ep cent first quarter fiscal year year moreover revenue inched year year cer quarter zack minute stock pick secretsince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar here something even more remarkable master proven system go single class seminar then apply portfolio little minute month learn secret
1226,MDT,medtronic plc mdt free report recently announce fda approval riptide aspiration system neurovascular unit broader restorative therapy group rtg add valuable tool company acute ischemic stroke ais product portfolio accord medtronic riptide aspiration system be design retrieve thrombus blood clot arc catheter restore blood flow patient experience blockage artery brain know ischemic stroke rtg rtg business currently include spine brain therapy specialty therapy pain therapy division notably last report second quarter fiscal revenue segment increase year year same cer improvement be drivenby low double digit growth brain therapy offset decline spine specialty therapy pain therapy rtg contribute total revenue last report quarter market prospectsper report transparency market research global ais diagnosis treatment market see cagr period market be expect reach worth end so latest development be strategic take bountiful opportunity niche space consideration stock performance estimate revisionover last month medtronic have outperformed broader industry stock have gain compare gain broader industry also estimate revision trend current year remain favorable estimate move north last month compare movement opposite direction estimate moved zack rank key picksmedtronic carry zack rank hold few better rank stock broader medical sector be amedisys inc am free report bio rad laboratory inc bio free report intuitive surgical inc isrg free report bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here company have long term expect earning growth rate amedisys have long term expect earning growth rate stock carry zack rank buy intuitive surgical have long term expect earning growth rate stock have zack rank zack top stock addition stock discuss know finest buy hold ticker entirety last year zack top stock portfolio produce double digit winner include fmc corp vmware rac stellar gain now brand new portfolio have be handpick company cover zack rank don miss chance get long term buy access zack top stock today
1227,MDT,medtronic plc mdt free report announce fda approval new clinician programmer use synchrome ii intrathecal drug delivery system be implantable pump provide target drug delivery chronic pain severe spasticity notably target drug delivery be consider alternative oral treatment chronic pain help reduce systemic opioid accord company new synchrome ii clinician programmer be design make therapy management simple provide clinician visual tool intuitive workflow company also plan make synchrome ii available unite state soon new synchrome ii clinician programmer help simplify therapy management also enable physician reduce pain intrathecal delivery medication so systemic opioid be reduce eliminate entirely synchrome ii clinician programmer be application run tablet good quality screen display well simple guide workflow also company implement design change enhance performance synchrome ii pump keep patient safety mind market prospectsper transparency market research report global pain management therapeutic market be expect reach worth so latest development be strategic take bountiful opportunity niche space consideration development pain be consistently try boost pain therapy division be part restorative therapy group recently company announce study result show superiority medtronic itb intrathecal baclofen therapy conventional medical management cmm reduction severe post stroke spasticity pss adult september company announce fda approval launch intelli platform management certain type chronic intractable pain stock performance estimate revisionover last month medtronic have outperformed broader industry stock have gain versus gain broader industry also estimate revision trend current year remain favorable estimate move north last month compare movement opposite direction company current estimate moved same time frame zack rank key picksmedtronic carry zack rank hold few better rank stock broader medical sector be amedisys inc am free report bio rad laboratory inc bio free report intuitive surgical inc isrg free report bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here company have long term expect earning growth rate amedisys have long term expect earning growth rate stock carry zack rank buy intuitive surgical have long term expect earning growth rate stock have zack rank more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1228,MDT,medtronic plc mdt free report announce study result show superiority medtronic itb intrathecal baclofen therapy conventional medical management cmm reduction severe post stroke spasticity pss adult notably result spasticity stroke randomise study sister trial be publish journal neurology neurosurgery psychiatry jnnp result demonstrate itb therapy lioresal intrathecal baclofen injection deliver synchrome ii infusion system be superior oral antispastic medication decrease muscle tone affected lower upper extremity go american association neurological surgeon datum more person suffer spasticity worldwide accord company severe spasticity patient have tight stiff muscle make everyday activity tire difficult proper treatment be not provide then excessive muscle tone significantly reduce quality life hence initiative provide effective treatment severe pss patient company demonstrated efficacy itb therapy oral medication sister be first randomize controlled open label multicentre study examine effectiveness safety itb therapy compare cmm oral medication treatment pss month active treatment development pain be consistently try boost pain therapy division be part restorative therapy group recently company announce fda approval new clinician programmer use synchrome ii intrathecal drug delivery system be implantable pump provide target drug delivery chronic pain severe spasticity september company announce fda approval launch intelli platform management certain type chronic intractable pain stock performance estimate revisionover last month medtronic have outperformed broader industry stock have gain versus gain broader industry also estimate revision trend current year remain favorable estimate move north last month compare movement opposite direction estimate moved zack rank key picksmedtronic carry zack rank hold few better rank stock broader medical sector be amedisys inc am free report bio rad laboratory inc bio free report intuitive surgical inc isrg free report bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here company have long term expect earning growth rate amedisys have long term expect earning growth rate stock carry zack rank buy intuitive surgical have long term expect earning growth rate stock have zack rank today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
1229,MDT,jan issue update research report surmodic inc srdx free report solid growth medical device ivd business drive surmodic growth trajectory however foreign exchange wo continue be headwind company stock have zack rank hold robust sale growth core business segment hold promise surmodic medical device segment contribute quarters company total revenue majority come hydrophilic coating royalty product sale include balloon catheter specialty catheter base technology other meanwhile ivd segment have witness strong sale stabilization reagent molecular diagnostic product company plan continue develop surmodic core medical device coating diagnostic reagent business company initiative strengthen research development program be also positive last few year company have make several acquisition have diversify revenue base further latest regulatory approval surveil reflect surmodic solid foothold drug delivery space buoy development surmodic issue solid guidance fiscal negative side weaken dollar compare euro be headwind result surmodic report foreign exchange loss euro denominate contingent consideration obligation related creagh medical acquisition last quarter company have significant foreign currency loss operate loss ireland other major concern cutthroat competition niche space be drawback surmodic flagship surveil drug coat balloon face stiff competition medtronic mdt free report admiral pact platformgloomy price share have underperform industry last year specifically stock have gain industry rally current level be also lower index return same time frame cutthroat competition limit consumer base be likely affect company business key picksa few better rank stock broader medical sector be integer holding corporation itgr free report bio rad laboratory inc bio free report bio rad laboratory flaunt zack rank strong buy see complete list today zack rank stock here company have long term expect earning growth rate integer holding have long term expect earning growth rate stock carry zack rank buy wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
1230,MDT,angiodynamic inc ango free report be set report second quarter fiscal result jan market open last quarter company report adjust earning cent share miss zack consensus estimate cent average angiodynamic deliver positive earning surprise trail quarters however lackluster price performance last year high debt level continue hinder company angiodynamic share have return mere compare industry rally let see thing be shape prior announcement factor playstrong product portfolio angiodynamic wide array product angiovac bioflo nanoknife enhance market opportunity notably pv business peripheral vascular sale have also build strong momentum angiodynamic have be experience growth other product family food management thrombus management bioflo product nanoknife disposable oncology section solero mta system drive growth company ride market solid response solero microwave tissue ablation mta system especially microwave ablation space platform be intend be used ablation soft tissue open procedure management solero be primary driver whopping year year increase oncology surgery sale last quarter robust fundamental growth story last year company sale witness cagr earning share see cagr company expect benefit ongoing market transition less invasive interventional procedure upcoming year unfavorable estimate revision trend estimate revision trend current quarter have be unfavorable angiodynamic current quarter zack consensus estimate revenue fall year year further zack consensus estimate earning decline cent share year year basis angiodynamic inc price ep surprise angiodynamic inc price ep surprise angiodynamic inc quoteearning quantitative model do not conclusively show earning beat angiodynamic quarter be stock need have positive earning esp zack rank strong buy buy hold be able beat estimate be not case here see zack esp angiodynamic currently have earning esp be most accurate estimate zack consensus estimate be peg cent uncover best stock buy sell re report earning esp filter zack rank angiodynamic currently carry zack rank increase predictive power esp however esp make surprise prediction difficult caution stock zack rank sell rate stock go earning announcement especially company be see negative estimate revision momentum stock considerhere be company want consider model show have right combination element post earning beat quarter edward lifescience corp ew free report have earning esp zack rank thermo fisher scientific inc tmo free report have earning esp zack rank medtronic plc mdt free report have earning esp zack rank investor alert breakthrough pendinga medical advance be now flashpoint theory realization billion dollar research have pour company be already generate substantial revenue even more wondrous product be pipeline cure variety deadly disease be sight so be big potential profit early investor zack name stock buy now click here see
1231,MDT,have be month last earning report medtronic plc mdt free report share have lose time frame underperform market recent negative trend continue lead stock next earning release be due dive investor analyst have react late let take quick look most recent earning report order get better handle important driver recent report second quarter fiscal adjust earning share ep beating zack consensus estimate earning however decline year year adjustment quarter primarily include impact restructure charge intangible asset amortization divestiture related item adverse effect hurricane marium acquisition related item adjust unfavorable foreign exchange impact adjust ep be adjustment company report ep be year year total revenue report quarter gross constant exchange rate cer basis report basis top line miss zack consensus estimate foreign currency fluctuation affected medtronic second quarter revenue quarter review sale total revenue decline year year develop market revenue totale total revenue reflect increase cer report emerge market revenue total revenue amount cer report segment company currently generate revenue major group viz cardiac vascular group cvg minimally invasive therapy group mitg restorative therapy group rtg diabetes group cvg comprise cardiac rhythm heart failure crhf coronary structural heart csh aortic peripheral vascular division apv mitg now include surgical innovation si respiratory renal rgr division divestiture patient care deep vein thrombosis compression nutritional insufficiency enteral fee business rtg comprise spine brain therapy specialty therapy pain therapy segment diabetes group incorporate intensive insulin management iim intensive diabetes therapy ndt diabetes service solution dss division cvg revenue improve cer report drive strong balanced growth division crhf sale totale year year cer report come back growth arrhythmia management lead high teen growth atrial fibrillation solution low double digit rise diagnostic cer amplify penetration micra transcatheter pace system strong uptake tyrx absorbable antibacterial envelope apart strong demand company suite quadripolar cardiac therapy pacemaker crt growth mechanical circulatory support drive heart failure division revenue csh revenue be cer report back high constant currency growth transcatheter aortic valf result strong customer uptake corevalve evolut pro platform moreover company recent launch resolute onyx drug eluting stent unite state japan revive coronary business apv revenue register growth cer report drive continue adoption valiant stent graft system strength heli fx endoanchor system peripheral be drive double digit growth percutaneous transluminal angioplasty drug coat balloon moreover recently launch concerto detachable coil system drive mid single digit growth endovenous mitg worldwide sale reach mark year year increase cer report basis mid single digit growth si be affected hurricane marium partially offset low single digit decline rgr rtg worldwide revenue be year year cer same report low double digit growth brain therapy offset decline spine specialty therapy pain therapy moreover spine pain therapy division pelvic health business specialty therapy division unite state be affected hurricane marium however revenue diabetes group decline cer flat report marginsgross margin report quarter expand basis point bps decline gross profit adjust operate margin contract bps year year owing rise research development expense uptick selling general administrative expense other expense report quarter totale compare year quarter reiterate fiscal constant currency revenue ep guidance company maintain full year revenue growth projection range cer however company revise foreign currency fluctuation estimation be now project have positive impact fiscal result compare estimate earlier zack consensus estimate revenue remain fiscal adjust earning share growth be still expect range cer currency translation be expect have adverse impact cent compare earlier expectation negative effect cent positive impact zack consensus estimate fiscal earning be peg third quarter fiscal medtronic expect currency translation have favorable impact revenue currency translation be expect contribute third quarter earning share have estimate be move then turn fresh estimate flatlined past month have be revision higher current quarter compare lower medtronic plc price consensus medtronic plc price consensus medtronic plc quote vgm scoresat time stock have poor growth score however momentum be do bit better stock be allocate also grade value side putt top investment strategy overall stock have aggregate vgm score aren focuse strategy score be be interested zack style score indicate company stock be solely suitable value investor stock have zack rank hold be look inline return stock next few month
1232,MDT,re actually see pre market index green hour today latter third month be pace biggest monthly decline october be also seasonal period trading volume be vacation day be be spend wrap earning season still have few notable company worth hearing medical device major medtronic mdt free report report mixed result ahead open bell today zack rank hold rate company post cent beat share bottom line revenue quarter reach shy expect medtronic stronger department cardiac vascular minimally invasive therapy rise year year respectively luxury home builder toll brother tol free report beat expectation top bottom line post cent share revenue compare cent share analyst have be look sale rise year year zack rank buy firm also narrow forecast full year trimming top end guidance raise lower end average price home sell year solar energy supplier ja solar jaso free report post big beat morning pre market report american depositary share ad cent well past expect year year revenue easily surpass zack consensus estimate rise year year external shipment be big story here solar power module fuel cell pre market share be more today bell macy pluck ebay execin bid bolster streamline online sale strategy macy free report morning have announce be bring former ebay ebay free report senior vp hal lawton serve president major big box retailer former macy president current ceo jeff gennette make room year old lawton report directly gennette also macy be consolidate merchandise plan private label segment unit strategy be report save cut job order grow sale faster gennette say morning
1233,MDT,medtronic plc mdt free report announce fda nod launch resolute onyx mm drug eluting stent de new stent be smallest size market presently resolute onyx de be available use size unite state europe country recognize ce mark stent have be exclusively design help interventional cardiologist treat patient coronary artery disease cad patient have small vessel be often untreatable larger stent technology percutaneous coronary intervention pci management believe introduction resolute onyx mm de enable doctor broaden treatment option patient smaller vessel notably resolute onyx de platform be only de feature core wire technology evolution continuous sinusoid technology be also be note resolute onyx mm clinical study support resolute onyx mm de study be present europcr annual meeting simultaneously publish journal american college cardiology jacc cardiovascular intervention coronary structural heart be consistently try enhance coronary structural heart csh segment be part cardiac vascular group cvg segment csh revenue third quarter fiscal be cer report low constant currency growth transcatheter aortic valf result strong customer uptake corevalve evolut pro platform expand fda approval include patient intermediate risk moreover continue uptake resolute onyx drug eluting stent unite state japan revive business market strategy gain traction csh sub segment seem be align datum provide transparency market research report global coronary stent market be expect see cagr more specifically de market coronary stent market be expand fast be estimate witness cagr period market be likely expand unite state asia pacific europe well rest world stock performance estimate revisionover last month medtronic have underperform industry decline compare industry gain last month also underperform gain market same time frame also estimate revision trend current year remain unfavorable estimate move south last month compare movement opposite direction earning estimate rise share same time frame zack rank key picksmedtronic carry zack rank hold few better rank stock broader medical sector be perkinelmer pki free report bio rad laboratory bio free report becton dickinson company bdx free report bio rad laboratory sport zack rank buy see complete list today zack rank strong buy stock here company have long term expect earning growth rate perkinelmer have long term expect earning growth rate stock carry zack rank becton dickinson company be zack rank player company have long term expect earning growth rate zack top stock addition stock discuss know finest buy hold ticker entirety last year zack top stock portfolio produce double digit winner include fmc corp vmware rac stellar gain now brand new portfolio have be handpick company cover zack rank don miss chance get long term buy access zack top stock today
1234,MDT,feb issue update research report cardinal health inc cah free report stock carry zack rank buy company exit second quarter solid note courtesy encourage performance medical segment pharmaceutical segment also witness strong growth specialty business gain large number pharmaceutical distribution customer strong fiscal outlook buoy optimism cardinal health share price movement last year have fail impress stock have lose almost compare unfavorably industry gain cardinal health face risk lose considerable business case loss major customer turn severely impair revenue however company share price have be rise second quarter earning release stock have gain yesterday close cardinal health medical pharmaceutical offering lend company competitive edge niche space company offer industry expertise expand portfolio safe product also cardinal health follow acquisition drive strategy continue focus investment key growth business gain market traction boost profit cardinal health recently announce acquisition medtronic mdt free report patient care deep vein thrombosis nutritional insufficiency business buyout particularly boost company medical segment further cardinal health be pursue growth joint venture long term supply agreement company enter long term strategic agreement henry schein latter purchase cardinal health medical supply physician practice collaboration be expect drive core sale prove accretive cardinal health earning long term growth business profit company pharmaceutical segment be hurt generic pharmaceutical pricing huge investment pharmaceutical platform lackluster generic performance be likely mar cardinal health operational efficiency upcoming quarter intense competition customer concentration be other bottleneck other key picksa couple other top rank stock broader medical sector be perkinelmer pki free report bio rad laboratory bio free report bio rad laboratory have zack rank strong buy see complete list today zack rank stock here company have long term expect earning growth rate perkinelmer have long term expect earning growth rate stock carry zack rank zack top stock addition stock discuss know finest buy hold ticker entirety last year zack top stock portfolio produce double digit winner include fmc corp vmware rac stellar gain now brand new portfolio have be handpick company cover zack rank don miss chance get long term buy access zack top stock today
1235,MDT,medtronic plc mdt free report expand product portfolio introduction minime advance infusion set recent offer diabetes business be commercially available canada hong kong certain country europe fourth quarter fiscal however company plan extensive launch same notably minime advance infusion set witness limit launch country initial product introduction period third quarter fiscal customer be satisfied experience minime advance infusion set limit launch period company be optimistic effectiveness system be expect witness greater customer adoptability time drive top line progress minime have be forge ahead initiative boost performance minime portfolio recently company report positive datum home pediatric study patient age year datum be base minime system be demonstrated advanced technology treatment diabetes international conference vienna austria notably medtronic commercially launch minime system june be hybrid close loop insulin delivery system type diabetic patient age year older minime system feature medtronic latest guardian sensor glucose sensor increase accuracy enhance performance development diabetes witness rise constant exchange rate revenue diabetes business third quarter fiscal company benefit positive uptake new sensor augment insulin pump system unite state well international market enhance production capacity same notably medtronic expect double digit growth segment fourth quarter fiscal courtesy consistent performance minime system unite state enhance sensor supply capacity additionally medtronic have be gear international launch minime launch cgm system guardian connect sugar iq late new professional cgm ipro regard company also announce favorable result support use cgm patient type diabetes october market potentialan agee population unhealthy lifestyle rise awareness expenditure healthcare be likely drive growth diabetes market report mordor intelligence global market diabetes care device be project reach value cagr consider bullish market sentiment believe latest development have arrived opportune moment price have be underperform broader industry past month stock have decline versus industry rally however believe introduction minime advance infusion set help company regain investor optimism zack rank key picksmedtronic carry zack rank hold few better rank stock broader medical sector be perkinelmer pki free report bio rad laboratory bio free report becton dickinson company bdx free report bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here company have long term expect earning growth rate perkinelmer have long term expect earning growth rate stock carry zack rank buy becton dickinson be zack rank player company have long term expect earning growth rate zack top stock addition stock discuss know finest buy hold ticker entirety last year zack top stock portfolio produce double digit winner include fmc corp vmware rac stellar gain now brand new portfolio have be handpick company cover zack rank don miss chance get long term buy access zack top stock today
1236,MDT,tuesday august re actually see pre market index green hour today latter third month be pace biggest monthly decline october be also seasonal period trading volume be vacation day be be spend wrap earning season still have few notable company worth hearing medical device major medtronic mdt free report report mixed result ahead open bell today zack rank hold rate company post cent beat share bottom line revenue quarter reach shy expect medtronic stronger department cardiac vascular minimally invasive therapy rise year year respectively luxury home builder toll brother tol free report beat expectation top bottom line post cent share revenue compare cent share analyst have be look sale rise year year zack rank buy firm also narrow forecast full year trimming top end guidance raise lower end average price home sell year solar energy supplier ja solar jaso free report post big beat morning pre market report american depositary share ad cent well past expect year year revenue easily surpass zack consensus estimate rise year year external shipment be big story here solar power module fuel cell pre market share be more today bell macy pluck ebay execin bid bolster streamline online sale strategy macy free report morning have announce be bring former ebay ebay free report senior vp hal lawton serve president major big box retailer former macy president current ceo jeff gennette make room year old lawton report directly gennette also macy be consolidate merchandise plan private label segment unit strategy be report save cut job order grow sale faster gennette say morning mark vickerysenior editorquestion comment article author click here
1237,MDT,expect ireland base medical device major medtronic plc mdt free report beat expectation report first quarter fiscal result aug open bell last quarter company post earning share surpass zack consensus estimate cent fact medtronic earning outpaced zack consensus estimate past quarters average beat let see thing be shape prior announcement likely positive surprise proven model show medtronic be likely beat earning have perfect combination key ingredient zack esp medtronic have earning esp most accurate estimate be higher zack consensus estimate favorable zack esp serve meaningful lead indicator likely positive earning surprise uncover best stock buy sell re report earning esp filter zack rank medtronic currently carry zack rank hold note stock zack rank strong buy buy have significantly higher chance beating earning estimate conversely caution stock zack rank sell rate stock go earning announcement especially company be see negative estimate revision combination favorable zack rank positive esp make reasonably confident earning beat medtronic plc price ep surprise medtronic plc price ep surprise medtronic plc quotewhat be drive better expect earning look forward quarter solid growth successful execution growth strategy therapy innovation globalization economic value medtronic combine demographic age population positive have start open opportunity medtronic get reflect first quarter well therapy innovation have be multiple development cardiac vascular group new therapy be help company gain traction rapidly grow medtech market such left ventricular assist device lvad transcatheter aortic valve replacement tavr drug coat balloon atrial fibrillation ablation insertable diagnostic cardiac rhythm implantable company be fast capture market share differentiate mri technology tavr expect medtronic register strong growth quarter back fda approval extend use self expand corevalve evolut tavr platform july approval patient symptomatic severe aortic stenosis intermediate risk open heart surgery be eligible treatment used technology coronary medtronic have be see weak drug eluting stent de performance particularly unite state management fda approval resolute onyx de put check decline de sale fiscal also medtronic have start selling resolute onyx de high growth japan market jul cardiovascular business report release jul development buoy optimism strengthen belief strong quarterly performance company first quarter fiscal recent past company have be witness soft sequential performance diabetes business owing anticipate full launch minime hybrid close loop system june medtronic announce launch minime system type diabetes reflect company top line first quarter fiscal june medtronic announce new outcome base agreement aetna type type diabetes patient currently multiple daily insulin injection development also start contribute company diabetes business term also brain therapy space restorative therapy group business company see encourage development medtronic announce receipt health canada licence suretune software deep brain stimulation dbs june latest innovation suretune technology allow more precise efficient treatment also improve patient management centralize datum storage easy reference company receive ce mark suretune software deep brain stimulation same month company estimate revision trend fiscal first quarter have also be positive past day analyst moved north movement opposite direction however magnitude estimate revision trend earning estimate remain same time frame medtronic have provide initial fiscal revenue ep guidance company expect full year revenue growth range cer foreign currency fluctuation be expect have positive impact fiscal fiscal adjust earning share be expect grow cer currency translation negatively impact full year earning approximately cent cent include cent cent impact first quarter fiscal medtronic gain significant portion sale international market currency fluctuation be major concern have be dampener company last few quarters consider first quarter fiscal medtronic anticipate currency headwind affect revenue other stock considerhere be other company want consider proven model show have right combination element post earning beat upcoming quarter big lot inc big free report have earning esp zack rank see complete list today zack rank stock here best buy co inc bby free report have earning esp zack rank bank montreal bmo free report have earning esp zack rank surprising tech stock keep eye tech stock have be major force market record high pick best one buy be tough simple way invest success entire sector zack have just release special report reveal thing tech company literally function more importantly reveal top stock set skyrocket increase demand device encourage get report now next wave innovation really take see stock now
1238,MDT,medical device major medtronic plc mdt free report be focuse expand core coronary structural heart business keep line company recently announce global randomize clinical trial evaluate month dual antiplatelet therapy dapt patient implanted resolute onyx drug eluting stent de percutaneous coronary intervention pci procedure dapt be combination aspirin clot medication notably resolute onyx de be first de work core wire technology evolution continuous sinusoid technology cst resolute onyx de provide enhance visibility surgeon deliver superior clinical performance accord medtronic resolute onyx month dapt study aim help inform dapt guideline newer generation de currently support bare metal stent bms stable ischemic heart disease patient require shorter dual antiplatelet regimen study also demonstrate medtronic clinical investment provide relevant dapt evidence physician current previous generation de dapt therapy guideline vary geographically well patient presentation duration dapt evaluation be make base individual clinical judgment evaluate benefit risk ratio product labele patient preference study be base approximately patient worldwide company press release resolute onyx month dapt study outcome build resolute pooled dapt interruption analysis show increase risk stent thrombosis dapt interruption discontinuation month take consideration huge grow global coronary stent market believe latest initiative medtronic be well time report transparency market research global coronary stent market be expect see cagr recent development coronary stentrecently medtronic announce de have meet primary endpoint target lesion failure tlf year treatment coronary artery disease extra small vessel also late resolute onyx de receive fda approval further post successful launch resolute onyx de medtronic have start selling japan market jul cardiovascular business report release jul note last month medtronic have outperformed index latest share price movement company have gain compare gain zack rank key picksmedtronic currently carry zack rank hold few better rank medical stock be edward lifescience corp ew free report lantheus holding inc lnth free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy lantheus holding carry zack rank see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month align technology have long term expect earning growth rate stock have rally roughly last month lantheus holding have long term expect earning growth rate stock have gain last month hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
1239,MDT,investor be always look stock be poise beat earning season medtronic plc mdt free report be such company firm have earning come pretty soon event be shape quite nicely report be medtronic be see favorable earning estimate revision activity late be generally precursor earning beat analyst raise estimate right earning most date information possible be pretty good indicator favorable trend surface mdt report fact most accurate estimate current quarter be currently share mdt compare broader zack consensus estimate share suggest analyst have very recently bump estimate mdt give stock zack earning esp head earning season medtronic plc price ep surprise medtronic plc price ep surprise medtronic plc quotewhy be important positive read zack earning esp have proven be very powerful produce positive surprise outperform market recent year backtest show stock have positive earning esp zack rank hold better show positive surprise nearly time have return average annual return see more top earning esp stock here give mdt have zack rank hold esp positive territory investor want consider stock ahead earning see complete list today zack rank strong buy stock here clearly recent earning estimate revision suggest good thing be ahead medtronic beat be card upcoming report hottest tech mega trend last year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionary still leave plenty money regular investor make right trade early see zack best stock play trend
1240,MDT,unite therapeutic corporation uthr free report report adjust earning share fourth quarter decline year quarter due higher operate cost zack consensus estimate be peg share adjust earning exclude impact share base compensation expense impact tax reform revenue report quarter be beating zack consensus estimate revenue also grow year year stronger sale pah franchise pull top line quarter quarter detailunite therapeutic market product treatment pah remodulin tyvaso adcirca orenitram please note unite therapeutic buy exclusive right commercialize adcirca treatment pah unite state eli lilly lly free report november adcirca sale be year year orenitram sale amount quarter year year due patient growth remodulin sale be year year tyvaso sale totale year year sale tyvaso however improve sequentially quarter unituxin treatment pediatric patient high risk neuroblastoma sale surge year year research development expense escalate due higher cost support company pipeline cardiopulmonary cancer drug develop organ manufacturing project conference call company say cost continue rise advance company expand pipeline share unite therapeutic be almost wednesday probably management hint potentially higher cost fact stock have underperform industry past year have decline industry have increase period selling general administrative sg expense rise pipeline update unite therapeutic be work expand indication market product orenitram tyvaso company present have phase iii program field cardiopulmonary disease oncology phase iv freedom ev study be evaluate oral combination therapy orenitram oreniplus full datum study be expect year meanwhile phase iii beat study be evaluate tysuberprost esuberaprost combination tyvaso unite therapeutic have also begin clinical development dinutuximab active ingredient unituxin small cell lung cancer phase ii iii distinct study other high risk form cancer gd express cell tumor such ovarian cancer several sarcomas unite therapeutic be also work new delivery mechanism remodulin company be work medtronic plc mdt free report get remosynch implantable pump deliver remodulin intravenously approve fda unite therapeutic expect launch remosynch system year unite therapeutic be also work deka development pre filled semi disposable pump system subcutaneous delivery remodulin remunity clinical study remopro pain free new chemical entity version treprostinil be expect begin year several datum read out regulatory update be expect patent settlementslast week unite therapeutic announce settlement ongoing patent litigation actavis laboratory subsidiary teva pharmaceutical industry teva free report related orenitram actavis be look bring generic version orenitram settlement deal actavis launch generic version orenitram jun however investor remember remodulin adcirca start face generic competition middle year unite therapeutic carry zack rank hold see complete list today zack rank strong buy stock here unite therapeutic corporation price consensus ep surprise unite therapeutic corporation price consensus ep surprise unite therapeutic corporation quotemore stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1241,MDT,medtronic plc mdt free report report third quarter fiscal adjust earning share ep beating zack consensus estimate penny earning rise year year adjustment quarter primarily include impact restructure charge intangible asset amortization divestiture related item acquisition related item adjust unfavorable foreign exchange impact penny adjust ep be adjustment company report net loss share compare cent previous year include net tax expense related tax reform total revenue report quarter gross constant exchange rate cer basis report basis top line surpass zack consensus estimate foreign currency fluctuation favorably impact medtronic third quarter revenue quarter review sale total revenue fall year year cer develop market revenue totale total revenue reflect increase cer report emerge market revenue total revenue amount cer report medtronic plc price consensus ep surprise medtronic plc price consensus ep surprise medtronic plc quote segment company currently generate revenue major group viz cardiac vascular group cvg minimally invasive therapy group mitg restorative therapy group rtg diabetes group cvg comprise cardiac rhythm heart failure crhf coronary structural heart csh aortic peripheral vascular division apv mitg now include surgical innovation si respiratory renal rgr division divestiture patient care deep vein thrombosis compression nutritional insufficiency enteral fee business rtg comprise spine brain therapy specialty therapy pain therapy segment diabetes group incorporate intensive insulin management iim intensive diabetes therapy ndt diabetes service solution dss division cvg revenue improve cer report drive strong balanced growth division crhf sale totale year year cer report come back growth arrhythmia management lead high teen growth atrial fibrillation solution cer amplify penetration micra transcatheter pace system strong uptake tyrx absorbable antibacterial envelope apart strong demand company suite quadripolar cardiac therapy pacemaker crt growth mechanical circulatory support drive heart failure division revenue csh revenue be cer report back low constant currency growth transcatheter aortic valf result strong customer uptake corevalve evolut pro platform expand fda approval include patient intermediate risk moreover continue uptake resolute onyx drug eluting stent unite state japan revive coronary business apv revenue register growth cer report drive continue adoption valiant stent graft system peripheral be drive double digit growth percutaneous transluminal angioplasty drug coat balloon moreover solid contribution venaseal closure system drive high single digit growth endovenous mitg worldwide sale reach mark year year increase cer report basis high single digit growth si low single digit growth rgr cer rtg worldwide revenue be year year cer report low double digit growth brain therapy mid single digit growth specialty therapy high single digit growth pain therapy cer however revenue spine business remain flat cer year year basis moreover revenue diabetes group increase cer report marginsgross margin report quarter expand basis point bps rise gross profit adjust operate margin expand bps year year owing rise research development expense uptick selling general administrative expense other expense report quarter totale compare year quarter reiterate fiscal constant currency revenue ep guidance company maintain full year revenue growth projection range cer however company revise foreign currency fluctuation estimation be now project have positive impact fiscal result compare estimate earlier zack consensus estimate revenue remain fiscal adjust earning share growth be still expect range cer currency translation be likely have adverse impact cent compare earlier expectation negative effect cent zack consensus estimate fiscal earning be peg fourth quarter fiscal medtronic expect currency translation have favorable impact revenue currency translation be expect affect fourth quarter earning share cent takemedtronic exit fiscal third quarter solid note company demonstrated improve segmental performance cer growth business segment however escalate cost continue be concern moreover major business group contribute solid top line growth cer highlighted sustainability group region addition display successful integration achievement synergy target be also encourage company solid growth trend unite state well healthy global acceptance advanced therapy apart product innovation company be focuse geographical diversification business moreover company recent receipt fda approval riptide aspiration system neurovascular unit rtg business buoy optimism add valuable tool company acute ischemic stroke ais product portfolio zack rank peer have zack rank hold few better rank stock report solid result earning season be petm express pet free report perkinelmer pki free report becton dickinson company bdx free report petm sport zack rank strong buy perkinelmer becton dickinson carry zack rank buy see complete list today zack rank stock here petm report third quarter fiscal adjust earning share cent prior year quarter revenue rise perkinelmer post fourth quarter adjust earning share cent adjust revenue be approximately year quarter becton dickinson report first quarter fiscal adjust earning share constant currency revenue totale constant currency hacker put money portfolio earlier month credit bureau equifax announce massive datum breach affect american cybersecurity industry be expand quickly response similar event stock be better investment other zack have just release cybersecurity investor guide help zack com reader make most year investment opportunity create hacker other threat reveal stock worth look right away download new report now
1242,MDT,be medical practitioner yes then be aware minnesota base world lead medical technology giant medtronic plc mdt free report have global reach extend roughly country last year more person benefit medtronic medical therapy treat cardiac vascular disease diabetes neurological musculoskeletal condition currently medtronic have zack rank hold change follow positive third quarter fiscal earning report have just release see complete list today zack rank strong buy stock here have highlighted key detail just release announcement earning current zack consensus estimate stand share medtronic adjust earning share exceed estimate penny revenue medtronic post revenue beating zack consensus estimate revenue medtronic plc price ep surprise medtronic plc price ep surprise medtronic plc quote key stat revenue medtronic cardiac vascular group rise constant exchange rate cer revenue minimally invasive therapy group increase cer also revenue restorative therapy group rise cer revenue diabetes group rise cer major factor management third quarter performance be encourage moreover company witness growth business segment also buoy optimism stock price follow earning release share price decline pre market trading session now check back later full medtronic earning report later hacker put money portfolio earlier month credit bureau equifax announce massive datum breach affect american cybersecurity industry be expand quickly response similar event stock be better investment other zack have just release cybersecurity investor guide help zack com reader make most year investment opportunity create hacker other threat reveal stock worth look right away download new report now
1243,MDT,major development ear nose throat ent product business medtronic plc mdt free report recently launch stealthstation ent fda approve ce marked surgical navigation system allow surgeon treat condition ent anatomy technology used proprietary electromagnetic tracking technology similar gps system used car company generate electromagnetic field target patient anatomy surgery so instrument position be dynamically track procedure stealthstation ent system enable surgeon gain better visualization accord company system offer edge traditional endoscope sense former include software hardware innovation virtual endoscopy help surgeon gain simulate view sinus cavity latter accord report market market global surgical navigation system market be expect reach worth cagr period consider huge potential market believe latest development be strategical fit last month medtronic have underperform broader industry latest share price movement company lose compare gain broader industry period however expect slew new development business help make comeback zack rank key picksmedtronic currently carry zack rank sell few better rank medical stock medical sector be edward lifescience corporation ew free report lantheus holding inc lnth free report amedisys inc am free report edward lifescience sport zack rank strong buy lantheus holding amedisys carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have rally roughly last month lantheus holding have long term expect earning growth rate stock have gain last month amedisys have long term expect earning growth rate stock have gain last month more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1244,MDT,medtronic plc mdt free report have initiate voluntary product recall specific series infusion set used model medtronic insulin pump share company register drop close follow announcement company decide recall insulin pump risk device potentially deliver insulin expose respective patient threat hypoglycemia medtronic have take decision basis recent field report patient root cause analysis report vent membrane component recall infusion set be susceptible blockage fluid process prime fill tubing medtronic plan replace recall lot infusion set currently manufacture specimen cost new version have be use april include design update vent membrane company reduce risk insulin delivery infusion set be change good press release medtronic have not specifically mentioned number defective infusion set however apprehend huge chunk dispute unit be replace follow statement pamela reese medtronic senior manager communication publish medscape medical news recall apply version infusion set be used medtronic insulin pump publish list specific lot number be unwieldy be design online lot look tool product recall be anticipate act setback medtronic grow diabetes business consider large number minime infusion set already be rolled believe recall flaw bunch adversely impact company diabetes arm revenue ongoing quarter particular business space company be currently putt effort capitalize distinctive innovation strengthen foothold market base company class apart strategy move fully close loop system algorithms cgm sensor automate insulin dose medtronic have be late consistently observe strong demand graph globally new diabetes technology apprehend latest recall news positive momentum diabetes group get interrupt extent past month medtronic have be constantly trading broader industry company have lose versus industry gain period zack rank stock currently carry zack rank sell better rank medical stock include edward lifescience corporation ew free report lantheus holding inc lnth free report cheme corporation che free report edward lifescience sport zack rank strong buy lantheus holding cheme carry zack rank buy cansee complete list today zack rank stock here edward lifescience have long term expect earning growth rate gain roughly last month lantheus holding have long term expect earning growth rate rally last month cheme have long term expect earning growth rate gain last month more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
1245,MDT,most healthcare community have start rejoice capitol hill regulatory apprise recent past way full obamacare repeal proposal republican prime agenda healthcare roster fall flat face be intense thing get even stagier skinny repeal bill also fail get passable support senate believe immense support retain affordable care act aca obamacare come heel latest cost estimate release congressional budget office cbo staff joint committee taxation jct republican bill primarily promise improve insurance coverage exist law significantly lower american premium cost estimate reveal something totally contrary report aca be repeal number uninsured person increase present uninsured number apart average premium nongroup market individual policy purchase marketplace directly insurer increase trouble time medtech twist turn continue unfold capitol hill thus boost chance exist healthcare policy scenario medical device space be get gloomier such political conundrum market watcher be keep tab medtech space community have be quite hopeful change power trump propose policy always talk abolition infamous medical device sale tax dreadful tax be commonly address fund aca simply take toll entire medical device industry enactment tax be impose selling price instead net profit amount stupendous sum wipe almost quarter profit medical technology owner report fiercemedical device release time reveal johnson johnson jnj free report make payment medical device sale tax medtronic mdt free report legacy covidien nephew snn free report paid respectively year be story industry forerunner position smaller company be much let alone make profit be fact struggle survive realize severe linkage effect tax medtech bigwig well small player finally begin house senate temporarily suspend year only now medtech player find face similar situation begin policy remain intact note voter be favor aca be also talk abolishment cadillac tax excise tax high cost healthcare plan dreadful fiscal revenue generate mean democrat unfortunately trump administration have be target complete annulment cadillac tax future have not come concrete plan replace medtech tax yet future medtech fraternity thus hang balance medtech community perceive be accord medtech community suspension medtech tax have directly address issue lack opportunity research development innovation pipeline development increase investment need accelerate patient provider access innovative health care product have also help boost job creation quality patient care accordingly be go shelve tax go article peter sullivan publish hill follow congress failure approve repeal exist healthcare law trade group medical device company be launch new campaign push lawmaker repeal obamacare tax medical device await medtech player political cacophony market watcher have bearish stance space ponder medical device stock stand gain lose due political gridlock find retention repeal obamacare actually create vicious circle sector hand obamacare stay medtech profit be hit significantly thus pose challenge research development be quite expensive other hand repeal obamacare lead intensive research development creation expensive cut edge medtech product be question effectiveness be higher number uninsured industry be likely witness shrink customer base post enactment indicate decline demand expensive medical procedure device matter policy shape prove be beneficial well challenge same time player space investor meanwhile be hopeful fact overall impact exist policy amendment retention not be appalling apparently seem simple trading ideasince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar proven stock pick system be ground single big idea be fortune shape life change apply portfolio start today learn more
1246,MDT,medtronic plc mdt free report mazor robotic ltd recently announce amendment exist partnership be initially sign distribute range mazor product modification company have enter next phase agreement earlier expect mazor robotic be israel base medical device company field robotic surgical guidance system meanwhile medtronic assume right exclusive worldwide distribution mazor system mazor robotic spine surgery system make third tranche investment mazor robotic early payment come back achievement certain pre agree sale marketing target advance grow demand mazor system also act favor follow third installment medtronic total investment mazor robotic rise partnership help company get platform explore development product spine market medtronic be make consistent effort expand spine business restorative therapy group rtg last report first quarter fiscal rtg report year year revenue increase constant exchange rate spine business witness low single digit growth also rtg company have announce plan launch solera voyager fixation system accord report mordor intelligence global market spinal surgery device be estimate reach worth cagr take bountiful opportunity niche space consideration believe company latest development be strategic last month medtronic have underperform broader industry last share price movement stock lose compare gain broader industry period zack rank key picksmedtronic carry zack rank sell few better rank medical stock be edward lifescience corporation ew free report lantheus holding inc lnth free report idexx laboratory inc idxx free report edward lifescience sport zack rank strong buy lantheus holding idexx laboratory carry zack rank buy cansee complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have rally roughly last month lantheus holding have long term expect earning growth rate stock have gain last month idexx laboratory have long term expect earning growth rate stock have gain last month zack minute stock pick secretsince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar here something even more remarkable master proven system go single class seminar then apply portfolio little minute month learn secret
1247,MDT,dec issue update research report becton dickinson company bdx free report popularly know bd stock carry zack rank hold see complete list today zack rank strong buy stock here lead medtech company be steadily progress acquisition bard post completion bd expect growth adjust earning start fiscal acquisition enable company generate profit complementary business geographical expansion nov bd announce divest soft tissue core needle biopsy product merit medical system inc mmsi free report product be currently sell bard aspira product line tunnele home drainage catheter accessory divestment be contingent completion bd acquisition bard year date bd have outperformed industry term stock price company have return compare favorably industry rally just notably current return be relatively higher increase becton dickinson company price consensus becton dickinson company price consensus becton dickinson company quote flip side lackluster performance bd medical unit be concern performance segment be affected sluggishness medication management solution pharmaceutical system unit unite state diabetes care unit bd temporarily have pause shipment insulin infusion set thank higher anticipate rate complaint associate insertion pilot launch product however management conduct clinical trial gather insight ensure patient ultimately realize full benefit bd flowsmart technology bd continue collaborate medtronic plc mdt free report full productad wo ongoing political conundrum pertain repeal obamacare republican have give rise uncertainty dental stock bd conm corporation thus lack favorable development regulatory front be concern medtech major zack editor chief go stock full disclosure kevin matra now have more own money particular stock other believe short term profit potential also prospect more double today reveal explain surprising move new special report download free
1248,MDT,month discussion house republican have finally pass much controversial tax reform bill vote nov member senate finance committee vote approve version tax package nov pave way full senate hold debate bill once session resume post thanksgiving however republican be go make effort get bill sign president trump christmas overwhelmed house victory trump say cabinet meeting re go give american person huge tax cut christmas hopefully be great big beautiful christmas present meanwhile investor keen medtech space be closely follow development hope final tax stature result abolition infamous medtech tax delve deeper let take look primary objective bill brief house senate billsas article thomas kaplan alan rappeport publish new york time house bill propose reduction corporate tax rate also shrink number tax bracket bill intend introduce international tax system nation more consistent tax structure rest world also revoke scale back many well accept deduction include state local taxe bill also focus double standard deduction claim most tax payer same time root lift child tax credit simultaneously call complete eradication estate tax allowance roughly property tax deduction meanwhile senate bill raise child tax credit also cut top marginal tax rate also tax cut individual be suppose expire end same time plan do not propagate complete repeal estate taxe fact call abolishment individual mandate provision affordable care act aca majority person be require have health insurance pay penalty consider difference bill be challenge task republican come neutral ground decide final structure tax reform bill boon bane medtech accord business insider report republican tax plan repeal itemize deduction apply healthcare expense affect family high healthcare expenditure expense not be deduct taxe hence most person refrain opt expensive healthcare medtech procedure report hill say section republican tax bill plan impose excise tax good manufacture overseas subsidiary company tax code puerto rico be consider foreign land imply parent company have pay excise taxe purchase subsidiary island regard fda recently find puerto rico gross domestic product be drive pharmaceutical medical device undoubtedly latest tax plan have create uproar medtech player witness huge reduction turnover follow approval bill reduction corporate taxe lead extensive research development creation expensive cut edge medtech product question effectiveness loom large be higher number uninsured lesser deduction healthcare expense industry be likely witness shrink customer base post enactment indicate decline demand expensive medical procedure device matter policy shape prove beneficial challenge other player medtech space meanwhile best investor stay sideline tax situation stabilize bill mum medical device tax community have be hopeful trump propose policy entail abolition infamous medical device sale tax dread tax be commonly address fund aca dealt heavy blow medical device industry enactment tax be impose selling price instead net profit amount stupendous sum wipe almost quarter profit medical technology company realize severe linkage effect tax medtech bigwig well small player house senate temporarily suspend year begin thus reimposition tax jan be much fear medical device stalwart report fiercemedical device release time reveal johnson johnson jnj free report make payment medical device sale tax medtronic plc mdt free report covidien nephew plc snn free report shell respectively year situation smaller company have be much context abiom inc abmd free report ceo michael minogue quote article cheryl swanson publish motley fool be quite pertinent state don think tax innovator tax group company provide innovation healthcare be smart idea biggest concern have unprecedented be tax company be not yet profitable industry company be not yet profitable be go have detrimental effect job growth survival datum provide medical device trade group ken blackwell article publish daily caller partial year repeal medtech tax have result rise research development investment medtech player comeback tax lead rise taxe largely discourage activity undoubtedly future medtech industry depend republican decision medical device tax today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
1249,MDT,benchmark finished green tuesday follow gain technology healthcare sector increase apple share boost broader tech sector healthcare stock rally upward medtronic post strong quarterly performance reiterate fiscal revenue ep guidance key index reach time high tuesday move level intra day trade dow jone industrial average djia increase point close index inx rise close tech laden nasdaq composite index ixic close gain total share be trade tuesday lower last session average share advancer outnumber decliner nyse ratio nasdaq ratio favore advance issue cboe vix decrease close technology healthcare boost marketsshare apple inc aapl free report increase yesterday other tech giant facebook inc fb free report alphabet inc googl free report gain respectively gain major tech company have broad base positive impact technology select sector spdr xlk increase emerge best performer key sector technology sector reach best level share medtronic plc mdt free report advanced company report fiscal second quarter adjust earning share ep beating zack consensus estimate moreover company maintain full year fiscal revenue growth projection range cer also still expect adjust earning share growth be range cer read more medtronic be best perform stock healthcare sector health care select sector spdr xlv rise be second biggest gain sector key holding include unitedhealth group incorporate unh free report pfizer inc pfe free report advanced respectively healthcare company have zack rank hold see complete list today zack rank strong buy stock here follow gain technology healthcare stock key index moved northward small cap index russell advanced tuesday close settle best level ever exist home sale datum upbeatin economic news exist home sale rise october september seasonally adjust rate accord national association realtor sale previously own home also come higher consensus estimate follow steady increase last month exist home sale rise best pace june stock make loss widen earning view trimmedkirkland inc kirk free report post third quarter fiscal result company report wider anticipate loss read more gamestop earning top raise comp view stock upgamestop corp gme free report report robust third quarter fiscal result top bottom line surpass zack consensus estimate read more wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
1250,MDT,medtronic plc mdt free report report second quarter fiscal adjust earning share ep beating zack consensus estimate earning however decline year year adjustment quarter primarily include impact restructure charge intangible asset amortization divestiture related item adverse effect hurricane marium acquisition related item adjust unfavorable foreign exchange impact penny adjust ep be adjustment company report ep be year year total revenue report quarter gross constant exchange rate cer basis report basis top line miss zack consensus estimate foreign currency fluctuation affected medtronic second quarter revenue quarter review sale total revenue decline year year develop market revenue totale total revenue reflect increase cer report emerge market revenue total revenue amount cer report medtronic plc price consensus ep surprise medtronic plc price consensus ep surprise medtronic plc quote segment company currently generate revenue major group viz cardiac vascular group cvg minimally invasive therapy group mitg restorative therapy group rtg diabetes group cvg comprise cardiac rhythm heart failure crhf coronary structural heart csh aortic peripheral vascular division apv mitg now include surgical innovation si respiratory renal rgr division divestiture patient care deep vein thrombosis compression nutritional insufficiency enteral fee business rtg comprise spine brain therapy specialty therapy pain therapy segment diabetes group incorporate intensive insulin management iim intensive diabetes therapy ndt diabetes service solution dss division cvg revenue improve cer report drive strong balanced growth division crhf sale totale year year cer report come back growth arrhythmia management lead high teen growth atrial fibrillation solution low double digit rise diagnostic cer amplify penetration micra transcatheter pace system strong uptake tyrx absorbable antibacterial envelope apart strong demand company suite quadripolar cardiac therapy pacemaker crt growth mechanical circulatory support drive heart failure division revenue csh revenue be cer report back high constant currency growth transcatheter aortic valf result strong customer uptake corevalve evolut pro platform moreover company recent launch resolute onyx drug eluting stent unite state japan revive coronary business apv revenue register growth cer report drive continue adoption valiant stent graft system strength heli fx endoanchor system peripheral be drive double digit growth percutaneous transluminal angioplasty drug coat balloon moreover recently launch concerto detachable coil system drive mid single digit growth endovenous mitg worldwide sale reach mark year year increase cer report basis mid single digit growth si be affected hurricane marium partially offset low single digit decline rgr rtg worldwide revenue be year year cer same report low double digit growth brain therapy offset decline spine specialty therapy pain therapy moreover spine pain therapy division pelvic health business specialty therapy division unite state be affected hurricane marium however revenue diabetes group decline cer flat report marginsgross margin report quarter expand basis point bps decline gross profit adjust operate margin contract bps year year owing rise research development expense uptick selling general administrative expense other expense report quarter totale compare year quarter reiterate fiscal constant currency revenue ep guidance company maintain full year revenue growth projection range cer however company revise foreign currency fluctuation estimation be now project have positive impact fiscal result compare estimate earlier zack consensus estimate revenue remain fiscal adjust earning share growth be still expect range cer currency translation be expect have adverse impact cent compare earlier expectation negative effect cent positive impact penny zack consensus estimate fiscal earning be peg third quarter fiscal medtronic expect currency translation have favorable impact revenue currency translation be expect contribute penny third quarter earning share takemedtronic exit fiscal second quarter mixed note company demonstrated improve segmental performance cer escalate cost expense continue weigh bottom line unfavorable currency translation also act dampener bright side major business group contribute solid top line growth cer highlighted sustainability group region addition display successful integration achievement synergy target be also encourage company solid growth trend unite state well healthy global acceptance advanced therapy apart product innovation company be focuse geographical diversification business moreover company recent receipt fda approval commercial launch azure pacemaker bluesync technology buoy optimism zack rank peer currently have zack rank sell few better rank stock broader medical sector be petm express pet free report luminex corporation lmnx free report idexx laboratory idxx free report notably petm express sport zack rank strong buy company have long term expect earning growth rate see complete list today zack rank stock here luminex represent return year stock have zack rank idexx laboratory have long term expect earning growth rate stock have climb year time have zack rank buy zack hide tradeswhile share many recommendation idea public certain move be hide everyone select member portfolio service peek curtain today view start now next month invite follow zack private buy sell real time value momentum stock etf option mover insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack secret trade
1251,MDT,medtronic plc mdt free report announce receipt fda approval commercial launch portfolio azure pacemaker bluesync technology accord company technology enable secure automatic wireless remote monitoring medtronic carelink network security control implement validate bluesync enabled device include access restriction protect integrity device functionality end end encryption protect patient datum azure xt mri azure mri pacemaker be available single chamber dual chamber model pacemaker offer improve longevity longer predecessor better ability detect reduce atrial fibrillation af af most common heart rhythm disorder be irregular rapid beating heart upper chamber pacemaker patient probably need lesser device replacement azure xt pacemaker feature medtronic reactive atp atrial base antitachycardia pace algorithm be prove slow progression af implanted cardiac device patient company be consistently try improve cardiac rhythm heart failure division part cardiac vascular group cvg line medtronic come favorable study result reactive atp atrial base antitachycardia pace therapy june reactive atp therapy slow progression af patient implanted cardiac device couple achievement month be worth mention medtronic receive fda approval portfolio quadripolar cardiac therapy pacemaker crt ps improve therapy delivery patient heart failure medtronic also announce favorable result clinical study show insertable cardiac monitor icm detected high incidence af patient previously undiagnosed suspect be high risk af stroke accord report ally market research global cardiac monitoring cardiac rhythm management market be expect reach worth cagr look bountiful opportunity niche space believe company latest development be strategic last month medtronic have underperform broader industry latest share price movement company have lose broader industry gain estimate revision estimate revision trend have be favorable company current year estimate moved north compare movement opposite direction last month result zack consensus estimate full year have rise share zack rank key picksmedtronic carry zack rank sell few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year zack hide tradeswhile share many recommendation idea public certain move be hide everyone select member portfolio service peek curtain today view start now next month invite follow zack private buy sell real time value momentum stock etf option mover insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack secret trade
